piracetam has been researched along with levetiracetam in 1829 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (0.33) | 18.7374 |
| 1990's | 20 (1.09) | 18.2507 |
| 2000's | 733 (40.08) | 29.6817 |
| 2010's | 1009 (55.17) | 24.3611 |
| 2020's | 61 (3.34) | 2.80 |
| Authors | Studies |
|---|---|
| Differding, E; Frycia, AM; Fuks, B; Gillard, MR; Kenda, BM; Klitgaard, HV; Lallemand, BI; Matagne, AC; Michel, P; Moureau, FG; Pasau, PM; Talaga, PE | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Gobert, J; Gower, AJ; Noyer, M; Verloes, R; Wülfert, E | 1 |
| Hanin, I; Verloes, R; Wülfert, E | 1 |
| Ottonello, D; Perria, B; Rosadini, G; Sannita, WG; Timitilli, C | 1 |
| Sara, SJ | 1 |
| Rolly, G; Van Aken, J | 1 |
| Grünberger, J; Saletu, B | 1 |
| Wolthuis, OL | 1 |
| Aldenkamp, AP; Alpherts, WC; Neyens, LG | 1 |
| Edelbroek, PM; Vermeij, TA | 1 |
| Patsalos, PN; Sander, JW | 1 |
| Hönack, D; Löscher, W | 2 |
| Gillard, M; Hénichart, JP; Matagne, A; Noyer, M; Wülfert, E | 1 |
| Margineanu, DG; Wülfert, E | 2 |
| Doheny, HC; Patsalos, PN; Ratnaraj, N | 1 |
| Bloms-Funke, P; Hönack, D; Löscher, W | 1 |
| Edelbroek, PM; Kasteleijn-Nolst Trenité, DG; Marescaux, C; Oosting, J; Stodieck, S | 1 |
| Bialer, M; Johannessen, SI; Kupferberg, HJ; Levy, RH; Loiseau, P; Perucca, E | 1 |
| Boehrer, A; Gower, AJ; Hirsch, E; Marescaux, C; Noyer, M | 1 |
| Brodie, MJ; Forrest, G; Fraser, CM; Leach, JP; Patsalos, PN; Sills, GJ | 1 |
| Beck, SG; Birnstiel, S; Wülfert, E | 1 |
| Hönack, D; Löscher, W; Rundfeldt, C | 1 |
| Klitgaard, H; Matagne, A | 1 |
| Gobert, J; Klitgaard, H; Matagne, A; Wülfert, E | 1 |
| Collart, P; Gerin, B; Levy, R; Mather, G; Nicolas, JM; Roba, J; Trager, W | 1 |
| Doheny, HC; Jefferys, JG; Patsalos, PN; Ratnaraj, N; Whittington, MA | 1 |
| Patsalos, PN | 3 |
| Löscher, W; Richter, A | 1 |
| Ebert, U; Löscher, W; Reissmüller, E | 1 |
| Betts, T; Crawford, P; Waegemans, T | 1 |
| Baltes, E; Browne, TR; Jensen, CM; Josephs, E; Leppik, IE; Paz, J; Szabo, GK | 1 |
| Arrigo, C; Cereghino, JJ; Cramer, JA; Gauer, LJ; Van Hammée, G | 1 |
| Abou-Khalil, B; Biton, V; Cereghino, JJ; Dreifuss, F; Gauer, LJ; Leppik, I | 1 |
| Arrigo, C; Bromfield, EB; Cramer, JA; Van Hammée, G | 1 |
| Genton, P; Van Vleymen, B | 1 |
| Klitgaard, H; Margineanu, DG | 3 |
| Bielen, E; Janz, D; Loiseau, P; Löwenthal, A; Shorvon, SD | 1 |
| Bialer, M; Isoherranen, N; Roeder, M; Schurig, V; Soback, S; Yagen, B | 2 |
| Ben-Menachem, E; Falter, U | 1 |
| Jain, KK | 1 |
| Grant, R; Shorvon, SD | 1 |
| Dooley, M; Plosker, GL | 1 |
| Foletti, GB | 1 |
| Johannessen, SI; Nakken, KO; Rytter, E | 1 |
| Bergin, A; Cho, YW; Kramer, RE; Krauss, GL; Reich, SG | 1 |
| Gélisse, P; Genton, P | 2 |
| Chaisewikul, R; Hutton, JL; Marson, AG; Privitera, MD | 1 |
| Klitgaard, H; Margineanu, DG; Niespodziany, I | 2 |
| Aldenkamp, AP | 1 |
| Krakow, K; Otoul, C; Sander, JW; Walker, M | 1 |
| Boon, PA; van Rijckevorsel, K | 2 |
| Nash, EM; Sangha, KS | 1 |
| Patsalos, PN; Tong, X | 1 |
| Baltes, E; Levy, RH; Ragueneau-Majlessi, I | 1 |
| Bernardi, G; Klitgaard, H; Marchetti, C; Margineanu, DG; Niespodziany, I; Zona, C | 1 |
| Hanon, E; Klitgaard, H | 1 |
| Castillo, S; Chadwick, DW; Chaisewikul, R; Hutton, JL; Leach, JP; Marson, AG; Privitera, M; Schmidt, D; White, S | 1 |
| Hallett, M; Jung, HY; Kaelin-Lang, A; Sohn, YH | 2 |
| Leppik, IE | 3 |
| Klitgaard, H | 2 |
| Faught, E | 1 |
| Radtke, RA | 1 |
| Ferrendelli, JA | 1 |
| Privitera, M | 1 |
| Harden, C | 1 |
| French, J | 1 |
| Chuang, C; Fahn, S; Frucht, SJ; Louis, ED | 1 |
| Levy, RH; Meyerhoff, C; Ragueneau-Majlessi, I | 1 |
| Cramer, JA; Edrich, P; French, J | 1 |
| Hovinga, CA | 1 |
| Calleja, S; Salas-Puig, J | 1 |
| Burdick, KE; Goldberg, JF | 1 |
| Kolmsee, S; Steinhoff, BJ; Stodieck, S; van Rijckevorsel, K | 1 |
| Biederman, TS; McAuley, JW; Moore, JL; Smith, JC | 1 |
| Boon, P; Chauvel, P; Otoul, C; Pohlmann-Eden, B; Wroe, S | 1 |
| Ficker, DM; Gidal, BE; Privitera, MD; Welty, TE | 1 |
| Bebin, EM; Coupez, RM; Fountain, NB; Glauser, TA; Pellock, JM; Ritter, FJ; Shields, WD | 1 |
| Bergey, GK; Freeman, JM; Kossoff, EH; Vining, EP | 1 |
| Kostyuk, PG; Lukyanetz, EA; Shkryl, VM | 1 |
| Margineanu, DG; Poulain, P | 1 |
| Patsalos, PN; Sander, JW; Sisodiya, SM | 1 |
| Doheny, HC; Jefferys, JG; Patsalos, PN; Whittington, MA | 1 |
| Shorvon, SD; van Rijckevorsel, K | 1 |
| Wheless, JW | 1 |
| Kofler, M; Saltuari, L; Schauer, R; Singer, M | 1 |
| Gower, AJ; Klitgaard, H; Lamberty, Y | 1 |
| Brandt, C; Glien, M; Löscher, W; Potschka, H | 1 |
| Frucht, SJ | 1 |
| Bebin, EM; Fountain, NB; Glauser, TA; Jensen, CM; Pellock, JM; Ritter, FJ; Shields, WD | 1 |
| Belachew, S; Hans, G; Klitgaard, H; Leprince, P; Malgrange, B; Matagne, A; Moonen, G; Nguyen, L; Rigo, JM; Rocher, V; Selak, I | 1 |
| Janik, F; Levy, RH; Ragueneau-Majlessi, I | 1 |
| Somerville, ER | 1 |
| Chatterjee, A; Frucht, S; Louis, ED | 1 |
| Szökó, E | 1 |
| Vecht, ChJ; Wagner, GL; Wilms, EB | 1 |
| Ng, YT; Wheless, JW | 1 |
| Rugino, TA; Samsock, TC | 1 |
| Bell, C; Hiersemenzel, R; Nutt, D; Otoul, C; Vanderlinden, H; Wilson, S | 1 |
| Hagerty, C; Keswani, SC; Kossoff, EH; Krauss, GL | 1 |
| Argumosa, A; Herranz, JL | 1 |
| Chifari, R; Paola Canevini, M; Piazzini, A | 1 |
| Behne, F; Ebner, A; Gorji, A; Höhling, JM; Köhling, R; Lahl, R; Madeja, M; Panneck, HW; Speckmann, EJ; Straub, H; Tuxhorn, I; Wolf, P | 1 |
| Bazil, CW; Hirsch, LJ; Resor, S; Rose, A; Yapicular, B | 1 |
| Sirven, JI | 1 |
| Eriksson, AS; Johannessen, SI; Lossius, R; Nakken, KO | 1 |
| Barrueto, F; Hoffman, RS; Howland, MA; Nelson, LS; Williams, K | 1 |
| Rekling, JC | 1 |
| Baumann, RJ; deGrauw, TJ; Fakhoury, TA; Grim, SA; Miles, MV; Ryan, M; Strawsburg, RH; Tang, PH | 1 |
| Browne, TR; Coupez, R; Nicolas, JM | 1 |
| Blumenfeld, H; Mattson, R; Motamedi, M; Nguyen, DK; Novotny, E; Singh, SP; Spencer, SS; Thompson, JL; Westerveld, M; Zaatreh, M | 1 |
| Grimee, R; Klitgaard, H; Margineanu, DG; Matagne, A; Vanneste-Goemaere, J | 1 |
| Baltès, E; Gidal, BE; Perucca, E | 1 |
| Ben-Menachem, E; Edrich, P; Sander, JW; Schmidt, B; Van Vleymen, B | 1 |
| Cox, B; Davies, G; Hagan, RM; Large, CH; Stratton, SC | 1 |
| Hoppen, T; Rister, M; Sandrieser, T | 1 |
| Bergin, AM; Connolly, M | 1 |
| Angehagen, M; Ben-Menachem, E; Hansson, E; Klitgaard, H; Margineanu, DG; Rönnbäck, L | 1 |
| Bortolotto, S; Buffa, C; Cassano, D; Cucatto, A; Imperiale, D; Schiffer, P | 1 |
| Koch, HJ; Szecsey, A; Vogel, M | 1 |
| Ben-Menachem, E; Gilland, E | 1 |
| Barrett, M; Betts, T; Greenhill, L; Yarrow, H | 1 |
| Abou-Khalil, B; Hemdal, P; Privitera, MD | 1 |
| Cohen, J | 1 |
| Alsaadi, TM; Thieman, C | 1 |
| Bello-Espinosa, LE; Roberts, SL | 1 |
| Ivanova, M; Kenndler, E; Komarova, N; Marziali, E; Piunti, A; Raggi, MA | 1 |
| Baldy-Moulinier, M; Crespel, A; Gelisse, P; Genton, P | 1 |
| Cramer, JA; Van Hammée, G | 1 |
| Cramer, JA; De Rue, K; Devinsky, O; Edrich, P; Trimble, MR | 1 |
| Delanty, N; Ibrahim, N; Järvela, I; Kinrions, P; Lehesjoki, AE; Murphy, K | 1 |
| Cardile, V; Gulino, R; Pavone, A; Perciavalle, V; Renis, M; Scifo, C | 1 |
| Falter, U; Gower, AJ; Klitgaard, H; Lamberty, Y | 1 |
| Buyse, G; Ceulemans, B; Deconinck, A; Lagae, L | 1 |
| Brodtkorb, E; Johannessen, SI; Lossius, R; Mariero Klees, T; Nakken, KO | 1 |
| Chabolla, DR; Harnois, DM; Meschia, JF | 1 |
| Ferrendelli, J; French, J; Han, J; Leppik, I; Magnus, L; Morrell, MJ | 1 |
| Bräunig, P; Krüger, S | 1 |
| Karagianni, J; Lazopoulou, D; Michelakou, D; Youroukos, S | 1 |
| Alloui, A; Ardid, D; Coudore-Civiale, MA; Eschalier, A; Klitgaard, H; Lamberty, Y | 1 |
| Long, L | 1 |
| John, V; McGavin, CL; Musser, WS | 1 |
| Chadwick, D; Wolf, P | 1 |
| Klitgaard, H; Pitkänen, A | 1 |
| Johannessen, SI; Perucca, E | 1 |
| Devinsky, O; Elger, C | 1 |
| Abou-Khalil, B; Lazenby, B | 1 |
| Hirsch, E; Kasteleijn-Nolst Trenité, DG | 1 |
| Dulac, O; Glauser, TA | 1 |
| Ben-Menachem, E | 2 |
| Arroyo, S; Crawford, P | 1 |
| Brodie, MJ; French, JA | 1 |
| Hinsdale, M; Oles, K; Shihabi, ZK | 1 |
| Born, C; Grunze, H; Langosch, J; Schaub, G; Walden, J | 1 |
| Boerrigter, P; Gorji, A; Klitgaard, H; Madeja, M; Margineanu, DG; Siep, E; Speckmann, EJ | 1 |
| Liu, RS; Mula, M; Sander, JW; Trimble, MR; Yuen, A | 1 |
| Manville, NS; Ren, J; Rowbotham, MC | 1 |
| Bialer, M; Finnell, RH; Isoherranen, N; Merriweather, M; Roeder, M; Schurig, V; Spiegelstein, O; Triplett, AA; Yagen, B; Zhang, J | 1 |
| Arrigo, C; Godfroid, P; Leppik, I; Morrell, M | 1 |
| Dietl, T; Dinkelacker, V; Elger, CE; Lengler, U; Widman, G | 1 |
| Boatman, D; Freeman, JM; Kossoff, EH | 1 |
| Pinto, A; Sander, JW | 1 |
| Baltes, E; Nicolas, JM; Strolin Benedetti, M; Whomsley, R; Young, C | 1 |
| Chatelain, P; Fuks, B; Gillard, M; Massingham, R; Michel, P; Vertongen, P | 1 |
| Chatelain, P; Fuks, B; Gillard, M; Klitgaard, H; Leprince, P; Lynch, B; Michel, P; Vertongen, P | 1 |
| Hadjikoutis, S; Pickersgill, TP; Smith, PE | 1 |
| Beniak, TE; Gumnit, RJ; Leppik, IE; Matchinsky, DJ; Rarick, J; Tran, T; Walczak, TS; White, JR | 1 |
| Coupez, R; Lu, ZS; Sehgal, G; Stockis, A; Straetemans, R | 1 |
| Van Donselaar, CA; Vecht, ChJ; Wagner, GL; Wilms, EB | 1 |
| Bird, JM; Joseph, ZA | 1 |
| Abou-Khalil, B; Betts, T; Gergey, G; Krauss, GL; Miller, A; Yarrow, H | 1 |
| Obeng, K; Post, RM; Russell, S; Xing, GQ; Zhang, ZJ | 1 |
| Biton, V; Leppik, IE; Sander, JW; Wieser, HG | 1 |
| Falter, U; Gower, AJ; Lamberty, Y | 1 |
| Jürgens, U; May, TW; Rambeck, B | 1 |
| Bezard, E; Brotchie, JM; Crossman, AR; Grimée, R; Hill, MP; Klitgaard, H; McGuire, SG; Michel, A | 1 |
| Gidal, BE; Herbeuval, AF; Magnus, L; Sheth, RD | 1 |
| Cramer, JA; Edrich, P; Krämer, G; Leppik, IE; Rue, KD | 1 |
| Frohman, E; Hawker, K; Racke, M | 1 |
| Attarian, HP; Brown, KM; Eisenman, LN; Erbayat-Altay, E; Fessler, AJ; Gallagher, MJ; Gilliam, FG; Hecimovic, H | 1 |
| Adamo, EB; Altavilla, D; Calabresi, P; Campo, GM; Costa, C; Esposito, M; Ientile, R; Marini, H; Marini, R; Minutoli, L; Passaniti, M; Pisani, F; Squadrito, F | 1 |
| Ferrendelli, JA; French, J; Han, J; Herbeuval, A; Leppik, I; Magnus, L; Morrell, MJ | 1 |
| Anderson, D; Ebert, U; Elashoff, M; Gu, J; Klitgaard, H; Löscher, W; Lu, S; Lynch, BA; Potschka, H | 1 |
| Bermúdez, F; Gavilán, JC; González Santos, P; Romero, M | 1 |
| Mula, M; Sander, JW; Trimble, MR | 3 |
| Alsaadi, TM; Apperson, M; Farias, S; Koopmans, S | 1 |
| Fuhr, P; Rüegg, SJ; Steck, AJ | 1 |
| Bezard, E; Brotchie, JM; Crossman, AR; Grimée, R; Hill, MP; Klitgaard, H; Michel, A | 1 |
| Helmers, SL; LaRoche, SM | 1 |
| Bugamelli, F; Ferranti, A; Kenndler, E; Mandrioli, R; Pucci, V; Raggi, MA | 1 |
| Adam, C; Baulac, M; Crest, C; Dupont, S; Leguern, E | 1 |
| Bezard, E; Brotchie, JM; Crossman, AR; Grimée, R; Hill, MP; Klitgaard, H; Michel, A; Ravenscroft, P | 1 |
| Appleton, RE; Tan, MJ | 1 |
| Bömmel, W; Hauser, I; Horstmann, V; Huber, B; Liem, S; May, T; Meinert, T; Robertson, E; Schulz, L; Seidel, M; Tomka-Hoffmeister, M; Wagner, W | 1 |
| Miller, GS | 1 |
| Fauser, S; Feil, B; Homberg, V; Schulze-Bonhage, A | 1 |
| De Los Reyes, EC; Hale, SE; Sharp, GB; Williams, JP | 1 |
| Abou-Khalil, B; Bautista, J; Bazil, C; Bergen, D; Beydoun, A; Bourgeois, B; Browne, T; Faught, RE; Fischer, JH; French, JA; Gidal, B; Glauser, TA; Harden, CL; Hirtz, D; Kanner, AM; Marks, WJ; Montouris, GD; Nespeca, M; Sachdeo, RC; Schachter, SC; Stern, J; Theodore, WH; Turk, WR; Wilner, A | 3 |
| Meencke, HJ; Paul, F | 1 |
| Baltes, S; Löscher, W; Potschka, H | 1 |
| Baldwin, R; Klitgaard, H; Matagne, A; Mazarati, AM; Wasterlain, CG | 1 |
| Bolwig, TG; Hansen, SL; Husum, H; Mathé, AA; Sánchez, C | 1 |
| Brodtkorb, E; Johannessen, SI; Klees, TM; Lossius, R; Nakken, KO | 1 |
| Harden, C; MacLusky, NJ | 1 |
| Boon, P; Bosman, T; Claeys, P; De Clercq, M; De Reuck, J; Van Vlierberghe, H; Vonck, K | 1 |
| Coppola, G; Fels, A; Habetswallner, F; Licciardi, F; Mangano, S; Nardello, R; Operto, FF; Pascotto, A; Pelliccia, A; Romano, A; Tortorella, G | 1 |
| Gelisse, P; Genton, P; Magaudda, A | 1 |
| Goldszmidt, A; Niedermeyer, E; Ryan, D | 1 |
| Deleu, D | 1 |
| Baltes, E; Benedetti, MS; Collart, P; Coupez, R; Nicolas, JM; Whomsley, R | 1 |
| Bajjalieh, SM; Fuks, B; Kensel-Hammes, P; Lambeng, N; Lynch, BA; Matagne, A; Nocka, K | 1 |
| Bernardi, G; Bonsi, P; Calabresi, P; Costa, C; De Persis, C; Martella, G; Pisani, A; Pisani, F | 1 |
| Altschuler, Y; Bialer, M; Eyal, S; Shmuel, M; Sobol, E; Yagen, B | 1 |
| Höjeberg, B; Kimland, E; von Euler, M | 1 |
| Yatham, LN | 1 |
| Bingmann, D; Bonnet, U; Hufnagel, A; Leniger, T; Thöne, J; Wiemann, M | 1 |
| Bersani, G | 1 |
| Albani, F; Baruzzi, A; Contin, M; Riva, R | 1 |
| Ilag, VL | 1 |
| Beccaria, F; Cagdas, S; Capovilla, G; Montagnini, A; Paganelli, D; Segala, R | 1 |
| Lewis, SA; Nicolson, A; Smith, DF | 1 |
| Kumar, SP; Smith, PE | 1 |
| Briggs, DE; French, JA | 1 |
| Acharyulu, PV; Gopi Chand, I; Om Reddy, G; Praveen Kumar, K; Rao, BM; Ravi, R; Shyam Sundar Reddy, B; Sivakumar, S; Srinivasu, MK | 1 |
| Beran, RG; Weber, S | 1 |
| Stahl, SM | 1 |
| Doyle, AC; Fischmann, D; Hoge, EA; Kinrys, G; Link, N; Pollack, MH; Simon, NM; Worthington, JJ | 1 |
| Accornero, N; Di Piero, V; Lenzi, GL; Mecarelli, O; Pulitano, P; Romolo, FS; Vanacore, N; Vicenzini, E | 1 |
| Handforth, A; Martin, FC | 1 |
| Dunne, PB; Hauser, RA; Louis, ED; Menkin, M; Sullivan, KL; Zesiewicz, TA | 1 |
| Buchhalter, JR; Cascino, GD; Dove, GH | 1 |
| Cavitt, J; Privitera, M | 1 |
| Hamer, HM; Knake, S; Mueller, HH; Oertel, WH; Reis, J; Rosenow, F; Tergau, F; Wentrup, A | 1 |
| Bouwman, BM; van Rijn, CM | 1 |
| Frediani, F | 1 |
| Guay, DR | 1 |
| Callari, G; D'Amelio, M; Gammino, M; Lupo, I; Ragonese, P; Saia, V; Salemi, G; Savettieri, G | 1 |
| Brodie, MJ; Kelly, K; Stephen, LJ | 1 |
| Kaufman, KR | 2 |
| Leach, JP | 1 |
| Brodie, MJ; Mohanraj, R; Parker, PG; Stephen, LJ | 1 |
| Buyse, G; Ceulemans, B; Lagae, L | 1 |
| Annunziato, L; Cataldi, M; di Renzo, G; Lariccia, V; Secondo, A | 1 |
| Bayerlein, K; Beyer, B; Bleich, S; Frieling, H; Kornhuber, J | 1 |
| Arrigo, C; French, J | 1 |
| Alsaadi, TM; Farias, S; Jorgensen, J; Marquez, AV; Shatzel, A | 1 |
| Devlin, AM; Lawlor, KM | 1 |
| Awaad, Y; Michon, AM; Minarik, S | 1 |
| Chadaev, VA; Mironov, MB; Mukhin, KIu; Petrukhin, AS; Pilin, SV | 1 |
| Guarino, EJ; Koukkari, MW | 1 |
| Beran, RG; Berkovic, SF; Black, AB; Danta, G; Hiersemenzel, R; Schapel, GJ; Vajda, FJ | 1 |
| Richards, KC; Smith, MC; Verma, A | 1 |
| Ahmed, A; Lim, LL | 1 |
| Dagonnier, M; Laute, MA; Manto, M; Pandolfo, M | 1 |
| Hauser, RA; Louis, ED; Radhashakar, H; Recio, MV; Sullivan, KL; Zesiewicz, TA | 1 |
| Hauser, RA; Sullivan, KL; Zesiewicz, TA | 1 |
| Altshuler, LL; Frye, MA; Grunze, H; Keck, PE; Kupka, R; Leverich, GS; Luckenbaugh, DA; McElroy, SL; Nolen, WA; Post, RM; Suppes, T; Walden, J | 1 |
| Bushara, KO; Exconde, RE; Malik, T | 1 |
| Bergethon, PR; Freeman, R; Glass, GA; Mithoefer, A; Stankiewicz, J | 1 |
| Vigevano, F | 1 |
| Bode-Böger, SM; Martens-Lobenhoffer, J | 1 |
| Dunteman, ED | 1 |
| Bassetti, CL; Khatami, R; Siegel, AM | 1 |
| Aldenkamp, AP; Bootsma, HP; Kessels, AG; Leenen, LA; Leonard, BE; Majoie, HJ; Roberts, GM | 1 |
| Brodtkorb, E; Helde, G; Johannessen, SI | 1 |
| van Breemen, MS; Vecht, CJ | 1 |
| Asimiadou, S; Bittigau, P; Fassbender, J; Ikonomidou, C; Kaindl, AM; Manthey, D; Stefovska, V | 1 |
| Atefy, R; Tettenborn, B | 1 |
| Bernier, G; Blais, L; Godfroid, P; LeLorier, JJ; Sheehy, O; St-Hilaire, JM | 1 |
| Acampora, B; Balestri, P; Coppola, G; Cordelli, DM; Franzoni, E; Grosso, S; Iannetti, P; Marchiani, V; Morgese, G; Pascotto, A; Spalice, A; Verrotti, A | 1 |
| Andres, MM; Cioczek-Czuczwar, A; Czuczwar, P; Czuczwar, SJ; Luszczki, JJ; Patsalos, PN; Ratnaraj, N; Wojcik-Cwikla, J | 1 |
| Bigal, ME; Rapoport, AM | 1 |
| Kitano, Y; Komiyama, C; Makino, M; Sakurada, S; Takasuna, K; Takazawa, A | 1 |
| Nasrallah, K; Silver, B | 1 |
| Enggaard, TP; Klitgaard, NA; Sindrup, SH | 1 |
| Subramanian, T; Tousi, B | 1 |
| Hauser, RA; Maldonado, JL; Sullivan, KL; Tatum, WO; Zesiewicz, TA | 1 |
| Brockmöller, J; Coupez, R; Lochs, H; Roots, I; Thomsen, T; Wittstock, M | 1 |
| Aguiar, LM; Fonteles, MM; Freitas, RM; Nascimento, VS; Nogueira, CR; Oliveira, AA; Sousa, FC; Viana, GS | 1 |
| Fay, MA; Gidal, BE; Sheth, RD | 1 |
| Chari, G; Hauser, RA; Louis, ED; Sullivan, KL; Zesiewicz, TA | 1 |
| Hynan, LS; Martin-Cook, K; Svetlik, DA; Weiner, MF; Womack, KB | 1 |
| Green, AC; Harrison, PK; Sheridan, RD; Tattersall, JE | 1 |
| Ishihara, K; Ji-qun, C; Nagayama, T; Sasa, M; Serikawa, T; Yan, HD | 1 |
| Arrigo, C; di Nicola, S; French, J | 1 |
| Boccella, P; Manganelli, F; Perretti, A; Striano, P; Striano, S | 1 |
| Chappell, B; Crawford, P | 1 |
| Boon, P; Bosman, T; Claeys, P; De Smedt, T; Dedeurwaerdere, S; Raedt, R; Van Hese, P; Van Maele, G; Vonck, K | 1 |
| Bromfield, EB; Rossetti, AO | 2 |
| Karlov, VA; Vlasov, PN | 2 |
| Artemowicz, B; Sobaniec, W | 1 |
| Chatelain, P; Fuks, B; Gillard, M; Lambeng, N; Vertongen, P | 1 |
| Ishihara, K; Ji-qun, C; Nagayama, T; Sasa, M; Serikawa, T | 1 |
| Bunch, M; Kugler, SL; Mandelbaum, DE; Venkatasubramanian, A; Wollack, JB | 2 |
| Di Bonaventura, C; Egeo, G; Fattouch, J; Giallonardo, AT; Manfredi, M; Mari, F; Prencipe, M; Vaudano, AE | 2 |
| Basner, RC; Battista, J; Bazil, CW | 1 |
| Connor, KM; Davidson, JR; Zhang, W | 1 |
| Steinhoff, BJ; Trinka, E; Wieser, HG | 1 |
| Zaffanello, M; Zamboni, G | 1 |
| Abou-Khalil, B | 1 |
| Bettendorf, U; Brandl, U; Gross-Selbeck, G; Härtel, C; Kluger, G; Korn-Merker, E; Kurlemann, G; May, T; Opp, J; Rating, D; Tuxhorn, I; Wiemer-Kruel, A | 1 |
| Kasai, Y; Kinoshita, M; Kitano, Y; Komiyama, C; Makino, M; Sakurada, S; Takasuna, K; Takazawa, A; Yamauchi, T; Yamazaki, O | 1 |
| Berges, AA; Lea, JW; Stoner, SC; Wolf, AL | 1 |
| Sander, JW | 1 |
| Willmore, LJ | 1 |
| Bruneau, MA; Chouinard, MJ; Clément, JF; Nguyen, DK | 1 |
| Abou-Khalil, B; Schaich, L | 1 |
| Boon, P; Claeys, P; De Smedt, T; Dedeurwaerdere, S; Legros, B; Raedt, R; Vonck, K; Wadman, W; Wyckhuys, T | 1 |
| Panayiotopoulos, CP | 1 |
| Grünewald, R | 1 |
| Hauser, RA; Pathak, A; Shamayev, M; Sullivan, KL; Zesiewicz, TA | 1 |
| Canevini, MP; Canger, R; Chifari, R; Fontana, SP; Piazzini, A; Turner, K | 1 |
| Bell, GS; Depondt, C; Duncan, JS; Koepp, MJ; Mitchell, T; Sander, JW; Yuen, AW | 1 |
| Agudo, R; Bargalló, N; Boget, T; Carreno, M; Donaire, A; Falip, M; Fossas, P; Gómez, B; Obach, V; Raspall, T; Rumiá, J; Setoaín, X | 1 |
| Bonnier, C; Hmaimess, G; Kadhim, H; Nassogne, MC; van Rijckevorsel, K | 1 |
| Dong, X; Leppik, IE; Rarick, J; White, J | 1 |
| Aeby, A; Poznanski, N; Van Bogaert, P; Verheulpen, D; Wetzburger, C | 1 |
| Beghi, E; Boero, G; de Tommaso, M; De Agazio, G; De Palo, A; La Neve, A; Specchio, LM; Specchio, N | 1 |
| Filosto, M; Galli, R; Mancuso, M; Murri, L; Pizzanelli, C; Siciliano, G | 1 |
| Andres, MM; Cioczek-Czuczwar, A; Czuczwar, P; Czuczwar, SJ; Luszczki, JJ; Patsalos, PN; Ratnaraj, N | 1 |
| Chen, SS; Edrich, P; Hiersemenzel, R; Hsih, MS; Lai, CW; Tsai, JJ; Yen, DJ | 1 |
| Bucca, C; Cicolin, A; Giordano, A; Magliola, U; Mutani, R; Terreni, A | 1 |
| Ambrosio, R; Colosimo, E; Gambardella, A; Labate, A; Leggio, U; Quattrone, A | 1 |
| Polesin, A; Stern, M | 1 |
| Landan, IR; Levin, J; Patel, NC; Szaflarski, J; Wilner, AN | 1 |
| Akoglu, H; Aksoy, S; Cakar, M; Erman, M; Kilickap, S; Onal, IK; Tekuzman, G; Tufan, A | 1 |
| Hurtado, B; Koepp, MJ; Sander, JW; Thompson, PJ | 1 |
| Mula, M; Trimble, MR | 1 |
| French, JA; Friedman, D | 1 |
| Kofler, M | 1 |
| Cock, HR; Gibbs, JE; Walker, MC | 1 |
| Dennhöfer, S; Fraunberger, B; Gefeller, O; Genow, A; Halboni, P; Kerling, F; Koebnick, C; Lorber, B; Pauli, E; Stefan, H; Tilz, C; Wang-Tilz, Y | 1 |
| Goldlust, SA; Newton, HB; Pearl, D | 1 |
| Della Marca, G; Mariotti, P; Mazza, M; Mazza, S; Mennuni, GF; Tonali, P; Vollono, C | 1 |
| Chuck, G; Collins, JJ; Franz, DN; Leonard, JM; Tudor, C | 1 |
| Chatelain, P; Fuks, B; Gillard, M | 1 |
| Kinrys, G; Melo, M; Pardo, TB; Wygant, LE | 1 |
| Edrich, P; Niklson, I; Verdru, P | 1 |
| Ro, SI; Ryan, RK; Tarsy, D | 1 |
| Lin, FC; Shih, PY; Wei, LJ | 1 |
| Bona, JR | 1 |
| Konitsiotis, S; Mantas, C; Mavreas, V; Pappa, S | 1 |
| Ayala, R; Elterman, RD; Gauer, LJ; Glauser, TA; Lu, Z; Mitchell, WG; Van Orman, CB | 1 |
| Carré, S; Hirsch, E; Rudolf, G; Szepetowski, P; Thibault, A; Valenti, MP; Vrielynck, P | 1 |
| Despland, PA; Fejerman, N; Genton, P; Maubrey, MC; Peltola, J; Rektor, I; Sadzot, B; Schlit, AF; Steinhoff, B; van Hammée, G; van Paesschen, W; Vandervelden, C; Wroe, S | 1 |
| Brescia Morra, V; Coppola, A; Orefice, G; Striano, P; Striano, S; Vacca, G; Zara, F | 1 |
| Albani, F; Baruzzi, A; Carapella, CM; Dinapoli, L; Jandolo, B; Maschio, M; Occhipinti, E; Pace, A; Pompili, A; Zarabla, A | 1 |
| Heinz, A; Hinzpeter, A; Kienast, T; Krebs, M; Leopold, K; Richter, C; Schaefer, M | 1 |
| Delanty, N; Doherty, CP; Kinirons, P; McCarthy, M | 1 |
| Benli, S; Karatas, M; Kilinc, M; Yardimci, N | 1 |
| Fogarasi, A; Hegyi, M; Herczegfalvi, A; Kollár, K; Móser, J; Neuwirth, M; Paraicz, E; Rosdy, B; Saracz, J | 1 |
| De Rue, K; Edrich, P; Leppik, I; Perucca, E | 1 |
| Sasa, M | 1 |
| Boero, G; Gambardella, A; Giallonardo, AT; La Neve, A; Michelucci, R; Specchio, LM; Specchio, N | 1 |
| Allegaert, K; Lagae, L; Lewi, L; Naulaers, G | 1 |
| Rocamora, R; Schulze-Bonhage, A; Wagner, K | 1 |
| Boulanger, P; De Smedt, F; Otoul, C; Ramael, S; Riethuisen, JM; Stockis, A; Toublanc, N | 1 |
| Huber, B; Seidel, M | 1 |
| Jain, DS; Pal, U; Sanyal, M; Shrivastav, PS; Subbaiah, G | 1 |
| Daoust, A; Lu, ZS; Otoul, C; Ramael, S; Stockis, A; Toublanc, N; Troenaru, M | 1 |
| Avoli, M; D'Antuono, M; D'Arcangelo, G; Tancredi, V | 1 |
| Carpenter, LL; Price, LH; Tavares, SB; Tyrka, AR; Wier, LM | 1 |
| Boon, PA; Bourgeois, P; Carpay, J; Lambrechts, DA; Sadzot, B; Urbain, E; van Leusden, JA; van Paesschen, W | 1 |
| Boon, P; De Herdt, V; De Smedt, T; Dedeurwaerdere, S; Delbeke, J; Legros, B; Raedt, R; Van Hese, P; Van Laere, K; Vonck, K; Wadman, W; Waterschoot, L; Wyckhuys, T | 1 |
| Bauer, J; Ben-Menachem, E; Da Silva, S; Fryze, W; Kasteleijn-Nolst Trenité, DG; Krämer, G | 1 |
| Guo, T; Mendu, DR; Oswald, LM; Soldin, SJ | 1 |
| Anderson, NJ; Slough, S; Watson, WP | 1 |
| Buyle, S; Meencke, HJ | 1 |
| Brázdil, M; Kocvarová, J; Kuba, R; Mastík, J; Novotná, I; Rektor, I; Tyrliková, I | 2 |
| Hauser, RA; Sanchez-Ramos, J; Sullivan, KL; Zesiewicz, TA | 1 |
| Ciesielski, AS; Samson, S; Steinhoff, BJ | 1 |
| Gao, J; Laskowitz, DT; Lassiter, TF; Lynch, JR; McDonagh, DL; Sheng, H; Wang, H; Warner, DS | 1 |
| Cocco, GA; D'Onofrio, M; Deriu, MG; Rosati, G; Sechi, G | 1 |
| Gregoraszczuk, EL; Ropstad, E; Taubøll, E; Tworzydø, A; Wójtowicz, AK | 1 |
| Krämer, G; Kröll-Seger, J; Mothersill, IW; Novak, S; Sälke-Kellermann, RA | 1 |
| Anagnostou, E; Chaplin, WF; Hollander, E; Iyengar, R; Soorya, L; Waldoks, SE; Wasserman, S; Watner, D | 1 |
| Holmes, GL; Zhao, Q; Zhou, JL | 1 |
| Feuerstein, TJ; Stefan, H | 1 |
| Baltes, S; Fedrowitz, M; Gastens, AM; Kaever, V; Löscher, W; Potschka, H | 1 |
| Johannessen, SI; Tomson, T | 1 |
| Coppola, G; Franzoni, E; Garone, C; Operto, FF; Pascotto, A; Sarajlija, J; Verrotti, A | 1 |
| Bozdemir, H; Gunay, I; Guven, M; Kahraman, I; Koc, F; Sarica, Y | 1 |
| Kyomen, HH | 1 |
| Cock, HR; Gibbs, JE | 1 |
| Aldenkamp, AP; Bootsma, HP; de Krom, M; Diepman, L; Hulsman, J; Lambrechts, D; Leenen, L; Majoie, M; Schellekens, A | 1 |
| Papp, LA | 1 |
| Ghattaura, S; Patsalos, PN; Ratnaraj, N; Sander, JW | 1 |
| Genow, A; Hopfengaertner, R; Kerling, F; Stefan, H; Tilz, C; Wang-Tilz, Y | 1 |
| Craig, J; Guthrie, E; Hunt, S; Irwin, B; Morrison, PJ; Morrow, J; Parsons, L; Robertson, I; Russell, A; Waddell, R | 1 |
| Bhagwagar, Z; Muralidharan, A | 1 |
| Clouse, RE; Lustman, PJ; Prakash, C; Sayuk, GS | 1 |
| Fitzek, S; Franke, K; Hagemann, G; Rupprecht, S; Witte, OW | 1 |
| Bilo, L; Fulvia de Leva, M; Meo, R | 1 |
| Archer, DP; Davis, MJ; Lamberty, Y; Roth, SH; Samanani, N; Wang, B | 1 |
| Snoeck, E; Stockis, A | 1 |
| Amaro, S; Carreño, M; Delgado, R; Donaire, A; Falip, M; Maestro, I; Toledo, M | 1 |
| Balestri, P; Chiarelli, F; Ciambra, G; Coppola, G; Franzoni, E; Grosso, S; Iannetti, P; Manco, R; Verrotti, A | 1 |
| Aguiar, LM; Almeida, JP; Fonseca, FN; Fonteles, MM; Freitas, RM; Júnior, HV; Nascimento, VS; Oliveira, AA; Sousa, FC; Viana, GS | 1 |
| Davies, SL; Moral, MA | 1 |
| Bonakis, A; Kalfakis, N; Kontaxis, T; Papageorgiou, SG | 1 |
| Kkolou, E; Papacostas, S; Papathanasiou, E | 1 |
| Coupez, R; De Smedt, F; Lins, RL; Otoul, C; Stockis, A | 1 |
| Buch, S; Crane, J; Donnelly, J; Gosalakkal, J; Mordekar, S; Mukhtyar, B; Peake, D; Philip, S; Rittey, C; Wheway, R; Whitehouse, WP | 1 |
| Ben-Ezra, J; Massey, GV; Riley, RS; Russell, EC; Williams, DC | 1 |
| Conry, JA; Coupez, R; Fountain, NB; Gutierrez-Moctezuma, J; Lu, ZS; Rodríguez-Leyva, I; Salas, E; Stockis, A | 1 |
| Choub, A; Filosto, M; Fontanini, G; Mancuso, M; Massetani, R; Nesti, C; Petrozzi, L; Pistolesi, S; Rocchi, A; Siciliano, G | 1 |
| Ben-Menachem, E; Brodie, MJ; Meencke, HJ; Perucca, E; Ryvlin, P | 1 |
| Albo, F; Carunchio, I; Ciotti, MT; Pieri, M; Zona, C | 1 |
| Andres-Mach, MM; Czuczwar, SJ; Luszczki, JJ; Patsalos, PN; Ratnaraj, N | 1 |
| Miura, Y | 1 |
| Mangelings, D; Saevels, J; Vander Heyden, Y | 1 |
| Aldenkamp, AP; Bootsma, HP; de Krom, M; Diepman, L; Gehring, J; Hulsman, J; Lambrechts, D; Leenen, L; Majoie, M; Ricker, L; Schellekens, A | 2 |
| Hu, P; Jiang, J; Li, X; Lu, ZS; Zhao, Q | 1 |
| Baulac, M; Brodie, MJ; Elger, CE; Falter, U; Krakow, K; Meyvisch, P; Stockis, A | 1 |
| De Fazio, S; De Sarro, G; Gallelli, L; Siniscalchi, A | 1 |
| Myrianthopoulou, P; Papacostas, SS; Papathanasiou, ES; Stylianidou, G | 1 |
| Hefft, S; Oehl, B; Schulze-Bonhage, A | 1 |
| Balestri, P; Capovilla, G; Coppola, G; Cordelli, DM; Franzoni, E; Grosso, S; Morgese, G; Verrotti, A; Zamponi, N | 1 |
| Dubois, C; Heo, K; Huh, K; Kim, JM; Kim, JY; Lee, BI; Lee, SA; Lee, SK; Lu, S; Shin, DJ; Song, HK; Tonner, F; Yi, SD | 1 |
| Coppola, A; Elefante, A; Minetti, C; Striano, P; Striano, S; Tortora, F; Zara, F | 1 |
| Kring, D; Meier, L; Pakalnis, A | 1 |
| Ben-Menachem, E; Danielsson, B; Johansson, R; Källén, K; Luef, G; Ohman, I; Palm, R; Söderfeldt, B; Tomson, T | 1 |
| Yoshino, A | 2 |
| Löscher, WN; Luef, GJ | 1 |
| Doi, T; Nagatomo, K; Takaki, M; Tokumaru, J; Ueda, Y; Willmore, LJ | 1 |
| Carius, A; Frings, L; Gomer, B; Härle, M; Saar, J; Schulze-Bonhage, A; Steinhoff, BJ; Wagner, K | 1 |
| Das, B; Desarkar, P; Sinha, VK | 1 |
| Benatar, M; Perry, MS | 1 |
| Dalton, J; Goldlust, S; Newton, HB; Pearl, D | 1 |
| Barcs, G; Szucs, A | 1 |
| Khurana, DS; Kothare, SV; Legido, A; Melvin, JJ; Valencia, I | 1 |
| Bebin, M; Chen, D; Coupez, R; Glauser, TA; Lu, ZS; Mitchell, WG; Stockis, A; Weinstock, A | 1 |
| Holthausen, H; Kluger, G; von Stuelpnagel, C | 1 |
| Boon, P; De Smedt, T; Raedt, R; Vonck, K | 2 |
| Feucht, M; Hall, RE; Kindler, J; Mayer, H; Pahs, G; Plattner, B; Steiner, H; Williams, RP | 1 |
| Chandler, KE; Luján Feliu-Pascual, A; Matiasek, LA; Platt, SR; Volk, HA | 1 |
| Auriel, E; Blatt, I; Chistik, V; Margolin, N; Neufeld, M | 1 |
| Safdieh, JE; Sirsi, D | 1 |
| Farooq, MU; Kassab, MY; Majid, A; Pysh, JJ | 1 |
| Jacqmin, P; Pigeolet, E; Sargentini-Maier, ML; Stockis, A | 1 |
| Rothman, SM; Weisenfeld, A; Yang, XF | 1 |
| Cantore, G; Di Angelantonio, S; Di Gennaro, G; Esposito, V; Eusebi, F; Maiolino, F; Manfredi, M; Mascia, A; Miledi, R; Palma, E; Quarato, P; Ragozzino, D | 1 |
| Bellantone, D; Di Rosa, G; Pustorino, G; Sgro, DL; Spano, M; Tortorella, G; Tricomi, G | 1 |
| Accornero, N; Li Voti, P; Mecarelli, O; Pro, S; Pulitano, P; Romolo, FS; Rotolo, M; Vanacore, N | 1 |
| Deb, S; Kaur Saini, ST | 1 |
| Mula, M; Sander, JW | 1 |
| Davoli, A; De Sarro, G; Donato Di Paola, E; Gareri, P; Gratteri, S; Naccari, C; Scicchitano, F | 1 |
| Hering, S; Mueller, J; Poewe, W; Seppi, K; Wenning, GK | 1 |
| Bridges, DD; Paynter, NP; Singer, HS; Smith-Hicks, CL | 1 |
| Arif, H; Bazil, CW; Buchsbaum, R; Chang, JT; Hirsch, LJ; Lee, J; Resor, SR; Weintraub, D | 1 |
| Bethmann, K; Brandt, C; Fedrowitz, M; Gastens, AM; Glien, M; Löscher, W; Potschka, H; Volk, HA | 1 |
| Bardia, A; Barton, DL; Christensen, B; Kottschade, L; Loprinzi, CL; Sloan, JA; Smith, D; Tan, A; Thompson, S | 1 |
| Meckler, JM; Privitera, MD; Shutter, LA; Szaflarski, JP; Szaflarski, M; Yates, SL | 1 |
| Rotenberg, JS; Shoemaker, MT | 1 |
| Franzoni, E; Garone, C; Malaspina, E; Marchiani, V; Sarajlija, J | 1 |
| Dannhardt, G; Kiefer, W | 1 |
| Bortolato, M; Fà, M; Frau, R; Marrosu, F; Mereu, G; Muroni, A; Orrù, M; Puligheddu, M; Tuveri, A | 1 |
| Berkovic, SF; Falter, U; Knowlton, RC; Leroy, RF; Schiemann, J | 1 |
| Baldessarini, RJ; Kyomen, HH; Whitfield, TH | 1 |
| Gjerstad, L; Jemtland, R; Lekva, T; Melhus, G; Nissen-Meyer, LS; Reinholt, FP; Reppe, S; Solberg, LB; Svalheim, S; Taubøll, E | 1 |
| Gale, K; Kim, J; Kondratyev, A | 1 |
| Beccaria, F; Besana, D; Capovilla, G; Ciampa, C; Coppola, A; Coppola, GG; Elia, M; Gaggero, R; Gennaro, E; Granata, T; Mancardi, MM; Pezzella, M; Ragona, F; Rasmini, P; Specchio, N; Striano, P; Striano, S; Vecchi, M; Vigevano, F; Viri, M; Zara, F | 1 |
| De Smedt, H; Otoul, C; Stockis, A | 1 |
| Bergqvist, AGC; Kilaru, S | 1 |
| Farooq, MU; Gupta, R; Kassab, MY; Majid, A; Naravetla, B; Pysh, JJ | 1 |
| Ryvlin, P; Schelstraete, I; Somerville, ER; Steinhoff, BJ; Van Paesschen, W | 1 |
| Carreño, MM; Parellada, E; Roig, J | 1 |
| Kinrys, G; Nery, F; Pollack, MH; Reese, H; Worthington, JJ; Wygant, L | 1 |
| Castaneda, GY; Jennings, T; Newsome, SD; Xue, LY | 1 |
| Costanza, MC; De Rinaldis, M; Gesualdi, M; Profice, P; Trabacca, A | 1 |
| Tai, KK; Truong, DD | 1 |
| Abou-Khalil, B; Fenichel, GM; Patel, AD; Sharpe, DV | 1 |
| Awaad, Y | 1 |
| Avila-Ordoñez, MU; Díaz-Galviz, JL; García-Reyna, JC; Jiménez-Genchi, A | 1 |
| de Tommaso, M; Guido, M; Marinazzo, D; Nitti, L; Pellicoro, M; Serpino, C; Stramaglia, S | 1 |
| Arsura, E; Sethi, NK; Torgovnick, J | 1 |
| Yilmaz, H | 1 |
| Bret, ME; Brown, ES; Frol, AB; Khan, DA; Larkin, GL | 1 |
| Coubes, P; Crespel, A; Diaz, O; Gelisse, P; Genton, P; Hillaire-Buys, D; Juntas-Morales, R | 1 |
| Jacqmin, P; Sargentini-Maier, ML; Snoeck, E; Stockis, A | 1 |
| Berkovic, SF; McLaughlin, DB; Robinson, MK; Somerville, ER | 1 |
| Karakatsanis, NA; Karapoulios, E; Kouzoupis, AV; Masdrakis, VG; Oulis, P; Papadimitriou, GN; Papageorgiou, C; Soldatos, CR | 1 |
| Belcastro, V; Calabresi, P; Costa, C; Galletti, F; Parnetti, L; Pisani, F | 1 |
| Bauer, S; Gruener, J; Hamer, HM; Hattemer, K; Klein, KM; Knake, S; Oertel, WH; Rosenow, F | 1 |
| Brovedani, S; Chassoux, F; Franchon, E; Garciau, I; Kraoul, L; Lancelin, F; Landré, E; Paubel, P; Piketty, ML; Tabaouti, K | 1 |
| Gale, K; Kim, JS; Kondratyev, A; Tomita, Y | 1 |
| Auvinen, A; Keränen, T; Kharazmi, E; Peltola, J; Peltola, M; Raitanen, J | 1 |
| Boatman, DF; Kossoff, EH; Los, JG | 1 |
| Arts, WF; Augustijn, P; Brouwer, OF; Callenbach, PM; Geerts, AT; Geerts, Y; Gunning, WB; Peeters, EA; Stroink, H; ten Houten, R; Weber, AM | 1 |
| Gümüş, H; Kumandaş, S; Per, H | 1 |
| Häusler, M; Ott, H; Schlüter, A; Wurpts, G | 1 |
| Lai, XH; Liao, DQ; Liu, J; Zhang, Q; Zhou, D | 1 |
| Giannoutsos, S; Greiner-Sosanko, E; Krasowski, MD; Lower, DR; Virji, MA | 1 |
| Abu-Elmagd, KM; Bond, G; Costa, G; Zivković, SA | 1 |
| Stefan, H; Tian, L; Xiao, J; Zhang, Q; Zhou, B; Zhou, D | 1 |
| Martini, A; Mazza, M; Mazza, S; Scoppetta, M | 1 |
| Appleton, RE; Macleod, S | 1 |
| Baum, C; Evans, BM; Gevins, A; Loring, DW; McEvoy, LK; Meador, KJ; Motamedi, GK; Ray, PG; Smith, ME | 1 |
| Lay-Son Rivas, L; Meza Flores, R; Pizarro Segura, J | 1 |
| Di Bonaventura, C; Fabbrini, G; Fattouch, J; Giallonardo, TA; Manfredi, M; Prencipe, M | 1 |
| Farooq, MU; Gupta, R; Kassab, M; Majid, A; Reeves, M; Zemke, D | 1 |
| Bauer, J | 1 |
| Auvinen, A; Fallah, M; Keränen, T; Kharazmi, E; Liimatainen, S; Peltola, J; Peltola, M | 1 |
| Aleksandersen, M; Dahl, E; Gjerstad, L; McNeilly, A; Ormel, L; Ropstad, E; Surdova, K; Svalheim, S; Taubøll, E | 1 |
| Ben-Ari, Y; Franco, V; Jorquera, I; Manent, JB; Perucca, E; Represa, A | 1 |
| Aloisi, P; Cerminara, C; Chiarelli, F; Coppola, G; Curatolo, P; Cusmai, R; Franzoni, E; Iannetti, P; Parisi, P; Tozzi, E; Verrotti, A; Vigevano, F | 1 |
| Carreno, M | 1 |
| Brodtkorb, E; Helde, G; Nakken, KO; Reimers, A; Westin, AA | 1 |
| Abend, NS; Dlugos, DJ; Finkel, RS; Florance, N; Licht, DJ | 1 |
| Benatar, M; Holt, P; Perry, S | 1 |
| Gupta, PP; Misra, P; Thacker, AK | 1 |
| Alehan, F; Haberal, M; Ozcay, F | 1 |
| Baykan, B; Bebek, N; Bilgic, B; Coban, A; Gokyigit, A; Gurses, C; Hepgul, KT; Karasu, A; Sencer, S | 1 |
| Jensen, JE; Kaufman, RE; Pollack, MH; Renshaw, PF; Simon, NM | 1 |
| Mattes, JA | 1 |
| Biondi, R; Capovilla, G; Coppola, A; Di Bonaventura, C; Fontanillas, L; Giallonardo, AT; Romeo, A; Rubboli, G; Sofia, V; Striano, P; Striano, S; Viri, M; Vitale, G; Zara, F | 1 |
| da Silva, FH; Edelbroek, PM; Gorter, JA; van Schaik, R; van Vliet, EA; Wadman, WJ | 1 |
| Boero, G; de Palo, A; Di Bonaventura, C; Fattouch, J; Gambardella, A; Giallonardo, AT; La Neve, A; Ladogana, M; Lamberti, P; Michelucci, R; Specchio, LM; Specchio, N; Vigevano, F | 1 |
| El Banna, D; Mikati, MA; Mroueh, S; Sinno, D | 1 |
| Cruz, M; Goraya, JS; Khurana, DS; Kothare, SV; Legido, A; Melvin, JJ; Valencia, I | 1 |
| Gassmann, M; Keller, S; Ogunshola, OO; Rascher, W; Schneider, J; Strasser, K; Trollmann, R; Wenzel, D | 1 |
| Andermann, E; Andermann, F; Gough, WB; Meyvisch, P; Noachtar, S; Schiemann-Delgado, J | 1 |
| Burns, A; Devinsky, O; Hetherington, H; Kuzniecky, R; Pan, J | 1 |
| Fuhr, P; Hardmeier, M; Marsch, S; Naegelin, Y; Rüegg, S; Winkler, DT | 1 |
| Neft, RA; Vaisleib, II | 1 |
| Baker, CB; Cohen, SJ; Saksa, JR; Tek, C; Woods, SW | 1 |
| Holmes, GL; Marolewski, A; Rusche, JR; Shatskikh, T; Zhao, Q | 1 |
| Eriksson, K; Kälviäinen, R; Khyuppenen, J; Koskenkorva, P; Mervaala, E; Vanninen, R | 1 |
| Daugherty, J; Houry, D; Murphy, R | 1 |
| Hwang, H; Kim, KJ | 1 |
| Bialer, M | 1 |
| Trinka, E | 3 |
| Bleck, TP | 1 |
| Dermietzel, R; Faustmann, PM; Haghikia, A; Heupel, K; Hinkerohe, D; Ladage, K; Vollmar, P | 1 |
| Bailey, KS; Barone, G; Boothe, DM; Dewey, CW; Kortz, GD | 1 |
| Bridson, WE; Hulhoven, R; Meeus, MA; Rosillon, D; Salas, E; Stockis, A | 1 |
| Czarnecka, E; Pietrzak, B | 1 |
| Bräunig, P; Hasenclever, D; Krüger, S; Pietsch, R; Sarkar, R | 1 |
| Grib, AV; Lavrova, SA; Shershever, AS; Telegin, AV | 1 |
| Lee, YC; Reutens, DC; Solinas, C | 1 |
| van Rijn, CM; Vinogradova, LV | 1 |
| Ehrenberg, JA; Epstein, CM; Girard-Siqueira, L | 1 |
| Jacqmin, P; Lacroix, B; Sargentini-Maier, ML; Stockis, A; Toublanc, N | 1 |
| DeLorenzo, RJ; Deshpande, LS; Nagarkatti, N | 1 |
| Jackson, MJ | 1 |
| Boon, P; Hulhoven, R; Offner, F | 1 |
| Bormans, G; Bosier, B; Casteels, C; Goffin, K; Grachev, ID; Lambert, DM; Van Laere, K; Van Paesschen, W | 1 |
| Meschede, A; Runge, U; Sabolek, M | 1 |
| Krief, P; Maytal, J | 1 |
| Bhatia, R; Bhushan Singh, M; Prasad, K; Srivastava, MV; Tripathi, M; Vibha, D | 1 |
| Aldenkamp, AP; Backes, WH; de Baets, MH; de Krom, MC; Jansen, JF; Rieckmann, P; Vlooswijk, MC | 1 |
| Cloyd, JC; Dunn, AW; Fisher, JE; Goel, V; Leppik, IE; O'Brien, TD; Patterson, EE | 1 |
| Abuarqub, S; Brichetto, G; Capello, E; Sanguineti, V; Solaro, C | 1 |
| Ayar, A; Canpolat, S; Kutlu, S; Ozcan, M | 1 |
| Barcs, G; Clemens, Z; Fabó, D; Holló, A; Jakus, R; Janszky, J; Kelemen, A; Rásonyi, G; Szucs, A | 1 |
| Alpay, K; Baykan, B; Bebek, N; Ciftçi, FD; Gökyiğit, A; Gürses, C | 1 |
| Halbreich, U; Kayatekin, ZE; Sabo, AN | 1 |
| Kenda, B; Klitgaard, H; Margineanu, DG; Matagne, A; Michel, P | 1 |
| Amina, S; Bergey, GK; Koubeissi, MZ; Pita, I; Werz, MA | 1 |
| Matveeva, EA; Slevin, JT; Vanaman, TC; Whiteheart, SW | 1 |
| Hemming, K; Hutton, JL; Maguire, MJ; Marson, AG | 1 |
| Buturovic-Ponikvar, J; Cebular, B; Gubensek, J; Ponikvar, R | 1 |
| Carius, A; Frings, L; Lehmann, C; Maiwald, T; Schinkel, A; Schulze-Bonhage, A; Wagner, K | 1 |
| Gomceli, YB; Inan, LE; Kutlu, G; Unal, Y | 1 |
| Lee, CH; Lee, CY; Liou, HH; Tsai, TS | 1 |
| Rogawski, MA | 2 |
| Bromfield, E; Kesari, S; Lee, JW | 1 |
| Cold, S; Rasmussen, L; Sindrup, SH; Vilholm, OJ | 1 |
| John, T; Kinirons, P; Manchharam, D; Michaelides, C; Shapiro, MJ; Thibert, RL; Thiele, EA | 1 |
| Elger, CE; Fritz, NE; Helmstaedter, C; Kockelmann, E; Kosanetzky, N | 1 |
| Afshar, M; Ciraulo, D; Devine, E; Knapp, C; Koplow, J; Piechniczek-Buczek, J; Richambault, C; Sarid-Segal, O; Sickles, L; Uwodukunda, E | 1 |
| Belcastro, V; Costa, C; Striano, P | 1 |
| Hubschmid, M; Michel, P; Novy, J; Rossetti, AO | 1 |
| Matar, KM | 1 |
| Auvinen, A; Fallah, M; Keränen, T; Peltola, J; Peltola, M; Raitanen, J | 1 |
| De Stefano, G; de Tommaso, M; Di Claudio, T; Guido, M; Livrea, P; Sardaro, M; Serpino, C; Specchio, LM; Vecchio, E | 1 |
| Kaminski, RM; Klitgaard, H; Matagne, A; Patsalos, PN | 1 |
| Altenmüller, DM; Kühn, A; Schulze-Bonhage, A; Surges, R | 1 |
| Ferriero, DM; Silverstein, FS | 1 |
| Fan, PC; Lee, WT; Wang, SB; Weng, WC | 1 |
| Greenberg, E; Khan, A; Major, P; Thiele, EA | 1 |
| Hong, Z; Lv, CZ; Wang, XF; Wu, LW; Wu, X; Wu, XY; Zhao, ZX; Zhou, D | 1 |
| Bidlack, JM; Morris, HH | 1 |
| Azar, AE; Ballas, ZK | 1 |
| Kalinin, VV | 1 |
| Auvin, S | 1 |
| Gubanova, NB; Shevtsov, KI; Zenkov, LR | 1 |
| Brännström, A; Hauzenberger, E; Jansson, M; Lynch, BA; Matagne, A; Söderhäll, JA; von Euler, A | 1 |
| Helmstaedter, C; Witt, JA | 2 |
| Aronica, E; Boer, K; Gorter, JA; Redeker, S; van Vliet, EA | 1 |
| Kaminski, RM; Klitgaard, H; Margineanu, DG; Matagne, A | 1 |
| Bromfield, EB; Hurwitz, S; Milligan, TA | 1 |
| Adams, LA; de Boer, BW; Delriviere, L; Jeffrey, GP; Macquillan, G; Mitchell, A; Tan, TC | 1 |
| Desai, J | 1 |
| Albani, F; Baruzzi, A; Contin, M; Mohamed, S; Riva, R | 2 |
| Aalbers, K; Carpay, JA; Engelsman, M; Graveland, GA | 1 |
| Dang, CV; Nelson, L; Wade, JF; Wasserberger, J | 1 |
| Barrocu, M; Cocco, GA; Deiana, GA; Piluzza, MG; Sau, GF; Sechi, G | 1 |
| Ferlazzo, E; Girlanda, P; Magaudda, A; Meduri, M; Morgante, F; Quartarone, A; Rizzo, V; Sciarrone, G | 1 |
| Belcastro, V; Costa, C; Galletti, F; Rossi, A; Striano, P; Tambasco, N | 1 |
| Cerminara, C; Coppola, G; Curatolo, P; Domizio, S; Franzoni, E; Iannetti, P; Mohn, A; Parisi, P; Verrotti, A; Zamponi, N | 1 |
| Bedlack, RS; Hawes, J; Heydt, D; Pastula, DM | 1 |
| Benedict, N; Darby, JM; Fabio, A; Falcione, B; Fischer, M; Harshman, KJ; Jankowitz, BT; Jones, KE; Okonkwo, DO; Puccio, AM; Sauber-Schatz, EK; Stippler, M | 1 |
| Autuori, A; Belcastro, V; Calabresi, P; Costa, C; Galletti, F; Parnetti, L; Pierguidi, L; Pisani, F | 1 |
| Fisher, PG; Partap, S | 1 |
| Li Voti, P; Mecarelli, O; Pro, S; Pulitano, P; Randi, F; Vicenzini, E; Zarabla, A | 1 |
| Edginton, AN; Willmann, S | 1 |
| Auvin, S; Mazarati, A; Pandit, F; Riquet, A; Tamarelle, C; Vallée, L | 1 |
| Levin, FR; Mariani, JJ | 1 |
| Gallentine, WB; Hunnicutt, AS; Husain, AM | 1 |
| Bromfield, EB; Kesari, S; Lee, JW | 1 |
| Huang, CW; Pai, MC; Tsai, JJ | 1 |
| Beyenburg, S; Maraite, N; Reuber, M | 1 |
| Davenport, RD; Patel, HN; Patel, NC | 1 |
| Cavalleri, GL; Delanty, N; Depondt, C; Doherty, CP; Goldstein, DB; Kinirons, P; Lynch, JM; Murphy, K; O'Rourke, D; Sander, JW; Shianna, KV; Sisodiya, SM; Tate, SK; Weale, ME; Wood, NW | 1 |
| Bao, X; Liu, X; Qin, J; Xiong, H; Yang, Z; Zhang, Y | 1 |
| Almeida, S; Filipe, A; Franco Spínola, AC; Neves, RI; Tanguay, M; Yritia, M | 1 |
| Hepler, M; Irwin, D; Jenssen, S; Lippa, CF; Pillai, J; Rosso, A | 1 |
| Eeg-Olofsson, O; Larsson, PG; Wilson, J | 1 |
| Bentsion, DL; Lavrova, SA; Shershever, AS; Sorokova, EV | 1 |
| Haberlandt, E; Karall, D; Rauchenzauner, M; Rostásy, K; Scholl-Buergi, S; Sigl, SB | 1 |
| Hamann, M; Richter, A; Sander, SE | 1 |
| Chung, SS; Ettinger, AB; Fakhoury, TA; Hammer, AE; Labiner, DM; Messenheimer, JA; Mitchell Miller, J; Shneker, B; Tatum Iv, WO; Vuong, A | 1 |
| Escartín, A; García, C; López-Góngora, M; Martínez-Domeño, A | 1 |
| Hendriksen, JG; Nicolai, J; Speth, L; Visschers, A; Vles, GF; Vles, JS | 1 |
| Anderson, GD; Bubalo, JS; Eberly, AL; McCune, JS | 1 |
| Barton, D; Buckley, M; Kuan, S | 1 |
| Engelsman, J; Peeters, E; Touw, DJ; Uges, JW; van Huizen, MD; Vecht, CJ; Wilms, EB | 1 |
| Bonsi, P; Cuomo, D; Madeo, G; Martella, G; Pisani, A; Platania, P; Sciamanna, G; Tassone, A | 1 |
| Alonso-Lomillo, MA; Arcos-Martínez, MJ; Domínguez-Renedo, O; Matos, P | 1 |
| Ammar, H; Malani, A; Mughal, S | 1 |
| Beavis, J; Felce, D; Kerr, M; Meek, A | 1 |
| Treiman, DM; Wheless, JW | 1 |
| Gao, ZJ; Jiang, YW | 1 |
| Aldenkamp, AP; Bootsma, HP; de Krom, M; Hekster, YA; Hulsman, J; Lambrechts, D; Majoie, M; Ricker, L; Schellekens, A | 1 |
| Dolezal, T; Krsiak, M; Prochazkova, M; Sliva, J; Votava, M | 1 |
| Wijdicks, EF; Zubkov, AY | 1 |
| Carota, A; Novy, J; Rossetti, AO | 1 |
| Abou-Khalil, BW; Becker, D; Patel, A; Pina-Garza, JE | 1 |
| Blok, B; Campeau, L; Corcos, J; Elzayat, EA; Karsenty, G; Padjen, AL | 1 |
| Andres-Mach, MM; Czuczwar, SJ; Dudra-Jastrzebska, M; Luszczki, JJ; Patsalos, PN; Ratnaraj, N; Sielski, M | 1 |
| D'hooghe, MB; Feys, P; Helsen, WF; Nagels, G | 1 |
| Barbaro, N; Burt, M; Chakalian, L; Chang, E; Chang, S; Lamborn, KR; Lim, DA; McDermott, MW; Tarapore, P | 1 |
| Chhun, S; Chiron, C; Dulac, O; Jullien, V; Pons, G; Rey, E | 1 |
| Li, JM; Lv, Y; Sun, HB; Wang, XF; Xi, ZQ; Xiao, F; Xiao, Z | 1 |
| Divertie, GD; Freeman, WD; Nau, KM; Valentino, AK | 1 |
| Brannon Morris, E; Ledet, DS; Rubnitz, JE; Wheless, JW | 1 |
| Brown, M; Legoff, D; Levin-Allen, S; Mintz, M; Mintz, P; Scornaienchi, J; Smith, C | 1 |
| Rouvel-Tallec, A | 1 |
| Iwanowski, P; Jallon, P; Landis, T; Vulliemoz, S | 1 |
| Budziszewska, B; Lasoń, W; Leśkiewicz, M | 1 |
| Calleja-Pérez, B; Fernández-Jaén, A; Fernández-Mayoralas, DM; Muñoz-Jareño, N | 1 |
| Mazoit, JX; Navarro, V | 1 |
| Cáceres-Agra, JJ; Fernández-Arroyo, M; Sánchez-Palacios, M; Santana-Cabrera, L | 1 |
| Legido, A; Valencia, I | 1 |
| Duncan, B; Nordli, DR; Piña-Garza, JE; Rating, D; Schiemann-Delgado, J; Yang, H | 1 |
| Haase, CG; Hopmann, B | 1 |
| Burton, I; Guénolé, E; Rouits, E; Sargentini-Maier, ML; Stockis, A; Troenaru, MM | 1 |
| Clarke, D; Durmeier, M; Ellis, M; Hovinga, CA; McGregor, A; Perkins, F; Wheless, JW | 1 |
| Bhatt, A; Farooq, MU; Gupta, R; Kassab, MY; Khasnis, A; Majid, A | 1 |
| Doi, T; Nagatomo, K; Nakajima, A; Takaki, M; Ueda, Y; Willmore, LJ | 1 |
| Haettig, H; Meencke, HJ; Veauthier, J | 1 |
| Archer, J; Datta, S; Gutteridge, G; Hart, GK; Opdam, H | 1 |
| Moonen, G; Sadzot, B | 1 |
| Coetzee, C; Jiménez, F; Litovchenko, T; Lu, ZS; Peltola, J; Ramaratnam, S; Sykes, DM; Zaslavaskiy, L | 1 |
| Abend, NS; Dlugos, DJ; Licht, DJ; Monk, HM | 1 |
| Benbadis, S; Edrich, P; Hirsch, E; Rosenfeld, WE; Tassinari, CA | 1 |
| Bazaz, R; Lily, O; Maniyar, F; Rooney, C | 1 |
| Cuvellier, JC | 1 |
| Cid, AO; Juste, AO; López-Fraile, IP; Modrego, PJ | 1 |
| Coffey, B; Davis, GP; Magill, DB; McCarthy, JT | 1 |
| Bernardi, G; Buttari, F; Castelli, M; Centonze, D; Codecà, C; Fiore, S; Mataluni, G; Musella, A; Rossi, S | 1 |
| Cholongitas, E; Dasenaki, M; Georgousaki, C; Karatzi, C; Spyrou, S | 1 |
| Segers, K | 1 |
| Menard, W; Phillips, KA | 1 |
| Dinapoli, L; Fabi, A; Jandolo, B; Maschio, M; Muti, P; Pace, A; Sperati, F | 1 |
| Ben Salem, C; Biour, M; Elouni, B | 1 |
| García, C; Rubio, G | 1 |
| Lebedeva, AV; Nemenov, DG | 1 |
| Hedderick, EF; Morris, CM; Singer, HS | 1 |
| Rijsman, RM; Taphoorn, MJ; van Breemen, MS; Vecht, CJ; Walchenbach, R; Zwinkels, H | 1 |
| Chu, YK; Kwan, SY; Liao, KK; Liao, SQ; Lirng, JF; Yu, HY | 1 |
| Hacquard, M; Lacour, JC; Lecompte, T; Richard, S; Vespignani, H | 1 |
| Bunten, S; Dobis, C; Dogan, M; Dziewas, R; Evers, S; Fischera, M; Happe, S; Kovac, S; Möddel, G; Schäbitz, WR | 1 |
| Pellock, JM | 1 |
| Amabile, GA; Giacomini, P; Marchione, P; Marianetti, M; Romeo, T; Vento, C | 1 |
| Braun, EK; Bruno, P; Conant, KD; Nespeca, MP; Said, RR; Thibert, RL; Thiele, EA | 1 |
| Berning, S; Boesebeck, F; Kellinghaus, C; van Baalen, A | 1 |
| Ahishali, B; Arican, N; Bilgic, B; Ekizoglu, O; Elmas, I; Gurses, C; Kalayci, R; Karadeniz, A; Kaya, M; Kemikler, G; Kucuk, M; Orhan, N; Ustek, D | 1 |
| Johnston, A; Jorns, TP; Zakrzewska, JM | 1 |
| Dassesse, D; Gillard, M; Hanon, E; Kaminski, RM; Klitgaard, H; Leclercq, K; Lorent, G; Matagne, A | 1 |
| Gregoraszczuk, EL; Milewicz, T; Taubøll, E; Wojtowicz, AK | 1 |
| Bas, DB; Bilge, S; Bozkurt, A; Ciftcioglu, E; Ilkaya, F; Ozyurek, H | 1 |
| Schwankhaus, J; Singh, S | 1 |
| Biering-Sørensen, F; Bing, J; Finnerup, NB; Grydehøj, J; Jensen, TS; Johannesen, IL; Sindrup, SH | 1 |
| Crisp, ED; Kayani, S; Kirmani, BF; Rajab, H | 1 |
| Hurwitz, KA; Ingulli, EG; Krous, HF | 1 |
| Balestri, M; Bianchi, R; Cilio, MR; Di Capua, M; Giovannini, S; Onofri, A; Vigevano, F | 1 |
| Carletti, F; D'Agostino, S; Ferraro, G; Lonobile, G; Rizzo, V; Sardo, P | 1 |
| Carmant, L; Giroux, PC; Salas-Prato, M; Théorêt, Y | 1 |
| Mink, JW | 1 |
| Dahl, E; Gustavsen, MW; Olsaker, I; Ropstad, E; Taubøll, E; Verhaegen, S; von Krogh, K; Zimmer, KE | 1 |
| Bal, J; Friedman, A; Jurek, M; Mazurczak, T; Milewski, M; Szczałuba, K; Szczepanik, E | 1 |
| Luszczki, JJ; Patsalos, PN; Wlaz, A; Wojda, E | 1 |
| Bromfield, EB; Hurwitz, S; Milligan, TA; Sethi, NK | 1 |
| Weber, P | 1 |
| Eue, S; Grumbt, M; Müller, M; Schulze, A | 1 |
| Anderson, DG; Cifu, DX; Deschner, S; Hamza, MS; Snyder, JW | 1 |
| Andres-Mach, MM; Czuczwar, SJ; Dudra-Jastrzebska, M; Luszczki, JJ; Patsalos, PN; Ratnaraj, N | 1 |
| Rothman, SM; Yang, XF | 1 |
| Kan, L; Levy, AS; Maytal, J; Shinnar, S; Sogawa, Y | 1 |
| Alonso-Lomillo, MA; Arcos-Martínez, MJ; Domínguez-Renedo, O; Hernández-Martín, A | 1 |
| Edelbroek, PM; Gorter, JA; van Vliet, EA | 1 |
| Eggers, C; Hofer, T; Resch, R; Tilz, C | 1 |
| Forinash, AB; Longo, B; Murphy, JA | 1 |
| Banerjee, S; Brabant, Y; Helmers, S; Richy, FF | 1 |
| Godoy, J; Mellado, P; Soler, B | 1 |
| Abou-Khalil, B; Montouris, G | 1 |
| Hunter, SJ; Jones, J; Levisohn, PM; Mintz, M; Yang, H | 1 |
| Bertelsen, M; Gjerstad, L; Lossius, A; Luef, G; Mørkrid, L; Rauchenzauner, M; Sandvand, F; Svalheim, S; Taubøll, E | 1 |
| Attinà, G; Battaglia, D; Mastrangelo, S; Riccardi, R; Rizzo, D; Ruggiero, A | 1 |
| Balestri, P; Chiarelli, F; Curatolo, P; Grosso, S; Iannetti, P; Loiacono, G; Mohn, A; Parisi, P; Tozzi, E; Verrotti, A | 1 |
| Barsi, P; Farsang, M; Györke, T; Kamondi, A; Kovács, T; Szirmai, I; Vitaszil, E | 1 |
| Jeevan, RG; Manigandan, P; Radhakrishnan, G; Subramanian, NH | 1 |
| Cai, F; Cao, J; Li, S; Xiao, N | 1 |
| Chen, CC; Chen, TC; Chiang, CB; Hung, CC; Liou, HH; Tseng, YF; Wu, T | 1 |
| Córdoba López, A; Granado Martínez, D; Jimeno Torres, B; Pérez Frutos, MD | 1 |
| Boari, B; Carletti, R; Cavallo, M; Gallerani, M; Mari, E; Marra, A | 1 |
| Burghaus, L; Dohmen, C; Eggers, C; Fink, GR | 1 |
| Aristín, JL; Fernández, E; Gámez-Leyva, G; Pascual, J | 1 |
| Milteer, WE; Modur, PN; Zhang, S | 1 |
| Farooq, MU; Kassab, MY; Lobeck, IN; Majid, A; Xie, Y | 1 |
| Husain, AM; Shah, D | 1 |
| Chiba, S; Inaba, H; Ishimaru, Y; Ishimoto, T; Sakamoto, K; Sasa, M; Serikawa, T; Takasaki, H; Tamura, Y; Yamaguchi, K | 1 |
| Chen, CC; Lee, CY; Liou, HH | 1 |
| Aldaz, A; Giráldez, J; Ibáñez, N; Viteri, C; Zufía, L | 1 |
| Jinde, S; Kato, N; Maru, E; Sugaya, Y | 1 |
| Lindsell, CJ; Sangha, KS; Shutter, LA; Szaflarski, JP | 1 |
| Belcastro, V; Calabresi, P; Mattucci, E; Rossi, A; Tambasco, N | 1 |
| Balestri, M; Cilio, MR; Cusmai, R; D'Orsi, G; Fusco, L; Margiotta, ML; Nardello, R; Patanè, S; Russo, S; Specchio, LM; Specchio, N; Striano, P; Striano, S; Vigevano, F | 1 |
| Citraro, R; Constanti, A; De Fazio, S; De Sarro, G; Di Paola, ED; Russo, E; Scicchitano, F | 1 |
| Armstrong, TS; Choi, S; Gilbert, MR; Walker, J | 1 |
| Mendu, DR; Soldin, SJ | 1 |
| Bainbridge, JL; Linnebur, SA; Vande Griend, JP | 1 |
| Duane, DD | 1 |
| Alarcon, G; Brex, PA; Elwes, RD; Rosenzweig, I; Valentin, A | 1 |
| Bitsche, G; Haberlandt, E; Luef, G; Rauchenzauner, M; Rostasy, K; Svalheim, S; Tauboll, E; Wildt, L | 1 |
| Brawman-Mintzer, O; Khan, A; Liebowitz, MR; Lydiard, RB; Pollack, MH; Ravindran, LN; Simon, NM; Stein, MB | 1 |
| Foti, S; Gallagher, M; Haberman, RP; Koh, MT; McCown, TJ | 1 |
| Bhatia, R; Chandra, SP; Choudhary, N; Prasad, K; Srivastava, MV; Tripathi, M; Vibha, D | 1 |
| Belova, IuA; Kotov, AS; Kotov, SV; Lavrent'eva, NS; Rudakova, IG | 1 |
| Frycia, A; Jadot, S; Kenda, B; Lallemand, B; Leclercq, K; Lo Brutto, P; Matagne, A; Mercier, J; Starck, JP; Verbois, V | 1 |
| Holthausen, H; Kluger, G; Leiz, S; von Stülpnagel, C | 1 |
| Huang, CC; Huang, CW; Tsai, JJ; Wu, SN | 1 |
| Abou-Khalil, BW; Azar, NJ; Lagrange, AH; Song, Y; Wang, L | 1 |
| Choi, HC; Choi, SY; Jo, SM; Kang, TC; Kim, DS; Kim, JE; Kim, YI; Song, HK | 1 |
| Christensen, KV; Egebjerg, J; Kallunki, P; Leffers, H; Sánchez, C; Watson, WP | 1 |
| Bauer, J; Burr, W; Pfeiffer, C | 1 |
| Kang, HC; Kim, HD; Lee, JS; Lee, YJ | 1 |
| Bast, T; Bussmann, C; Ebinger, F; Fürwentsches, A; Philippi, H; Pöschl, J; Ramantani, G; Rating, D; Schubert, S | 1 |
| Crepeau, AZ; Treiman, DM | 1 |
| Ishihara, S; Ohno, Y; Sasa, M; Serikawa, T; Terada, R | 1 |
| Blonk, MI; Mathot, RA; Smit, LS; van der Nagel, BC | 1 |
| Finch, CK; Michael, LM; Sills, AK; Usery, JB | 1 |
| Feltner, DE; Haig, G | 1 |
| Baruzzi, A; Bisulli, F; Broli, M; Naldi, I; Provini, F; Riva, R; Sama, C; Tinuper, P | 1 |
| Depositario-Cabacar, DT; Peters, JM; Pong, AW; Riviello, JJ; Rotenberg, A; Roth, J; Takeoka, M | 1 |
| Raghuram, P; Soma Raju, IV; Sriramulu, J | 1 |
| Moore, SA; Muñana, KR; Nettifee-Osborne, J; Papich, MG | 1 |
| Cumbo, E; Ligori, LD | 1 |
| Dai, J; Han, L; Wang, L; Zhang, LL | 1 |
| Cilio, MR; Ferriero, DM | 1 |
| Buttolo, L; Cenzato, M; Padovani, A; Rosati, A; Stefini, R; Todeschini, A | 1 |
| Mohamed, BP; Peer Mohamed, B; Prabhakar, P | 1 |
| Juba, KM; Weiland, D | 1 |
| Dingledine, R; Gjerstad, L; Hassel, B; Shaw, R; Taubøll, E | 1 |
| Boettcher, U; Bogner, W; Doelken, MT; Doerfler, A; Hammen, T; Mennecke, A; Stadlbauer, A; Stefan, H | 1 |
| Chen, S; Li, J; Xiao, N | 1 |
| Arif, H; Bazil, CW; Buchsbaum, R; Hirsch, LJ; Pierro, J; Resor, SR; Sims, J; Whalen, M | 1 |
| Arcieri, S; Coppola, G; D'Aniello, A; Messana, T; Pascotto, A; Signoriello, G; Verrotti, A | 1 |
| Cardenas, JF; Chapman, KE; Hastriter, EV; Khoury, EM; Ng, YT | 1 |
| Chen, L; Hu, Y; Huang, TS; Li, B; Liao, JX | 1 |
| Dericioglu, N; Saygi, S | 1 |
| Ben-Menachem, E; Boon, P; Kuhn, HG; Paulson, L; Persson, A; Raedt, R; Van Dycke, A; Vonck, K | 1 |
| Bugg, KS; Foley, KT | 1 |
| Akiyama, T; Otsubo, H | 1 |
| Dinapoli, L; Jandolo, B; Maschio, M | 1 |
| Aziz, ZA; Beh, K; Cabral-Lim, L; Chinvarun, Y; Edrich, P; Kwan, P; Lim, SH; Lo, YK; Tonner, F | 1 |
| Tellez-Zenteno, JF | 2 |
| Bilo, L; de Leva, MF; Meo, R | 1 |
| Amina, S; Koubeissi, M; Sangani, M; Shahid, A | 1 |
| Caraballo, RH; Cersósimo, R; De los Santos, C | 1 |
| Chiarelli, F; Curatolo, P; D'Adamo, E; Parisi, P; Verrotti, A | 1 |
| Alexandrou, A; Antoniou, A; Armeni, E; Creatsa, M; Damaskos, C; Kaparos, G; Kouskouni, E; Lambrinoudaki, I; Logothetis, E; Triantafyllou, N | 1 |
| Aygul, R; Gundogdu, OL; Sahin, YN; Varoglu, AO; Yildirim, A | 1 |
| Förg, A; Heimann, HM; Hein, J; Heinz, A; Hinzpeter, A; Müller, CA; Schäfer, M; Schneider, S; Volkmar, K | 1 |
| Beswick, TC; Cohen, JB | 1 |
| Chen, PH; Liu, HC | 1 |
| Avgeropoulos, NG; Baker, CH; Bobustuc, GC; Jenkins, WD; Konduri, SD; Limaye, A; Pearl, G | 1 |
| Donat, M; Oberndorfer, S; Roessler, K; Zachenhofer, I | 1 |
| Ghosh, P; Mora, CA; Motamedi, G; Osborne, B | 1 |
| de la Loge, C; Hunter, SJ; Schiemann, J; Yang, H | 1 |
| Anderson, SK; Lachance, DH; Merrell, RT; Meyer, FB | 1 |
| Itakura, C; Niimi, K; Takahashi, E | 3 |
| Eeg-Olofsson, O; Lantz, G; Larsson, PG; Michel, CM; Seeck, M | 1 |
| Bonini, F; Casciato, S; Di Bonaventura, C; Fattouch, J; Giallonardo, AT; Lapenta, L; Manfredi, M; Petrucci, S; Prencipe, M | 1 |
| Gjerstad, L; Luef, G; Mørkrid, L; Rauchenzauner, M; Svalheim, S; Taubøll, E | 1 |
| Kato, N; Kudo, K; Maru, E; Shibasaki, T; Sugaya, Y | 1 |
| Alvarez-Soria, MJ; Cabello-De la Rosa, JP; Flores-Barragan, JM; Ibanez, R; Martinez-Palomeque, G; Vaamonde-Gamo, J | 1 |
| Huff, AD; Knupp, KG; Reiter, PD; Valuck, RJ | 1 |
| Ghazavi, M; Ghofrani, M; Karimzadeh, P; Mahvelati, F; Tonekaboni, SH | 1 |
| Belcastro, V; Pierguidi, L; Tambasco, N | 1 |
| Cheng, M; Huang, Z; Li, SX | 1 |
| Obeid, M; Pong, AW | 1 |
| Clark, A; Malur, C | 1 |
| Günes, HV; Kabay, SC; Ozbayer, C; Ozden, H; Toker, A; Ustüner, D; Ustüner, MC | 1 |
| Cloyd, JC; Goel, V; Leppik, IE; Nixdorf, DR; Rarick, J | 1 |
| Syed, KN | 1 |
| Almås, C; Dahl, E; Harjen, H; Olsaker, I; Ropstad, E; Taubøll, E; Verhaegen, S; von Krogh, K; Zimmer, KE | 1 |
| Micov, A; Popović, B; Stepanović-Petrović, R; Tomić, M | 1 |
| Baldelli, P; Benfenati, F; Boido, D; Cesca, F; Farisello, P; Ferrea, E; Valtorta, F | 1 |
| Ohno, Y; Sasa, M; Serikawa, T; Sofue, N; Tokuda, S | 1 |
| Fedotova, IB; Malikova, LA; Poletaeva, II; Raevskiĭ, KS; Surina, NM | 1 |
| Khan, S | 1 |
| Dahlin, MG; Ohman, I; Wide, K | 1 |
| Aggarwal, A; Kumar, R; Sharma, DD; Sharma, RC | 2 |
| Diehl, JL; Espinoza, S; Fagon, JY; Guerot, E; Imbert, A; Tadie, JM; Venot, M; Weiss, N | 1 |
| Ahishali, B; Arican, N; Ekizoglu, O; Elmas, I; Gurses, C; Kalayci, R; Kaya, M; Kemikler, G; Kucuk, M; Orhan, N | 1 |
| Fu, Z; Kaminski, RM; Leclercq, K; Mazzuferi, M; Seutin, V; Venkatesan, K; Vicini, S | 1 |
| Gevins, A; Leese, PT; Loring, DW; Meador, KJ; Otoul, C | 1 |
| Lang, SY; Shi, XB; Tian, HJ; Wang, RF; Wang, XQ; Yang, F | 1 |
| Ehtisham, A; Heinrichs, RJ; Janzen, JM; Taylor, S | 1 |
| Kleinebudde, P; Kuntz, T; Schubert, MA | 1 |
| Arzy, S; Genoud, D; Ghika, J; Groppa, S; Ignatenco, A; Kaplan, PW; Seeck, M | 1 |
| Aricò, I; Calarese, T; Cedro, C; Condurso, R; Gagliano, A; Germanò, E; Silvestri, R; Spina, E | 1 |
| Chan, A; Dambach, H; Dermietzel, R; Faustmann, PM; Gold, R; Haghikia, A; Hinkerohe, D; Prochnow, N; Stienen, MN; Thöne, J; Wiemann, M | 1 |
| Cremonini, MA; Parmeggiani, A; Pellicciari, A; Posar, A | 1 |
| Bhagwagar, Z; Blumberg, HP; Lorberg, B; Maloney, K; Muralidharan, A; Pittman, B; Ruf, B; Sanacora, G; Saricicek, A | 1 |
| Avramidis, TG; Fili, VA; Gatzonis, SD; Karageorgiou, KE; Mitsikostas, DD; Pantes, GV; Siatouni, AD; Stathis, PG; Vikelis, M | 1 |
| Beran, RG; Spira, PJ | 1 |
| Alexopoulos, AV; Devarajan, J; Farag, E; Siyam, AM; Weil, R | 1 |
| Matías-Guíu, J; Mauri, JA; Molins, A; Villar, E | 1 |
| Koubeissi, M; Nock, C; Oghlakian, R | 1 |
| Aricò, I; Bruni, O; Condurso, R; Granata, F; Nobili, L; Silvestri, R | 1 |
| Dinger, J; Ikonomidou, C; Ramantani, G; Rating, D; Walter, B | 1 |
| Duncan, B; Hadac, J; Hunter, SJ; Piña-Garza, JE; Schiemann-Delgado, J; Yang, H | 1 |
| Heinz, A; Hinzpeter, A; Kienast, T; Plenge, T; Preuss, UW; Richter, C; Schaefer, M; Schmidt, F | 1 |
| Engh, JA | 1 |
| Dinapoli, L; Fabi, A; Maschio, M; Muti, P; Pace, A; Sperati, F; Vidiri, A | 1 |
| Chen, LL; Dorsch, A; Haneef, Z; Keselman, I; Stern, JM | 1 |
| Blazejewski, S; Blin, P; Droz-Perroteau, C; Dureau-Pournin, C; Fourrier-Réglat, A; Jové, J; Marchal, C; Moore, N; Pollet, C; Robinson, P; Vespignani, H | 1 |
| Aiguabella, M; de la Peña, P; Falip, M; Garcia-Morales, I; Miró, J; Molins, A; Pardo, J; Saiz, RA; Sansa, G; Tortosa, D; Villanueva, V | 1 |
| Gulati, S; Lodha, R; Raj, D | 1 |
| Lawson, SE; Lembright, KE; Reineks, EZ; Wang, S | 1 |
| Bilbao Ornazabal, N; Maroto Rubio, M; Martín-Sánchez, FJ; Rojano Martín, B | 1 |
| Arikka, H; Arola, A; Ekblad, H; Lukkarinen, H; Peltola, M; Virtanen, I | 1 |
| Harden, CL; Kandula, P; Labar, DR; Nikolov, BG; Pannullo, S | 1 |
| Bach, FW; Holbech, JV; Jensen, TS; Otto, M; Sindrup, SH | 1 |
| Bajer, B; Czarnecka, E; Dyr, W; Gorska, D; Zalewska-Kaszubska, J | 1 |
| Connor, A; Otoul, C; Sargentini-Maier, ML; Stockis, A; Wilding, I; Wray, H | 1 |
| Bergin, A; Bourgeois, BF; Guilhoto, LM; Kothare, SV; Loddenkemper, T; Vendrame, M | 1 |
| Goyal, MK; Sahaya, K; Sarwal, A; Singh, NN | 1 |
| Chayasirisobhon, S; Chayasirisobhon, WV; Tsay, CC | 1 |
| Krahe, TE; Medina, AE; Pohl-Guimaraes, F | 1 |
| Moore, SA; Muñana, KR; Nettifee-Osborne, JA; Papich, MG | 1 |
| Abend, NS; Clancy, RR; Dlugos, DJ; Gutierrez-Colina, AM; Monk, HM | 1 |
| Harbord, MG | 1 |
| Bernstein, RA; Gibbs, M; Hunt Batjer, H | 1 |
| Goodwin, H; Hinson, HE; Karanjia, N; Lewin, JJ; Shermock, KM | 1 |
| Agresta, A; Bisogno, A; Busillo, V; Capasso, A; Pizza, V | 1 |
| Alberti, C; Chhun, S; Chiron, C; Dulac, O; Helfen, S; Motte, J; Napuri, S; Pons, G; Pouplard, F; Soufflet, C; Troude, P; Villeneuve, N | 1 |
| Balkaya, S; Klimpe, S; Krämer, G; Trinka, E; Werhahn, KJ | 1 |
| Baker, GA; Bonnett, LJ; Bromley, RL; Irwin, B; Morrow, J; Shallcross, R | 1 |
| Iniesta, I | 1 |
| Aldenkamp, AP; de Krom, MC; Lodder, J; van Raak, EP; van Tuijl, JH | 1 |
| Baho, MJ; Corn, S; Fenner, W; Hostutler, R | 1 |
| Alexandre, V; Feletti, F; Freitas-Lima, P; Pereira, LR; Perucca, E; Sakamoto, AC | 1 |
| Brown, PI; Johnson-Davis, KL; Juenke, JM; McMillin, GA | 1 |
| Cho, YW; Kim, DH; Motamedi, GK | 1 |
| Boniver, C; Capovilla, G; Cerminara, C; Citterio, A; Coppola, G; Costa, P; Darra, F; Fattore, C; Perucca, E; Vecchi, M | 1 |
| Ishii, Y; Tanaka, T | 1 |
| Born, M; Eis-Hübinger, AM; Fleischhack, G; Köster, B; Lentze, M; Linden, K; Moser, O; Rosenbaum, T; Simon, A; Tschampa, H | 1 |
| Bodmer, M; Kokko, J; Monte, AA; Yin, S | 1 |
| Brismar, T; Englund, M; Hyllienmark, L | 1 |
| Carneado Ruiz, J; Díaz Negrillo, A; González Salaices, M; Martín Del Valle, F; Prieto Jurczynska, C | 1 |
| Gajda, Z; Horváth, Z; Kéri, G; Orfi, L; Szántai-Kis, C; Szente, M; Török, R | 1 |
| Kamada, K | 1 |
| Karlov, VA; Komel'kova, EG; Vlasov, PN | 1 |
| Djuric, M; Kovacevic, G; Kravljanac, R; Martic, J | 1 |
| Lyseng-Williamson, KA | 2 |
| Chang, E; Cipriani, C; Crisp, E; Khan, O; Kirmani, B; Wright, C | 1 |
| Konitsiotis, S; Peterson, D; Stathis, P; Tagaris, G | 1 |
| Chaluvadi, S; Chiang, S; Friedman, DE; Goldsmith, CE; Tran, L | 1 |
| Morikawa, T | 1 |
| Bonetti, S; Brunetto, D; Franzoni, E; Gentile, V; Leo, I; Verrotti, A | 1 |
| Alvarez, V; Burnand, B; Januel, JM; Rossetti, AO | 1 |
| Andrade, DM; Dalmau, J; Tai, P; Wennberg, R | 1 |
| Saito, N; Usami, K | 1 |
| Dhar, R; Diringer, MN; Murphy-Human, T; Welch, E; Zipfel, G | 1 |
| Alkan, F; Asan, Z; Erdincler, P; Eser, M; Tanriverdi, T; Tureci, E | 1 |
| Akl, EA; Jichici, D; Kyu, HH; Lo, BW; Meade, MO; Upton, AM | 1 |
| Lerner, V; Miodownik, C | 1 |
| Fitzgerald, CL; Jacobson, MP | 1 |
| Boćkowski, L; Iłendo, E; Jaworowska, B; Sendrowski, K; Smigielska-Kuzia, J; Sobaniec, W | 1 |
| Brighina, F; Cosentino, G; Fierro, B; Giglia, G; Palermo, A; Talamanca, S; Vigneri, S | 1 |
| Brodie, MJ; Kelly, K; Parker, P; Stephen, LJ | 1 |
| Feuerstein, TJ; Freiman, TM; Kammerer, M; Rassner, MP | 1 |
| Abdel-Gadir, A; Dubrey, SW; Rakowicz, WP | 1 |
| Alty, JE; Goy, AG; Kempster, PA; Raghav, S; Reutens, DC; Wong, KK | 1 |
| Christensen, J; Sabers, A | 1 |
| Almas, M; Emir, B; Giordano, S; Leon, T; Uthman, BM | 1 |
| Aas, P; Enger, S; Jonassen, M; Myhrer, T | 1 |
| Jia, TM; Li, XL; Liu, T; Luan, B; Zhang, XL | 1 |
| Balmakund, T; Meinzen-Derr, J; Merhar, SL; Schibler, KR; Sherwin, CM; Shi, J; Vinks, AA | 1 |
| Citraro, R; Constanti, A; De Fazio, S; De Sarro, G; Di Paola, ED; Perrota, I; Perrotta, I; Russo, E; Scicchitano, F | 1 |
| McAdams, BD; Meehan, AL; Rothman, SM; Yang, X; Yuan, L | 1 |
| Arita, K; Hanaya, R; Kumafuji, K; Kurisu, K; Sasa, M; Serikawa, T; Sugata, S; Tokudome, M | 1 |
| Auvin, S; Berquin, P; Chhun, S; Chiron, C; Delanoë, C; Ponchel, E | 1 |
| Bakke, KA; Eeg-Olofsson, O; Eriksson, AS; Larsson, PG | 1 |
| Bjeljac, M; Keller, E; Mink, S; Muroi, C; Seule, M | 1 |
| Bachmann, T; Bertheussen, KH; Gjerstad, L; Luef, G; Rauchenzauner, M; Svalheim, S; Taubøll, E | 1 |
| Del Pozo, E; González-Contreras, LG; Pereira-Pérez, E | 1 |
| Ascenção, R; Borges, M; Costa, J; Fareleira, F; Sampaio, C; Vaz-Carneiro, A | 1 |
| Atkins, M; Nikanorova, M | 1 |
| McCaulley, JA; Pates, JA | 1 |
| Awonuga, AO; Hobson, DTG; Imudia, AN; Soto, E | 1 |
| Banas, R; Förg, A; Heimann, HM; Hein, J; Heinz, A; Müller, CA; Schäfer, M; Volkmar, K | 1 |
| Li, L; Si, YK | 1 |
| Aronica, E; de Groot, M; Heimans, JJ; Reijneveld, JC | 1 |
| Cantarin-Extremera, V; Duat-Rodriguez, A; Gutierrez-Solana, LG; Leon-Gonzalez, M; Lopez-Marin, L; Perez-Villena, A; Ruiz-Falco, ML | 1 |
| Fahie, K; Fowler, D; Levine, B; Naso, C; Phipps, RJ | 1 |
| Cook, M; Moses, D; Plummer, C; Vogrin, S | 1 |
| Cotton, BA; Holcomb, JB; Kao, LS; Kozar, R | 1 |
| Grant, R; Kerrigan, S | 1 |
| Antonilli, L; Brusadin, V; Filipponi, F; Guglielmi, R; Nencini, P | 1 |
| Duparc, A; Maury, P; Mondoly, P; Probst, V; Rollin, A; Sacher, F | 1 |
| Degroote, E; Ghariani, S; Rostomashvili, N; van Rijckevorsel, K; Vrielynck, P | 1 |
| Jones, J; Legoff, D; Loge, Cde L; Mintz, M; Schiemann-Delgado, J; Stalvey, TJ; Yang, H | 1 |
| Axlund, TW; Boothe, DM; Carnes, MB | 1 |
| Doreswamy, M; Gingrich, KJ; Kolls, BJ; Swisher, CB; Vredenburgh, JJ | 1 |
| Akiyama, M; Kobayashi, K; Ohtsuka, Y; Oka, M; Takeuchi, A | 1 |
| Brown, CR; Nash, TE; Ooi, WW; Quezado, M; Thomas, CB; Wijemanne, S | 1 |
| Kalita, J; Maurya, PK; Misra, UK | 1 |
| Bähr, O; Franz, K; Hermisson, M; Körtvelyessy, P; Nussbaum, S; Rieger, J; Rona, S; Seifert, V; Steinbach, JP; Tatagiba, M; Weller, M | 1 |
| Akamatsu, N | 1 |
| Anderson, D; Castaigne, JG; Foerch, P; Lebon, F; Lynch, BA; Shi, J | 1 |
| Filip, D; Florek-Luszczki, M; Luszczki, JJ | 1 |
| Kaufman, KR; Struck, PJ; Wong, S; Wu, B | 1 |
| Ávila-Ordóñez, MU; Ballesteros-Montero, AT; Félix-Orta, F; Jiménez-Genchi, A | 1 |
| Fleck, JD; Jacobi, J; Juenke, JM; Kays, MB; Spencer, DD | 1 |
| Deuschl, G; Hellriegel, H; Raethjen, J; Volkmann, J | 1 |
| Cloyd, JC; Coles, LD; Craft, EM; Leppik, IE; Patterson, EN | 1 |
| An, K; Baulac, M; Bolgert, F; Carli, P; Dagron, C; Demeret, S; Lamhaut, L; Navarro, V | 1 |
| Arita, K; Hanaya, R; Kiura, Y; Kurisu, K; Sasa, M; Serikawa, T | 1 |
| Baker, G; Tan, GM; Wieshmann, UC | 1 |
| Badjatia, N; Choi, HA; Claassen, J; Ko, SB; Lee, K; Mayer, SA; Ortega-Gutierrez, S; Presciutti, M; Schmidt, JM | 1 |
| Cho, JR; Hong, SB; Joo, EY; Ju, E; Kim, DY; Koo, DL; Lee, J; Yoon, SM | 1 |
| Dehmel, T; Kieseier, BC; Köhne, A; Mausberg, AK; Rose, CR; Stettner, M | 1 |
| Delanty, N; Jones, J; Tonner, F | 1 |
| Athanassiadou, F; Balakou, E; Hatzipantelis, E; Pana, ZD; Papageorgiou, T; Pavlou, E; Tragiannidis, A; Tsotoulidou, V | 1 |
| Deriaz, N; Galli Carminati, G; Orihuela-Flores, M; Ratib, O; Willi, JP | 1 |
| Kesari, S; Kim, RY; Mahta, A | 1 |
| Eadie, M; Graham, J; Lander, CM; O'Brien, TJ; Roten, A; Vajda, FJ | 1 |
| Bührer, C; Kaindl, AM; Koppelstäetter, A | 1 |
| Campbell, TE; Cook, MJ; Halliday, AJ; McLean, KJ; Nelson, TS; Razal, JM; Wallace, GG | 1 |
| Akar, FY; Celikyurt, IK; Erden, F; Komsuoglu, SS; Mulayim, S; Mutlu, O; Ulak, G | 1 |
| Sasidaran, K; Singhi, P; Singhi, S | 1 |
| Brawanski, AT; Feigl, GC; Hansen, E; Kern, K; Lange, M; Schebesch, KM; Schlaier, J | 1 |
| Johnson-Davis, KL; Juenke, JM; McGraw, JP; McMillin, GA | 1 |
| Berquin, P; Bourel-Ponchel, E; de Broca, A; Delignières, A; Doumbia-Ouattara, M; Le Moing, AG; Querne, L | 1 |
| Dostic, M; Jankovic, SM | 1 |
| Gregoraszczuk, EŁ; Kwiecińska, P; Wiśniewska, J | 1 |
| Abdel-Salam, RA; Emara, S; Hadad, GM | 1 |
| Bajjalieh, SM; Bleckert, A; Hill, J; Malarkey, EB; Nowack, A; Yao, J | 1 |
| Azim, A; Patel, M; Robins, A | 1 |
| Chen, Z; Liu, X; Ma, M; Su, L; Wu, Y | 1 |
| Kendrick-Adey, AC; Sponsler, JL | 1 |
| Carvalho, KS; Farooque, P; Goraya, J; Hardison, HH; Khurana, DS; Legido, A; Valencia, I | 1 |
| Aydoğan, H; Büyükfrat, E; Karahan, MA; Yalçn, S | 1 |
| Meehan, AL; Rothman, SM; Yang, X; Yuan, LL | 1 |
| Gebarski, SS; Hulsing, KL; Lorincz, MT; Osman, NI | 1 |
| Barnett, CC; Beauchamp, K; Bensard, DD; Biffl, WL; Burlew, CC; Johnson, JL; Moore, EE; Pieracci, FM; Stoval, RT; Tebockhorst, S | 1 |
| Kumlien, E; Zelano, J | 1 |
| A Tompkins, D; Brunette, MF; Ciraulo, D; Devine, E; Falk, DE; Fertig, JB; Green, AI; Johnson, B; Kampman, K; Litten, RZ; Mattson, ME; Pettinati, H; Ransom, J; Rickman, WJ; Ryan, ML; Scott, C; Stout, R; Strain, EC; Tiouririne, NA | 1 |
| Slivka, AP; Sun, LQ | 1 |
| Falah, M; Holbech, JV; Madsen, C; Sindrup, SH | 1 |
| Bacsói, G; Fekete, J; Oláh, E; Sharma, VK | 1 |
| Lindsell, CJ; Shutter, LA; Steinbaugh, LA; Szaflarski, JP | 1 |
| Bode-Böger, SM; Drust, A; Firsching, R; Luchtmann, M; Martens-Lobenhoffer, J; Tröger, U | 1 |
| de Mey, C; Dimitrova, V; Lennartz, P; Wangemann, M | 1 |
| Coker, AR; Grossman, LE; Messing, RO; Mitchell, JM | 1 |
| Bajwa, RP; Gross, TG; Pai, V; Skeens, M; Soni, S; Termuhlen, AM | 1 |
| Altun, F; Bilgili, SG; Bulut, G; Burakgazi, AZ; Calka, O; Karadag, AS | 1 |
| Abou-Khalil, BW; El-Feki, A; Haykal, MA; Sonmezturk, HH | 1 |
| Hayashi, T; Inoue, K; Shinoda, J | 1 |
| Fedotova, IB; Kalinina, TS; Malikova, LA; Poletaeva, II; Rayevsky, KS; Surina, NM; Volkova, AV | 1 |
| Bingaman, W; Irwin, AI; Jehi, LE; Kayyali, H; Najm, I; Vadera, S | 1 |
| Ayar, A; Ozcan, M | 1 |
| Angenard, F; Gazaigne, L; Ilboudo, JC; Mataam, K; Wafo, E | 1 |
| Dave, P; Gohel, KH; Krishna, K; Raut, AL | 1 |
| Fukuyama, K; Motomura, E; Nakagawa, M; Okada, M; Shiroyama, T; Tanahashi, S; Tanii, H; Yamamura, S | 1 |
| Bakke, KA; Bjørnæs, H; Brager-Larsen, L; Eriksson, AS; Heminghyt, E; Larsson, PG; Rytter, E | 1 |
| Capparelli, EV; Farrell, MJ; Haas, RH; Mower, A; Sharpe, CM; Soldin, SJ | 1 |
| Badoud, A; Badoud, S; Burkhard, PR; Fisch, L; Mégevand, P; Seeck, M | 1 |
| Aĭvazian, SO; Shiriaev, IuS | 1 |
| Buchneva, IA; Ermakov, AIu; Ermolenko, NA; Voronkova, KV | 1 |
| Brixner, DI; Durkin, M; Forlenza, J; Goodman, MJ; Ye, X | 1 |
| Avakyan, G; Ceja, H; Chung, S; Gawłowicz, J; Lu, S; McShea, C; Schiemann, J | 1 |
| Alkhotani, A; McLachlan, RS | 1 |
| Albert, I; Hefti, M; Luginbuehl, V | 1 |
| Andersen, NB; Beniczky, SA; Jensen, LT; Viken, J | 1 |
| Balzer-Geldsetzer, M; Dodel, R; Graf, W; Hamer, HM; Knake, S; Kostev, K; Oertel, WH; Reese, JP; Rosenow, F; Schöffski, O; Schwab, S; Strzelczyk, A | 1 |
| Berkovic, SF; Dibbens, LM; Helbig, KL; Hodgson, BL; Mulley, JC; Oliver, KL; Scheffer, IE | 1 |
| Mochida, S; Stephens, GJ; Vogl, C; Whalley, BJ; Wolff, C | 1 |
| Azzopardi, L; Quirk, J | 1 |
| Bramanti, P; Calabrò, RS; Italiano, D; Militi, D | 1 |
| Bledsoe, K; Brophy, G; Castle, A; Cook, AM; Gokun, J; Goodwin, H; Green, A; Lesch, C; Liang, N; Makii, J; McAllen, K; Morrison, C; Murphy-Human, T; Parker, D; Rhoney, D; Sangha, K; Tesoro, E; Weant, K | 1 |
| Knight, EM; Lenz, T; Tuxhorn, I; Vaca, GF | 1 |
| Aydın, M; Baka, M; Demirel, A; Özdemir, N; Ozer, FD; Uyanıkgil, Y; Yılmaz Dilsiz, O | 1 |
| Albert, MS; Bakker, A; Bassett, SS; Gallagher, M; Jones, LR; Krauss, GL; Shelton, AL; Speck, CL; Stark, CE; Yassa, MA | 1 |
| Gregoraszczuk, EL; Kwiecińska, P; Taubøll, E | 2 |
| Aoto, T; Baulac, S; Boillot, M; Fumoto, N; Ikeda, A; Ishida, S; Kuwamura, M; LeGuern, E; Mashimo, T; Ohno, Y; Serikawa, T; Takahashi, R; Takizawa, A; Ueda, M | 1 |
| Huang, LL; Lei, F; Tang, XD; Zhong, ZQ; Zhou, D; Zhou, JY | 1 |
| Arnold, S; Bauer, S; Beige, A; Berrouschot, J; Burchardi, N; Eisensehr, I; Evers, S; Haag, A; Hallmeyer-Elgner, S; Hamer, HM; Klein, KM; Kovac, S; Lerche, H; Niedhammer, M; Oertel, WH; Reif, PS; Rosenow, F; Roth, E; Schade-Brittinger, C; Schröder, M; Springub, J; Strzelczyk, A; Weber, Y; Winkler, G | 1 |
| Buchneva, IA; Ermakov, AIu; Ermolenko, NA; Voronkova, KV; Zakharova, EI | 1 |
| Ju, J; Li, XY; Zhang, WN; Zou, LP | 1 |
| Bishop-Freeman, SC; Kornegay, NC; Winecker, RE | 1 |
| Ghauri, AA; Khan, AA; Shamim, MS; Zafar, SN | 1 |
| Craig, J; Hoeritzauer, I; Hunt, SJ; Irwin, B; Mawhinney, E; Morrow, J | 1 |
| Lu, W; Shang, DW; Wang, L; Wang, YH; Wei, MJ; Wu, Y | 1 |
| Ait, S; Bonnefoy, M; Cotton, F; Gilbert, T | 1 |
| Baxter, MG | 1 |
| Ellrichmann, G; Faustmann, PM; Gold, R; Haghikia, A; Thöne, J | 1 |
| Hadidi, S; Shahabadi, N | 2 |
| Camacho, A; Espín, JC; Nuñez, N; Simón, R | 1 |
| Appleton, R; Kneen, R; Kumar, R; McTague, A; Spinty, S | 1 |
| Bonnet, U; Bschor, T; Effenberger, S; Förg, A; Glauner, T; Haasen, C; Heinz, A; Preuss, UW; Richter, C; Schaefer, M; Volkmar, K | 1 |
| Catalano, G; Catalano, MC; Cohen-Oram, AN; Larkin, TM | 1 |
| Cook, MJ; D'Souza, WJ; Fuller, KL; Murphy, MA; Wang, YY | 1 |
| Atabaki, SM; He, J; Herr, D; Klein, P; Levine, Z; McCarter, R; Natale, J; Nogay, C; Pearl, PL; Sandoval, F; Soldin, SJ; Trzcinsky, S; Tsuchida, T; van den Anker, J | 1 |
| Aysal, F; Baybas, S; Kucukoglu, H; Ozturk, M; Selçuk, HH; Sozmen, V; Urer, NH | 1 |
| Choi, K; Han, YM; Hwang, SH; Kang, SY | 1 |
| Atabaki, SM; He, J; Herr, D; Klein, P; Levine, Z; McCarter, R; Natale, J; Nogay, C; Pearl, PL; Sandoval, F; Soldin, SJ; Trzcinski, S; Tsuchida, T; van den Anker, J | 1 |
| Baftiu, A; Johannessen Landmark, C; Johannessen, SI; Larsson, PG; Rytter, E; Tysse, I; Valsø, B | 1 |
| Ehtesham, Z; Hashmi, M; Mustafa, MS; Saleem, F; Sheerani, M; Siddiqui, K | 1 |
| Koroglu, OA; Kultursay, N; Tanriverdi, S; Tekgul, H; Terek, D; Yalaz, M | 1 |
| Le Strat, Y | 1 |
| Esteve-Belloch, P; Fernández-Torrón, R; Iriarte, J; Palma, JA; Riverol, M | 1 |
| Aerts, L; Haut, B; Herman, C; Leyssens, T | 1 |
| Cirrito, JR; Devidze, N; Ho, K; Mucke, L; Orr, AG; Palop, JJ; Sanchez, PE; Verret, L; Vossel, KA; Yu, GQ; Zhu, L | 1 |
| Aihara, M; Kanemura, H; Sano, F; Sugita, K; Tando, T | 1 |
| Markhus, R; Nakken, KO; Selmer, KK; Syvertsen, MR | 1 |
| Bhandari, HS | 1 |
| Elger, CE; Helmstaedter, C; Hurlemann, R; Kunz, WS; Mihov, Y; Nuernberg, P; Schoch, S; Surges, R; Thiele, H; Toliat, MR | 1 |
| Aroor, S; Mathew, T; Nadig, R; Sarma, G | 1 |
| Benecke, R; Pohley, I; Rantsch, K; Rösche, J; Walter, U | 1 |
| Brunecker, P; Israel, H; Jungehulsing, GJ; Nolte, CH; Safar, N; Taskin, B; Villringer, A; Wernecke, KD | 1 |
| Buyle, S; Duncan, B; Hallström, Y; Hon, P; Kälviäinen, R; Marovac, J; Marson, AG; Meencke, HJ; Muscas, GC; Newton, M; Pohlmann-Eden, B; Smith, PE; Trinka, E; Van Paesschen, W | 1 |
| Arnold, S; Brandt, C; Elger, CE; Hagemann, A; May, TW; Nieder, E; Pohlmann-Eden, B; Schulze-Bonhage, A; Straub, HB; Tergau, F; Witte-Bölt, K | 1 |
| Dixon, P; Hutton, JL; Marson, AG; Mbizvo, GK | 2 |
| Droz-Perroteau, C; Dureau-Pournin, C; Fourrier-Réglat, A; Jové, J; Lassalle, R; Lavernhe, G; Marchal, C; Moore, N; Robinson, P; Vespignani, H | 1 |
| Akın, R; Arslan, M; Ince, S; Ünay, B; Vurucu, S; Yiş, U | 1 |
| Freĭdkova, NV; Karlov, VA; Rusanova, LV | 1 |
| Magomaev, MF; Magomedov, MM; Magomedova, AKh; Magomedova, AM | 1 |
| Kotov, AS | 1 |
| Nau, JY | 1 |
| Deng, YC; Liu, YH; Wang, XL; Zhao, G | 1 |
| Hou, L; Huang, Y; Lu, N; Mohamed, AA; Wang, T; Xiong, N | 1 |
| Fujii, N; Isoda, K; Nishimura, A; Tomoyasu, C | 1 |
| Bilgili, SG; Burakgazi-Dalkilic, E; Calka, O; Karadag, AS; Kosem, M; Onder, S | 1 |
| Hong, SB; Joo, EY; Kim, D; Koo, DL | 1 |
| Ding, CH; Li, XF; Song, ZJ; Zou, LP | 1 |
| Enoki, H; Fujimoto, A; Ohashi, T; Okanishi, T; Tanaka, T; Uchiyama, T; Yamamoto, T; Yamazaki, M; Yamazoe, T; Yokota, T | 1 |
| Deik, AF; Shanker, VL | 1 |
| Campbell, TE; Cook, MJ; Halliday, AJ; McLean, KJ; Nelson, TS; Wallace, GG | 1 |
| Alldredge, B; Bell, R; Bleck, TP; Brophy, GM; Claassen, J; Glauser, T; LaRoche, SM; Riviello, JJ; Shutter, L; Sperling, MR; Treiman, DM; Vespa, PM | 1 |
| Arita, K; Hanaya, R; Ishihara, K; Kurisu, K; Sasa, M; Seki, T; Serikawa, T; Yan, HD | 1 |
| Buchneva, IA; Ermakov, AIu; Ermolenko, NA; Kalikina, TA; Zakharova, EI | 1 |
| Sönnichsen, AC | 1 |
| Aihara, M; Kanemura, H; Sano, F; Sugita, K | 1 |
| Bosco, D; Consoli, D; Galati, F; Neri, G; Ottonello, GA; Passarella, B; Perticoni, GF; Plastino, M; Postorino, P; Ricci, S; Toni, D | 1 |
| Chastagner, P; Contet, A; Mansuy, L; Parentelli, AS; Phulpin-Weibel, A; Trechot, P | 1 |
| Chang, M; Fitzgerald, E; Folkerth, RD; Jensen, FE; Kosaras, B; Murphy, A; Talos, DM | 1 |
| Micov, AM; Stepanović-Petrović, RM; Tomić, MA; Ugrešić, ND | 1 |
| Bell, DS | 1 |
| Chen, KF; Lai, SC; Lu, CS; Lu, MK; Tsai, CH; Wu, YC | 1 |
| Eidlitz-Markus, T; Feldman, L; Goldberg-Stern, H; Kramer, U; Perez, S; Phatal-Valevski, A; Pollak, L | 1 |
| Frøland, SS; Luef, G; Mochol, M; Mushtaq, U; Rauchenzauner, M; Svalheim, S; Taubøll, E | 1 |
| Asanuma, K; Kaji, R; Koizumi, H; Miyazaki, Y; Sako, W; Sato, K | 1 |
| Inoue, Y; Terada, K | 1 |
| Metin, SZ; Ozkara, C; Ozmen, E; Ozmen, M | 1 |
| Bosma, I; de Groot, M; Douw, L; Froklage, FE; Heimans, JJ; Klein, M; Postma, TJ; Reijneveld, JC; Sizoo, EM | 1 |
| Chiyonobu, T; Hosoi, H; Morimoto, M; Morioka, S; Morita, T; Moroto, M; Nishimura, A; Sakaue, S; Tokuda, S; Yoshida, M | 1 |
| Carapella, CM; Dinapoli, L; Fabi, A; Maschio, M; Pace, A; Pompili, A; Sperati, F; Vidiri, A | 1 |
| Jääskeläinen, S; Majamaa, K; Martikainen, MH; Päivärinta, M | 1 |
| Almeida, DM; Chystsiakova, A; Jean, MR; Monahan, E; Monteiro, IM; Oliveira, SB | 1 |
| Geisler, F; Klostermann, F; Nolte, CH; Oechtering, J; Smyth, M; Tuetuencue, S | 1 |
| Daglıoglu, K; Erdogan, S; Guzel, A; Kilicdag, H; Polat, S; Sencar, L; Zorludemir, S | 1 |
| Maren Staack, A; Steinhoff, BJ; Wisniewski, I | 1 |
| Kang, JK; Kim, BM; Lee, GH; Lee, SA | 1 |
| Craig, J; Delanty, N; Hunt, SJ; Irwin, B; Liggan, B; Mawhinney, E; Morrison, PJ; Morrow, J; Parsons, L; Russell, A; Smithson, WH | 1 |
| Chosidow, O; Duong, TA; Haddad, C; Sbidian, E; Valeyrie-Allanore, L; Wolkenstein, P | 1 |
| Chen, M; Faccidomo, S; Fish, EW; Hodge, CW; Howard, EC; Krouse, MC; Malanga, CJ; Robinson, JE; Stamatakis, AM | 1 |
| Bakke, KA; Bjørnæs, H; Brager-Larsen, LM; Eriksson, AS; Heminghyt, E; Larsson, PG; Rytter, E | 1 |
| Devi, L; Ohno, M | 1 |
| Arsura, E; Cukierwar, F; Sethi, NK; Sethi, PK; Torgovnick, J | 1 |
| Branco, BC; Demetriades, D; Dubose, J; Gooch, J; Herrold, J; Inaba, K; Menaker, J; Okoye, OT; Scalea, TM | 1 |
| Chung, WH; Ko, JH; Lee, YY | 1 |
| Lossius, MI; Markhus, R; Nakken, KO; Sætre, E | 1 |
| Ozardali, I; Sonmez, A; Turan, E; Yesilova, Y | 1 |
| Choi, HC; Kang, TC; Kim, JE; Kim, YI; Lee, DS; Ryu, HJ; Song, HK | 1 |
| Bonuccelli, U; Ienco, EC; Mancuso, M; Orsucci, D; Rocchi, A; Siciliano, G | 1 |
| Miller, D; Salazar, R | 1 |
| Chen, CW; Hwang, JC; Ju, MS; Lin, CC; Tsai, JJ | 1 |
| Erol, I; Özkale, M; Özkale, Y; Saygi, S | 1 |
| Centeno, C; Larumbe, A; López-Saca, JM; Urdíroz, J; Vaquero, J | 1 |
| Al-Tannir, MA; Ali, JA; Mahmoud, AA; Mansy, AA; Rizk, TM | 1 |
| Goodwin, H; Harris, LH; Haut, ER; Kornbluth, J; Kruer, RM; Slater, LA; Thomas, KP | 1 |
| Al Sherbini, K; Jensen, MB; Sattar, A | 1 |
| Geater, A; Leelawattana, R; Limapichat, K; Phabphal, K; Sathirapanya, P; Setthawatcharawanich, S | 1 |
| Ambrosini, R; Combi, R; Ferini-Strambi, L; Forcella, M; Fusi, P; Mozzi, A; Sansoni, V | 1 |
| Chiyonobu, T; Hosoi, H; Kato, M; Morimoto, M; Morioka, S; Morita, T; Moroto, M; Saitsu, H; Yamashita, S; Yoshida, M | 1 |
| DeDea, L | 1 |
| Allenhöfer, L; Bauer, S; Hamer, HM; Höglinger, GU; Höllerhage, M; Li, G; Nowak, M; Oertel, WH; Rosenow, F; Schlegel, K; Stei, S; Tackenberg, B; Wang, X; Waschbisch, A; Wegner, S | 1 |
| Bast, T; Bonfert, M; Borggraefe, I; Heinen, F; Maßmann, K; May, TW; Neubauer, BA; Noachtar, S; Schotten, KJ; Tuxhorn, I | 1 |
| Desbiens, R; Nguyen, DK; Savard, M; Tayah, T | 1 |
| Kohan, R; Nagarajan, L; Rakshasbhuvankar, A; Rao, S; Simmer, K | 1 |
| Dielemans, JC; Kerkhof, M; Taphoorn, MJ; van Breemen, MS; Vecht, CJ; Walchenbach, R; Zwinkels, H | 1 |
| Bien, CG; Boesebeck, F; Dohmen, B; Graef, U; Kramme, C; Schwarz, O; Vestring, T | 1 |
| Mangum, B; Pressler, RM | 1 |
| Fontana, A; Giordano, G; Mangano, GR; Mangano, S; Nardello, R; Spitaleri, C; Tripi, G | 1 |
| Iakovleva, IuA; Popov, IuV | 1 |
| Beaufils, E; Constans, T; De Toffol, B; Hommet, C; Mondon, K; Ripault, H; Roubeau, V | 1 |
| Gallagher, M; Koh, MT; Rapp, PR; Spiegel, AM; Vogt, NM | 1 |
| Tanaka, S; Tanaka, T | 1 |
| Weller, M | 1 |
| Hong, SB; Hwang, KJ; Joo, EY; Kim, D; Kim, JY; Kim, MR; Kim, YJ; Koo, DL; Lee, JM; Shin, W | 1 |
| Broglio, KR; Connor, JT; Elm, JJ | 1 |
| Barrera-Bailón, B; Garcia-Cairasco, N; López, DE; Muñoz, LJ; Oliveira, JA; Sancho, C | 1 |
| Herman, C; Leyssens, T; Norberg, B; Vermylen, V; Wouters, J | 1 |
| Atabaki, SM; He, J; Klein, P; McCarter, R; McGavin, CL; Pearl, PL; Sandoval, F; Trzcinski, S; Tsuchida, T; van den Anker, J; Yu, Y | 1 |
| Lacroix, BD; Toublanc, N; Yamamoto, J | 1 |
| Abeliovich, A; Cheng, R; Fujita, R; Lee, JH; Qiang, L; Rhinn, H | 1 |
| Gao, L; Jiang, T; Shi, JQ; Tian, YY; Wang, BR; Xie, HG; Xu, J; Zhang, YD; Zhao, SL | 1 |
| Biber, B; Björklund, U; Block, L; Hansson, E; Jörneberg, P; Westerlund, A | 1 |
| Chan, BC; Ho, PC; Kong, ST; Luo, W; Yang, S | 1 |
| Arora, S; Cook, AM; Davis, J; Pittman, T | 1 |
| Deguchi, I; Fukuoka, T; Hayashi, T; Kato, Y; Maruyama, H; Ohe, Y; Tanahashi, N | 1 |
| Cipriani, C; Crisp, E; Khan, O; Kirmani, B; Wright, C | 1 |
| Bae, SH; Han, JH; Kim, CY; Kim, T; Kim, YH; Lee, YJ; Yun, CH | 1 |
| Bernhard, MK; Bertsche, A; Bertsche, T; Dahse, AJ; Frontini, R; Kiess, W; Merkenschlager, A; Neininger, MP; Syrbe, S | 1 |
| Berning, S; Kellinghaus, C; Stögbauer, F | 1 |
| Bramanti, P; Calabrò, RS; Italiano, D; Spina, E | 1 |
| Daoliang, X; Hengzhong, Z; Xiaotian, X; Yao, X; Yumei, W; Zhipan, Z | 1 |
| Micov, AM; Stepanović-Petrović, RM; Tomić, MA | 1 |
| Akdemir, A; Erbaş, O; Ergenoğlu, AM; Peker, G; Taskiran, D; Yeniel, AÖ; Yilmaz, M | 1 |
| Kim, DW; Kim, JH; Lee, SY; Shon, YM | 1 |
| Chu, K; Jung, KH; Kang, BS; Kim, YS; Lee, SK; Lee, ST; Moon, HJ | 1 |
| Bleck, T; Chamberlain, J; Cloyd, J; Cock, H; Connor, J; Elm, J; Fountain, N; Jones, E; Kapur, J; Lowenstein, D; Shinnar, S; Silbergleit, R; Treiman, D; Trinka, E | 1 |
| Becker, AJ; Cichon, S; Grimminger, T; Hoffmann, P; Niehusmann, P; Pernhorst, K; Priebe, L; Schoch, S; Surges, R; von Lehe, M | 1 |
| Nakamura, H; Osawa, M; Suzuki, A; Yokoyama, T; Yoshida, K | 2 |
| Burrall, B; Konia, T; Shahbaz, S; Sivamani, RK | 1 |
| Aas, P; Enger, S; Mariussen, E; Myhrer, T | 2 |
| Fekete, S; Gradosova, I; Malakova, J; Palicka, V; Simko, J; Zivna, H; Zivny, P | 1 |
| Droz-Perroteau, C; Dureau-Pournin, C; Fourrier-Réglat, A; Jové, J; Lavernhe, G; Mann, M; Moore, N; Pédespan, JM; Pollet, C; Robinson, P | 1 |
| Maitre, NL; Slaughter, JC; Smolinsky, C; Stark, AR | 1 |
| Buniak, L; Henry, JC; Mohile, N; Wang, H; Wychowski, T | 1 |
| Budhram, A; Harvey, D; Lipson, D; Nesathurai, S; Rathbone, MP | 1 |
| Boškovic, BD; Kovacevic, JM; Micov, AM; Stepanovic-Petrovic, RM; Tomic, MA | 1 |
| Harada, S; Kuwabara, H; Matsumura, H; Nakahari, T; Nakano, T; Sawabe, Y; Shimamoto, C; Takahashi, Y; Tanaka, S | 1 |
| Hirota, T; Hollander, E; Kishi, T; Veenstra-Vanderweele, J | 1 |
| Abdallah, DM; Al-Shorbagy, MY; El Sayeh, BM | 1 |
| Aydin, S; Belen, D; Billur, D; Daglioglu, E; Dalgic, A; Guvenc, Y; Karaoglu, D; Nacar, OA; Ozdol, C; Yildirim, AE | 1 |
| Cook, MJ; Freestone, DR; Frey, S; Giftakis, JE; Long, SN; Stypulkowski, PH | 1 |
| Häuser, W; Sommer, C; Üçeyler, N; Walitt, B | 2 |
| Belcastro, V; Caraballo, RH; Romeo, A; Striano, P | 1 |
| Gregoraszczuk, EŁ; Kwiecińska, P; Taubøll, E; Wróbel, A | 1 |
| Hayasaka, K; Kato, M; Kikuchi, T; Nakamura, K; Takahashi, N | 1 |
| Florek-Luszczki, M; Luszczki, JJ; Wlaz, A | 1 |
| Fang, Y; Hong, Z; Tang, X; Wang, J; Wu, X; Xu, L; Zhu, G | 1 |
| Cataldi, M; Cuomo, O; di Renzo, G; Leo, A; Politi, GB; Rispoli, V; Vinciguerra, A | 1 |
| López-González, FJ; Novoa, D; Pardo, J; Pintos, E; Rodríguez-Osorio, X | 1 |
| Bain, E; Birhiray, RE; Reeves, DJ | 1 |
| Akaike, N; Kogure, K; Kotani, N; Wakita, M | 1 |
| Ariguloglu, EA; Koklu, E; Koklu, S | 1 |
| Bansal, S; Blalock, D; Carpenter, JL; Dean, NP; Kebede, T | 1 |
| Aune, P; Azar, NJ | 1 |
| Jeckelmann, S; Novy, J; Rossetti, AO; Roth, P; Stupp, R; Weller, M | 1 |
| Iyoda, K; Ogawa, K; Okazaki, T | 1 |
| Hong, Z; Zhou, D; Zou, X | 1 |
| Cai, FC; Chen, X; Chen, XQ; Gao, L; Huang, SP; Pang, BD; Yang, ZX; Zhang, WN; Zhao, M; Zou, LP | 1 |
| Bergamo, DF; Carr, SB; Emmanuel, PJ; Ferreira, JA | 1 |
| Agoglia, AE; Fish, EW; Krouse, MC; Malanga, CJ; Muller, RG; Robinson, JE | 1 |
| Jin, DI; Kang, JW; Lee, JE; Lee, SH; Lin, T | 1 |
| Bagiella, E; DiVentura, BD; French, JA; Kasteleijn, D; Krauss, GL | 1 |
| Bashir, S; Burakgazi, E; Doss, V; Pellock, J | 1 |
| Holtkamp, M; Kauert, A; Ott, DV | 1 |
| Hadidi, S; Shahabadi, N; Taherpour, AA | 1 |
| Eleni, K | 1 |
| Klein, P; Mathews, GC | 1 |
| Baker, GA; Bromley, RL; Cheyne, CP; García-Fiñana, M; Irwin, B; Morrow, J; Shallcross, R | 1 |
| Agostinelli, S; Baumann, M; Haberlandt, E; Luef, G; Pizzolorusso, A; Prieschl, M; Rauchenzauner, M; Roscia, S; Rostasy, K; Verrotti, A; Wildt, L | 1 |
| Hughes, SE; Prohotsky, DL; Zhao, F | 1 |
| Akça, M; Kamaşak, K; Ocak, H; Turan, Y; Yildirim, M; Yılmaz, T | 1 |
| Finsterer, J; Höftberger, R; Rolinski, B; Stöllberger, C; Winkler, WB; Wöhrer, A | 1 |
| Balci, S; Beydagi, H; Celik, Y; Erdogan, S; Komur, M; Okuyaz, C; Polat, A; Resitoglu, B; Tamer, L | 1 |
| Griesmaier, E; Kiechl-Kohlendorfer, U; Medek, K; Obermair, GJ; Posod, A; Stanika, RI; Stock, K; Urbanek, M; Wegleiter, K | 1 |
| Chou, SH; Du, R; Lee, JW; Radic, JA | 1 |
| Dearborn, JL; Kaplan, PW | 1 |
| Arfini, C; Bianchi, V; Vidali, M | 1 |
| Chaudhry, SA; Jong, G; Koren, G | 1 |
| Junewar, V; Rathaur, BP; Verma, R | 1 |
| Attilakos, A; Dinopoulos, A; Garoufi, A; Moustaki, M; Papaevangelou, V; Paschalidou, M; Siafakas, N; Tsirouda, M | 1 |
| Beran, RG; Stepanova, D | 1 |
| Azık, F; Tavil, B; Teber, S; Tunç, B; Uçkan, D; Yazal Erdem, A | 1 |
| Tang, Z; Zhai, Q; Zhang, Y; Zhuo, M | 1 |
| Aihara, M; Kanemura, H; Ohyama, T; Sano, F; Sugita, K | 1 |
| Bahte, SK; Hiss, M; Kielstein, JT; Lichtinghagen, R | 1 |
| Acharya, M; Kochar, A; Kumawat, BL; Sharma, C | 1 |
| Anwar, MJ; Radhakrishna, KV; Vohora, D | 1 |
| Brenn, S; Schrope, DP; Shih, JL | 1 |
| Gortner, L; Kutschke, G; Meyer, S; Oster, I; Peterlini, S | 1 |
| Rheims, S; Ryvlin, P | 1 |
| Ioannidis, P; Karacostas, D; Parissis, D | 1 |
| Bhattacharyya, S; Cai, X; Klein, JP; LaBuzetta, JN; Munshi, NC; Plitt, A; Raibagkar, P; Schleicher, SM | 1 |
| Garrity, LC; Standridge, SM; Turner, M | 1 |
| Aas, P; Myhrer, T | 1 |
| Nieoczym, D; Raszewski, G; Socała, K; Wlaź, P | 1 |
| Bauer, S; Guenther, S; Hagge, M; Hamer, HM; Knake, S; Olmes, DG; Rosenow, F; Tackenberg, B | 1 |
| Almas, M; Knapp, L; Pitman, V; Posner, H; Zaccara, G | 1 |
| Aksoy, D; Cevik, B; Kurt, S; Pekdas, E; Solmaz, V | 1 |
| Ito, S; Oguni, H | 1 |
| Ohtsuka, Y | 1 |
| Fletcher, JJ; Karamchandani, RR; Pandey, AS; Rajajee, V | 1 |
| Ladizinski, B; Sankey, C | 1 |
| Aldenkamp, AP; de Louw, AJ; Halma, E; IJff, DM; Klinkenberg, S; Majoie, M | 1 |
| Hohler, AD; Montouris, GD; Spengler, DC | 1 |
| Eadie, M; Graham, J; Lander, C; O'Brien, T; Vajda, FJ | 1 |
| Lubszky, S; Reinhart, WH; Schulzki, T; Thöny, S | 1 |
| An, D; Chen, S; Deng, H; Ren, J; Xiao, F; Zhou, D | 1 |
| Derry, S; Lunn, MP; Moore, RA; Wiffen, PJ | 1 |
| Hande, HM; Naha, K; Naha, S; Vivek, G | 1 |
| Fujikawa, M; Iwasaki, M; Jin, K; Kakisaka, Y; Kato, K; Kishimoto, Y; Nakasato, N | 1 |
| Eadie, MJ; Graham, J; Lander, CM; O'Brien, TJ; Vajda, FJ | 1 |
| Aschermann, Z; Horváth, K; Komoly, S; Kovács, A; Kovács, N | 1 |
| Gudausky, TM; Kovach, J; Loomba, RS; Singh, AK | 1 |
| Chae, JH; Choi, J; Hwang, H; Hwang, YS; Kim, H; Kim, JS; Kim, KJ; Lee, JH; Lim, BC; Ryu, HW | 1 |
| Beker van Woudenberg, A; Bouma, M; de Groot, D; Hermsen, S; Menke, A; Piersma, A; Rijkmans, E; Snel, C; Wolterbeek, A | 1 |
| Ahmad, M; Naseem, H; Shafi, N; Sher, N; Siddiqui, FA; Wafa Sial, A | 1 |
| Chen, L; Su, TF; Xu, SQ | 1 |
| Borgert, AJ; Gundrum, JD; Mahoney, LJ; Miller, RF; Youland, KM | 1 |
| Bunnell, K; Pucci, F | 1 |
| Gabriel, WM; Rowe, AS | 1 |
| Ağın, H; Akarcan, SE; Celik, T; Güzel, O; İşgüder, R; Ünalp, A; Yılmaz, Ü | 1 |
| Imamura, A; Maegaki, Y; Maruta, K; Matsunami, K; Narita, A; Nishimura, Y; Ohno, K; Saiki, Y; Saito, Y; Sokota, T; Sugihara, S; Tamasaki, A; Ueda, R | 1 |
| Bell, GS; Chinnasami, S; Duncan, JS; Novy, J; Sander, JW; Wehner, T | 1 |
| de Goede, C; Gupta, R; Singh, J; Tan, HJ | 1 |
| Hasegawa, Y; Iuchi, T; Kawasaki, K; Sakaida, T | 1 |
| Deeb, S; Logan, BK; McKeown, DA; Scott, KS; Torrance, HJ; Wylie, FM | 1 |
| Arık, AE; Bağırıcı, F; Marangoz, C; Sefil, F | 1 |
| Athanaselis, S; Dona, A; Nikolaou, P; Papoutsis, I; Spiliopoulou, C | 1 |
| Beck, VC; Forcelli, PA; Gutherz, SB; Kulick, CV; Medvedeva, N; Soper, C | 1 |
| Centeno, M; Duncan, JS; Koepp, MJ; Kozák, LR; Sidhu, M; Stretton, J; Symms, M; Thompson, PJ; Wandschneider, B | 1 |
| Cendes, F; Woermann, FG | 1 |
| Fowler, L; Hurwitz, M; Wagner, AK; Zou, H | 1 |
| Chung, HJ; Kang, HC; Kim, HD; Kim, HJ; Kim, SH; Lee, JS | 1 |
| Greenfield, LJ; Herlopian, AS; Shihabuddin, BS | 1 |
| Albertson, TE; Lewis, JC; Walsh, MJ | 1 |
| Andreas, JO; Boyce, M; Chan, R; Mugitani, A; Okagaki, T; Toublanc, N; Watanabe, S; Yamamoto, K; Yoshida, K | 1 |
| Kumagai, Y; Stockis, A; Toublanc, N; Yamamoto, J | 1 |
| Feddersen, B; Lorenzl, S; Rastorfer, K; Rémi, C; Vyhnalek, B | 1 |
| Chen, L; Wang, W; Xiao, J; Zheng, HB; Zhou, D | 1 |
| Kovács, AD; Madeo, M; Pearce, DA | 1 |
| Baumgartner, S; Kampuš, NJ; Klančar, U; Kočevar, K; Krajcar, D; Legen, I; Markun, B; Smrdel, P | 1 |
| Christophersen, AS; Hasvold, I; Karinen, R; Olsen, KM; Vindenes, V; Øiestad, E | 1 |
| Azzam, H; El-Farahaty, RM; El-Mitwalli, A; Elrakhawy, MM; Hasaneen, BM; Wasel, Y | 1 |
| Geroldinger, A; Gleiss, A; Grisold, W; Marosi, C; Moser, W; Oberndorfer, S; Sax, C; Sherif, C; Tinchon, A | 1 |
| Lo, YL; Yeap, LL | 1 |
| Cappellari, AM; Cattaneo, D; Clementi, E; Kustermann, A | 1 |
| Loiacono, G; Masci, M; Verrotti, A; Zaccara, G | 1 |
| Albertini, G; De Sarro, G; Gallelli, L; Gratteri, S; Iemolo, F; Manes, MT; Mercuri, NB; Quirino, G; Sanzaro, E; Scaglione, F; Siniscalchi, A | 1 |
| Ali, K | 1 |
| Ciraulo, DA; Colaneri, L; Devine, E; Knapp, CM; Oscar-Berman, M; Putnam, M; Richambault, C; Richardson, MA; Sarid-Segal, O; Streeter, CC; Surprise, C; Waters, M | 1 |
| Czuczwar, SJ; Lukawski, K; Raszewski, G | 1 |
| Chauhan, N; Malhotra, N; Narang, J; Pundir, CS | 1 |
| An, DM; Chen, L; Lei, D; Li, JM; Li, YH; Zeng, TF; Zhang, B; Zhou, D | 1 |
| Bankstahl, M; Klein, S; Löscher, W | 1 |
| Freeburg, JD; Hohler, AD; Montouris, GD; Wong, LC | 1 |
| Ebell, W; Hernáiz Driever, P; Kühl, JS; Peyrl, A; Weichert, N | 1 |
| Arroyo Pérez, R; Fernández-Candil, JL; León Jorba, A; Pacreu Terradas, S; Villalba Martínez, G; Vivanco-Hidalgo, RM | 1 |
| Fleming, DH; Kodagali, R; Mathew, BS; Mathew, V; Naik, GS; Prabha, R; Thomas, M | 1 |
| Chen, YX; Feng, XF; Liu, L; Xiao, N | 1 |
| Hasegawa, Y; Iuchi, T; Kawasaki, K; Kuwabara, K; Matsumoto, M; Sakaida, T | 1 |
| Buchsbaum, R; Chen, B; Choi, H; Detyniecki, K; Hirsch, LJ; Javed, A; Kato, K; Legge, A; Moeller, J | 1 |
| Kaminski, RM; Leclercq, K | 2 |
| Benninger, F; Dressler, A; Feucht, M; Grassl, R; Gröppel, G; Mühlebner, A; Reiter-Fink, E; Reithofer, E; Trimmel-Schwahofer, P | 1 |
| Lerner, PP; Lerner, V; Miodownik, C | 1 |
| Hamada, S; Hashimoto, T; Naito, E; Satomura, S; Shimakawa, S | 1 |
| Ishii, M; Iwasaki, T; Nonoda, Y; Toki, T | 1 |
| Chen, F; Chen, SH; Cheng, L; Hong, Z; Lei, S; Li, HX; Li, JM; Li, L; Yang, TH; Zhou, D | 1 |
| Heuer, GG; Hsu, G; Janik, LS; Rehman, MA; Schwartz, AJ; Simpao, AF; Warrington, AP | 1 |
| Chen, X; Wang, H | 1 |
| Kossoff, EH; McNally, MA | 1 |
| Cai, F; Chen, J; Feng, C; Hu, Y; Jiang, L | 1 |
| Andersen, H; Lindstrøm, P; Nakken, KO | 1 |
| Avoli, M; Behr, C; Lévesque, M | 1 |
| Aller-Alvarez, JS; Álvarez-Sabin, J; Menéndez-González, M; Ribacoba-Montero, R; Salas-Puig, J; Salvado, M; Suárez-Moro, R; Sueiras, M; Toledo, M; Vega, V | 1 |
| Abrahamsson, B; Berglez, S; Cristofoletti, R; Dressman, J; Groot, DW; Kopp, S; Krisch, I; Langguth, P; Legen, I; Megušar, K; Mehta, M; Peternel, L; Petruševska, M; Polli, JE; Shah, VP | 1 |
| Choupoo, NS; Das, H; Das, N; Das, SK; Momin, K; Sohkhia, WE | 1 |
| Covita, J; García-Pérez, E; Mahfooz, K; Wesseling, JF; Zandueta, A | 1 |
| Biggin, PC; Daniels, V; Lebon, F; Lee, J; Sands, ZA; Shi, J | 1 |
| Micov, AM; Pecikoza, UB; Popović, BV; Stepanović-Petrović, RM; Tomić, MA | 1 |
| Craner, M; Cranley, MR; McGilloway, E | 1 |
| Popko, J; Sendrowski, K; Sobaniec, P; Sobaniec, W; Stasiak-Barmuta, A | 1 |
| Hattori, N; Hayashi, A; Miyamoto, N; Shimura, H; Ueno, S; Ueno, Y; Urabe, T; Watanabe, M | 1 |
| Liu, Q; Liu, S; Lone, SR; Spira, AP; Tabuchi, M; Wu, MN; Zhang, J | 1 |
| Chiba, Y; Inamine, M; Ishihara, Y; Itoh, K; Kotani, M; Oshima, W; Ueno, M | 1 |
| Inoue, S; Murahara, T; Shimohama, S; Yamauchi, R; Yazawa, S | 1 |
| Berkovitch, M; Dagan, Z; Gandelman-Marton, R; Heyman, E; Kohn, E; Sheinberg, R; Youngster, I | 1 |
| Khongkhatithum, C; Thampratankul, L; Visudtibhan, A; Wiwattanadittakul, N | 1 |
| Goodwin, M; Kotecha, PN; Mateo-Carrasco, H; Molina-Cuadrado, E; Nguyen, TV; Serrano-Castro, PJ | 1 |
| Pruitt, AA | 1 |
| Albert, MS; Bakker, A; Gallagher, M; Krauss, G; Speck, CL | 1 |
| Afrikanova, T; Buenafe, OE; Crawford, AD; De Prins, A; de Witte, PA; Esguerra, CV; Kaminski, RM; Langlois, M; Leclercq, K; Rospo, CC; Smolders, I; Van Eeckhaut, A | 1 |
| Agrawal, N; Cock, HR; Lozsadi, DA; Mohanalingham, K; Mula, M; Mustafa, Z; von Oertzen, TJ | 1 |
| Berger, C; De la Gastine, B; Goutelle, S; Maison, O; Peter-Derex, L | 1 |
| Ikeda, A; Inoue, Y; Ishida, S; Sasagawa, M; Suzuki, A; Yagi, K; Yoshida, K | 1 |
| Buckingham, SC; Hall, AM; Hoffman, DA; Markwardt, SJ; Peng, Y; Roberson, ED; Throesch, BT; Wang, Q | 1 |
| Beydoun, A; Fawaz, A; Hmaimess, G; Makke, Y; Nasreddine, W | 1 |
| Nye, G; Packer, RM; Porter, SE; Volk, HA | 1 |
| Bhalla, A; Chakravarthi, S; Goyal, MK; Modi, M; Singh, P | 1 |
| Chroni, P; Geladari, E; Kokkinakis, E; Vallianou, NG | 1 |
| Acaban, MB; Arı, H; Kahraman, F | 1 |
| Chen, T; Li, MQ; Liu, L; Zhang, WW | 1 |
| Adhikary, A; Agarwal, G; Barik, KL; Bhattacharyya, AK; Paul, UK; Rana, KS | 1 |
| Eichenbaum, H; Farb, DH; Ratner, MH; Robitsek, J; Stewart, T | 1 |
| Abe, S; Arai, E; Fujimaki, T; Ikeno, M; Kitamura, Y; Okumura, A; Shimizu, T; Yamamoto, T | 1 |
| Eom, S; Eun, BL; Eun, SH; Hwang, SK; Jung, DE; Kang, DR; Kang, HC; Kim, GH; Kim, HD; Kwon, SH; Lee, JS; Lee, YJ; Nam, SO; Yoon, JR; Yu, R | 1 |
| Cao, D; Chua-Tuan, JL; Hoyte, CO; Iwanicki, JL | 1 |
| Micov, A; Pecikoza, U; Stepanović-Petrović, R; Tomić, M; Ugrešić, N | 1 |
| Edwards, JC; Smith, G; Wagner, JL | 1 |
| Han, JH; Joo, JD; Kim, CY; Kim, IA; Kim, T; Kim, YH; Kim, YJ; Yun, CH | 1 |
| Gefroh-Grimes, HA; Gidal, BE | 1 |
| Huq, AM; Serajee, FJ | 1 |
| Brouwer, OF; Callenbach, PM; Weijenberg, A | 1 |
| Abdel-Wahab, BA; Habeeb, SM; Khateeb, MM; Shaikh, IA | 1 |
| Boza, FM; Gumà I Padró, J; Peralta Muñoz, S; Taberner Bonastre, MT | 1 |
| Czuczwar, SJ; Florek-Luszczki, M; Luszczki, JJ; Miziak, B; Zagaja, M | 1 |
| Daurignac, E; Dubovsky, SL; Leonard, KE; Serotte, JC | 1 |
| Blakeley, J; Piotrowski, AF | 1 |
| Jiewen, L; Maling, G; Peizhi, Z; Qing, M; Ruofei, L; Wu, L; Xiang, W; Yanhui, L; Yuan, Y; Yunhe, M | 1 |
| Ishida, S; Kanemoto, K; Kawai, K; Shirai, H; Tokumasu, T; Yamada, M; Yamamura, K; Yamauchi, T | 1 |
| Altenmüller, DM; Bast, T; Boor, R; Burghaus, L; Esser, W; Evers, S; Fiedler, B; Gaida, B; Gburek-Augustat, J; Happe, S; Hoffmann, F; Kellinghaus, C; Lang, N; Nguento, A; Rehfeld, T; Schlegel, U; Seitz, RJ; Stephani, U | 1 |
| Fisher, WG; Issa, NP; Narayanan, JT | 1 |
| Atmaca, MM; Bebek, N; Gurses, C; Orhan, EK | 1 |
| Bindu, PS; Mundlamuri, RC; Nagappa, M; Prathyusha, PV; Satishchandra, P; Sinha, S; Subbakrishna, DK; Taly, AB; Umamaheswara Rao, GS | 1 |
| Crawford-Faucher, A; Huijon, RM | 1 |
| Chan, R; Chen, Q; Du, X; Liu, Y; Singh, P; Stockis, A; Toublanc, N | 1 |
| Božić, K; Divjak, I; Gebauer-Bukurov, K; Ješić, A; Sakalaš, L | 1 |
| Chen, W; Fuda, F; Hatanpaa, KJ; Koduru, P; Lega, B; Young, K | 1 |
| Chen, K; Liang, Y; Liu, J; Sun, H; Xie, Y; Yu, N | 1 |
| Aso, E; Clos, MV; Di Pietro, O; Espargaró, A; Ferrer, I; Frattini, D; López-González, I; Luque, FJ; Muñoz-Torrero, D; Sabaté, R; Sola, I | 1 |
| Horvath, R; Janszky, J; Komoly, S | 1 |
| Ketola, RA; Malm, H; Ruuskanen, JO; Timonen, S; Ylikotila, P | 1 |
| Fukui, M; Nomura, S; Shimakawa, S; Tamai, H; Tanabe, T; Yoshikawa, S | 1 |
| Chen, Q; Gong, Q; Huang, X; Li, H; Stefan, H; Tang, Y; Wu, X; Xia, W; Yu, X; Zhang, X; Zhou, D; Zou, X | 1 |
| Arnold, RD; Barron, LE; Boozer, LB; Haley, AC; Kent, M; Linville, AV; Nie, B; Platt, SR | 1 |
| Barbieri, S; Cristofori, G; Dilena, R; Romeo, A; Striano, P; Tadini, L; Traverso, M; Viri, M; Zara, F | 1 |
| Etherton, MR; Gupta, AS; Lovitch, SB; McKee, KE; Micalizzi, DS; Tierney, T; Vaitkevicus, H; Wadleigh, M | 1 |
| Çelik, T; Çelik, Ü; Gezgin, AE; Kaya, MS; Kömür, M; Tolunay, O | 1 |
| Brandt, C; Daniluk, J; DeRossett, S; Edwards, S; Lerche, H; Lotay, N | 1 |
| Bentea, E; Coppens, J; Maes, K; Massie, A; Smolders, I; Van Eeckhaut, A; Van Liefferinge, J; Walrave, L | 1 |
| Bensadoun, ES; Buch, KP; Flannery, AH; Thompson Bastin, ML; Willey, MD | 1 |
| Frazee, EN; Kashani, KB; Nei, SD; Wittwer, ED | 1 |
| Abel, H; Campbell, LA; Pohlmann-Eden, B; Thompson, K | 1 |
| Xiao, R | 1 |
| Akingbola, O; Ayers, T; Barbiero, L; Lau, M; Nelson, S; Singh, D; Singh, Y | 1 |
| Akdemir, A; Akman, L; Erbas, O; Kazandi, M; Taskiran, D; Yavasoglu, A | 1 |
| Esen, İ; Koç, ZP; Serin, HM; Temelli, B | 1 |
| Bernhard, MK; Bertsche, A; Bertsche, T; Dahse, AJ; Frontini, R; Kiess, W; Merkenschlager, A; Neininger, MP; Syrbe, S; Thome, U; Ullmann, M | 1 |
| Citraro, R; Coppola, A; De Sarro, G; Del Gaudio, L; Palleria, C; Russo, E; Striano, S | 1 |
| Guo, L; Li, H; Li, S; Tang, P; Wang, L; Wu, D; Xiong, X; Xu, K; Yan, J | 1 |
| Baba, H; Fuji, A; Matsuo, M; Matsuzaka, T; Moriuchi, H; Ono, T; Sato, T; Tanaka, S; Toda, K | 1 |
| Chiarelli, F; Di Sabatino, F; Franco, V; Prezioso, G; Verrotti, A; Zaccara, G | 1 |
| Kang, TC; Ko, AR | 1 |
| Clemens, B; Dömötör, J | 1 |
| Altunbasak, S; Besen, S; Herguner, OM; Incecik, F | 1 |
| Ah, YM; Cho, YS; Jung, AH; Kim, KJ; Lee, JY | 1 |
| Chen, CL; Chen, NC; Chuang, YC; Lin, CH; Lin, TK; Tsai, MH | 1 |
| Du, C; Wang, X; Zheng, F | 1 |
| Afsar, S; Dixit, NS; Motwani, N; Sharma, N | 1 |
| Borghs, S; D'Souza, J; Eckhardt, K; Fakhoury, T; Liang, W; Yates, SL | 1 |
| Janszky, J | 1 |
| Armagan, E; Bozkurt, M; Eroglu, U; Kahilogullari, G; Ozgural, O; Unlu, A | 1 |
| Enoki, H; Okanishi, T; Yokota, T | 1 |
| Allahverdiyev, O; Büget, B; Enginar, N; Türkmen, AZ | 1 |
| Bao, H; Hao, J; Li, G; Li, Y; Wang, X; Xu, X; Zhang, Y; Zuo, L | 1 |
| Kalita, J; Misra, UK | 1 |
| Krishnamoorthy, V; Sharma, D; Vavilala, MS; Wilson, T | 1 |
| Asanuma, M; Kitamura, Y; Miyazaki, I; Murakami, S; Torigoe, N | 1 |
| Awaya, T; Heike, T; Ide, M; Kato, T; Nakata, M; Saito, K; Yoshida, T | 1 |
| del Gaudio, L; Francavilla, T; Giudizioso, G; La Neve, A; Mencaroni, E; Minetti, C; Piccioli, M; Pinto, F; Striano, P; Striano, S; Tovo, P; Vari, MS; Verrotti, A | 1 |
| Bognar, J; Dubinsky, JM; Esguerra, M; He, T; Mohammed, M; Niespodziany, I; Rothman, SM; Wolff, C; Yang, X | 1 |
| Breuer, L; Gschossmann, JM; Kasper, BS; Kornhuber, J; Müller, HH; Schwarze, B | 1 |
| Eadie, MJ; Graham, J; Lander, CM; O'Brien, TJ; Vajda, FJE | 1 |
| Gladov, BP; Kamelkova, EG; Karlov, VA; Vlasov, PN | 1 |
| Ahn, MH; Choi, EJ; Hong, JP; Kang, JK; Lee, HB; Lee, HJ; Park, S; Park, SJ; Ryu, HU | 1 |
| Allen, GB; Babi, MA; Borden, NM; Nathan, MH; Tandan, R; Waheed, W | 1 |
| Fujino, O; Itoh, Y; Kawakami, Y; Okazaki, T; Takase, M | 1 |
| Arhan, EP; Erdogan, KM; Gurkas, E; Karalok, ZS | 1 |
| Bayram, AK; Canpolat, M; Çınar, SL; Gumus, H; Kumandaş, S; Per, H; Tahan, F | 1 |
| Daley, MJ; Hobbs, AL; Roberts, KM; Shea, KM | 1 |
| Chen, YN; Lang, SY; Ma, YF; Shi, XB; Wang, XQ; Zhang, JT; Zhang, X; Zhu, F | 1 |
| Kurita, A; Patanwala, AE; Truong, E | 1 |
| An, K; Baulac, M; Bolgert, F; Carli, P; Dagron, C; Demeret, S; Elie, C; Lamhaut, L; Navarro, V; Tréluyer, JM; Urien, S | 1 |
| Brigo, F; Höfler, J; Kalss, G; Leitinger, M; Rohracher, A; Trinka, E | 1 |
| Ardeshna, N | 1 |
| Berendt, M; Fredsø, N; Møller, A; Sabers, A; Toft, N | 1 |
| Arrey, TN; Baeumlisberger, M; Friedland, K; Karas, M; Miano, D; Müller, WE; Pallas, T; Stockburger, C | 1 |
| Belton, RJ; Lawrence, JE; Rovin, RA; Steele, CJ; Winn, RJ | 1 |
| Hughes, SE; Juba, KM; Raphael, CD; Zhao, F | 1 |
| Carlow, DC; Schofield, RC; Shi, H | 1 |
| Carson, RE; Chanteux, H; Hannestad, J; Holden, D; Huang, Y; Kervyn, S; Klitgaard, H; Matagne, A; Mathy, FX; Mercier, J; Nabulsi, N; Nicolas, JM; Staelens, L; Stockis, A; Tytgat, D | 1 |
| Andermann, E; Andermann, F; de la Loge, C; Frucht, SJ; Genton, P; Gerard, D; Kälviäinen, R; Magaudda, A; Schlit, AF; von Rosenstiel, P | 1 |
| Chung, MG; O'Brien, NF | 1 |
| Bramlett, HM; Browning, M; Dietrich, WD; Dixon, CE; Hayes, RL; Kochanek, PM; Mondello, S; Poloyac, SM; Povlishock, JT; Schmid, KE; Shear, DA; Tortella, FC; Wang, KK | 1 |
| Brodie, MJ; Chowdhury, A | 1 |
| Dadoun, Y; Froelich, S; Lozeron, P; Madadaki, C; Mandonnet, E; Poisson, I | 1 |
| Bessant, C; Garosi, L; Harvey, RJ; Lowrie, M; Sparkes, A; Thomson, S | 1 |
| Fidzinski, P; Gaus, V; Holtkamp, M; Kowski, AB; Losch, F; Weissinger, F | 1 |
| Moustafa, YM; Reda, HM; Zaitone, SA | 1 |
| Ceja, H; Chung, S; Gawłowicz, J; Lu, S; McShea, C; Schiemann, J | 1 |
| Kumar, D; Laurenza, A; Meador, KJ; Piña-Garza, JE; Wesnes, KA; Yang, H | 1 |
| Agarwal, S; Chung, DY; Claassen, J; Mayer, SA; Schmidt, JM | 1 |
| Kurzrock, R; Stewart, DJ | 1 |
| Chambers, J; Foreman, E; Mason, LD; Wells, GH | 1 |
| Artemiadis, AK; Bougea, A; Gatzonis, S; Giannopoulos, S; Lambrinoudaki, I; Safouris, A; Triantafyllou, N; Tsivgoulis, G; Voskou, P | 1 |
| García Estévez, DA; García-Dorrego, RM; Hierro-Torner, T; Marey-Garrido, M; Nieto-Baltar, B | 1 |
| Gajdošová, M; Grof, Z; Pěček, D; Sarvašová, N; Štěpánek, F | 1 |
| Chinot, O; Cloughesy, T; Gilbert, MR; Gorlia, T; Happold, C; Hegi, M; Mehta, MP; Nabors, LB; Perry, JR; Pugh, SL; Reardon, DA; Roth, P; Stupp, R; Weller, M; Wick, W | 1 |
| Grice, JE; Isbister, GK; Mostafa, A; Page, CB; Roberts, MS; Saiao, A | 1 |
| Erbaş, O; Oltulu, F; Taşkıran, D; Yavaşoğlu, A; Yılmaz, M | 1 |
| Frazee, EN; Kashani, KB; Nei, SD; New, AM; Rabinstein, AA | 1 |
| Murray-Brown, FL; Stewart, A | 1 |
| Kamm, C; Paschen, I; Rösche, J; Walter, U | 1 |
| Christie, J; Gorelik, A; Hakami, T; Kantor, S; O'Brien, TJ; Petty, SJ; Sakellarides, M; Seibel, MJ; Todaro, M; Wark, JD; Yerra, R | 1 |
| Abou-Khalil, BW | 1 |
| Çavuşoğlu, D; Dündar, NO; Gencpinar, P; Tekgül, H | 1 |
| Arzimanoglou, A; Bentz, J; Garate, P; Lösch, C | 1 |
| Caudle, KL; Lu, XC; Mountney, A; Shear, DA; Tortella, FC | 1 |
| Ko, JY; Kwon, HI; Moon, SH; Oh, SJ; Ro, YS | 1 |
| Erbaş, O; Taşkıran, D; Yılmaz, M | 1 |
| Borczuk, P; Miller, ES; Ptak, T; Sonis, J | 1 |
| Gunasekar, P; Madabushi, JS; Selvaraj, V; Singh, SP | 1 |
| Aydın, A; Aydınlı, N; Bektaş, G; Çalışkan, M; Özmen, M; Pembegül Yıldız, E; Tatlı, B | 1 |
| Hashi, S; Ikeda, A; Ito, S; Matsubara, K; Sugimoto, M; Tsuda, M; Yano, I; Yonezawa, A | 1 |
| Dong, C; Jin, H; Li, W; Ma, L; Wu, J; Zhao, W | 1 |
| Choonara, I; Egunsola, O; Sammons, HM | 1 |
| Löscher, W; Töllner, K; Twele, F | 1 |
| Amaniti, E; Apostolidou, E; Karakoulas, K; Kouvelas, D; Pourzitaki, C; Tsaousi, G | 1 |
| Bhoi, SK; Kalita, J; Misra, UK | 1 |
| Alberghini, L; Benini, G; Candela, C; Contin, M; Riva, R | 1 |
| Fuller, HR; Garton, M; Wilson, EL | 1 |
| Boudriau, S; Hanzel, C; Lefebvre, M; Massicotte, J; Sayegh, L; Wang, J | 1 |
| Abe, S; Azuma, Y; Ishihara, N; Ito, Y; Itomi, K; Kidokoro, H; Kojima, S; Kurahashi, H; Kurahashi, N; Maruyama, K; Natsume, J; Negoro, T; Okumura, A; Suzuki, M; Takeuchi, T; Tsuji, T; Watanabe, K; Yamada, K; Yamamoto, H | 1 |
| Bártfai, G; Devosa, I; Szok, D; Vanya, M | 1 |
| Externbrink, A; Gao, Z; Jiang, W; Keire, D; Krauss, G; Sun, D; Wen, H | 1 |
| Brunnert, M; De Backer, M; Doty, P; Eckhardt, K; Schulze-Bonhage, A; Steinhoff, BJ | 1 |
| Chervoneva, I; Miller, R; Mintzer, S; Nei, M; Shah, K; Skidmore, C; Sperling, MR | 1 |
| Ağın, H; Ceylan, G; Güzel, O; İşgüder, R; Yılmaz, Ü | 1 |
| Chen, YH; Chiang, YH; Chou, YC; Hoffer, BJ; Huang, EY; Kuo, TT; Ma, HI; Tsai, JJ; Wu, PJ | 1 |
| Barary, MA; El-Yazbi, AF; Ibrahim, F; Wagih, MM | 1 |
| An, DM; Chen, JN; Hu, FY; Ren, JC; Wang, W; Zhou, D | 1 |
| Datta, P; Hope, O; Kalamangalam, GP | 1 |
| Nasr, ZG; Paravattil, B; Wilby, KJ | 1 |
| Dabaghian, Y; Kesler, SR; Manchon, JF; Tsvetkov, AS; Uzor, NE; Wefel, JS | 1 |
| Lipton, SA; McKercher, SR; Piña-Crespo, JC; Sanz-Blasco, S; Zhang, X | 1 |
| Arora, MK; Baidya, DK; Gupta, S; Maitra, S; Som, A | 1 |
| Floeter, AE; McCune, JS | 1 |
| Bendix, I; Bertsche, A; Fandrey, J; Felderhoff-Mueser, U; Hoeber, D; Kluever, V; Lueckemann, L; Strasser, K; Thavaneetharajah, S | 1 |
| Garcia, A; Garcia-Garcia, P; Mauri-Llerda, JA; Pardo-Merino, A; Rocamora, R; Serrano-Castro, PJ | 1 |
| Li, H; Li, S; Zhang, L; Zou, X | 1 |
| Gupta, YK; Kakkar, AK; Sarangi, SC; Tripathi, M | 1 |
| Ayas, B; Elbistan, M; Guvenc, T; Kara, N; Tekcan, A; Tural, S | 1 |
| Antoni, G; Buchanan, T; Estrada, S; Gillard, M; Kenda, B; Lubberink, M; Mercier, J; Mestdagh, N; Provins, L; Sprycha, M; Thibblin, A; Tytgat, D | 1 |
| Jiang, W; Polli, JE; Ting, TY; Vaithianathan, S | 1 |
| Litofsky, NS; Tanaka, T | 1 |
| Li, J; Qi, L; Shao, WZ; Shen, J; Sun, YZ; Tang, LJ; Xu, JC; Zhai, XF; Zheng, JY | 1 |
| Friese, R; Gruessner, A; Joseph, B; Khalil, M; Kulvatunyou, N; Latifi, R; O'Keeffe, T; Rhee, P; Wynne, J; Zangbar, B | 1 |
| Arana-Lechuga, Y; Collado-Corona, MA; González-Robles, R; Ruiz-Chow, A; Sánchez-Escandón, O; Shkurovich-Bialik, P; Terán-Pérez, G; Velázquez-Moctezuma, J | 1 |
| Ben-Menachem, E; Eckhardt, K; Gamage, J; Johnson, ME; Klein, P; Mameniškienė, R; McDonough, B; Quarato, PP; Schiemann, J; Whitesides, J | 1 |
| Bari, E; Javed, G; Murtaza, G; Qadeer, M; Waqas, M | 1 |
| Afonso, D; Bigoni, M; Glard, Y; Griffet, J; Turati, M | 1 |
| Ge, YX; Lin, YY; Liu, XY; Tian, XZ | 1 |
| Bramanti, P; Caminiti, F; Ciurleo, R; De Salvo, S; Granata, F; Marino, S; Nunnari, D | 1 |
| Chen, W; Chen, Y; Ge, Y; Liu, X; Tan, Y | 1 |
| Asadi, F; Moradian, M; Moradian, N; Sedighi, M; Vakiliamini, M | 1 |
| Al-Qudah, AA; Alabbadi, I; Albsoul-Younes, A; Gharaibeh, L; Masri, A; Murtaja, AA | 1 |
| Fujishiro, H; Kosaka, K; Ozaki, N; Ukai, K; Watanabe, M | 1 |
| Drossos, D; Giannakaki, V; Papapetrou, K; Triantafyllou, T | 1 |
| Béné, J; Gautier, S; Lemaire, N; Ramon, M; Tourteau, E | 1 |
| Chen, J; Chen, SZ; Liu, XM; Yue, X | 1 |
| Wang, X; Xu, X; Yang, Y; Zheng, F | 1 |
| Brandt, C; De Backer, M; Dedeken, P; Eckhardt, K; Elger, CE; Elmoufti, S; Rademacher, M; Tennigkeit, F | 1 |
| Ertl, J; Forth, B; Hapfelmeier, J; Peckmann, T; Strzelczyk, A | 1 |
| Escartin Siquier, A; Forcadas Berdusan, M; Martin Moro, M; Martinez Ferri, M; Peña Mayor, P; Perez López-Fraile, I | 1 |
| Fujita, K; Ishigaki, S; Kato, H; Kuroda, T; Murakami, H; Ono, K; Saito, Y; Yano, S | 1 |
| Ayzenberg, I; Börnke, C; Gold, R; Grüter, T | 1 |
| Bayraktutan, OF; Ceylan, M; Karabulut, I; Sonkaya, AR; Yalcin, A | 1 |
| Reuter-Rice, K; Vaewpanich, J | 1 |
| DiDominick, S; Finn, S; Kim, HJ; Reeves, D; Shake, A | 1 |
| Devine, EG; Falk, DE; Fertig, JB; Litten, RZ; Ryan, ML | 1 |
| Borghs, S; Brandt, C; Charokopou, M; Klein, P | 1 |
| Inaba, Y; Kurata, T; Morita, D; Motobayashi, M; Nakazawa, Y; Shigemura, T; Shimozawa, N | 1 |
| Bastin, ML; Cook, AM; Oyler, DR; Smetana, KS | 1 |
| Marson, AG; Noack-Rink, M; Pohlmann-Eden, B; Ramirez, F; Tofighy, A; Trinka, E; Werhahn, KJ; Wild, I | 1 |
| Bast, T; Bonfert, M; Borggraefe, I; Cornell, S; Gerstl, L; Heinen, F; Heukaeufer, I; Neubauer, BA; Tacke, M | 1 |
| Dante, M; Hu, Z; Li, K; Li, Q; Li, Z; Lu, G; Wu, H; Xu, Q; Yang, F; Zhang, Q; Zhang, Z | 1 |
| Lin, Z; Xiaoyi, Z | 1 |
| Halbert, RK | 1 |
| Baker, GA; Bromley, RL; Calderbank, R; Cheyne, CP; Clayton-Smith, J; García-Fiñana, M; Irwin, B; Morrow, JI; Rooney, C; Shallcross, R; Trayner, P | 1 |
| Derian, A; Khurana, S; Plumlee, C; Rothenberg, J | 1 |
| Abuhadra, N; Al Hail, H; Al Jurdi, A; Alarcon, G; Alsamman, Y; Aqeel, F; Azar, N; Deleu, D; Elzafarany, A; Haddad, N; Laswi, M; Mahfoud, Z; Melikyan, G; Mesraoua, B; Streletz, L; Uthman, B | 1 |
| Cheng, Z; Li, Y; Qiang, W; Wang, L; Xie, M; Zhang, S | 1 |
| Hopkins Tanne, J | 1 |
| Barary, MA; El-Yazbi, AF; Ibrahim, FA; Wagih, MM | 2 |
| Bonuccelli, U; Giorgi, FS; Guida, M; Vergallo, A; Zaccara, G | 1 |
| Chiba, Y; Dohgu, S; Ishihara, Y; Itoh, K; Kataoka, Y; Komori, R; Nochi, H; Takata-Tsuji, F; Taniguchi, R; Ueno, M | 1 |
| Baulac, M; Borghs, S; Byrnes, W; De Backer, M; Dedeken, P; Webster, E; Williams, P | 1 |
| Agrawal, V; Jena, AB; Rawat, KJ; Redkar, N; Shah, JH | 1 |
| Bragazzi, N; Brigo, F; Nardone, R; Trinka, E | 1 |
| Aeberhard, C; Huber, A; Mühlebach, S; Saxer, C; Stanga, Z; Steuer, C | 1 |
| Arakawa, H; Hazama, K; Ida, K; Makioka, N; Motojima, T; Muramatsu, K; Ogata, T; Sawaura, N; Tomita, K | 1 |
| Barker, F; Evans, LT; Fierst, TM; Hoes, K; Hymel, C; Khan, NR; Klimo, P; Mayer, R; VanLandingham, MA | 1 |
| Agarwal, P; Gupta, A; Poornima, S; Shukla, G | 1 |
| Baker, G; Wieshmann, UC | 1 |
| Habets, JGV; Leentjens, AFG; Schijns, OEMG | 1 |
| Al-Bewerat, A; Schattner, A | 1 |
| Florek-Łuszczki, M; Kondrat-Wróbel, MW; Tutka, P; Zaluska, K; Żółkowska, D; Łuszczki, JJ | 1 |
| Liu, J; Wang, LN; Wang, YP; Wu, LY | 1 |
| Fernandez-Gonzalez, N; González-Cordero, PL; Molina-Infante, J | 1 |
| Hallett, M; Mathew, P; Maurer, CW; Paine, R; Park, JE; Ramos, VL; Sackett, J; Srivanitchapoom, P | 1 |
| Biondi, A; Carlesso, S; Premoli, I; Richardson, MP; Rivolta, D | 1 |
| Ahmad, KA; Ahmad, SF; Bennett, MM; Clark, RH; Desai, SJ; Ng, YT; Tolia, VN | 1 |
| Gupta, YK; Kakkar, AK; Kumar, R; Sarangi, SC | 1 |
| André-Obadia, N; Bouchier, B; Demarquay, G; Gobert, F; Guérin, C | 1 |
| Dambach, H; Faustmann, PM; Förster, E; Haase, CG; Hinkerohe, D; Ismail, FS; Moinfar, Z; Prochnow, N | 1 |
| Chen, YM; Li, JN | 1 |
| Brawanski, A; Höhne, J; Lange, M; Ott, C; Schebesch, KM | 1 |
| Beaumont, J; Holl, JL; Jahromi, B; Kho, A; Naidech, AM; Prabhakaran, S | 1 |
| Foudraine, NA; Janssen, PK; Kornips, FH; le Noble, JL; Neef, C; van Dam, DG | 1 |
| Schapiro, M; Thomas, C; Venkatesan, C; Young, S | 1 |
| Kawataki, T; Kinouchi, H; Ogiwara, M; Sato, H; Suzuki, K | 1 |
| Carpenter, AF; Goodwin, SJ | 1 |
| García Carretero, R; Olid-Velilla, M; Romero Brugera, M; Salamanca-Ramirez, I | 1 |
| Ajit, NE; Burton, GV; El-Osta, H; Peddi, P | 1 |
| Gillard, M; Wood, MD | 1 |
| Beydemir, Ş; Demir, Y | 1 |
| Abu Rmeileh, A; Benson, AA; Chen, S; Cohen, J; Daher, S; Khoury, T; Mizrahi, M; Yaari, S | 1 |
| Di Lorenzo, R; Li, Y | 1 |
| Auvin, S; Baud, O; Bonnin, P; Charriaut-Marlangue, C; Dupuis, N; Enderlin, J; Leger, PL; Morin, L; Perrotte, G | 1 |
| Fung, BB; Fung, EL | 1 |
| Goel, RK; Kaur, T; Singh, T | 1 |
| Duzcu, SE; Karapinar, T; Sereflican, B; Turkoglu, ŞA | 1 |
| Gallagher, M; Haberman, RP; Koh, MT | 1 |
| Chemali, Z; Gholipour, T; Mitchell, S; Sarkis, RA | 1 |
| Gao, JY; Gao, L; Huang, SP; Liao, JX; Liu, MJ; Mai, JN; Md, XS; Shu, XM; Su, XJ; Wang, H; Wang, W; Wu, GF; Zhang, L; Zhang, YQ; Zou, LP | 1 |
| Arslankoylu, AE; Beydagi, H; Celik, Y; Erdogan, S; Komur, M; Okuyaz, C; Polat, A; Resitoglu, B | 1 |
| Chan, EL; Chan, I; Chang, RS; Fong, GC; Fong, JK; Fung, BB; Fung, EL; Leung, H; Lui, CH; Poon, TL; Siu, D; Wong, HT; Yeung, E; Yung, AW; Zhu, CX | 1 |
| Levy, ZD; Schulder, M; Slowey, M | 1 |
| Akinyemi, A; Michel, G; Sanchez-Gonzalez, MA; Sterkel, S | 1 |
| Kim, J; Shin, JW | 1 |
| Danish, A; Müller, CE; Namasivayam, V; Schiedel, AC | 1 |
| Chimato, N; Frank, RD; Karceski, SC; Shih, JJ; Vargas, E; Whitlock, JB | 1 |
| Fagan, A; Fuld, J; Soon, E | 1 |
| Chu, K; Jang, IJ; Jung, KH; Jung, KY; Kim, TJ; Lee, S; Lee, SK; Lee, ST; Moon, J; Park, KI; Rhee, SJ; Shin, JW; Yu, KS | 1 |
| Mäkinen, J; Peltola, J; Rainesalo, S; Raitanen, J | 1 |
| Engelbrecht, L; Grobler, CJ; Rheeders, M | 1 |
| Ain, Q-; Khan, MA; Khan, SA; Memon, MH; Shahbaz, N; Younus, SM | 1 |
| Ding, P; Liang, S; Wu, Y; Zhang, J; Zhang, S | 1 |
| Belcastro, V; Bellocchi, S; Casiraghi, P; Gorgone, G; Mula, M; Pisani, F; Pisani, LR | 1 |
| Poskrobko, E; Rusak, M; Sendrowski, K; Sobaniec, P; Sobaniec, W | 1 |
| Sarfaraz, M; Syeda, RH | 1 |
| Blatsioris, AD; Carter, RJL; Cohen-Gadol, AA; Hulin, AL; Leipzig, TJ; Mackey, J; Moser, EAS; O'Neill, DP; Saha, C; Stevenson, A; Williams, LS | 1 |
| Kaindl, AM; Tountopoulou, M; Weschke, B | 1 |
| Micov, A; Pecikoza, U; Stepanović-Petrović, R; Tomić, M | 1 |
| Aicua Rapun, I; Novy, J; Oddo, M; Rossetti, AO; Solari, D | 1 |
| Ukai, K; Watanabe, M | 1 |
| Ensom, MHH; Levine, M; Paquette, V; Tan, J | 1 |
| Ghadikolaei, HS; Kashipazha, D; Siavashi, M | 1 |
| Chatzistefanidis, D; Gatzonis, S; Kyritsis, AP; Markoula, S; Patsalos, PN; Siarava, E; Siatouni, A; Verentzioti, A | 1 |
| Bacher, M; Bucurenciu, I; Hillenbrand, B; Intravooth, T; Kornmeier, R; Kurth, C; Staack, AM; Steinhoff, BJ; Stockinger, J | 1 |
| Hong, SB; Kim, JH; Lee, HW; Lee, SK; Loesch, C; Namgoong, K | 1 |
| Cárcamo-Rodríguez, C; Ciampi, E; Cruz, JP; Godoy-Santín, J; Juri, C; Uribe-San-Martín, R | 1 |
| Atli, O; Baysal, M; Ilgin, S; Kilic, G; Kilic, V; Ucarcan, S | 1 |
| Arslan, M; Güngör, S; Kılıç, B; Selimoğlu, MA; Yılmaz, S | 1 |
| Cava, LF; Fish, DN; Kiser, TH; MacLaren, R; Mueller, SW; Neumann, RT; Van Matre, ET | 1 |
| Ii, Y; Ishikawa, H; Maeda, M; Matsuura, K; Niwa, A; Tomimoto, H | 1 |
| Cao, Y; Liao, Z; Lu, XM; Mountney, A; Shear, DA; Tortella, FC | 1 |
| Redecker, J; Rösche, J; Wittstock, M | 1 |
| Ambrosi, M; Pavone, P; Striano, P; Verrotti, A | 1 |
| Coppola, G; Operto, FF; Piccorossi, A; Verrotti, A | 1 |
| Bienkowski, P; Karaś-Ruszczyk, K; Kuczyńska, J; Kurkowska-Jastrzębska, I; Mierzejewski, P; Restel, M; Samochowiec, J; Sienkiewicz-Jarosz, H | 1 |
| Godley, A; Goetghebeur, PJ; Havolli, E; Hill, MD | 1 |
| Herman, ST; Musaeus, CS; Press, DZ; Santarnecchi, E; Shafi, MM | 1 |
| Al-Amrani, K; Al-Asmi, A; Al-Hashim, A; Ganguly, SS; Gujjar, AR; Jacob, PC; Nandhagopal, R | 1 |
| Brodie, MJ; Stephen, LJ; Wishart, A | 1 |
| Company-Albir, MJ; Marqués-Miñana, MR; Poveda, JL; Ruíz-Ramos, J; Solana Altabella, A; Vicent, C | 1 |
| Agrawal, N; Cock, HR; Lozsadi, DA; Mula, M; von Oertzen, TJ; Yogarajah, M | 1 |
| Aydınlı, N; Bektaş, G; Çalışkan, M; Özkan, MU; Özmen, M; Tekin, U; Yıldız, EP | 1 |
| Sands, KA; Shiue, HJ; Taylor, M | 1 |
| Agrawal, A; Banergee, A | 1 |
| Hoff, E; Källén, K; Lundgren, A; Nilsson, J; Olsson, P; Reimers, A; Reis, M; Strandberg, M | 1 |
| Bongiovanni, LG; Casari, R; Faccini, M; Federico, A; Franchini, E; Lugoboni, F; Morbioli, L; Tamburin, S | 1 |
| Fabi, A; Giannarelli, D; Maialetti, A; Maschio, M; Vidiri, A; Villani, V; Zarabla, A | 1 |
| Appleton, RE; Babl, FE; Bacon, NEA; Dalziel, SR; Gamble, C; Hickey, H; Humphreys, A; Iyer, A; Lyttle, MD; Messahel, S; Roper, L; Ryan, M; Woolfall, K | 1 |
| Doherty, W; Kennedy, J; Orme, R; Simmonds, L | 1 |
| Gallagher, M; Koh, MT; Rosenzweig-Lipson, S; Shao, Y | 1 |
| Fujita, N; Oyake, M; Tsuboguchi, S; Umeda, M; Umeda, Y; Wakasugi, T | 1 |
| Daidoji, H; Doi, K; Hashimoto, H; Hiruma, T; Inokuchi, R; Morimura, N; Nakamura, K; Naraba, H; Sonoo, T; Tokunaga, K | 1 |
| Kwan, P; Palmini, A | 1 |
| Babl, FE; Bonisch, M; Borland, M; Brabyn, C; Cheng, N; Craig, S; Dalziel, SR; Davidson, A; Donath, S; Furyk, J; George, S; Harvey, S; Kochar, A; Neutze, J; Oakley, E; Phillips, N; Rao, A; Sharpe, C; Sinn, K; Zhang, M | 1 |
| Altmeyer, WB; Moise, AM; Singh, AK; Tantiwongkosi, B | 1 |
| Marson, AG; Nevitt, SJ; Sudell, M; Tudur Smith, C; Weston, J | 2 |
| Banda, JM; Duke, JD; Hripcsak, G; Jin, P; Khoma, Y; Reich, C; Ryan, PB; Schuemie, MJ; Schwalm, MS; Shah, NH; Suchard, MA; Wu, Y; Xu, H | 1 |
| Brozmanova, H; Grundmann, M; Kacirova, I; Koristkova, B | 1 |
| Hashimoto, N; Kurita, T; Kusumi, I; Nakagawa, S; Narita, H; Saitoh, T; Sawagashira, R | 1 |
| Osborn, KE; Rum, RS; Schoenberg, MR; Werz, MA | 1 |
| Bradley, V; Bush, O; Curtin, J; Hedges, V; Naessens, K; Presswood, M; Sutherland, AE | 1 |
| Aroni, S; Marrosu, F; Melis, M; Milioli, G; Muntoni, AL; Parrino, L; Pillolla, G; Pistis, M; Puligheddu, M; Sagheddu, C; Terzano, GM | 1 |
| Cincioğlu-Palabiyik, M; Ertoy-Baydar, D; Karahan, H; Kelicen-Uğur, P; Sara, Y; Üner, M | 1 |
| Abdelhakim, K; Casey, WF; Chaari, A; Kauts, V; Mohamed, AS | 1 |
| Bedetti, C; Calabresi, P; Costa, C; Di Bonaventura, C; Dispenza, S; Eusebi, P; Maschio, M; Nardi Cesarini, E; Romoli, M; Siliquini, S | 1 |
| Bosak, M; Słowik, A; Turaj, W | 1 |
| Burakgazi-Dalkilic, E; Carran, M; Hunter, K; Taneja, R | 1 |
| Citraro, R; Mula, M; Russo, E | 1 |
| Chung, S; Dobrinsky, C; Laurenza, A; Patten, A; Williams, B; Yang, H | 1 |
| Alexopoulos, AV; Gonzalez-Martinez, J; Najm, IM; Nemes, AD; O'Dwyer, R; Ying, Z | 1 |
| Chiş, C; Chiş, V; Leopold, N; Luchian, R; Prates Ramalho, JP; Vasilescu, M; Vinţeler, E | 1 |
| Kelly, D; Raimondi, F; Shihab, N | 1 |
| Chen, D; Liu, L; Tan, G; Wang, HJ; Xu, D; Zhu, LN | 1 |
| Borghs, S; Fang, A; Plumb, J; Signorovitch, J; Swallow, E | 1 |
| Andres-Mach, M; Chmielewski, J; Florek-Luszczki, M; Kondrat-Wrobel, MW; Luszczki, JJ; Patrzylas, P; Szpringer, M; Zagaja, M; Zaluska, K | 1 |
| Lampe, R; Manens, J; Sharp, N | 1 |
| Abraham Koshy, A; Kumar A, A | 1 |
| Canotilho, J; Castro, RAE; Eusébio, MES; Machado, SMT; Maria, TMR | 1 |
| Bassolé, IHN; Gnankiné, O | 1 |
| Fujikawa, M; Jin, K; Kakisaka, Y; Kato, K; Kitazawa, Y; Nakasato, N | 1 |
| Feyissa, AM | 1 |
| Brohi, H; Kumar, R; Mughul, A | 1 |
| Kamate, M | 1 |
| Jiang, D; Shen, H; Wang, J; Xu, P; Yan, BC; Yu, X; Zhang, Y; Zhu, X | 1 |
| Barnes Heller, H | 1 |
| Izumo, N; Kanda, J; Kobayashi, Y; Onodera, K; Shimakura, T; Takahashi, HE; Wakabayashi, H; Yamamoto, N | 1 |
| Barnard, L; Barnes Heller, H; Boothe, DM | 1 |
| Gustafsson, LL; Hansson, A; Linder, C; Pohanka, A; Sadek, S | 1 |
| Fujii, K; Natori, Y; Saeki, S; Sakata, S; Terasaki, Y | 1 |
| Benjamin, E; Demetriades, D; Hong, Q; Inaba, K; Khor, D; Wu, J; Xiao, S | 1 |
| Alunday, RL; Bussmann, S; Lee, T; Sarangarm, P; Seifert, SA; Smolinske, SC; Warrick, BJ | 1 |
| Hieger, MA; Maskell, KF | 1 |
| Lancaster, S; Manganas, LN; McHugh, DC | 1 |
| Berghaus, LJ; Davis, JL; Giguère, S; Hart, KA; MacDonald, KD | 1 |
| Cortez, MA; Fischer, A; James, FMK; Kluger, G; Lohi, H; Neßler, JN; Tipold, A; Wielaender, F | 1 |
| Bakare, AA; Burks, JD; Evans, RM; Rodgers, RB; Safavi-Abbasi, S; Wilson, CD | 1 |
| Aldaz, A; Alzueta, N; Viteri, C | 1 |
| George, R; Langford, A | 1 |
| Gómez-Ruiz, LM; Lima-Rogel, V; López-López, EJ; Medellín-Garibay, SE; Milán-Segovia, RC; Romano-Moreno, S; Romero-Méndez, C | 1 |
| Crescioli, G; De Masi, S; Guerrini, R; Ilvento, L; Lucenteforte, E; McGreevy, KS; Mugelli, A; Pugi, A; Rosati, A; Virgili, G | 1 |
| Furtado, I; Gonçalves, F; Gonçalves, J; Neves, J | 1 |
| Ceusters, M; Klein, BD; Lavreysen, H; Metcalf, CS; Pype, S; Smith, MD; Twyman, R; Van Osselaer, N; White, HS | 1 |
| Jung, YS; Lee, SM; Park, K; Park, MS | 1 |
| Bacek, LM; Biddick, AA; Taylor, AR | 1 |
| Choonara, I; Egunsola, O; Sammons, HM; Whitehouse, WP | 1 |
| Fekete, S; Karesova, I; Malakova, J; Palicka, V; Pavlikova, L; Simko, J; Zimcikova, E; Zivna, H | 1 |
| Arican, P; Cavusoglu, D; Gencpinar, P; Olgac Dundar, N | 1 |
| Brown, H; Dionisio, S; Gillinder, L; Lehn, A | 1 |
| Baethmann, M; Bast, T; Baumeister, F; Bentele, K; Blank, C; Blank, HM; Bode, H; Bonfert, M; Borggraefe, I; Bosch, F; Brandl, U; Brockmann, K; Dahlem, P; Ernst, JP; Feldmann, E; Fiedler, A; Freitag, H; Gerigk, M; Gerstl, L; Heinen, F; Heß, S; Hikel, C; Hoffmann, HG; Hoovey, Z; Kieslich, M; Klepper, J; Kluger, G; Koch, H; Koch, W; Korinthenberg, R; Krois, I; Kühne, H; Kurlemann, G; Mandl, M; Mause, U; Muhle, H; Navratil, P; Neubauer, BA; Opp, J; Penzien, J; Polster, T; Prietsch, V; Quattländer, A; Rating, D; Reinhardt, K; Schara, U; Shamdeen, MG; Sönmez, Ö; Sprinz, A; Stephani, U; Straßburg, HM; Tacke, M; Töpke, B; Traus, M; Trollmann, R; Tuschen-Hofstätter, E; Vill, K; Waltz, S; Weber, G; Wendker-Magrabi, H; Wien, FU; Wolff, M | 1 |
| Andres-Mach, M; Czuczwar, M; Czuczwar, SJ; Kruszyński, K; Łukawski, K; Łuszczki, JJ | 1 |
| Alfaro-Rodriguez, A; Bandala, C; Bonilla-Jaime, H; Carrillo-Mora, P; Cortes-Altamirano, JL; Olmos-Hernández, A; Reyes-Long, S | 1 |
| Abed El-Gaphar, OAM; Abo-Youssef, AM; Halal, GK | 1 |
| Parveen, B; Tripathi, M; Vohora, D | 1 |
| Brniak, W; Jachowicz, R; Jamroz, W; Kurek, M; Lyszczarz, E | 1 |
| Beltrán, L; Caraballo, R; Lizama, R; Valenzuela, GR; Vargas, R | 1 |
| Rosini, JM; Whyte, CJ | 1 |
| Alves, G; Bicker, J; Falcão, A; Fortuna, A; Gonçalves, J | 1 |
| Abe, S; Fukuma, K; Higashida, K; Ihara, M; Nagatsuka, K; Okuno, Y; Tanaka, T; Tomari, S; Toyoda, K; Yamagami, H | 1 |
| Hintz, M; Novitskaya, Y; Schulze-Bonhage, A | 1 |
| Amantini, A; Campostrini, R; Giannasi, G; Giorgi, FS; Giovannelli, F; Nazerian, P; Paganini, M; Zaccara, G | 1 |
| Horsuwan, S; Jenjirattithigarn, N; Khongkhatithum, C; Prempunpong, C; Prommas, S; Puangpetch, A; Sukasem, C; Thampratankul, L; Visudtibhan, A; Worachat, N | 1 |
| Armahizer, M; Dahmane, E; Gopalakrishnan, M; Kalaria, SN; McCarthy, P | 1 |
| Liu, C; Lv, Y; Shi, M; Sun, L; Zhang, N | 1 |
| Barnes Heller, H; Boothe, DM; Granick, M; Van Hesteren, M | 1 |
| Bakr, A; Belli, A | 1 |
| Cai, XT; Liu, S; Wang, L; Wang, Z; Yu, D; Zhou, H | 1 |
| Calissendorff, J; Falhammar, H; Farmand, S; Lindh, JD; Mannheimer, B; Nathanson, D; Skov, J | 1 |
| Brown, JN; Gee, ME; Watkins, AK | 1 |
| Phuong, L; Shimanovsky, A | 1 |
| Dundar, Y; Greenhalgh, J; Marson, AG; Nevitt, SJ; Weston, J | 2 |
| Hu, LY; Li, H; Ma, SF; Shi, XY; Zhang, MN; Zou, LP | 1 |
| Amedeo, S; Bertone, I; Cagnotti, G; D'Angelo, A; Dappiano, E; Gardini, G; Guerriero, G; Lentini, L; Odore, R | 1 |
| Norton, G; Vallat, W; Yong, CH | 1 |
| Dae, SJ; Gha-Hyun, L | 1 |
| Guerra, D; Marques Mendes, E; Mendes, A; Ribeiro, C | 1 |
| Heo, K; Ki, CS; Kim, KH; Park, CW; Song, JS | 1 |
| Garner, O; Iardino, A; Ramirez, A | 1 |
| Takagi, K | 1 |
| Akef, GH; Allah, HMS; El-Haggar, SM; Mostafa, TM | 1 |
| Hintz, M; Hirsch, M; Schulze-Bonhage, A; Specht, A | 1 |
| Caffrey, DR; Cheung, A; Futai, K; Germain, G; Golenbock, DT; Hasegawa, Y; Heneka, MT; Iguchi, R; Latz, E; Mao, W; Okabe, S; Tamburro, ND; Thatcher, EJ; Tzeng, TC | 1 |
| Mitsuo, K; Nagata, S; Nishimura, Y | 1 |
| Attilakos, A; Dinopoulos, A; Garoufi, A; Prasouli, A; Tsirouda, M | 1 |
| Du, J; Gao, L; Lin, Y; Ren, L; Wang, D; Wang, Y; Zhou, Q | 1 |
| Baudou, E; Cances, C; Dimeglio, C; Hachon Lecamus, C | 1 |
| Kaushik, JS; Swami, M | 1 |
| Clark, K; Mohamudally, A | 1 |
| Hernández-Mitre, MP; Jung-Cook, HH; Medellín-Garibay, SE; Milán-Segovia, RDC; Roberts, JA; Rodríguez-Leyva, I; Rodríguez-Pinal, CJ; Romano-Moreno, S; Zarazúa, S | 1 |
| Bergamaschi, R; de Sire, A; Gasperini, C; Messmer Uccelli, M; Mueller, M; Patti, F; Restivo, DA; Solaro, C; Stabile, MR | 1 |
| Aihara, M; Hoshino, H; Kanemura, H; Sano, F; Takayama, K | 1 |
| DeMott, JM; Gottlieb, M; Peksa, GD; Slocum, GW | 1 |
| Dai, H; Feng, J; Yu, L; Yu, Z | 1 |
| Darwich, M; Hanneyan, S; Hnaini, M; Jaafar, F; Koleilat, N; Maalouf, FI; Mikati, IE; Nabout, R; Obeid, M; Rahal, S; Shbarou, RM | 1 |
| Adedokun, KI; Adekomi, DA; Atere, TG; Oladokun, OO; Olayiwola, G; Osuntokun, OS | 1 |
| Hussain, AM; Sharma, D; Sharma, SS | 1 |
| Cortes, C; Manterola, C | 1 |
| Harrison, T; Meldon, C; Miller, M; Sutherland, A | 1 |
| Jiao, Z; Li, ZR; Wang, CY; Zhu, X | 1 |
| Abraira, L; Ballvé, A; Campos, D; Fonseca, E; Llauradó, A; Quintana, M; Raspall, M; Salas-Puig, J; Santamarina, E; Toledo, M | 1 |
| Akıncı Göktaş, Ö; Bektaş, Ö; Şahin, S; Tıraş Teber, S; Yıldırım, M; Yüksel, MF | 1 |
| Hasegawa, N; Tohyama, J | 1 |
| Brand, F; Helmstaedter, C; Meschede, C; von Wrede, R | 1 |
| Afridi, LZ; Ahmad, M; Bzhilyanskaya, V; Menne, A; Palmer, J; Pourmand, A; Raffman, A; Rashid, A; Rehan, MA; Tran, QK | 1 |
| Church, EW; Cockroft, KM; Gigliotti, MJ; Simon, SD; Wilkinson, DA | 1 |
| Feng, J; Li, HJ; Ma, L; Sun, L; Sun, Y; Wang, TT; Yu, J; Yu, LH; Zhao, T | 1 |
| Hotta, M; Kaneko, J; Kondo, M; Kubota, M; Kuno, M; Nagano, M; Sugaya, K; Tagami, T; Takase, H; Unemoto, K | 1 |
| Kumar, J; Meena, J; Yadav, A | 1 |
| Adams, T; Greathouse, K | 1 |
| Bonnin, S; Haller, JT; Radosevich, J | 1 |
| Adekemi Abayomi, T; Grace Akingboye, B; Oladele Ayoka, A; Olayiwola, G; Samson Osuntokun, O | 1 |
| Aoki, S; Iida, K; Kikumoto, M; Maruyama, H; Neshige, S; Shishido, T; Ueno, H | 1 |
| Hayashi, M; Iijima, A; Isozaki, R; Kurishima, A; Shimozato, R; Shioda, T | 1 |
| Gupta, R; Halder, S; Kar, R; Labh, R; Narang, M | 1 |
| Cardon, AL; Cardon, M; García, FG | 1 |
| Chen, GD; Li, L; Salvi, R | 1 |
| Cao, JJ; Chen, HM; Chen, Q; He, W; Liu, LY; Lu, Q; Luo, XM; Shen, YW; Wang, J; Wang, QH; Wang, YY; Zhang, MN; Zou, LP | 1 |
| Branam, D; Maktabi, L; Reinert, JP; Snyder, M | 1 |
| Chen, PY; Chen, TJ; Chiu, HY; Hsieh, SH; Lin, CJ; Luh, HT; Wang, BC; Wu, CR | 1 |
| Akın, Y; Çağ, Y; Köle, MT; Sager, SG; Zeynel, H | 1 |
| Douville, A; Jense, A; Weiss, A | 1 |
| Chaneva, OG; Viteva, EI | 1 |
| Aydın, Z; Gözükızıl, ST; Yalçın, AD | 1 |
| Amin, TA; Elsawy, OA; Johnston, JP; Nerenberg, SF; Wang, A | 1 |
| El-Sherbiny, DT; El-Subbagh, HI; Ibrahim, FA; Mansour, NM | 1 |
| Methaneethorn, J | 1 |
| Blauensteiner, K; Calabek, B; Freydl, E; Hainz, K; Kindler, W; Konrath, E; Marhold, F; Oberndorfer, S; Popadic, B; Ristl, R; Scheichel, F; Sherif, C; Weber, M | 1 |
| Bartolini, L; Bassell-Hawkins, J; Lob, K; Nie, D; Patil, R | 1 |
| Hashimoto, R; Ishihara, Y; Itoh, K; Komori, R; Kono, T; Kozawa, C; Kubo, S; Matsuo, T; Yokota-Nakatsuma, A | 1 |
| Bradley, K; Kondasinghe, JS; Look, ML; Moffat, P | 1 |
| Tekin, E; Tekin, U; Uçar, HN | 1 |
| Amadori, E; D'Onofrio, G; Lattanzi, S; Riva, A; Rose, K; Striano, P; Verrotti, A | 1 |
| Pietrzak, B; Zwierzyńska, E | 1 |
| Kaleem, S; Komisarow, J; Kram, B; Lee, HJ; Ohman, K; Schultheis, J; Sigmon, J; Vatsaas, C; Yang, Z | 1 |
| Dirven, L; Fiocco, M; Koekkoek, JAF; Kouwenhoven, MCM; Taphoorn, MJB; van den Bent, MJ; van der Meer, PB; Vos, MJ | 1 |
| Alizadeh-Navaei, R; Asghari, F; Cheraghmakani, H; Ghazaeian, M; Rezapour, M; Tabrizi, N | 1 |
| Edens, M; Schelhaas, M; Ter Horst, P; Touw, D; Wammes-Van Der Heijden, E; Wegner, I | 1 |
| de la Fuente, E; de Toledo, M; de Toledo, MP; Ferreiros-Martinez, R; Lagares, A; Muro, I; Ovejero-Benito, MC; Ramos, C; Sobrado, M; Vieira Campos, A | 1 |
| Delil, S; Kemerdere, R; Kizilkilic, EK; Ozkara, C; Unkun, R | 1 |
| Diaz-Forero, AF; Estrada, J; Gaviria-Carrillo, M; Mora-Muñoz, L; Rodríguez, JH; Torres-Ballesteros, V; Vargas-Osorio, J; Vélez Van Meerbeke, A | 1 |
| Al Jayyousi, O; Hazaimeh, E; Ifraitekh, AS; Jbarah, OF; Samara, QA; Sawan, S | 1 |
| Imai, K; Kagawa, Y; Ohta, A; Takahashi, Y; Usui, N; Yamamoto, Y | 1 |
| Ansari, S; Davis, GE; Findlay, MC; Hawryluk, GWJ; Hedges, A; Menacho, ST; Wolfe, BM | 1 |
| Kuffer, I; Novy, J; Rossetti, AO | 1 |
| Atwood, R; Bradley, M; Elster, E; Walker, P; Walper, D | 1 |
| Botha, TL; Brouwer, G; Finger-Baier, K; van der Westhuizen, C; Wolmarans, W | 1 |
| Abdelmoneim, MS; Al Hail, HJ; Alrabi, A; El-Bardissy, A; Elalamy, O; Kamran, S; Melikyan, G; Mesraoua, B; Perkins, JD; Wilkins, SS | 1 |
236 review(s) available for piracetam and levetiracetam
| Article | Year |
|---|---|
Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
Topics: Acetamides; Acetates; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Dioxolanes; Epilepsy; Felbamate; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Phenobarbital; Phenylcarbamates; Piracetam; Propylene Glycols; Risk Factors; Tiagabine; Topiramate; Triazines; Vigabatrin; Zonisamide | 1994 |
Pharmacokinetic profile of levetiracetam: toward ideal characteristics.
Topics: Absorption; Adolescent; Adult; Aged; Anticonvulsants; Child; Cytochrome P-450 Enzyme System; Drug Interactions; Epilepsy; Humans; Kidney Diseases; Levetiracetam; Liver Diseases; Middle Aged; Piracetam; Therapeutic Equivalency | 2000 |
Piracetam and levetiracetam: close structural similarities but different pharmacological and clinical profiles.
Topics: Animals; Anticonvulsants; Brain; Cognition Disorders; Dogs; Epilepsy; Humans; Learning; Levetiracetam; Memory; Mice; Nootropic Agents; Piracetam; Rats | 2000 |
An assessment of levetiracetam as an anti-epileptic drug.
Topics: Animals; Anticonvulsants; Epilepsy; Humans; Levetiracetam; Piracetam | 2000 |
Levetiracetam. A review of its adjunctive use in the management of partial onset seizures.
Topics: Administration, Oral; Adult; Animals; Anticonvulsants; Child; Cognition; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Humans; Intestinal Absorption; Kidney; Levetiracetam; Models, Biological; Piracetam; Quality of Life; Seizures; Tissue Distribution | 2000 |
[Adverse effects of antiepileptic agents].
Topics: Acetates; Amines; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Clobazam; Cyclohexanecarboxylic Acids; Drug Utilization; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Nipecotic Acids; Norway; Piracetam; Tiagabine; Topiramate; Triazines; Vigabatrin; Zonisamide | 2000 |
Levetiracetam add-on for drug-resistant localization related (partial) epilepsy.
Topics: Anticonvulsants; Drug Resistance; Drug Therapy, Combination; Epilepsies, Partial; Humans; Levetiracetam; Piracetam; Quality of Life; Randomized Controlled Trials as Topic | 2001 |
The 'number needed to treat' with Levetiracetam (LEV): comparison with the other new antiepileptic drugs (AEDs).
Topics: Anticonvulsants; Data Interpretation, Statistical; Epilepsy; Humans; Levetiracetam; Piracetam; Randomized Controlled Trials as Topic; Sample Size | 2001 |
Levetiracetam.
Topics: Anticonvulsants; Area Under Curve; Biological Availability; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Epilepsy; Half-Life; Humans; Intestinal Absorption; Levetiracetam; Piracetam; Randomized Controlled Trials as Topic; Tissue Distribution | 2001 |
Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review.
Topics: Acetamides; Anticonvulsants; Carbamazepine; Controlled Clinical Trials as Topic; Drug Resistance; Epilepsies, Partial; Humans; Isoxazoles; Levetiracetam; Linear Models; Logistic Models; Oxcarbazepine; Piracetam; Zonisamide | 2001 |
Issues in the treatment of epilepsy.
Topics: Anticonvulsants; Drug Approval; Drug Interactions; Epilepsy; Female; Humans; Levetiracetam; Liver; Male; Piracetam; United States | 2001 |
Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?
Topics: Amygdala; Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electric Stimulation; Epilepsy; Kindling, Neurologic; Levetiracetam; Mice; Piracetam; Rats; Seizures | 2001 |
Pharmacokinetic considerations in prescribing antiepileptic drugs.
Topics: Adult; Age Factors; Aged; Anticonvulsants; Biological Availability; Child; Drug Interactions; Drug Prescriptions; Drug Therapy, Combination; Epilepsy; Female; Half-Life; Humans; Levetiracetam; Male; Piracetam; Pregnancy; Protein Binding; Sex Factors | 2001 |
Pharmacokinetics of levetiracetam.
Topics: Administration, Oral; Adult; Age Factors; Aged; Anticonvulsants; Biological Availability; Child; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Epilepsy; Half-Life; Humans; Levetiracetam; Piracetam | 2001 |
Concerns with antiepileptic drug initiation: safety, tolerability, and efficacy.
Topics: Anticonvulsants; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Epilepsy; Humans; Levetiracetam; Piracetam; Treatment Outcome | 2001 |
Efficacy of levetiracetam: a review of three pivotal clinical trials.
Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Drug Administration Schedule; Drug Therapy, Combination; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Multicenter Studies as Topic; Piracetam; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome | 2001 |
Safety profile of levetiracetam.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Central Nervous System Diseases; Controlled Clinical Trials as Topic; Death, Sudden; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Drug Overdose; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy; Female; Humans; Incidence; Infant, Newborn; Levetiracetam; Male; Piracetam; Placebos; Pregnancy | 2001 |
Use of levetiracetam in special populations.
Topics: Adult; Age Factors; Aged; Anticonvulsants; Child; Comorbidity; Contraceptives, Oral; Drug Approval; Drug Interactions; Epilepsy; Female; Humans; Kidney Failure, Chronic; Levetiracetam; Liver Diseases; Male; Middle Aged; Piracetam; Sex Factors | 2001 |
A systematic review of the safety profile of levetiracetam: a new antiepileptic drug.
Topics: Anticonvulsants; Clinical Trials as Topic; Epilepsy; Levetiracetam; Piracetam | 2001 |
Levetiracetam: a novel antiepileptic drug.
Topics: Animals; Anticonvulsants; Humans; Levetiracetam; Piracetam; Randomized Controlled Trials as Topic | 2001 |
Newer therapies in the drug treatment of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Drug Interactions; Epilepsy; Humans; Isoxazoles; Levetiracetam; Oxcarbazepine; Piracetam; Zonisamide | 2002 |
Levetiracetam: a different approach to the pharmacotherapy of epilepsy.
Topics: Animals; Anticonvulsants; Epilepsy; Humans; Levetiracetam; MEDLINE; Piracetam; Randomized Controlled Trials as Topic; Treatment Outcome | 2002 |
A new antiepileptic drug.
Topics: Anticonvulsants; Dose-Response Relationship, Drug; Drug Administration Schedule; Epilepsy; Humans; Levetiracetam; Piracetam; Randomized Controlled Trials as Topic; Treatment Outcome | 2002 |
Three new drugs for epilepsy: levetiracetam, oxcarbazepine, and zonisamide.
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Epilepsy; Humans; Isoxazoles; Levetiracetam; Oxcarbazepine; Piracetam; Treatment Outcome; Zonisamide | 2002 |
Using the new antiepilepsy drugs in children.
Topics: Anticonvulsants; Carbamazepine; Child; Clinical Trials as Topic; Epilepsy; Humans; Isoxazoles; Levetiracetam; Oxcarbazepine; Piracetam; Treatment Outcome; Zonisamide | 2002 |
Levetiracetam--a new drug for epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Epilepsies, Partial; Humans; Levetiracetam; Middle Aged; Piracetam; Treatment Outcome | 2002 |
[Levetiracetam: a molecule with a novel mechanism of action in the pharmaceutical treatment of epilepsy].
Topics: Action Potentials; Anticonvulsants; Calcium Channels; Epilepsies, Partial; Humans; Levetiracetam; Piracetam; Potassium Channels; Protein Conformation; Receptors, GABA-A | 2002 |
[Levetiracetam: an anti-epileptic drug with interesting pharmacokinetic properties].
Topics: Anticonvulsants; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Epilepsies, Partial; Humans; Levetiracetam; Piracetam; Treatment Outcome | 2002 |
[Characteristics and indications of levetiracetam].
Topics: Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy; Humans; Ion Channels; Levetiracetam; Molecular Structure; Piracetam; Treatment Outcome | 2002 |
Antiepileptic drug therapy for adults: when to initiate and how to choose.
Topics: Acetates; Adult; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Epilepsy; Felbamate; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Phenylcarbamates; Piracetam; Propylene Glycols; Recurrence; Risk Factors; Tiagabine; Topiramate; Treatment Outcome; Triazines; Zonisamide | 2002 |
New antiepileptic drug therapies.
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Child; Cyclohexanecarboxylic Acids; Dioxolanes; Epilepsy; Felbamate; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Phenylcarbamates; Phenytoin; Piracetam; Propylene Glycols; Thiazines; Tiagabine; Topiramate; Triazines; Vigabatrin; Zonisamide | 2002 |
A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials.
Topics: Anticonvulsants; Anxiety Disorders; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Epilepsy; Follow-Up Studies; Humans; Levetiracetam; Mood Disorders; Outcome Assessment, Health Care; Periodicity; Piracetam; Psychotic Disorders; Randomized Controlled Trials as Topic; Suicide, Attempted | 2003 |
The pharmacokinetic characteristics of levetiracetam.
Topics: Age Factors; Anticonvulsants; Blood Proteins; Clinical Trials as Topic; Drug Interactions; Drug Monitoring; Epilepsy; Humans; Levetiracetam; Piracetam; Protein Binding | 2003 |
Antiepileptogenesis, neuroprotection, and disease modification in the treatment of epilepsy: focus on levetiracetam.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Epilepsy; Humans; Kindling, Neurologic; Levetiracetam; Neuroprotective Agents; Piracetam | 2003 |
The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come?
Topics: Acetates; Amines; Animals; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Drug Interactions; Epilepsy; Felbamate; Fructose; Gabapentin; gamma-Aminobutyric Acid; Half-Life; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Phenylcarbamates; Piracetam; Propylene Glycols; Tiagabine; Topiramate; Triazines; Vigabatrin; Zonisamide | 2003 |
Efficacy of levetiracetam in partial seizures.
Topics: Animals; Anticonvulsants; Clinical Trials as Topic; Dose-Response Relationship, Drug; Epilepsies, Partial; Epilepsy; Humans; Levetiracetam; Meta-Analysis as Topic; Piracetam | 2003 |
Long-term experience with levetiracetam.
Topics: Anticonvulsants; Drug Evaluation; Drug Therapy, Combination; Epilepsy; Humans; Levetiracetam; Longitudinal Studies; Piracetam; Product Surveillance, Postmarketing; Quality of Life; Seizures | 2003 |
Levetiracetam: preliminary efficacy in generalized seizures.
Topics: Animals; Anticonvulsants; Clinical Trials as Topic; Electroencephalography; Epilepsy; Follow-Up Studies; Humans; Levetiracetam; Piracetam; Product Surveillance, Postmarketing; Prospective Studies; Seizures | 2003 |
Preliminary efficacy of levetiracetam in children.
Topics: Anticonvulsants; Child; Drug Administration Schedule; Epilepsy; Humans; Levetiracetam; Piracetam; Prospective Studies; Seizures | 2003 |
Preliminary efficacy of levetiracetam in monotherapy.
Topics: Anticonvulsants; Epilepsy; Humans; Levetiracetam; Piracetam; Seizures; Time Factors | 2003 |
Safety profile of levetiracetam.
Topics: Age Factors; Anticonvulsants; Drug Interactions; Epilepsy; Humans; Levetiracetam; Persons with Mental Disabilities; Piracetam; Renal Insufficiency; Seizures | 2003 |
Role of levetiracetam in the treatment of epilepsy.
Topics: Adult; Age Factors; Aged; Anticonvulsants; Drug Resistance; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Persons with Mental Disabilities; Piracetam; Prospective Studies; Seizures | 2003 |
Seizure-free days observed in randomized placebo-controlled add-on trials with levetiracetam in partial epilepsy.
Topics: Adult; Confidence Intervals; Dose-Response Relationship, Drug; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Randomized Controlled Trials as Topic; Seizures | 2003 |
Levetiracetam: a new therapeutic option for refractory epilepsy.
Topics: Animals; Anticonvulsants; Chronic Disease; Drug Evaluation; Drug Interactions; Epilepsy; Humans; Levetiracetam; Long-Term Care; Piracetam; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome | 2003 |
Levetiracetam: treatment in epilepsy.
Topics: Anticonvulsants; Epilepsy; Humans; Levetiracetam; Piracetam; Quality of Life | 2003 |
Levetiracetam and partial seizure subtypes: pooled data from three randomized, placebo-controlled trials.
Topics: Adult; Anticonvulsants; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy, Complex Partial; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Female; Humans; Levetiracetam; Male; Meta-Analysis as Topic; Middle Aged; Outcome Assessment, Health Care; Piracetam; Randomized Controlled Trials as Topic | 2003 |
Levetiracetam does not alter body weight: analysis of randomized, controlled clinical trials.
Topics: Adult; Anticonvulsants; Body Weight; Epilepsy; Europe; Female; Humans; Levetiracetam; Male; Piracetam; United States | 2003 |
The new antiepileptic drugs: scientific review.
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Felbamate; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Phenylcarbamates; Piracetam; Propylene Glycols; Tiagabine; Topiramate; Triazines; Zonisamide | 2004 |
Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
Topics: Acetates; Adolescent; Adult; Age Factors; Amines; Antipsychotic Agents; Carbamazepine; Child; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Drug Approval; Epilepsies, Partial; Epilepsy, Absence; Epilepsy, Generalized; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Piracetam; Tiagabine; Topiramate; Triazines; United States; United States Food and Drug Administration; Zonisamide | 2004 |
Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
Topics: Acetates; Adolescent; Adult; Age Factors; Amines; Anticonvulsants; Carbamazepine; Child; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Drug Approval; Epilepsies, Partial; Epilepsy, Generalized; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Piracetam; Practice Patterns, Physicians'; Tiagabine; Topiramate; Triazines; United States; United States Food and Drug Administration; Zonisamide | 2004 |
Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epile
Topics: Acetates; Adult; Amines; Anticonvulsants; Carbamazepine; Child; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Drug Resistance; Epilepsies, Partial; Epilepsy, Generalized; Evidence-Based Medicine; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Piracetam; Tiagabine; Topiramate; Treatment Outcome; Triazines; Zonisamide | 2004 |
Newer anticonvulsants in the treatment of bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Bipolar Disorder; Carbamazepine; Cyclohexanecarboxylic Acids; Depressive Disorder; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Phenytoin; Piracetam; Pregabalin; Tiagabine; Topiramate; Treatment Outcome; Triazines; Zonisamide | 2004 |
Clinical pharmacokinetics of levetiracetam.
Topics: Adult; Aged; Anticonvulsants; Chemical Phenomena; Chemistry, Physical; Child; Drug Interactions; Drug Monitoring; Humans; Kidney Diseases; Levetiracetam; Liver Diseases; Piracetam | 2004 |
Levetiracetam safety profiles and tolerability in epilepsy patients.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Age Factors; Aged; Animals; Anticonvulsants; Asthenia; Bone Density; Child; Child Behavior Disorders; Clinical Trials as Topic; Disorders of Excessive Somnolence; Dizziness; Drug Evaluation, Preclinical; Epilepsy; Female; Headache; Humans; Infections; Kidney Diseases; Levetiracetam; Liver Diseases; Male; Mental Disorders; Mice; Middle Aged; Patient Acceptance of Health Care; Piracetam; Pregnancy; Pregnancy Complications | 2004 |
Anticonvulsant drugs in primary headaches prophylaxis.
Topics: Amines; Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Fructose; Gabapentin; gamma-Aminobutyric Acid; Headache; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Oxcarbazepine; Piracetam; Topiramate; Triazines; Valproic Acid; Vigabatrin; Zonisamide | 2004 |
Oxcarbazepine, topiramate, zonisamide, and levetiracetam: potential use in neuropathic pain.
Topics: Aged; Analgesics, Non-Narcotic; Animals; Carbamazepine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fructose; Humans; Isoxazoles; Levetiracetam; Oxcarbazepine; Pain; Peripheral Nervous System Diseases; Piracetam; Topiramate; Zonisamide | 2003 |
Levetiracetam in the management of epilepsy.
Topics: Anticonvulsants; Epilepsy; Humans; Levetiracetam; Piracetam; Treatment Outcome | 2004 |
Rapid onset of action of levetiracetam in refractory epilepsy patients.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Disease-Free Survival; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Follow-Up Studies; Humans; Levetiracetam; Logistic Models; Middle Aged; Odds Ratio; Piracetam; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome | 2005 |
Levetiracetam in pediatrics.
Topics: Adult; Animals; Anticonvulsants; Child; Epilepsy; Humans; Levetiracetam; Piracetam; Treatment Outcome | 2005 |
Optimal seizure management in brain tumor patients.
Topics: Amines; Anticonvulsants; Antineoplastic Agents; Brain Neoplasms; Cyclohexanecarboxylic Acids; Drug Interactions; Gabapentin; gamma-Aminobutyric Acid; Humans; Levetiracetam; Piracetam; Retrospective Studies; Seizures | 2005 |
Migraine preventive therapy: current and emerging treatment options.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Anticonvulsants; Antidepressive Agents; Antihypertensive Agents; Calcium Channel Blockers; Coenzymes; Drug Therapy; Humans; Levetiracetam; Lisinopril; Migraine Disorders; Petasites; Piperazines; Piracetam; Preventive Medicine; Triazoles; Ubiquinone | 2005 |
Fast and sustained efficacy of levetiracetam during titration and the first 3 months of treatment in refractory epilepsy.
Topics: Adult; Anticonvulsants; Clinical Trials, Phase III as Topic; Double-Blind Method; Drug Administration Schedule; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Piracetam; Placebos; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome | 2005 |
Neuroprotection possibilities in epileptic children.
Topics: Anticonvulsants; Brain Diseases; Child; Epilepsy; Fructose; Humans; Levetiracetam; Neuroprotective Agents; Piracetam; Topiramate | 2005 |
Benefit-risk assessment of levetiracetam in the treatment of partial seizures.
Topics: Adult; Aged; Anticonvulsants; Child; Clinical Trials as Topic; Dose-Response Relationship, Drug; Economics, Pharmaceutical; Epilepsies, Partial; Humans; Levetiracetam; Piracetam; Quality of Life; Risk Assessment | 2005 |
Antiepileptic drugs and neuroprotection: current status and future roles.
Topics: Animals; Anticonvulsants; Brain; Epilepsy; Fructose; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Neuroprotective Agents; Piracetam; Seizures; Topiramate; Triazines; Zonisamide | 2005 |
Identifying baseline characteristics of placebo responders versus nonresponders in randomized double-blind trials of refractory partial-onset seizures.
Topics: Adolescent; Adult; Age of Onset; Aged; Anticonvulsants; Databases, Factual; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Placebo Effect; Randomized Controlled Trials as Topic | 2006 |
Measurement of seizure freedom in adjunctive therapy studies in refractory partial epilepsy: the levetiracetam experience.
Topics: Adult; Anticonvulsants; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Piracetam; Remission Induction; Research Design; Seizures | 2006 |
A new frontier in epilepsy: novel antiepileptogenic drugs.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Epilepsy; Levetiracetam; Models, Biological; Piracetam; Rats | 2006 |
Update on treatment of epilepsy in people with intellectual disabilities.
Topics: Anticonvulsants; Brain; Electric Stimulation Therapy; Epilepsy; Fructose; Humans; Intellectual Disability; Levetiracetam; Neurosurgical Procedures; Piracetam; Postoperative Complications; Topiramate; Vagus Nerve | 2006 |
Neuromodulation with levetiracetam and vagus nerve stimulation in experimental animal models of epilepsy.
Topics: Animals; Disease Models, Animal; Electric Stimulation Therapy; Epilepsy; Humans; Levetiracetam; Neurotransmitter Agents; Piracetam; Rats; Vagus Nerve | 2006 |
Novel anticonvulsant drugs.
Topics: Amines; Animals; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Epilepsy; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Nipecotic Acids; Piracetam; Pregabalin; Tiagabine; Topiramate; Treatment Outcome; Triazines; Zonisamide | 2007 |
Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
Topics: Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Drug Interactions; Drug Monitoring; Epilepsy; Felbamate; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Phenylcarbamates; Piracetam; Pregabalin; Propylene Glycols; Tiagabine; Topiramate; Triazines; Vigabatrin; Zonisamide | 2006 |
Potential of levetiracetam in mood disorders: a preliminary review.
Topics: Animals; Anticonvulsants; Clinical Trials as Topic; Humans; Levetiracetam; Mood Disorders; Piracetam; Treatment Outcome | 2006 |
Dose-response population analysis of levetiracetam add-on treatment in refractory epileptic patients with partial onset seizures.
Topics: Anticonvulsants; Clinical Trials, Phase III as Topic; Computer Simulation; Dose-Response Relationship, Drug; Double-Blind Method; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Nonlinear Dynamics; Piracetam; Seizures | 2007 |
[A new aspect in the research on antiepileptic drugs].
Topics: Acetamides; Amines; Animals; Anticonvulsants; Benzodiazepines; Carbamates; Cyclohexanecarboxylic Acids; Disease Models, Animal; Drug Design; Gabapentin; gamma-Aminobutyric Acid; Humans; Lacosamide; Levetiracetam; Phenylenediamines; Piracetam; Pregabalin; Pregnanolone; Pyrrolidinones; Triazoles | 2007 |
[Epilepsy in the elderly].
Topics: Aged; Aged, 80 and over; Aging; Amines; Anticonvulsants; Cerebrovascular Disorders; Comorbidity; Cyclohexanecarboxylic Acids; Diagnosis, Differential; Drug Interactions; Epilepsy; Gabapentin; gamma-Aminobutyric Acid; Humans; Levetiracetam; Pharmacokinetics; Piracetam | 2007 |
Levetiracetam: the profile of a novel anticonvulsant drug-part I: preclinical data.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Drug Evaluation, Preclinical; Epilepsy; Humans; Levetiracetam; MEDLINE; Piracetam | 2007 |
Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug.
Topics: Animals; Anticonvulsants; Epilepsy; Humans; Levetiracetam; Meta-Analysis as Topic; Piracetam | 2007 |
The safety of levetiracetam.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Blood Cells; Body Weight; Child; Child Behavior; Drug Hypersensitivity; Drug Interactions; Epilepsy; Female; Humans; Injections, Intravenous; Levetiracetam; Piracetam; Pregnancy; Psychoses, Substance-Induced; Safety | 2007 |
Population pharmacokinetics of levetiracetam in Japanese and Western adults.
Topics: Administration, Oral; Anticonvulsants; Body Weight; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Drug Interactions; Epilepsy; Ethnicity; Europe; Humans; Japan; Levetiracetam; Metabolic Clearance Rate; Models, Biological; Piracetam; Regression Analysis; United States | 2007 |
[New antiepileptics in development].
Topics: Animals; Anticonvulsants; Benzodiazepines; Carbamazepine; Epilepsy; Felbamate; Humans; Levetiracetam; Phenylcarbamates; Piracetam; Propylene Glycols; Valproic Acid | 2007 |
The new antiepileptic drugs.
Topics: Amines; Anticonvulsants; Carbamazepine; Child; Cyclohexanecarboxylic Acids; Dioxolanes; Epilepsies, Partial; Epilepsy; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Oxcarbazepine; Piracetam; Pregabalin; Topiramate; Triazines; Vigabatrin; Zonisamide | 2007 |
Levetiracetam.
Topics: Adolescent; Adult; Anticonvulsants; Child; Comorbidity; Controlled Clinical Trials as Topic; Dosage Forms; Drug Interactions; Epilepsy; Humans; Levetiracetam; Piracetam | 2007 |
Clinical picture of EPM1-Unverricht-Lundborg disease.
Topics: Adolescent; Adult; Age of Onset; Animals; Anticonvulsants; Clonazepam; Cystatin B; Cystatins; Diagnosis, Differential; DNA Mutational Analysis; Electroencephalography; Humans; Levetiracetam; Mice; Mutation; Piracetam; Unverricht-Lundborg Syndrome; Valproic Acid | 2008 |
Clinical pharmacology of parenteral use of antiepileptic drugs.
Topics: Anticonvulsants; Epilepsy; Humans; Infusions, Intravenous; Injections, Intravenous; Levetiracetam; Pharmaceutical Vehicles; Phenytoin; Piracetam; Solubility; Valproic Acid | 2007 |
The use of valproate and new antiepileptic drugs in status epilepticus.
Topics: Anticonvulsants; Drug Approval; Fructose; Humans; Infusions, Intravenous; Injections, Intravenous; Levetiracetam; Piracetam; Status Epilepticus; Topiramate; United States; Valproic Acid | 2007 |
Intensive care unit management of patients with status epilepticus.
Topics: Anesthesia, General; Anticonvulsants; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Humans; Intensive Care Units; Levetiracetam; Midazolam; Patient Care Management; Phenobarbital; Piracetam; Propofol; Status Epilepticus | 2007 |
Reporting and analysis of open-label extension studies of anti-epileptic drugs.
Topics: Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Databases, Factual; Drug Resistance; Epilepsy; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Levetiracetam; Patient Dropouts; Piracetam; Randomized Controlled Trials as Topic; Research Design; Topiramate | 2008 |
Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
Topics: Animals; Anticonvulsants; Brain; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Epilepsy; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Levetiracetam; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam | 2009 |
[Levetiracetam (keppra) in epileptology].
Topics: Anticonvulsants; Epilepsy; Humans; Levetiracetam; Piracetam; Treatment Outcome | 2007 |
Treatment of juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Female; Humans; Infant; Lamotrigine; Levetiracetam; Male; Myoclonic Epilepsy, Juvenile; Piracetam; Sex Factors; Triazines; Valproic Acid | 2008 |
Emergent complications of the newer anticonvulsants.
Topics: Acidosis; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Drug Overdose; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Piracetam; Psychoses, Substance-Induced; Seizures; Tiagabine; Topiramate; Triazines | 2010 |
Optimal prevention of seizures induced by high-dose busulfan.
Topics: Alkylating Agents; Animals; Anticonvulsants; Benzodiazepines; Busulfan; Dose-Response Relationship, Drug; Humans; Levetiracetam; Piracetam; Seizures | 2008 |
Antiepileptic drugs in aneurysmal subarachnoid hemorrhage.
Topics: Animals; Anticonvulsants; Electroencephalography; Head Injuries, Closed; Humans; Levetiracetam; Neurons; Neuroprotective Agents; Phenytoin; Piracetam; Seizures; Subarachnoid Hemorrhage; Treatment Outcome | 2008 |
[Endocrine effects of antiepileptic drugs].
Topics: Anticonvulsants; Carbamazepine; Endocrine System Diseases; Estradiol; Female; Hormones; Humans; Levetiracetam; Male; Oxcarbazepine; Piracetam; Seizures; Testosterone; Thyroid Hormones; Valproic Acid | 2008 |
[Drugs for status epilepticus treatment].
Topics: Anticonvulsants; Barbiturates; Benzodiazepines; Fructose; Humans; Hypnotics and Sedatives; Levetiracetam; Phenytoin; Piracetam; Propofol; Status Epilepticus; Topiramate; Valproic Acid | 2009 |
[Role of monotherapy with new antiepileptic drugs in the treatment of childhood epilepsy].
Topics: Anticonvulsants; Carbamazepine; Child; Drug Administration Schedule; Epilepsy; Fructose; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Piracetam; Topiramate; Triazines; Zonisamide | 2009 |
Levetiracetam for managing neurologic and psychiatric disorders.
Topics: Anticonvulsants; Humans; Levetiracetam; Mental Disorders; Nervous System Diseases; Piracetam | 2009 |
[Antiepileptic drugs for the prevention of pediatric migraine].
Topics: Adolescent; Amines; Anticonvulsants; Child; Cyclohexanecarboxylic Acids; Drug Tolerance; Fructose; Gabapentin; gamma-Aminobutyric Acid; Headache; Humans; Levetiracetam; Migraine Disorders; Piracetam; Placebos; Retrospective Studies; Topiramate; Treatment Failure; Valproic Acid | 2009 |
[The possibilities of using keppra (levetiracetam) in different neurological diseases].
Topics: Anticonvulsants; Epilepsy; Humans; Levetiracetam; Piracetam; Treatment Outcome | 2008 |
New pharmacotherapies for pediatric seizures.
Topics: Adolescent; Amines; Animals; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cyclohexanecarboxylic Acids; Epilepsy; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Nipecotic Acids; Pediatrics; Piracetam; Tiagabine; Topiramate; Treatment Outcome; Triazines; Vigabatrin; Zonisamide | 2004 |
Levetiracetam use in pregnancy.
Topics: Anticonvulsants; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Monitoring; Epilepsy; Female; Folic Acid; Humans; Levetiracetam; Piracetam; Pregnancy; Pregnancy Complications; Vitamin B Complex | 2009 |
The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
Topics: Anticonvulsants; Congenital Abnormalities; Delayed-Action Preparations; Drug Design; Epilepsy, Generalized; Female; Fructose; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Male; Myoclonic Epilepsy, Juvenile; Piracetam; Pregnancy; Risk Assessment; Topiramate; Treatment Outcome; Triazines; Valproic Acid; Weight Gain; Zonisamide | 2009 |
Interactions between antiepileptic and chemotherapeutic drugs in children with brain tumors: is it time to change treatment?
Topics: Anticonvulsants; Antineoplastic Agents; Brain Neoplasms; Child; Child, Preschool; Drug Interactions; Drug Therapy, Combination; Humans; Levetiracetam; Piracetam; Seizures | 2010 |
What is the relative value of the standard anticonvulsants: Phenytoin and fosphenytoin, phenobarbital, valproate, and levetiracetam?
Topics: Anticonvulsants; Benzodiazepines; Humans; Levetiracetam; Phenobarbital; Phenytoin; Piracetam; Prodrugs; Status Epilepticus; Treatment Outcome; Valproic Acid | 2009 |
Levetiracetam: a comprehensive review.
Topics: Animals; Anticonvulsants; Clinical Trials as Topic; Epilepsy; Humans; Levetiracetam; Piracetam | 2010 |
A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures.
Topics: Administration, Oral; Adult; Aged; Anticonvulsants; Brain Neoplasms; Dose-Response Relationship, Drug; Drug Interactions; Female; Follow-Up Studies; Glioma; Humans; Infusions, Intravenous; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Seizures; Survival Rate; Treatment Outcome | 2010 |
[Levetiracetam therapy for childhood epilepsy: a systematic review].
Topics: Anticonvulsants; Child; Epilepsy; Humans; Levetiracetam; Piracetam; Randomized Controlled Trials as Topic | 2010 |
Synergistic neuroprotective therapies with hypothermia.
Topics: Acetylcysteine; Anticonvulsants; Body Temperature; Cannabinoids; Combined Modality Therapy; Erythropoietin; Fructose; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Levetiracetam; Melatonin; Neuroprotective Agents; Piracetam; Topiramate; Xenon | 2010 |
[Antiepileptic drugs in North America].
Topics: Anticonvulsants; Carbamazepine; Drug Approval; Fructose; Humans; Japan; Lamotrigine; Levetiracetam; Lorazepam; North America; Phenytoin; Piracetam; Topiramate; Triazines | 2010 |
Levetiracetam in childhood epilepsy.
Topics: Animals; Child; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Humans; Levetiracetam; Piracetam | 2010 |
Levetiracetam in brain ischemia: clinical implications in neuroprotection and prevention of post-stroke epilepsy.
Topics: Animals; Anticonvulsants; Brain Ischemia; Clinical Trials as Topic; Disease Models, Animal; Epilepsy; Humans; Levetiracetam; Neuroprotective Agents; Piracetam; Stroke | 2011 |
[Pharmacology and clinical results of levetiracetam (E Keppra(®) Tablets), a new antiepileptic drug].
Topics: Acute Disease; Allosteric Regulation; Animals; Anticonvulsants; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; Disease Models, Animal; Epilepsy; Humans; Levetiracetam; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam; Randomized Controlled Trials as Topic; Seizures | 2011 |
[Are clinical features derived from evidences and experiences outside of Japan applicable to clinical practices in Japan? Comparisons of results among studies conducted in US, Europe, Asian Countries and Japan].
Topics: Anticonvulsants; Asia, Eastern; Clinical Trials as Topic; Epilepsies, Partial; Europe; Humans; Japan; Levetiracetam; Piracetam; United States | 2011 |
Levetiracetam: a review of its use in epilepsy.
Topics: Clinical Trials as Topic; Double-Blind Method; Epilepsy; Humans; Levetiracetam; Multicenter Studies as Topic; Piracetam; Randomized Controlled Trials as Topic | 2011 |
[Efficacy of new antiepileptic drugs and the next generation drugs].
Topics: Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Drug Approval; Drug Design; Drug Monitoring; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Induced Pluripotent Stem Cells; Lamotrigine; Levetiracetam; Piracetam; Topiramate; Triazines | 2011 |
Meta-analysis of randomized trials on first line and adjunctive levetiracetam.
Topics: Adult; Anticonvulsants; Bias; Databases, Bibliographic; Electroencephalography; Epilepsy; Female; Humans; Levetiracetam; Male; Piracetam; Randomized Controlled Trials as Topic | 2011 |
Motor symptoms of schizophrenia: is tardive dyskinesia a symptom or side effect? A modern treatment.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Fatty Acids, Omega-3; Ginkgo biloba; Humans; Levetiracetam; Melatonin; Movement Disorders; Neuroprotective Agents; Phytotherapy; Piracetam; Schizophrenia; Vitamin B 6; Vitamin E | 2011 |
[Rational combinations of antiepileptic drugs for refractory epilepsy].
Topics: Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbamazepine; Clinical Trials as Topic; Disease Models, Animal; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Epilepsy; Fructose; Humans; Lamotrigine; Levetiracetam; Multidrug Resistance-Associated Proteins; Piracetam; Prognosis; Topiramate; Triazines; Valproic Acid | 2011 |
Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysis.
Topics: Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Epilepsies, Partial; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Levetiracetam; Nipecotic Acids; Piracetam; Randomized Controlled Trials as Topic; Tiagabine; Topiramate; Treatment Outcome | 2011 |
Antiepileptic drugs for treating seizures in adults with brain tumours.
Topics: Adult; Anticonvulsants; Brain Neoplasms; Drug Substitution; Humans; Levetiracetam; Phenytoin; Piracetam; Randomized Controlled Trials as Topic; Seizures | 2011 |
Spotlight on levetiracetam in epilepsy.
Topics: Anticonvulsants; Carbamazepine; Chemotherapy, Adjuvant; Epilepsy; Humans; Levetiracetam; Piracetam; Randomized Controlled Trials as Topic; Seizures; Treatment Outcome | 2011 |
What is the evidence to use new intravenous AEDs in status epilepticus?
Topics: Acetamides; Humans; Injections, Intraventricular; Lacosamide; Levetiracetam; Lipoproteins; Piracetam; Status Epilepticus | 2011 |
Management of acute seizure and status epilepticus in pediatric emergency.
Topics: Anesthesia, Intravenous; Anticonvulsants; Benzodiazepines; Child; Child, Preschool; Combined Modality Therapy; Cross-Sectional Studies; Developing Countries; Dose-Response Relationship, Drug; Emergency Service, Hospital; Epilepsy; Humans; India; Infant; Infusions, Intravenous; Intensive Care Units, Pediatric; Levetiracetam; Lorazepam; Phenytoin; Piracetam; Seizures; Status Epilepticus; Thiopental; Valproic Acid | 2012 |
Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects.
Topics: Aged; Animals; Anticonvulsants; Carbamazepine; Cardiovascular Diseases; Choice Behavior; Drug Interactions; Epilepsy; Humans; Levetiracetam; Piracetam | 2012 |
A systematic review of randomized controlled trials on the theraputic effect of intravenous sodium valproate in status epilepticus.
Topics: Anticonvulsants; Diazepam; Humans; Injections, Intravenous; Levetiracetam; Phenytoin; Piracetam; Randomized Controlled Trials as Topic; Status Epilepticus; Valproic Acid | 2012 |
Levetiracetam as alternative stage two antiepileptic drug in status epilepticus: a systematic review.
Topics: Anticonvulsants; Humans; Levetiracetam; Piracetam; Status Epilepticus | 2012 |
Phenytoin versus Leviteracetam for seizure prophylaxis after brain injury - a meta analysis.
Topics: Adult; Aged; Brain Injuries; Causality; Comorbidity; Convulsants; Female; Humans; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Prevalence; Risk Factors; Seizures; Treatment Outcome | 2012 |
Overdose with levetiracetam: a case report and review of the literature.
Topics: Anticonvulsants; Drug Overdose; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Suicide, Attempted | 2013 |
[Juvenile myoclonic epilepsy].
Topics: Adolescent; Anticonvulsants; Diagnosis, Differential; Electroencephalography; Female; Humans; Lamotrigine; Levetiracetam; Male; Myoclonic Epilepsy, Juvenile; Myoclonus; Piracetam; Prognosis; Risk Factors; Treatment Outcome; Triazines; Valproic Acid | 2012 |
Presentation of opsoclonus myoclonus ataxia syndrome with glutamic acid decarboxylase antibodies.
Topics: Adult; Anticonvulsants; Anxiety; Ataxia; Autoantibodies; Diagnosis, Differential; Earache; Female; Follow-Up Studies; Glutamate Decarboxylase; Headache; Humans; Immunoglobulins, Intravenous; Lethargy; Levetiracetam; Meningoencephalitis; Opsoclonus-Myoclonus Syndrome; Piracetam; Treatment Outcome | 2012 |
Genetic variation in dopaminergic activity is associated with the risk for psychiatric side effects of levetiracetam.
Topics: Adult; Aggression; Anticonvulsants; Catechol O-Methyltransferase; Dopamine; Dopamine beta-Hydroxylase; Epilepsy; Female; Genetic Predisposition to Disease; Humans; Irritable Mood; Levetiracetam; Male; Piracetam; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Risk Factors | 2013 |
[Experience with levetiracetam in the treatment of status epilepticus].
Topics: Anticonvulsants; Epilepsia Partialis Continua; Humans; Levetiracetam; Piracetam; Status Epilepticus | 2013 |
Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review.
Topics: Adult; Anticonvulsants; Child; Drug Resistance; Drug Therapy, Combination; Epilepsies, Partial; Humans; Levetiracetam; Piracetam; Quality of Life; Randomized Controlled Trials as Topic | 2012 |
[Epilepsy in the elderly].
Topics: Age Factors; Aged; Aging; Anticonvulsants; Dose-Response Relationship, Drug; Epilepsy; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Piracetam; Quality of Life; Seizures; Triazines; Zonisamide | 2013 |
Newly emerging therapies for neonatal seizures.
Topics: Animals; Anticonvulsants; Brain; Bumetanide; Child Development; Epilepsy; Fructose; Humans; Infant, Newborn; Levetiracetam; Neurogenesis; Neurons; Neuroprotective Agents; Piracetam; Seizures; Sodium Potassium Chloride Symporter Inhibitors; Topiramate | 2013 |
Antiepileptic medications in autism spectrum disorder: a systematic review and meta-analysis.
Topics: Anticonvulsants; Child; Child Development Disorders, Pervasive; Fructose; Humans; Irritable Mood; Lamotrigine; Levetiracetam; Piracetam; Topiramate; Triazines | 2014 |
Anticonvulsants for fibromyalgia.
Topics: Acetamides; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Fibromyalgia; Gabapentin; gamma-Aminobutyric Acid; Humans; Lacosamide; Levetiracetam; Piracetam; Pregabalin | 2013 |
Randomized-controlled trials of levetiracetam as an adjunctive therapy in epilepsy of multiple seizure types.
Topics: Adult; Anticonvulsants; Child; Drug Therapy, Combination; Humans; Levetiracetam; Piracetam; Randomized Controlled Trials as Topic; Seizures; Treatment Outcome | 2014 |
The adverse effects profile of levetiracetam in epilepsy: a more detailed look.
Topics: Anticonvulsants; Epilepsy; Humans; Levetiracetam; Piracetam | 2014 |
Murine typhus as a cause of cognitive impairment: case report and a review of the literature.
Topics: Acetazolamide; Adolescent; Anticonvulsants; Brain; Chronic Disease; Cognition Disorders; Diagnosis, Differential; Electroencephalography; Female; Humans; Levetiracetam; Neuropsychological Tests; Piracetam; Typhus, Endemic Flea-Borne | 2014 |
The fetal safety of Levetiracetam: a systematic review.
Topics: Abnormalities, Drug-Induced; Animals; Anticonvulsants; Female; Fetal Diseases; Fetus; Humans; Levetiracetam; Piracetam; Pregnancy; Prenatal Exposure Delayed Effects; Safety | 2014 |
Pharmacotherapy for tonic-clonic seizures.
Topics: Acetamides; Anticonvulsants; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Fructose; Humans; Lacosamide; Lamotrigine; Levetiracetam; Piracetam; Risk Factors; Seizures; Topiramate; Treatment Failure; Triazines; Valproic Acid | 2014 |
Choice of approaches in developing novel medical countermeasures for nerve agent poisoning.
Topics: Animals; Anticonvulsants; Antidotes; Brain; Cholinergic Agents; Humans; Levetiracetam; Organophosphate Poisoning; Oximes; Piracetam; Procyclidine; Pyridinium Compounds; Rats; Seizures | 2014 |
[Treatment of pediatric epilepsy].
Topics: Adolescent; Amines; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cyclohexanecarboxylic Acids; Dioxolanes; Drug Approval; Drug Substitution; Epilepsy; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Infant; Lamotrigine; Levetiracetam; Patient Education as Topic; Piracetam; Practice Guidelines as Topic; Topiramate; Triazines; Triazoles; Valproic Acid | 2014 |
[New antiepileptic drugs: characteristics and clinical applications].
Topics: Amines; Anticonvulsants; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Dioxolanes; Drug Approval; Drug Interactions; Epilepsy; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Japan; Lamotrigine; Levetiracetam; Piracetam; Safety; Topiramate; Triazines; Triazoles | 2014 |
Behavioral side-effects of levetiracetam in children with epilepsy: a systematic review.
Topics: Anticonvulsants; Child; Child Behavior Disorders; Databases, Bibliographic; Epilepsy; Humans; Levetiracetam; Piracetam | 2014 |
Levetiracetam for neuropathic pain in adults.
Topics: Adult; Analgesics; Chronic Disease; Humans; Levetiracetam; Neuralgia; Piracetam; Randomized Controlled Trials as Topic | 2014 |
[Treatment of tardive syndromes].
Topics: Amantadine; Antipsychotic Agents; Botulinum Toxins; Central Nervous System Agents; Cholinergic Antagonists; Clinical Trials as Topic; Clonazepam; Deep Brain Stimulation; Dopamine Antagonists; Ginkgo biloba; Humans; Levetiracetam; Movement Disorders; Nootropic Agents; Piracetam; Primary Prevention; Propranolol; Syndrome; Tetrabenazine; Vitamin E | 2014 |
Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centro temporal spikes.
Topics: Anticonvulsants; Benzodiazepines; Carbamazepine; Child; Clobazam; Epilepsy; Fructose; Humans; Induction Chemotherapy; Levetiracetam; Oxcarbazepine; Piracetam; Placebos; Randomized Controlled Trials as Topic; Thiazines; Topiramate; Watchful Waiting | 2014 |
An 11-year review of levetiracetam ingestions in children less than 6 years of age.
Topics: Anticonvulsants; California; Child, Preschool; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Poison Control Centers | 2014 |
The treatment of neonatal seizures: focus on Levetiracetam.
Topics: Anticonvulsants; Humans; Infant, Newborn; Levetiracetam; Piracetam; Seizures; Treatment Outcome | 2016 |
Tardive dyskinesia (syndrome): Current concept and modern approaches to its management.
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; alpha-Tocopherol; Amantadine; Anticonvulsants; Antioxidants; Antipsychotic Agents; Clonazepam; Dopamine Agents; Drugs, Chinese Herbal; Fatty Acids, Omega-3; Ginkgo biloba; Humans; Isoleucine; Isoxazoles; Leucine; Levetiracetam; Melatonin; Movement Disorders; Nootropic Agents; Piracetam; Plant Extracts; Propranolol; Pyridoxine; Resveratrol; Stilbenes; Tetrabenazine; Valine; Vitamins; Zonisamide | 2015 |
Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Levetiracetam.
Topics: Animals; Anticonvulsants; Biological Availability; Biopharmaceutics; Chemistry, Pharmaceutical; Dosage Forms; Humans; Levetiracetam; Permeability; Piracetam; Therapeutic Equivalency | 2015 |
Role of high-dose levetiracetam as add-on therapy for intractable epilepsy: case report and brief review of the literature.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Resistant Epilepsy; Drug Synergism; Drug Therapy, Combination; Female; Humans; Levetiracetam; Oxcarbazepine; Piracetam | 2015 |
Medical management of patients with brain tumors.
Topics: Angiogenesis Inhibitors; Anticonvulsants; Brain Edema; Brain Neoplasms; Cognition Disorders; Dopamine Agents; Humans; Levetiracetam; Memantine; Palliative Care; Piracetam; Seizures | 2015 |
Antiepileptic drugs in patients with malignant brain tumor: beyond seizures and pharmacokinetics.
Topics: Animals; Anticonvulsants; Brain Neoplasms; Carbamazepine; Humans; Levetiracetam; Piracetam; Seizures; Valproic Acid | 2016 |
Levetiracetam Monotherapy in Children with Epilepsy: A Systematic Review.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Epilepsy; Humans; Infant; Infant, Newborn; Levetiracetam; Piracetam; Randomized Controlled Trials as Topic | 2015 |
Clinical Management of Seizures in Patients With Low-Grade Glioma.
Topics: Anticonvulsants; Brain Neoplasms; Glioma; Humans; Lamotrigine; Levetiracetam; Piracetam; Seizures; Triazines | 2015 |
The efficacy of levetiracetam for patients with supratentorial brain tumors.
Topics: Anticonvulsants; Epilepsy; Humans; Levetiracetam; Piracetam; Randomized Controlled Trials as Topic; Supratentorial Neoplasms; Treatment Outcome | 2015 |
[ZONISAMIDE: FIRST CHOICE AMONG THE FIRST-LINE ANTIEPILEPTIC DRUGS IN FOCAL EPILEPSY].
Topics: Adolescent; Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Drug Administration Schedule; Drug Approval; Drug Prescriptions; Electroencephalography; Encephalitis; Epilepsies, Partial; Humans; Hungary; Isoxazoles; Levetiracetam; Magnetic Resonance Imaging; Medication Adherence; Obesity; Phenytoin; Piracetam; Risk Assessment; Risk Factors; Seizures; Stroke; Weight Loss; Young Adult; Zonisamide | 2015 |
Pharmacological treatments for preventing epilepsy following traumatic head injury.
Topics: Adult; Anticonvulsants; Carbamazepine; Cause of Death; Child; Craniocerebral Trauma; Epilepsy; Humans; Levetiracetam; Magnesium Sulfate; Neuroprotective Agents; Phenytoin; Piracetam; Randomized Controlled Trials as Topic; Valproic Acid | 2015 |
Levetiracetam might act as an efficacious drug to attenuate cognitive deficits of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cognition Disorders; Humans; Levetiracetam; Piracetam | 2016 |
Perspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis.
Topics: Acetamides; Anticonvulsants; Carbamates; Clinical Trials as Topic; Dibenzazepines; Epilepsy, Temporal Lobe; Hippocampus; Humans; Lacosamide; Levetiracetam; Nitriles; Phenylenediamines; Piracetam; Pyridones; Sclerosis; Syndrome | 2015 |
The adverse event profile of levetiracetam: A meta-analysis on children and adults.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Child; Child, Preschool; Dose-Response Relationship, Drug; Humans; Levetiracetam; Middle Aged; Piracetam; Randomized Controlled Trials as Topic; Young Adult | 2015 |
Levetiracetam for the treatment of status epilepticus.
Topics: Anticonvulsants; Humans; Levetiracetam; Nootropic Agents; Piracetam; Status Epilepticus | 2015 |
Is carbamazepine a human teratogen?
Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Australia; Carbamazepine; Epilepsy; Female; Fetus; Humans; Levetiracetam; Piracetam; Pregnancy; Pregnancy Complications; Registries; Risk; Teratogens; Valproic Acid | 2016 |
Implications of Augmented Renal Clearance on Drug Dosing in Critically Ill Patients: A Focus on Antibiotics.
Topics: Anti-Bacterial Agents; Creatinine; Critical Illness; Drug Administration Schedule; Humans; Kidney Diseases; Levetiracetam; Piracetam; Pyridines; Renal Elimination; Risk Factors; Thiazoles | 2015 |
Pharmacologic treatment of status epilepticus.
Topics: Anticonvulsants; Benzodiazepines; Humans; Ketamine; Levetiracetam; Piracetam; Randomized Controlled Trials as Topic; Seizures; Status Epilepticus; Treatment Failure; Valproic Acid | 2016 |
Antiepileptic Drugs.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Lamotrigine; Levetiracetam; Oxcarbazepine; Phenytoin; Piracetam; Pregabalin; Seizures; Triazines | 2016 |
The efficacy, tolerability and safety of levetiracetam therapy in a pediatric population.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Databases, Factual; Epilepsy; Female; Humans; Infant; Levetiracetam; Male; Outcome Assessment, Health Care; Piracetam; Retrospective Studies; Time Factors; Treatment Outcome | 2016 |
Safety of Levetiracetam in Paediatrics: A Systematic Review.
Topics: Adolescent; Anticonvulsants; Child; Disorders of Excessive Somnolence; Epilepsy; Humans; Levetiracetam; Mental Disorders; Outcome Assessment, Health Care; Piracetam; Randomized Controlled Trials as Topic | 2016 |
Efficacy and safety of prophylactic levetiracetam in supratentorial brain tumour surgery: a systematic review and meta-analysis.
Topics: Anticonvulsants; Craniotomy; Humans; Levetiracetam; Perioperative Care; Phenytoin; Piracetam; Seizures; Supratentorial Neoplasms; Valproic Acid | 2016 |
Skin rash following levetiracetam.
Topics: Adult; Anticonvulsants; Exanthema; Female; Humans; Levetiracetam; Male; Piracetam; Seizures; Young Adult | 2016 |
[Preconceptional and perinatal challenges of pregnancy in women with epilepsy].
Topics: Adult; Amines; Anticonvulsants; Benzodiazepines; Carbamazepine; Cyclohexanecarboxylic Acids; Epilepsy; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Levetiracetam; Oxcarbazepine; Parturition; Perinatal Care; Phenobarbital; Phenytoin; Piracetam; Preconception Care; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Teratogens; Triazines; Valproic Acid | 2016 |
Levetiracetam for seizure prevention in brain tumor patients: a systematic review.
Topics: Anticonvulsants; Brain Neoplasms; Humans; Levetiracetam; Observational Studies as Topic; Piracetam; Prospective Studies; Randomized Controlled Trials as Topic; Reproducibility of Results; Retrospective Studies; Seizures; Treatment Outcome | 2016 |
Levetiracetam vs. brivaracetam for adults with refractory focal seizures: A meta-analysis and indirect comparison.
Topics: Adult; Anticonvulsants; Epilepsies, Partial; Humans; Levetiracetam; Outcome Assessment, Health Care; Piracetam; Pyrrolidinones | 2016 |
Anti-epileptic drugs in pediatric traumatic brain injury.
Topics: Anticonvulsants; Brain Injuries, Traumatic; Child; Humans; Levetiracetam; Phenytoin; Piracetam; Seizures | 2016 |
The safety and efficacy of levetiracetam versus phenytoin for seizure prophylaxis after traumatic brain injury: A systematic review and meta-analysis.
Topics: Anticonvulsants; Brain Injuries, Traumatic; Humans; Levetiracetam; Phenytoin; Piracetam; Seizures | 2016 |
Post-Traumatic Bifrontoparietal Extradural Hematoma with Superior Sagittal Sinus Detachment: A Case Report and Review of the Literature.
Topics: Adult; Anticoagulants; Anticonvulsants; Brain Injuries; Drug Therapy, Combination; Hematoma, Epidural, Cranial; Heparin, Low-Molecular-Weight; Humans; Levetiracetam; Male; Mannitol; Neuroimaging; Neuroprotective Agents; Parietal Lobe; Piracetam; Superior Sagittal Sinus; Treatment Outcome | 2016 |
Levetiracetam Versus Phenytoin for Seizure Prophylaxis Following Traumatic Brain Injury: A Systematic Review and Meta-Analysis.
Topics: Anticonvulsants; Brain Injuries, Traumatic; Cohort Studies; Humans; Levetiracetam; Observational Studies as Topic; Phenytoin; Piracetam; Randomized Controlled Trials as Topic; Seizures | 2016 |
Efficacy of levetiracetam in primary hemifacial spasm.
Topics: Aged; Anticonvulsants; Female; Hemifacial Spasm; Humans; Levetiracetam; Movement Disorders; Piracetam; Treatment Outcome | 2016 |
Response to Zhang et al.: Levetiracetam vs. brivaracetam for adults with refractory focal seizures: A meta-analysis and indirect comparison.
Topics: Adult; Anticonvulsants; Epilepsies, Partial; Humans; Levetiracetam; Piracetam; Pyrrolidinones | 2016 |
Antiepileptic dosing for critically ill adult patients receiving renal replacement therapy.
Topics: Acetamides; Acute Kidney Injury; Amines; Anticonvulsants; Carbamates; Critical Illness; Cyclohexanecarboxylic Acids; Dibenzazepines; Dose-Response Relationship, Drug; Ethosuximide; Felbamate; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lacosamide; Lamotrigine; Levetiracetam; Phenobarbital; Phenylcarbamates; Phenylenediamines; Phenytoin; Piracetam; Propylene Glycols; Renal Dialysis; Renal Replacement Therapy; Seizures; Topiramate; Triazines; Valproic Acid; Zonisamide | 2016 |
Response to "Response to Zhang et al.: Levetiracetam vs. brivaracetam for adults with refractory focal seizures: A meta-analysis and indirect comparison".
Topics: Adult; Anticonvulsants; Female; Humans; Levetiracetam; Male; Piracetam; Pyrrolidinones; Seizures | 2016 |
Treatment of epilepsy in patients with Alzheimer's disease.
Topics: Alzheimer Disease; Anticonvulsants; Epilepsy; Humans; Levetiracetam; Piracetam; Seizures | 2017 |
Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus.
Topics: Anticonvulsants; Humans; Levetiracetam; Phenytoin; Piracetam; Status Epilepticus; Valproic Acid | 2016 |
Should Levetiracetam or Phenytoin Be Used for Posttraumatic Seizure Prophylaxis? A Systematic Review of the Literature and Meta-analysis.
Topics: Anticonvulsants; Brain Injuries, Traumatic; Humans; Levetiracetam; Phenytoin; Piracetam; Seizures | 2016 |
Levetiracetam (Keppra), urinary retention and literature search.
Topics: Adult; Anticonvulsants; Epilepsy; Humans; Levetiracetam; Male; Piracetam; Urinary Retention | 2016 |
Treatment of epilepsy for people with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anticonvulsants; Cognition; Depression; Epilepsy; Female; Humans; Lamotrigine; Levetiracetam; Male; Phenobarbital; Piracetam; Randomized Controlled Trials as Topic; Triazines | 2016 |
[Comparisons of efficacy and safety of levetiracetam versus phenytoin for seizure prophylaxis in patients with brain injury: a meta analysis].
Topics: Anticonvulsants; Brain Injuries; Humans; Levetiracetam; Phenytoin; Piracetam; Randomized Controlled Trials as Topic; Seizures | 2016 |
Review and update of the Hong Kong Epilepsy Guideline on status epilepticus.
Topics: Acetamides; Anticonvulsants; Diet, Ketogenic; Hong Kong; Humans; Lacosamide; Levetiracetam; Magnesium; Midazolam; Piracetam; Practice Guidelines as Topic; Status Epilepticus; Treatment Outcome; Valproic Acid | 2017 |
An update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong Kong.
Topics: Acetamides; Anticonvulsants; Carbamazepine; Consensus; Drugs, Generic; Epilepsy; Hong Kong; Humans; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Piracetam; Practice Guidelines as Topic; Societies, Medical; Triazines | 2017 |
Epilepsy treatment in adults and adolescents: Expert opinion, 2016.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child; Depression; Double-Blind Method; Drug Therapy, Combination; Epilepsy; Expert Testimony; Female; Humans; Lamotrigine; Levetiracetam; Oxcarbazepine; Piracetam; Practice Guidelines as Topic; Pregnancy; Surveys and Questionnaires; Treatment Outcome; Triazines | 2017 |
A simple and cost-effective HPLC-UV method for the detection of levetiracetam in plasma/serum of patients with epilepsy.
Topics: Anticonvulsants; Blood Specimen Collection; Chromatography, High Pressure Liquid; Drug Stability; Epilepsy; Humans; Levetiracetam; Limit of Detection; Linear Models; Piracetam; Reproducibility of Results | 2017 |
Levetiracetam Clinical Pharmacokinetic Monitoring in Pediatric Patients with Epilepsy.
Topics: Anticonvulsants; Drug Monitoring; Epilepsy; Humans; Levetiracetam; Pediatrics; Piracetam | 2017 |
A case of 55-year-old man with first-ever generalized seizure diagnosed with Sturge-Weber syndrome type III by characteristic MRI findings.
Topics: Administration, Oral; Brain; Humans; Late Onset Disorders; Levetiracetam; Magnetic Resonance Imaging; Male; Middle Aged; Piracetam; Seizures; Sturge-Weber Syndrome; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2017 |
Pediatric status epilepticus: improved management with new drug therapies?
Topics: Algorithms; Anticonvulsants; Child; Clinical Protocols; Humans; Ketamine; Levetiracetam; Midazolam; Piracetam; Prospective Studies; Retrospective Studies; Status Epilepticus; Valproic Acid | 2017 |
Anticonvulsant drugs for generalized tonic-clonic epilepsy.
Topics: Acetamides; Anticonvulsants; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Female; Fructose; Humans; Isoxazoles; Lacosamide; Lamotrigine; Levetiracetam; Male; Nitriles; Piracetam; Pyridones; Randomized Controlled Trials as Topic; Topiramate; Treatment Outcome; Triazines; Valproic Acid; Zonisamide | 2017 |
A Review on Pharmacokinetics of Levetiracetam in Neonates.
Topics: Animals; Anticonvulsants; Humans; Infant, Newborn; Levetiracetam; Piracetam; Seizures | 2017 |
Association between switching antiepileptic drug products and healthcare utilization: A systematic review.
Topics: Adult; Anticonvulsants; Drug Substitution; Drugs, Generic; Epilepsy; Female; Fructose; Humans; Levetiracetam; Male; Patient Acceptance of Health Care; Piracetam; Prospective Studies; Retrospective Studies; Topiramate; Valproic Acid | 2017 |
Stroke-like migraine attacks after radiation therapy syndrome: Case report and review of the literature.
Topics: Adult; Brain Neoplasms; Female; Humans; Levetiracetam; Magnetic Resonance Imaging; Migraine Disorders; Nootropic Agents; Piracetam; Radiation Injuries; Syndrome | 2017 |
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Topics: Adult; Amines; Anticonvulsants; Carbamazepine; Child; Cyclohexanecarboxylic Acids; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Network Meta-Analysis; Oxcarbazepine; Phenobarbital; Phenytoin; Piracetam; Remission Induction; Topiramate; Triazines; Valproic Acid; Zonisamide | 2017 |
Subcutaneous levetiracetam for the management of seizures at the end of life.
Topics: Anticonvulsants; Disease Management; Humans; Infusions, Subcutaneous; Levetiracetam; Palliative Care; Piracetam; Seizures; Terminal Care; Treatment Outcome | 2018 |
Levetiracetam versus phenytoin for seizure prophylaxis in brain injured patients: a systematic review and meta-analysis.
Topics: Anticonvulsants; Brain Injuries; Humans; Levetiracetam; Phenytoin; Piracetam; Post-Exposure Prophylaxis; Randomized Controlled Trials as Topic; Seizures | 2017 |
The preclinical discovery and development of brivaracetam for the treatment of focal epilepsy.
Topics: Adult; Animals; Anticonvulsants; Drug Discovery; Epilepsies, Partial; Humans; Levetiracetam; Ligands; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam; Pyrrolidinones; Solubility | 2017 |
Perampanel with concomitant levetiracetam and topiramate: Post hoc analysis of adverse events related to hostility and aggression.
Topics: Adolescent; Adult; Aged; Aggression; Anticonvulsants; Child; Drug Therapy, Combination; Epilepsies, Partial; Fructose; Hostility; Humans; Levetiracetam; Middle Aged; Nitriles; Piracetam; Pyridones; Topiramate; Treatment Outcome; Young Adult | 2017 |
Newer antiepileptic drugs compared to levetiracetam as adjunctive treatments for uncontrolled focal epilepsy: An indirect comparison.
Topics: Anticonvulsants; Epilepsies, Partial; Humans; Levetiracetam; Piracetam | 2017 |
Regression of Recurrent High-Grade Glioma with Temozolomide, Dexamethasone, and Levetiracetam: Case Report and Review of the Literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Corpus Callosum; Craniotomy; Dacarbazine; Decompression, Surgical; Dexamethasone; Female; Humans; Levetiracetam; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Oligodendroglioma; Piracetam; Remission Induction; Temozolomide; Tomography, X-Ray Computed | 2017 |
Essential Oils as an Alternative to Pyrethroids' Resistance against Anopheles Species Complex Giles (Diptera: Culicidae).
Topics: Animals; Anopheles; Caco-2 Cells; Carbamazepine; Diptera; Hep G2 Cells; Humans; Lamotrigine; Levetiracetam; Oils, Volatile; Phenytoin; Piracetam; Pyrethrins; Triazines; Valproic Acid | 2017 |
WITHDRAWN: Anticonvulsants for fibromyalgia.
Topics: Acetamides; Amines; Anticonvulsants; Conflict of Interest; Cyclohexanecarboxylic Acids; Fibromyalgia; Gabapentin; gamma-Aminobutyric Acid; Humans; Lacosamide; Levetiracetam; Piracetam; Pregabalin | 2017 |
Feline Epilepsy.
Topics: Animals; Anticonvulsants; Cat Diseases; Cats; Epilepsy; Levetiracetam; Phenobarbital; Piracetam; Prognosis; Risk Factors; Seizures | 2018 |
A Systematic Review of the Efficacy of Levetiracetam in Neonatal Seizures.
Topics: Anticonvulsants; Humans; Infant, Newborn; Levetiracetam; Piracetam; PubMed; Seizures | 2018 |
Early and Late Posttraumatic Epilepsy in the Setting of Traumatic Brain Injury: A Meta-analysis and Review of Antiepileptic Management.
Topics: Anticonvulsants; Brain Injuries, Traumatic; Epilepsy, Post-Traumatic; Humans; Levetiracetam; Phenytoin; Piracetam | 2018 |
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Topics: Adult; Amines; Anticonvulsants; Carbamazepine; Child; Cyclohexanecarboxylic Acids; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Network Meta-Analysis; Oxcarbazepine; Phenobarbital; Phenytoin; Piracetam; Remission Induction; Topiramate; Triazines; Valproic Acid; Zonisamide | 2017 |
Comparative efficacy of antiepileptic drugs in children and adolescents: A network meta-analysis.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Resistant Epilepsy; Epilepsies, Partial; Epilepsy; Epilepsy, Absence; Ethosuximide; Hormones; Humans; Infant; Lamotrigine; Levetiracetam; Network Meta-Analysis; Nitriles; Odds Ratio; Piracetam; Pyridones; Spasms, Infantile; Treatment Outcome; Triazines; Valproic Acid | 2018 |
Mechanisms of epileptogenesis and preclinical approach to antiepileptogenic therapies.
Topics: Animals; Anticonvulsants; Biomarkers; Brain; Dibenzazepines; Epilepsy; Humans; Levetiracetam; Piracetam | 2018 |
PRINTING TECHNIQUES: RECENT DEVELOPMENTS IN PHARMACEUTICAL TECHNOLOGY.
Topics: Animals; Anticonvulsants; Diffusion of Innovation; Dosage Forms; Drug Compounding; Drug Discovery; Humans; Levetiracetam; Piracetam; Printing, Three-Dimensional; Technology, Pharmaceutical | 2017 |
Why we prefer levetiracetam over phenytoin for treatment of status epilepticus.
Topics: Administration, Cutaneous; Administration, Intravenous; Anticonvulsants; Exanthema; Humans; Infusions, Intravenous; Levetiracetam; Phenytoin; Piracetam; Status Epilepticus; Treatment Outcome | 2018 |
A systematic review of levetiracetam versus phenytoin in the prevention of late post-traumatic seizures and survey of UK neurosurgical prescribing practice of antiepileptic medication in acute traumatic brain injury.
Topics: Adult; Anticonvulsants; Brain Injuries, Traumatic; Cohort Studies; Epilepsy, Post-Traumatic; Female; Health Surveys; Humans; Levetiracetam; Neurosurgeons; Phenytoin; Piracetam; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic | 2018 |
Therapeutic benefits of ACTH and levetiracetam in STXBP1 encephalopathy with a de novo mutation: A case report and literature review.
Topics: Adrenocorticotropic Hormone; Anticonvulsants; Brain Diseases; Electroencephalography; Epilepsy; Female; Hormones; Humans; Infant; Levetiracetam; Munc18 Proteins; Mutation; Piracetam; Prednisone; Psychomotor Performance; Treatment Outcome | 2018 |
Efficacy and safety of levetiracetam for migraine prophylaxis: A systematic review.
Topics: Animals; Anticonvulsants; Humans; Levetiracetam; Migraine Disorders; Piracetam; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome | 2018 |
Antiepileptic drugs as prophylaxis for postcraniotomy seizures.
Topics: Anticonvulsants; Carbamazepine; Craniotomy; Humans; Isoxazoles; Levetiracetam; Phenobarbital; Phenytoin; Piracetam; Postoperative Complications; Randomized Controlled Trials as Topic; Seizures; Valproic Acid; Zonisamide | 2018 |
Levetiracetam at the End of Life: A Case Report and Discussion.
Topics: Anticonvulsants; Death; Humans; Levetiracetam; Piracetam; Seizures | 2020 |
Antiepileptic drugs as prophylaxis for postcraniotomy seizures.
Topics: Anticonvulsants; Carbamazepine; Craniotomy; Humans; Isoxazoles; Levetiracetam; Phenobarbital; Phenytoin; Piracetam; Postoperative Complications; Randomized Controlled Trials as Topic; Seizures; Valproic Acid; Zonisamide | 2020 |
Levetiracetam vs. phenytoin as 2nd-line treatment for status epilepticus: A systematic review and meta-analysis.
Topics: Anticonvulsants; Benzodiazepines; Drug Therapy, Combination; Humans; Levetiracetam; Phenytoin; Piracetam; Prospective Studies; Randomized Controlled Trials as Topic; Seizures; Status Epilepticus; Treatment Outcome | 2020 |
Efficacy of Levetiracetam in neonatal seizures: a systematic review.
Topics: Adult; Anticonvulsants; Child; Epilepsy; Humans; Infant, Newborn; Levetiracetam; Phenobarbital; Piracetam; Seizures | 2022 |
Subcutaneous Levetiracetam for the Management of Seizures at the End of Life: An Audit and Updated Literature Review.
Topics: Anticonvulsants; Death; Humans; Levetiracetam; Piracetam; Retrospective Studies; Seizures | 2021 |
Population Pharmacokinetics of Levetiracetam: A Systematic Review.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Female; Humans; Infant, Newborn; Levetiracetam; Phenytoin; Piracetam; Pregnancy | 2021 |
Preventing seizure occurrence following spontaneous intracerebral haemorrhage: A systematic review and meta-analysis of seizure prophylaxis.
Topics: Aged; Anticonvulsants; Cerebral Hemorrhage; Female; Humans; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Seizures | 2021 |
A Systematic Review and Meta-Analysis of Antiepileptic Prophylaxis in Spontaneous Intracerebral Hemorrhage.
Topics: Anticonvulsants; Cerebral Hemorrhage; Humans; Levetiracetam; Phenytoin; Piracetam; Seizures | 2021 |
Clinical considerations for rapid administration of undiluted or minimally diluted levetiracetam bolus doses.
Topics: Administration, Intravenous; Anticonvulsants; Drug-Related Side Effects and Adverse Reactions; Humans; Infusions, Intravenous; Levetiracetam; Piracetam; Status Epilepticus | 2022 |
Comparative efficacy of prophylactic anticonvulsant drugs following traumatic brain injury: A systematic review and network meta-analysis of randomized controlled trials.
Topics: Anticonvulsants; Brain Injuries, Traumatic; Carbamazepine; Child; Humans; Levetiracetam; Network Meta-Analysis; Phenytoin; Piracetam; Randomized Controlled Trials as Topic; Seizures | 2022 |
The safety of rapid infusion levetiracetam: A systematic review.
Topics: Anticonvulsants; Humans; Levetiracetam; Piracetam; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies | 2022 |
Pharmacokinetic considerations surrounding the use of levetiracetam for seizure prophylaxis in neurocritical care - an overview.
Topics: Anticonvulsants; Epilepsy; Humans; Levetiracetam; Phenytoin; Piracetam | 2022 |
Use of antiepileptic drugs as prophylaxis against posttraumatic seizures in the pediatric population: a systematic review and meta-analysis.
Topics: Adult; Anticonvulsants; Brain Injuries, Traumatic; Child; Humans; Levetiracetam; Phenytoin; Piracetam; Seizures | 2023 |
313 trial(s) available for piracetam and levetiracetam
| Article | Year |
|---|---|
Influence of piracetam and etiracetam compared to placebo, on rCBF and parameters of brain metabolism.
Topics: Acid-Base Equilibrium; Adult; Anesthesia, Intravenous; Cerebrovascular Circulation; Clinical Trials as Topic; Double-Blind Method; Female; Hemodynamics; Humans; Kinetics; Levetiracetam; Male; Middle Aged; Piracetam; Placebos; Pyrrolidinones; Pyruvates; Thiopental | 1980 |
Antihypoxidotic and nootropic drugs: proof of their encephalotropic and pharmacodynamic properties by quantitative EEG investigations.
Topics: Adult; Age Factors; Aged; Benzamides; Brain; Cinnarizine; Clinical Trials as Topic; Dihydroergotoxine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Electroencephalography; Female; Hexobendine; Humans; Isoxsuprine; Levetiracetam; Male; Middle Aged; Nicergoline; Piracetam; Psychotropic Drugs; Theophylline; Time Factors | 1980 |
Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy.
Topics: Administration, Oral; Adult; Anticonvulsants; Cognition; Drug Therapy, Combination; Epilepsy; Female; Humans; Levetiracetam; Male; Memory; Middle Aged; Neuropsychological Tests; Piracetam; Psychiatric Status Rating Scales; Reaction Time | 1995 |
Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam.
Topics: Administration, Oral; Adolescent; Adult; Anticonvulsants; Electroencephalography; Epilepsy; Europe; Evaluation Studies as Topic; Female; Humans; Levetiracetam; Male; Models, Neurological; Nootropic Agents; Photic Stimulation; Piracetam; Treatment Outcome | 1996 |
A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Dose-Response Relationship, Drug; Double-Blind Method; Drug Tolerance; Epilepsy; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Treatment Outcome | 2000 |
Effect of levetiracetam on epilepsy-related quality of life. N132 Study Group.
Topics: Adult; Anticonvulsants; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Female; Follow-Up Studies; Health Status Indicators; Humans; Levetiracetam; Male; Piracetam; Placebos; Quality of Life; Sickness Impact Profile; Surveys and Questionnaires; Treatment Outcome | 2000 |
Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Electroencephalography; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Treatment Outcome | 2000 |
Comparison between the QOLIE-31 and derived QOLIE-10 in a clinical trial of levetiracetam.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Anticonvulsants; Anxiety; Drug Therapy, Combination; Emotions; Epilepsies, Partial; Follow-Up Studies; Humans; Levetiracetam; Middle Aged; Piracetam; Placebos; Quality of Life; Surveys and Questionnaires | 2000 |
Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group.
Topics: Anticonvulsants; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Humans; Levetiracetam; Piracetam; Placebos; Treatment Outcome | 2000 |
Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group.
Topics: Anticonvulsants; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Humans; Levetiracetam; Piracetam; Placebos; Treatment Outcome | 2000 |
Efficacy and tolerability of 1000-4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Pilot Projects; Piracetam; Single-Blind Method; Statistics, Nonparametric | 2000 |
Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers.
Topics: Adult; Anticonvulsants; Cross-Over Studies; Digoxin; Double-Blind Method; Drug Administration Schedule; Female; Homeostasis; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Reference Values; Safety | 2001 |
A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus.
Topics: Adult; Aged; Anticonvulsants; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Myoclonic; Female; Humans; Levetiracetam; Male; Middle Aged; Pilot Projects; Piracetam; Treatment Outcome | 2001 |
Lack of effect of repeated administration of levetiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin.
Topics: Adolescent; Adult; Analysis of Variance; Anticoagulants; Anticonvulsants; Area Under Curve; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Female; Humans; International Normalized Ratio; Levetiracetam; Male; Middle Aged; Piracetam; Warfarin | 2001 |
Effect of levetiracetam in patients with epilepsy and interictal epileptiform discharges.
Topics: Adolescent; Adult; Anticonvulsants; Brain; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Electroencephalography; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Piracetam; Treatment Outcome | 2001 |
Dose-response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Anticonvulsants; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Epilepsies, Partial; Female; Humans; Levetiracetam; Logistic Models; Male; Middle Aged; Piracetam | 2002 |
Pharmacokinetic study of levetiracetam in children.
Topics: Adult; Age Factors; Anticonvulsants; Child; Creatine; Epilepsy; Female; Humans; Levetiracetam; Male; Metabolic Clearance Rate; Middle Aged; Piracetam | 2001 |
Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial.
Topics: Age Factors; Age of Onset; Anorexia; Anticonvulsants; Child; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Female; Headache; Humans; Infections; Levetiracetam; Male; Piracetam; Sleep Wake Disorders; Treatment Outcome | 2002 |
Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women.
Topics: Adult; Anticonvulsants; Contraceptives, Oral, Synthetic; Drug Interactions; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levetiracetam; Levonorgestrel; Piracetam | 2002 |
Levetiracetam in refractory pediatric epilepsy.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Cognition; Drug Administration Schedule; Epilepsy; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Treatment Outcome | 2002 |
Levetiracetam in autistic children: an open-label study.
Topics: Aggression; Anticonvulsants; Autistic Disorder; Cetirizine; Child; Child Behavior Disorders; Child, Preschool; Disruptive, Impulse Control, and Conduct Disorders; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Hyperkinesis; Incidence; Levetiracetam; Male; Nootropic Agents; Piracetam; Prospective Studies; Surveys and Questionnaires; Valproic Acid | 2002 |
The effects of levetiracetam on objective and subjective sleep parameters in healthy volunteers and patients with partial epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Cross-Over Studies; Double-Blind Method; Electroencephalography; Epilepsies, Partial; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Polysomnography; Severity of Illness Index; Sleep; Sleep, REM; Surveys and Questionnaires | 2002 |
A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Drug Resistance; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome | 2003 |
Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid.
Topics: Adult; Anticonvulsants; Biological Availability; Biotransformation; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Interactions; Female; Humans; Hydrolysis; In Vitro Techniques; Levetiracetam; Liver; Male; Metabolic Clearance Rate; Middle Aged; Piracetam; Serine Endopeptidases; Valproic Acid | 2003 |
Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials.
Topics: Adult; Aged; Algorithms; Anticonvulsants; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Sex Characteristics | 2003 |
Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy.
Topics: Adolescent; Adult; Anticonvulsants; Behavior; Cognition Disorders; Double-Blind Method; Drug Therapy, Combination; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Seizures | 2003 |
Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Survival Analysis; Treatment Outcome | 2003 |
Clinical experience of marketed Levetiracetam in an epilepsy clinic-a one year follow up study.
Topics: Anticonvulsants; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Epilepsy; Follow-Up Studies; Humans; Levetiracetam; Piracetam; Treatment Outcome | 2003 |
An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Neurologic Examination; Piracetam; Single-Blind Method; Treatment Outcome | 2003 |
Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Cognition Disorders; Drug Administration Schedule; Epilepsy; Female; Follow-Up Studies; Health Status; Humans; Levetiracetam; Male; Mental Disorders; Middle Aged; Neuropsychological Tests; Piracetam; Quality of Life; Social Behavior; Surveys and Questionnaires | 2003 |
The KEEPER trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Community Health Services; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies | 2003 |
Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design.
Topics: Acute Disease; Adult; Anticonvulsants; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Drug Tolerance; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Research Design | 2003 |
Pilot tolerability and effectiveness study of levetiracetam for postherpetic neuralgia.
Topics: Analgesics, Non-Narcotic; Calcium Channel Blockers; Fatigue; Female; Herpes Zoster; Humans; Levetiracetam; Male; Neuralgia; Pilot Projects; Piracetam; Prospective Studies; Receptors, GABA; Receptors, Glycine; Treatment Outcome | 2003 |
Levetiracetam: relative bioavailability and bioequivalence of a 10% oral solution (750 mg) and 750-mg tablets.
Topics: Administration, Oral; Adult; Anticonvulsants; Biological Availability; Cross-Over Studies; Female; Half-Life; Humans; Levetiracetam; Male; Metabolic Clearance Rate; Middle Aged; Piracetam; Solutions; Tablets; Therapeutic Equivalency | 2003 |
Levetiracetam does not alter body weight: analysis of randomized, controlled clinical trials.
Topics: Adult; Anticonvulsants; Body Weight; Epilepsy; Europe; Female; Humans; Levetiracetam; Male; Piracetam; United States | 2003 |
Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial.
Topics: Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Drug Tolerance; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Piracetam; Seizures; Time Factors; Treatment Outcome | 2003 |
Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Drug Therapy, Combination; Female; Humans; Levetiracetam; Male; Middle Aged; Myoclonus; Piracetam; Treatment Outcome; Unverricht-Lundborg Syndrome | 2004 |
Levetiracetam in bipolar spectrum disorders: first evidence of efficacy in an open, add- on study.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Levetiracetam; Male; Pilot Projects; Piracetam | 2004 |
Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
Topics: Adult; Anticonvulsants; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Epilepsy; Female; Humans; Levetiracetam; Male; Piracetam; Prospective Studies | 2004 |
Efficacy of levetiracetam in pharmacoresistant continuous spikes and waves during slow sleep.
Topics: Action Potentials; Anticonvulsants; Cerebral Cortex; Child; Child, Preschool; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Electroencephalography; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Piracetam; Recovery of Function; Sleep; Sleep Wake Disorders; Treatment Outcome; Valproic Acid | 2004 |
A prospective analysis of the outcome of levetiracetam in clinical practice.
Topics: Anticonvulsants; Consciousness Disorders; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Life Tables; Male; Mood Disorders; Patient Dropouts; Piracetam; Product Surveillance, Postmarketing; Prospective Studies; Remission Induction; Treatment Outcome | 2004 |
Levetiracetam as add-on therapy in generalised epilepsies.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Drug Therapy, Combination; Epilepsy, Generalized; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Treatment Outcome | 2004 |
A pilot study of compassionate use of Levetiracetam in patients with generalised epilepsy.
Topics: Adult; Anticonvulsants; Epilepsy, Generalized; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Pilot Projects; Piracetam; Treatment Outcome | 2004 |
An open-label study of levetiracetam for the treatment of social anxiety disorder.
Topics: Adult; Ambulatory Care; Anticonvulsants; Drug Administration Schedule; Female; Humans; Levetiracetam; Male; Phobic Disorders; Pilot Projects; Piracetam; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 2004 |
Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers.
Topics: Adult; Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Cognition; Cross-Over Studies; Double-Blind Method; Electroencephalography; Evoked Potentials, Visual; Female; Humans; Levetiracetam; Male; Oxcarbazepine; Piracetam; Psychomotor Performance; Reaction Time; Severity of Illness Index | 2004 |
Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor.
Topics: Aged; Anticonvulsants; Cross-Over Studies; Double-Blind Method; Essential Tremor; Female; Humans; Levetiracetam; Male; Pilot Projects; Piracetam; Severity of Illness Index | 2004 |
Levetiracetam influences human motor cortex excitability mainly by modulation of ion channel function--a TMS study.
Topics: Adult; Anticonvulsants; Brain Chemistry; Calcium Channels; Cerebral Cortex; Cross-Over Studies; Double-Blind Method; Electromagnetic Fields; Female; GABA Antagonists; Humans; Ion Channels; Levetiracetam; Male; Motor Cortex; Piracetam; Potassium Channels; Prospective Studies; Receptors, GABA-A; Receptors, Glycine; Recruitment, Neurophysiological; Spinal Cord; Stereoisomerism | 2004 |
Levetiracetam for people with mental retardation and refractory epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Behavior; Child; Drug Administration Schedule; Drug Evaluation; Epilepsy; Female; Follow-Up Studies; Humans; Intellectual Disability; Levetiracetam; Male; Middle Aged; Neurologic Examination; Piracetam; Sleep; Treatment Outcome | 2004 |
Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome.
Topics: Adolescent; Anticonvulsants; Child; Demography; Dose-Response Relationship, Drug; Educational Status; Female; Humans; Levetiracetam; Male; Piracetam; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Tics; Tourette Syndrome; Treatment Outcome | 2005 |
[Keppra in epilepsy treatment: efficacy and tolerability].
Topics: Adolescent; Adult; Anticonvulsants; Child; Drug Administration Schedule; Drug Tolerance; Epilepsy; Humans; Levetiracetam; Periodicity; Piracetam | 2005 |
Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Cross-Over Studies; Demography; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Multicenter Studies as Topic; Piracetam; Prospective Studies; Quality of Life; Severity of Illness Index; Single-Blind Method; Time Factors; Treatment Outcome | 2005 |
Limited efficacy of levetiracetam on myoclonus of different etiologies.
Topics: Adult; Anticonvulsants; Female; Humans; Levetiracetam; Male; Middle Aged; Myoclonus; Piracetam | 2005 |
Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder.
Topics: Adult; Ambulatory Care; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Levetiracetam; Longitudinal Studies; Male; Pilot Projects; Piracetam; Polyvinyls; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 2005 |
The effect of levetiracetam on essential tremor.
Topics: Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Essential Tremor; Female; Hand; Humans; Levetiracetam; Male; Middle Aged; Muscle Contraction; Muscle, Skeletal; Neurologic Examination; Piracetam; Placebos; Recovery of Function; Sex Factors; Time Factors; Treatment Outcome | 2005 |
Levetiracetam for seizures after liver transplantation.
Topics: Anticonvulsants; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Immunosuppressive Agents; Levetiracetam; Liver; Liver Transplantation; Male; Phenytoin; Piracetam; Postoperative Complications; Retrospective Studies; Seizures; Treatment Outcome | 2005 |
Ketter's hypothesis of the mood effects of antiepileptic drugs coupled to the mechanism of action of topiramate and levetiracetam.
Topics: Adult; Anticonvulsants; Chi-Square Distribution; Demography; Drug Therapy, Combination; Epilepsy; Female; Follow-Up Studies; Fructose; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Levetiracetam; Male; Middle Aged; Models, Biological; Mood Disorders; Odds Ratio; Piracetam; Time Factors; Topiramate | 2005 |
Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy.
Topics: Anticonvulsants; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Electroencephalography; Epilepsy; Female; Follow-Up Studies; Humans; Infant; Levetiracetam; Male; Neurologic Examination; Piracetam; Prospective Studies; Retrospective Studies; Treatment Outcome | 2005 |
Specific effect of levetiracetam in experimental human pain models.
Topics: Adult; Anticonvulsants; Cross-Over Studies; Double-Blind Method; Electric Stimulation; Female; Humans; Levetiracetam; Male; Neuralgia; Pain Threshold; Piracetam; Reaction Time; Sural Nerve | 2006 |
Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests.
Topics: Adult; Anticonvulsants; Caffeine; Humans; Kidney Function Tests; Levetiracetam; Lidocaine; Liver Cirrhosis, Alcoholic; Liver Function Tests; Male; Middle Aged; Piracetam; Sorbitol | 2005 |
Oral absorption kinetics of levetiracetam: the effect of mixing with food or enteral nutrition formulas.
Topics: Administration, Oral; Adult; Anticonvulsants; Area Under Curve; Cross-Over Studies; Enteral Nutrition; Female; Food-Drug Interactions; Food, Formulated; Humans; Intestinal Absorption; Levetiracetam; Male; Piracetam | 2005 |
Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study.
Topics: Adult; Aged; Anticonvulsants; Cerebral Cortex; Electroencephalography; Evoked Potentials, Somatosensory; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Myoclonus; Piracetam; Statistics, Nonparametric; Treatment Outcome | 2005 |
[Efficacy of keppra in combined therapy in pharmacoresistant adult epilepsy patients].
Topics: Adult; Anticonvulsants; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy, Generalized; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Valproic Acid; Vitamins | 2005 |
Clinical experience with levetiracetam in idiopathic generalized epilepsy according to different syndrome subtypes.
Topics: Anticonvulsants; Electroencephalography; Epilepsy, Absence; Female; Humans; Levetiracetam; Male; Myoclonic Epilepsy, Juvenile; Piracetam; Prospective Studies; Treatment Outcome | 2005 |
Effects of levetiracetam on sleep in normal volunteers.
Topics: Adolescent; Adult; Anticonvulsants; Female; Humans; Levetiracetam; Male; Piracetam; Polysomnography; Sleep | 2005 |
Levetiracetam in social phobia: a placebo controlled pilot study.
Topics: Adult; Anticonvulsants; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Levetiracetam; Male; Middle Aged; Outpatients; Phobic Disorders; Pilot Projects; Piracetam; Placebos; Psychiatric Status Rating Scales; Sleep Stages; Treatment Outcome | 2005 |
Levetiracetam in patients with refractory epilepsy: results of the SKATE trial in Austria, Germany and Switzerland.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Austria; Demography; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Epilepsy; Female; Germany; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Switzerland; Time Factors; Treatment Outcome | 2005 |
Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany.
Topics: Anticonvulsants; Child; Child, Preschool; Demography; Drug Evaluation; Drug Therapy, Combination; Epilepsy; Female; Germany; Humans; Infant; Infant, Newborn; Levetiracetam; Male; Piracetam; Prospective Studies; Retrospective Studies; Single-Blind Method; Treatment Outcome | 2005 |
Long-term efficacy of levetiracetam for partial seizures.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Demography; Epilepsies, Partial; Female; Follow-Up Studies; Humans; Levetiracetam; Longitudinal Studies; Male; Middle Aged; Piracetam; Time; Time Factors; Treatment Outcome | 2005 |
Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy.
Topics: Adult; Anticonvulsants; Attention; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Neuropsychological Tests; Nootropic Agents; Piracetam; Speech Disorders; Treatment Outcome | 2006 |
Levetiracetam efficacy in epileptic syndromes with continuous spikes and waves during slow sleep: experience in 12 cases.
Topics: Adolescent; Anticonvulsants; Cerebral Cortex; Child; Child Behavior Disorders; Child, Preschool; Cognition Disorders; Comorbidity; Electroencephalography; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Neuropsychological Tests; Piracetam; Retrospective Studies; Sleep Stages; Syndrome; Treatment Outcome | 2005 |
Evidence for a rapid action of levetiracetam compared to topiramate in refractory partial epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Drug Therapy, Combination; Epilepsies, Partial; Female; Fructose; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Topiramate; Treatment Outcome | 2006 |
Use of levetiracetam in treating epilepsy associated with other medical conditions.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy, Generalized; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Polypharmacy; Prospective Studies; Treatment Outcome | 2006 |
Efficacy and safety of levetiracetam (up to 2000 mg/day) in Taiwanese patients with refractory partial seizures: a multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Anticonvulsants; Asian People; Cross-Over Studies; Dizziness; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Epilepsies, Partial; Female; Headache; Humans; Levetiracetam; Male; Middle Aged; Pharmacogenetics; Piracetam; Placebos; Sleep Wake Disorders; Taiwan; Treatment Outcome | 2006 |
Effects of levetiracetam on nocturnal sleep and daytime vigilance in healthy volunteers.
Topics: Adult; Anticonvulsants; Arousal; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Epilepsy; Female; Humans; Levetiracetam; Male; Piracetam; Placebos; Polysomnography; Sleep; Sleep Wake Disorders; Treatment Outcome | 2006 |
Levetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label study.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Epilepsies, Myoclonic; Epilepsy, Generalized; Female; Humans; Levetiracetam; Male; Piracetam; Treatment Outcome | 2006 |
Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
Topics: Adult; Anticonvulsants; Disease-Free Survival; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Electroencephalography; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Monitoring, Physiologic; Piracetam; Placebos; Preoperative Care; Treatment Outcome; Videotape Recording | 2006 |
Levetiracetam for treatment-refractory posttraumatic stress disorder.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Levetiracetam; Male; Middle Aged; Personality Inventory; Piracetam; Psychiatric Status Rating Scales; Psychometrics; Retrospective Studies; Severity of Illness Index; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome | 2006 |
An open-label trial of levetiracetam for treatment of cervical dystonia.
Topics: Adult; Anticonvulsants; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Torticollis | 2006 |
Treatment of neuroleptic-induced tardive dyskinesia with levetiracetam: a case series.
Topics: Adult; Aged; Anticonvulsants; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Treatment Outcome | 2006 |
Levetiracetam in tardive dyskinesia: an open label study.
Topics: Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Humans; Levetiracetam; Middle Aged; Nootropic Agents; Piracetam; Single-Blind Method | 2006 |
Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
Topics: Anticonvulsants; Child; Child, Preschool; Double-Blind Method; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Pediatrics; Piracetam; Placebo Effect; Risk Assessment; Risk Factors; Treatment Outcome | 2006 |
Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial.
Topics: Adult; Anticonvulsants; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Drug Resistance; Epilepsy; Female; Headache; Humans; International Cooperation; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Sensation Disorders; Treatment Outcome | 2006 |
Levetiracetam therapy in patients with brain tumour and epilepsy.
Topics: Adult; Aged; Anticonvulsants; Brain Neoplasms; Drug Therapy, Combination; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam | 2006 |
Levetiracetam for the treatment of alcohol withdrawal syndrome: an open-label pilot trial.
Topics: Adult; Alcoholism; Dose-Response Relationship, Drug; Female; Humans; Levetiracetam; Male; Middle Aged; Nootropic Agents; Pilot Projects; Piracetam; Substance Withdrawal Syndrome | 2006 |
Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Dose-Response Relationship, Drug; Electroencephalography; Female; Humans; Levetiracetam; Male; Middle Aged; Myoclonic Epilepsy, Juvenile; Piracetam; Prospective Studies | 2006 |
Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Topics: Administration, Oral; Adult; Algorithms; Analysis of Variance; Anticonvulsants; Area Under Curve; Biological Availability; Cross-Over Studies; Double-Blind Method; Female; Humans; Infusions, Intravenous; Levetiracetam; Male; Middle Aged; Piracetam; Time Factors | 2006 |
Determination of levetiracetam in human plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to bioequivalence studies.
Topics: Anticonvulsants; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Humans; Levetiracetam; Piracetam; Reproducibility of Results; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Therapeutic Equivalency | 2006 |
Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study.
Topics: Administration, Oral; Adult; Anticonvulsants; Area Under Curve; Blood Pressure; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Epilepsy; Fatigue; Female; Half-Life; Headache; Heart Rate; Humans; Infusions, Intravenous; Levetiracetam; Male; Piracetam; Placebos; Single-Blind Method; Time Factors | 2006 |
Efficacy and safety of levetiracetam in clinical practice: results of the SKATE trial from Belgium and The Netherlands.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Belgium; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Netherlands; Piracetam; Prospective Studies | 2006 |
Levetiracetam: a long-term follow-up study of efficacy and safety.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Treatment Outcome | 2006 |
Assessment of a dose-response relationship of levetiracetam.
Topics: Anticonvulsants; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Humans; Levetiracetam; Outcome Assessment, Health Care; Piracetam | 2006 |
Disfluent speech in patients with partial epilepsy: beneficial effect of levetiracetam.
Topics: Adult; Anticonvulsants; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Speech Disorders | 2006 |
Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Dose-Response Relationship, Drug; Epilepsy, Rolandic; Female; Humans; Levetiracetam; Male; Oxcarbazepine; Pilot Projects; Piracetam; Prospective Studies; Sleep Stages | 2007 |
Safety and efficacy of levetiracetam for patients with panic disorder: results of an open-label, fixed-flexible dose study.
Topics: Adolescent; Adult; Agoraphobia; Ambulatory Care; Anticonvulsants; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Humans; Levetiracetam; Male; Middle Aged; Panic Disorder; Piracetam; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 2006 |
Influence of levetiracetame on ictal and postictal EEG in patients with partial seizures.
Topics: Adult; Anticonvulsants; Double-Blind Method; Electroencephalography; Epilepsy, Partial, Sensory; Female; Humans; Levetiracetam; Male; Middle Aged; Patient Selection; Piracetam | 2006 |
Comparison of plasma and saliva concentrations of levetiracetam following administration orally as a tablet and as a solution in healthy adult volunteers.
Topics: Administration, Oral; Adolescent; Adult; Anticonvulsants; Drug Monitoring; Feasibility Studies; Humans; Levetiracetam; Linear Models; Male; Middle Aged; Pharmaceutical Solutions; Piracetam; Reference Values; Reproducibility of Results; Saliva; Tablets; Time Factors | 2007 |
Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Therapy, Combination; Epilepsies, Partial; Humans; Levetiracetam; Piracetam; Saliva; Valproic Acid | 2007 |
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Epilepsy; Female; Humans; Levetiracetam; Male; Piracetam; Treatment Outcome | 2007 |
Single-dose pharmacokinetics of levetiracetam in healthy Chinese male subjects.
Topics: Adult; Anticonvulsants; Asian People; Cross-Over Studies; Dose-Response Relationship, Drug; Humans; Levetiracetam; Male; Piracetam | 2007 |
Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anticonvulsants; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Fatigue; Female; Follow-Up Studies; Headache; Humans; Infusions, Intravenous; Levetiracetam; Male; Middle Aged; Piracetam; Treatment Outcome | 2007 |
Efficacy and safety of levetiracetam as adjunctive treatment of refractory partial seizures in a multicentre open-label single-arm trial in Korean patients.
Topics: Adult; Anticonvulsants; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Korea; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2007 |
Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Drug Evaluation; Epilepsy; Female; Humans; Infant; Levetiracetam; Longitudinal Studies; Male; Piracetam; Prospective Studies; Severity of Illness Index | 2007 |
[Efficacy and safety of levetiracetam (keppra) add-on treatment in adult patients with refractory epilepsy in two tertiary centers].
Topics: Adolescent; Adult; Anticonvulsants; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Seizures; Treatment Outcome | 2007 |
Saliva and serum levetiracetam concentrations in patients with epilepsy.
Topics: Adult; Aged; Anticonvulsants; Drug Monitoring; Epilepsy; Female; Humans; Levetiracetam; Linear Models; Male; Middle Aged; Piracetam; Saliva | 2007 |
An open trial of levetiracetam for segmental and generalized dystonia.
Topics: Adult; Aged; Anticonvulsants; Dystonia; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Treatment Outcome | 2007 |
A double blind randomized placebo control trial of levetiracetam in Tourette syndrome.
Topics: Adolescent; Anticonvulsants; Child; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Levetiracetam; Male; Piracetam; Severity of Illness Index; Time Factors; Tourette Syndrome | 2007 |
Levetiracetam for the treatment of hot flashes: a phase II study.
Topics: Breast Neoplasms; Dizziness; Fatigue; Female; Hot Flashes; Humans; Levetiracetam; Middle Aged; Nootropic Agents; Patient Satisfaction; Pilot Projects; Piracetam; Quality of Life; Severity of Illness Index; Sleep Stages | 2008 |
Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Child; Child, Preschool; Double-Blind Method; Epilepsy, Generalized; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Placebos; Quality of Life; Research Design; Surveys and Questionnaires; Treatment Outcome | 2007 |
Levetiracetam for manic behavior in hospitalized geriatric patients with dementia of the Alzheimer's type.
Topics: Aged; Alzheimer Disease; Bipolar Disorder; Female; Humans; Levetiracetam; Male; Nootropic Agents; Pilot Projects; Piracetam; Psychiatric Status Rating Scales | 2007 |
An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy.
Topics: Adolescent; Adult; Child; Child, Preschool; Epilepsies, Myoclonic; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Piracetam | 2007 |
Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Fructose; Humans; Lamotrigine; Levetiracetam; Male; Outcome Assessment, Health Care; Piracetam; Placebos; Topiramate; Triazines; Valproic Acid | 2007 |
The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Female; Health Status; Humans; International Cooperation; Levetiracetam; Male; Middle Aged; Piracetam; Quality of Life; Residence Characteristics; Retrospective Studies; Single-Blind Method; Treatment Outcome | 2007 |
Effects of levetiracetam vs topiramate and placebo on visually evoked phase synchronization changes of alpha rhythm in migraine.
Topics: Adolescent; Adult; Algorithms; Alpha Rhythm; Brain Mapping; Cortical Synchronization; Double-Blind Method; Electroencephalography; Evoked Potentials, Visual; Female; Fructose; Humans; Levetiracetam; Male; Middle Aged; Migraine Disorders; Neuroprotective Agents; Nootropic Agents; Photic Stimulation; Piracetam; Topiramate | 2007 |
Impact of levetiracetam on mood and cognition during prednisone therapy.
Topics: Adolescent; Adult; Affect; Aged; Anti-Inflammatory Agents; Antidepressive Agents; Asthma; Cognition; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Levetiracetam; Male; Memory; Middle Aged; Neuropsychological Tests; Piracetam; Prednisone; Surveys and Questionnaires | 2007 |
Adjunctive therapy of uncontrolled partial seizures with levetiracetam in Australian patients.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Australia; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Evaluation; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Naphthalenes; Oxepins; Piracetam; Quality of Life; Treatment Outcome | 2007 |
A pilot study transitioning children onto levetiracetam monotherapy to improve language dysfunction associated with benign rolandic epilepsy.
Topics: Anticonvulsants; Child; Electroencephalography; Epilepsy, Rolandic; Female; Humans; Language Development Disorders; Language Tests; Levetiracetam; Male; Pilot Projects; Piracetam | 2007 |
Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
Topics: Adolescent; Anticonvulsants; Child; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Epilepsies, Partial; Epilepsy, Generalized; Female; Follow-Up Studies; Humans; Irritable Mood; Levetiracetam; Male; Piracetam; Prospective Studies; Seizures; Treatment Outcome | 2008 |
Levetiracetam monotherapy in newly diagnosed cryptogenic West syndrome.
Topics: Anticonvulsants; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Retrospective Studies; Spasms, Infantile; Treatment Outcome | 2007 |
Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures.
Topics: Adult; Anticonvulsants; Chi-Square Distribution; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Neuropsychological Tests; Piracetam; Problem Solving; Quality of Life; Statistics, Nonparametric; Treatment Outcome | 2008 |
Effect of levetiracetam on depression and anxiety in adult epileptic patients.
Topics: Adult; Age Factors; Anticonvulsants; Anxiety Disorders; Depressive Disorder; Dizziness; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Piracetam; Placebo Effect; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 2008 |
Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam.
Topics: Adolescent; Adult; Carbamazepine; Cross-Over Studies; Double-Blind Method; Electroencephalography; Female; Humans; Levetiracetam; Male; Middle Aged; Neuropsychological Tests; Piracetam; Psychomotor Performance; Sensitivity and Specificity | 2007 |
Clinical predictors in patients with refractory epilepsy exposed to levetiracetam: a single-center study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Drug Evaluation; Epilepsy; Female; Humans; Levetiracetam; Logistic Models; Male; Middle Aged; Piracetam; Predictive Value of Tests; Retrospective Studies; Treatment Outcome | 2008 |
Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents.
Topics: Adolescent; Anticonvulsants; Child; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Myoclonic Epilepsy, Juvenile; Piracetam; Prospective Studies; Time Factors; Treatment Outcome | 2008 |
Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Databases, Factual; Drug Evaluation; Epilepsies, Partial; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Piracetam; Retrospective Studies | 2008 |
High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Levetiracetam; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nootropic Agents; Piracetam | 2008 |
Levetiracetam in patients with impulsive aggression: a double-blind, placebo-controlled trial.
Topics: Adult; Aggression; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Female; Humans; Impulsive Behavior; Levetiracetam; Male; Middle Aged; Patient Selection; Piracetam; Treatment Failure | 2008 |
A pilot trial of levetiracetam in eyelid myoclonia with absences (Jeavons syndrome).
Topics: Adolescent; Adult; Anticonvulsants; Child; Comorbidity; Drug Therapy, Combination; Epilepsies, Myoclonic; Epilepsy, Absence; Epilepsy, Reflex; Eyelids; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Myoclonus; Pilot Projects; Piracetam; Syndrome; Treatment Outcome | 2008 |
Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Dose-Response Relationship, Drug; Drug Resistance; Electroencephalography; Epilepsy, Reflex; Female; Follow-Up Studies; Humans; Levetiracetam; Longitudinal Studies; Male; Middle Aged; Myoclonic Epilepsy, Juvenile; Photic Stimulation; Piracetam; Prospective Studies; Time Factors; Treatment Outcome | 2008 |
Response of infantile spasms to levetiracetam.
Topics: Anticonvulsants; Body Weight; Brain; Deglutition Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Electroencephalography; Female; Humans; Infant; Levetiracetam; Male; Muscle Hypotonia; Piracetam; Spasms, Infantile; Treatment Outcome | 2008 |
Intravenous levetiracetam in children with epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Epilepsy; Female; Humans; Infant; Infant, Newborn; Injections, Intraventricular; Levetiracetam; Male; Piracetam | 2008 |
Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Chi-Square Distribution; Child; Double-Blind Method; Epilepsies, Myoclonic; Epilepsy, Generalized; Evaluation Studies as Topic; Humans; Levetiracetam; Middle Aged; Piracetam; Retrospective Studies; Severity of Illness Index | 2008 |
Levetiracetam has no acute effects on brain gamma-aminobutyric acid levels.
Topics: Adult; Anticonvulsants; Brain Mapping; Cerebrum; Creatine; Female; gamma-Aminobutyric Acid; Humans; Levetiracetam; Magnetic Resonance Spectroscopy; Male; Piracetam; Reference Values | 2008 |
Intravenous levetiracetam: treatment experience with the first 50 critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Blood Platelets; Critical Illness; Dose-Response Relationship, Drug; Drug Evaluation; Epilepsy; Female; Humans; Injections, Intravenous; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Retrospective Studies | 2008 |
Effects of levetiracetam on tardive dyskinesia: a randomized, double-blind, placebo-controlled study.
Topics: Algorithms; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Levetiracetam; Male; Middle Aged; Nootropic Agents; Piracetam; Treatment Outcome | 2008 |
Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
Topics: Action Potentials; Adolescent; Adult; Anticonvulsants; Arrhythmias, Cardiac; Aza Compounds; Cross-Over Studies; Double-Blind Method; Electrocardiography, Ambulatory; Female; Fluoroquinolones; Heart Conduction System; Heart Rate; Humans; Levetiracetam; Male; Middle Aged; Moxifloxacin; Piracetam; Quinolines; Risk Assessment; Young Adult | 2008 |
Levetiracetam as monotherapy or add-on to valproate in the treatment of acute mania-a randomized open-label study.
Topics: Anticonvulsants; Bipolar Disorder; Drug Therapy, Combination; Humans; Levetiracetam; Piracetam; Psychiatric Status Rating Scales; Valproic Acid | 2008 |
Effect of levetiracetam on cortical excitability: a transcranial magnetic stimulation study.
Topics: Adult; Analysis of Variance; Differential Threshold; Electric Stimulation; Evoked Potentials, Motor; Female; Humans; Levetiracetam; Male; Middle Aged; Motor Cortex; Neural Inhibition; Nootropic Agents; Piracetam; Transcranial Magnetic Stimulation | 2008 |
Prolonged neurophysiologic effects of levetiracetam after oral administration in humans.
Topics: Adult; Anticonvulsants; Brain; Female; Half-Life; Humans; Intracellular Space; Levetiracetam; Male; Middle Aged; Piracetam; Psychomotor Performance; Receptors, Presynaptic; Synapses; Time Factors; Transcranial Magnetic Stimulation | 2008 |
Levetiracetam and bleeding disorders.
Topics: Adult; Anticonvulsants; Aspirin; Bleeding Time; Blood Coagulation; Cross-Over Studies; Double-Blind Method; Hemostatic Disorders; Humans; Levetiracetam; Male; Piracetam; Placebos; Platelet Aggregation Inhibitors | 2007 |
Efficacy of levetiracetam in children with epilepsy younger than 2 years of age.
Topics: Anticonvulsants; Drug Evaluation; Epilepsy; Female; Humans; Infant; Infant, Newborn; Levetiracetam; Male; Piracetam; Retrospective Studies | 2008 |
Activity, tolerability and efficacy of levetiracetam on cerebellar symptoms in multiple sclerosis patients: a pilot kinematic study.
Topics: Biomechanical Phenomena; Cerebellum; Female; Humans; Levetiracetam; Male; Multiple Sclerosis; Nootropic Agents; Pilot Projects; Piracetam; Tremor | 2008 |
The efficacy and tolerability of Levetiracetam as an add-on therapy in patients with startle epilepsy.
Topics: Adult; Age of Onset; Anticonvulsants; Child; Child, Preschool; Drug Tolerance; Epilepsy, Reflex; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Levetiracetam; Male; Piracetam; Prospective Studies | 2008 |
Levetiracetam for treatment of premenstrual dysphoric disorder: a pilot, open-label study.
Topics: Adult; Anticonvulsants; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follicular Phase; Headache; Humans; Irritable Mood; Kindling, Neurologic; Levetiracetam; Luteal Phase; Pilot Projects; Piracetam; Premenstrual Syndrome; Prospective Studies; Severity of Illness Index; Treatment Outcome; Women's Health | 2008 |
Tolerability and efficacy of oral loading of levetiracetam.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anticonvulsants; Drug Evaluation; Drug Tolerance; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Time Factors | 2008 |
Early detection of behavioral side effects of antiepileptic treatment using handheld computers.
Topics: Adult; Aggression; Ambulatory Care; Anticonvulsants; Attention; Attitude to Computers; Cognition; Computers, Handheld; Drug Therapy, Combination; Epilepsy; Feasibility Studies; Female; Humans; Levetiracetam; Male; Middle Aged; Neuropsychological Tests; Patient Compliance; Pilot Projects; Piracetam | 2008 |
Levetiracetam monotherapy for late poststroke seizures in the elderly.
Topics: Aged; Anticonvulsants; Drug Evaluation; Epilepsy; Female; Follow-Up Studies; Geriatrics; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Stroke; Time Factors | 2008 |
Effect of levetiracetam on the postmastectomy pain syndrome.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Double-Blind Method; Female; Humans; Levetiracetam; Mastectomy; Middle Aged; Neuralgia; Pain, Postoperative; Piracetam | 2008 |
Tolerability and dosing experience of intravenous levetiracetam in children and infants.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Drug Tolerance; Evaluation Studies as Topic; Female; Humans; Infant; Injections, Intravenous; Levetiracetam; Male; Piracetam; Retrospective Studies; Seizures | 2008 |
Positive and negative psychotropic effects of levetiracetam.
Topics: Adolescent; Adult; Affect; Analysis of Variance; Anticonvulsants; Behavioral Symptoms; Child; Cognition; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Personality; Piracetam; Young Adult | 2008 |
The effects of levetiracetam on alcohol consumption in alcohol-dependent subjects: an open label study.
Topics: Alcoholism; Anticonvulsants; Brain; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Receptors, AMPA; Receptors, GABA-A; Receptors, Glycine | 2008 |
Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients.
Topics: Acoustic Stimulation; Adolescent; Adult; Analysis of Variance; Anticonvulsants; Contingent Negative Variation; Double-Blind Method; Electroencephalography; Female; Fructose; Habituation, Psychophysiologic; Humans; Levetiracetam; Male; Middle Aged; Migraine without Aura; Piracetam; Time Factors; Topiramate | 2008 |
Levetiracetam in continuous spike waves during slow-wave sleep syndrome.
Topics: Anticonvulsants; Child; Child, Preschool; Electroencephalography; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Piracetam; Seizures; Sleep | 2008 |
Pyridoxine supplementation for the treatment of levetiracetam-induced behavior side effects in children: preliminary results.
Topics: Adolescent; Anticonvulsants; Behavioral Symptoms; Child; Child, Preschool; Epilepsy; Female; Humans; Levetiracetam; Male; Piracetam; Pyridoxine; Retrospective Studies; Vitamin B Complex; Young Adult | 2008 |
Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
Topics: Adolescent; Adult; Anticonvulsants; China; Cross-Cultural Comparison; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Young Adult | 2009 |
The effects of levetiracetam on cognition: a non-interventional surveillance study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Cognition Disorders; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Neuropsychological Tests; Piracetam; Prospective Studies; Regression Analysis; Young Adult | 2008 |
Levetiracetam in stiff-person syndrome.
Topics: Aged; Anticonvulsants; Electromyography; Female; Humans; Levetiracetam; Middle Aged; Muscle Rigidity; Muscle, Skeletal; Neurologic Examination; Piracetam; Respiration; Single-Blind Method; Spasm; Stiff-Person Syndrome | 2008 |
Levetiracetam in absence epilepsy.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Double-Blind Method; Electrocardiography; Electroencephalography; Epilepsy, Absence; Female; Humans; Levetiracetam; Male; Piracetam; Prospective Studies | 2008 |
Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease.
Topics: Adult; Aged; Anticonvulsants; Disease Progression; Humans; Levetiracetam; Middle Aged; Motor Neuron Disease; Muscle Cramp; Muscle Spasticity; Pilot Projects; Piracetam; Placebos; Randomized Controlled Trials as Topic | 2009 |
Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational study.
Topics: Aged; Aged, 80 and over; Aggression; Anticonvulsants; Brain Ischemia; Cardiovascular Agents; Drug Interactions; Epilepsy; Female; Fibrinolytic Agents; Gait Ataxia; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Sleep Stages | 2008 |
Levetiracetam for the treatment of co-occurring alcohol dependence and anxiety: case series and review.
Topics: Adult; Alcohol Drinking; Alcoholism; Anxiety Disorders; Diagnosis, Dual (Psychiatry); Female; Humans; Levetiracetam; Male; Middle Aged; Nootropic Agents; Piracetam | 2008 |
Comparative cognitive effects of levetiracetam and topiramate in intractable epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Cognition Disorders; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy, Complex Partial; Epilepsy, Tonic-Clonic; Female; Fructose; Humans; Levetiracetam; Male; Middle Aged; Neuropsychological Tests; Piracetam; Prospective Studies; Psychometrics; Taiwan; Topiramate; Young Adult | 2008 |
Bioequivalence of two formulations of levetiracetam.
Topics: Administration, Oral; Adult; Analysis of Variance; Anticonvulsants; Area Under Curve; Chemistry, Pharmaceutical; Cross-Over Studies; Fasting; Female; Half-Life; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Therapeutic Equivalency | 2008 |
Levetiracetam: a practical option for seizure management in elderly patients with cognitive impairment.
Topics: Aged; Aged, 80 and over; Aging; Anticonvulsants; Cognition; Cognition Disorders; Disease-Free Survival; Fatigue; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Psychiatric Status Rating Scales; Seizures; Severity of Illness Index; Treatment Outcome | 2010 |
Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy.
Topics: Adult; Affect; Anger; Anticonvulsants; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Female; Hostility; Humans; Lamotrigine; Levetiracetam; Male; Middle Aged; Personality Inventory; Piracetam; Psychometrics; Triazines | 2009 |
Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus.
Topics: Adult; Aged; Anticonvulsants; Bayes Theorem; Biological Availability; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infusions, Intravenous; Levetiracetam; Male; Metabolic Clearance Rate; Middle Aged; Piracetam; Prospective Studies; Status Epilepticus | 2009 |
A prospective multi-centre open label study of the use of levetiracetam as add-on treatment in patients with epilepsy and intellectual disabilities.
Topics: Adult; Aged; Anticonvulsants; Drug Therapy, Combination; Epilepsy; Female; Follow-Up Studies; Humans; Intellectual Disability; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Quality of Life; Time Factors; Treatment Outcome; Young Adult | 2009 |
The impact of side effects on long-term retention in three new antiepileptic drugs.
Topics: Anticonvulsants; Drug Utilization; Epilepsy; Fructose; Humans; Lamotrigine; Levetiracetam; Longitudinal Studies; Patient Compliance; Piracetam; Time Factors; Topiramate; Treatment Outcome; Triazines | 2009 |
The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis.
Topics: Administration, Oral; Adult; Anticonvulsants; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Levetiracetam; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Piracetam; Placebos; Severity of Illness Index; Treatment Outcome; Tremor | 2009 |
Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Brain Neoplasms; Craniotomy; Female; Glioma; Humans; Levetiracetam; Male; Middle Aged; Phenytoin; Pilot Projects; Piracetam; Seizures | 2009 |
Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Anticonvulsants; Body Weight; Chemotherapy, Adjuvant; China; Dizziness; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Psychomotor Agitation; Seizures; Sleep Wake Disorders; Treatment Outcome; Young Adult | 2009 |
The underrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production.
Topics: Adolescent; Anticonvulsants; Attention; Attention Deficit and Disruptive Behavior Disorders; Brain; Child; Electroencephalography; Epilepsy; Female; Humans; Learning Disabilities; Levetiracetam; Male; Memory; Neuropsychological Tests; Pilot Projects; Piracetam; Prospective Studies; Treatment Outcome | 2009 |
An open-label, prospective study of levetiracetam in children and adolescents with Tourette syndrome.
Topics: Adolescent; Child; Dose-Response Relationship, Drug; Female; Humans; Levetiracetam; Male; Nootropic Agents; Piracetam; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Tourette Syndrome; Treatment Outcome | 2009 |
Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
Topics: Anticonvulsants; Child, Preschool; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Electroencephalography; Epilepsies, Partial; Female; Humans; Infant; Infant, Newborn; International Cooperation; Levetiracetam; Male; Odds Ratio; Piracetam; Retrospective Studies; Time Factors; Treatment Outcome; Videotape Recording | 2009 |
Pharmacokinetics of levetiracetam XR 500mg tablets.
Topics: Adolescent; Adult; Analysis of Variance; Anticonvulsants; Area Under Curve; Biological Availability; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Electrocardiography; Humans; Levetiracetam; Middle Aged; Piracetam; Single-Blind Method; Tablets; Therapeutic Equivalency; Young Adult | 2009 |
Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study.
Topics: Adolescent; Adult; Anticonvulsants; Blood Pressure; Child; Child, Preschool; Electrocardiography; Epilepsy; Female; Heart; Humans; Injections, Intravenous; Levetiracetam; Male; Piracetam; Seizures; Time Factors; Young Adult | 2009 |
Impact of levetiracetam add-on therapy on different EEG occipital frequencies in epileptic patients.
Topics: Anticonvulsants; Electroencephalography; Epilepsy; Female; Fourier Analysis; Humans; Levetiracetam; Male; Neuropsychological Tests; Occipital Lobe; Piracetam; Statistics, Nonparametric; Time Factors | 2009 |
Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Anticonvulsants; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Treatment Outcome; Young Adult | 2009 |
Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Dose-Response Relationship, Drug; Double-Blind Method; Epilepsy, Absence; Epilepsy, Generalized; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Myoclonic Epilepsy, Juvenile; Piracetam; Young Adult | 2009 |
Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study.
Topics: Adult; Analgesics; Anticonvulsants; Depression; Disability Evaluation; Female; Humans; Levetiracetam; Male; Middle Aged; Multiple Sclerosis; Neuralgia; Pain Measurement; Pilot Projects; Piracetam; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2009 |
A prospective pilot study of levetiracetam for body dysmorphic disorder.
Topics: Adult; Anticonvulsants; Anxiety; Body Image; Dose-Response Relationship, Drug; Female; Humans; Levetiracetam; Male; Middle Aged; Personal Satisfaction; Phobic Disorders; Pilot Projects; Piracetam; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Self Concept; Somatoform Disorders; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2009 |
Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Child; Clonidine; Confidence Intervals; Cross-Sectional Studies; Double-Blind Method; Drug Administration Schedule; Female; Humans; Levetiracetam; Male; Nootropic Agents; Outcome Assessment, Health Care; Piracetam; Psychiatric Status Rating Scales; Severity of Illness Index; Tourette Syndrome; Young Adult | 2009 |
Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Levetiracetam; Male; Middle Aged; Pain Measurement; Patient Satisfaction; Pilot Projects; Piracetam; Prospective Studies; Treatment Outcome; Trigeminal Neuralgia | 2009 |
Levetiracetam in spinal cord injury pain: a randomized controlled trial.
Topics: Adult; Afferent Pathways; Aged; Analgesics; Anticonvulsants; Cross-Over Studies; Double-Blind Method; Female; Humans; Levetiracetam; Male; Middle Aged; Outcome Assessment, Health Care; Pain Measurement; Pain, Intractable; Parasympatholytics; Piracetam; Spasm; Spinal Cord; Spinal Cord Injuries; Treatment Failure | 2009 |
Levetiracetam in children with refractory epilepsy: lack of correlation between plasma concentration and efficacy.
Topics: Adolescent; Anticonvulsants; Chi-Square Distribution; Child; Child, Preschool; Chromatography, High Pressure Liquid; Epilepsy; Female; Humans; Infant; Infant, Newborn; Levetiracetam; Male; Piracetam; Retrospective Studies; Secondary Prevention; Treatment Outcome | 2009 |
Effectiveness of levetiracetam in the treatment of lumbar radiculopathy: an open-label prospective cohort study.
Topics: Adult; Aged; Analgesics; Female; Humans; Levetiracetam; Lumbar Vertebrae; Male; Middle Aged; Pain; Pain Measurement; Piracetam; Radiculopathy | 2009 |
Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: an indirect comparison of treatment-emergent adverse events using meta-analytic techniques.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Anticonvulsants; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Delivery Systems; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Meta-Analysis as Topic; Middle Aged; Piracetam; Severity of Illness Index; Treatment Outcome; Young Adult | 2009 |
Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
Topics: Adolescent; Adult; Age Distribution; Anticonvulsants; Child; Cognition; Cognition Disorders; Comorbidity; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Neuropsychological Tests; Piracetam; Placebos; Treatment Outcome | 2009 |
Differential effects of levetiracetam, carbamazepine, and lamotrigine on reproductive endocrine function in adults.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Carbamazepine; Cross-Sectional Studies; Epilepsy; Female; Gonadal Steroid Hormones; Gonadotropins; Humans; Immunoassay; Lamotrigine; Levetiracetam; Male; Middle Aged; Piracetam; Sex Factors; Surveys and Questionnaires; Testosterone; Triazines; Young Adult | 2009 |
Levetiracetam monotherapy for childhood occipital epilepsy of gastaut.
Topics: Adolescent; Anticonvulsants; Child; Drug Administration Schedule; Electroencephalography; Epilepsies, Partial; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Patient Selection; Pilot Projects; Piracetam; Prospective Studies; Seizures; Treatment Outcome | 2009 |
Clinical efficacy and cognitive and neuropsychological effects of levetiracetam in epilepsy: an open-label multicenter study.
Topics: Adult; Analysis of Variance; Anticonvulsants; Cognition Disorders; Epilepsy; Female; Humans; Levetiracetam; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Perception; Piracetam; Prospective Studies; Quality of Life; Retrospective Studies; Taiwan; Time Factors | 2009 |
Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis.
Topics: Adult; Anticonvulsants; Brain Injuries; Female; Humans; Infusions, Intravenous; Levetiracetam; Male; Phenytoin; Piracetam; Prospective Studies; Seizures; Single-Blind Method; Subarachnoid Hemorrhage | 2010 |
Levetiracetam in generalized social anxiety disorder: a double-blind, randomized controlled trial.
Topics: Adult; Anti-Anxiety Agents; Double-Blind Method; Female; Humans; Levetiracetam; Male; Phobic Disorders; Piracetam; Psychiatric Status Rating Scales | 2010 |
Management of refractory status epilepticus at a tertiary care centre in a developing country.
Topics: Adolescent; Adult; Anticonvulsants; Developing Countries; Electroencephalography; Female; Humans; India; Levetiracetam; Male; Piracetam; Status Epilepticus; Treatment Outcome; Valproic Acid; Young Adult | 2010 |
Levetiracetam in the treatment of neonatal seizures: a pilot study.
Topics: Anticonvulsants; Feasibility Studies; Female; Humans; Infant, Newborn; Levetiracetam; Male; Pilot Projects; Piracetam; Seizures; Treatment Outcome | 2010 |
Evaluation of the subjective and reinforcing effects of diphenhydramine, levetiracetam, and valproic acid.
Topics: Adolescent; Adult; Affect; Blood Pressure; Diphenhydramine; Female; Heart Rate; Humans; Hypnotics and Sedatives; Levetiracetam; Male; Middle Aged; Pentobarbital; Piracetam; Psychomotor Performance; Reinforcement, Psychology; Respiratory Rate; Self Report; Surveys and Questionnaires; Valproic Acid | 2011 |
Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Anticonvulsants; Case-Control Studies; Cognition Disorders; Cross-Sectional Studies; Double-Blind Method; Electroencephalography; Epilepsy; Female; Humans; Lamotrigine; Levetiracetam; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Phenobarbital; Piracetam; Time Factors; Treatment Outcome; Triazines | 2010 |
Cognitive outcome of antiepileptic treatment with levetiracetam versus carbamazepine monotherapy: a non-interventional surveillance trial.
Topics: Adult; Analysis of Variance; Anticonvulsants; Carbamazepine; Chi-Square Distribution; Epilepsy; Executive Function; Female; Humans; Levetiracetam; Male; Memory; Middle Aged; Piracetam; Quality of Life; Treatment Outcome | 2010 |
Efficacy and safety of levetiracetam as adjunctive therapy in adult patients with uncontrolled partial epilepsy: the Asia SKATE II Study.
Topics: Adolescent; Adult; Anticonvulsants; Asian People; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Intention to Treat Analysis; Levetiracetam; Male; Patient Selection; Piracetam; Treatment Outcome | 2010 |
Effects of valproate, carbamazepine, and levetiracetam on the antioxidant and oxidant systems in epileptic patients and their clinical importance.
Topics: Adolescent; Adult; Anticonvulsants; Antioxidants; Aryldialkylphosphatase; Biomarkers; Carbamazepine; Carboxylic Ester Hydrolases; Drug Therapy, Combination; Epilepsy; Female; Guanine; Humans; Levetiracetam; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Piracetam; Valproic Acid; Young Adult | 2010 |
Assessment of behavioral and emotional functioning using standardized instruments in children and adolescents with partial-onset seizures treated with adjunctive levetiracetam in a randomized, placebo-controlled trial.
Topics: Adolescent; Anticonvulsants; Behavioral Symptoms; Checklist; Child; Child, Preschool; Double-Blind Method; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Mood Disorders; Piracetam; Psychiatric Status Rating Scales; Surveys and Questionnaires | 2010 |
Intravenous Levetiracetam as first-line treatment of status epilepticus in the elderly.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Female; Geriatrics; Humans; Injections, Intravenous; Levetiracetam; Male; Pilot Projects; Piracetam; Status Epilepticus; Treatment Outcome | 2010 |
The effects of levetiracetam on urinary 15f-2t-isoprostane levels in epileptic patients.
Topics: Adult; Anticonvulsants; Biomarkers; Dinoprost; Epilepsies, Partial; Epilepsy; Female; Humans; Isoprostanes; Levetiracetam; Male; Oxidative Stress; Piracetam | 2010 |
Intramuscular and intravenous levetiracetam in humans: safety and pharmacokinetics.
Topics: Adult; Cross-Over Studies; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Levetiracetam; Male; Middle Aged; Pain Measurement; Piracetam; Young Adult | 2010 |
Neurocognitive effects of brivaracetam, levetiracetam, and lorazepam.
Topics: Adolescent; Adult; Anticonvulsants; Blood Cell Count; Cognition; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Electroencephalography; Evoked Potentials; Female; Humans; Levetiracetam; Lorazepam; Male; Memory, Short-Term; Mental Recall; Middle Aged; Neuropsychological Tests; Piracetam; Pyrrolidinones; Sample Size; Treatment Outcome; Young Adult | 2011 |
Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Double-Blind Method; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome | 2011 |
An observational trial to investigate the efficacy and tolerability of levetiracetam in trigeminal neuralgia.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Female; Humans; Levetiracetam; Male; Middle Aged; Pilot Projects; Piracetam; Prospective Studies; Treatment Outcome; Trigeminal Neuralgia; Young Adult | 2010 |
Levetiracetam in chronic daily headache: a double-blind, randomised placebo-controlled study. (The Australian KEPPRA Headache Trial [AUS-KHT]).
Topics: Adolescent; Adult; Aged; Analgesics; Australia; Cross-Over Studies; Double-Blind Method; Headache Disorders; Humans; Levetiracetam; Middle Aged; Pain Measurement; Piracetam; Quality of Life; Treatment Outcome; Young Adult | 2011 |
Levetiracetam for the treatment of alcohol withdrawal syndrome: a multicenter, prospective, randomized, placebo-controlled trial.
Topics: Adult; Alcoholism; Anticonvulsants; Diazepam; Double-Blind Method; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Severity of Illness Index; Substance Withdrawal Syndrome; Treatment Outcome | 2010 |
Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life.
Topics: Adult; Aged; Anticonvulsants; Brain Neoplasms; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Neuropsychological Tests; Piracetam; Quality of Life; Statistics, Nonparametric; Treatment Outcome; Young Adult | 2011 |
The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial.
Topics: Adult; Aged; Anticonvulsants; Cross-Over Studies; Double-Blind Method; Female; Humans; Levetiracetam; Male; Middle Aged; Neuralgia; Pain Measurement; Piracetam; Polyneuropathies; Treatment Outcome | 2011 |
Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Biological Availability; Capsules; Colon, Ascending; Cross-Over Studies; Drug Delivery Systems; Electromagnetic Fields; Gastrointestinal Transit; Humans; Intestinal Absorption; Intestine, Small; Levetiracetam; Male; Middle Aged; Piracetam; Radionuclide Imaging; Tablets; Technetium Tc 99m Pentetate; Young Adult | 2010 |
The pharmacokinetics of levetiracetam in healthy dogs concurrently receiving phenobarbital.
Topics: Absorption; Animals; Anticonvulsants; Area Under Curve; Dogs; Drug Interactions; Half-Life; Levetiracetam; Phenobarbital; Piracetam | 2011 |
Elderly patients with migraine: an open-label study on prophylaxis therapy with levetiracetam.
Topics: Aged; Anticonvulsants; Female; Humans; Levetiracetam; Male; Middle Aged; Migraine Disorders; Piracetam; Treatment Outcome | 2011 |
A prospective open-labeled trial with levetiracetam in pediatric epilepsy syndromes: continuous spikes and waves during sleep is definitely a target.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Epilepsy; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Sleep | 2011 |
The safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: a one-year observational study.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Piracetam | 2011 |
Early treatment after stroke for the prevention of late epileptic seizures: a report on the problems performing a randomised placebo-controlled double-blind trial aimed at anti-epileptogenesis.
Topics: Aged; Anticonvulsants; Double-Blind Method; Epilepsy; Female; Humans; Levetiracetam; Male; Multicenter Studies as Topic; Patient Selection; Piracetam; Randomized Controlled Trials as Topic; Stroke | 2011 |
Influence of enzyme inducing antiepileptic drugs on the pharmacokinetics of levetiracetam in patients with epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Area Under Curve; Case-Control Studies; Enzyme Induction; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Time Factors; Young Adult | 2011 |
The effect of levetiracetam monotherapy on subjective sleep quality and objective sleep parameters in patients with epilepsy: compared with the effect of carbamazepine-CR monotherapy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Polysomnography; Sleep; Young Adult | 2011 |
A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy.
Topics: Adolescent; Age Factors; Anticonvulsants; Child; Child, Preschool; Double-Blind Method; Drug Resistance; Epilepsy, Absence; Female; Humans; Levetiracetam; Male; Outcome Assessment, Health Care; Piracetam | 2011 |
[Monotherapy with levetiracetam in adult patients with partial epilepsy].
Topics: Adolescent; Adult; Aged; Anticonvulsants; Epilepsies, Partial; Humans; Levetiracetam; Middle Aged; Piracetam; Treatment Outcome; Withholding Treatment; Young Adult | 2010 |
Levetiracetam for the management of levodopa-induced dyskinesias in Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Cross-Over Studies; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Levetiracetam; Levodopa; Male; Middle Aged; Parkinson Disease; Piracetam; Treatment Outcome | 2011 |
A randomized, double-blind, placebo-controlled trial of levetiracetam for dyskinesia in Parkinson's disease.
Topics: Anticonvulsants; Antiparkinson Agents; Cross-Over Studies; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Levetiracetam; Levodopa; Parkinson Disease; Piracetam; Severity of Illness Index; Time Factors; Video Recording | 2011 |
A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures.
Topics: Adolescent; Age Factors; Anticonvulsants; Behavioral Symptoms; Child; Child, Preschool; Cognition Disorders; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetiracetam; Longitudinal Studies; Male; Neuropsychological Tests; Piracetam; Psychiatric Status Rating Scales; Treatment Outcome | 2012 |
Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Child; Child, Preschool; Female; Humans; Infant; Levetiracetam; Lorazepam; Male; Middle Aged; Pilot Projects; Piracetam; Status Epilepticus; Young Adult | 2012 |
Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial.
Topics: Administration, Oral; Adult; Aged; Anticonvulsants; Brain Neoplasms; Chemotherapy, Adjuvant; Electroencephalography; Feasibility Studies; Female; Follow-Up Studies; Glioma; Humans; Infusions, Intravenous; Levetiracetam; Male; Meningioma; Middle Aged; Monitoring, Physiologic; Neurosurgery; Neurosurgical Procedures; Pilot Projects; Piracetam; Prospective Studies; Seizures; Treatment Outcome; Young Adult | 2012 |
Steady-state pharmacokinetics of intravenous levetiracetam in neurocritical care patients.
Topics: Anticonvulsants; Brain Injuries; Critical Care; Female; Hematoma, Subdural; Humans; Infusions, Intravenous; Levetiracetam; Male; Middle Aged; Monte Carlo Method; Piracetam; Prospective Studies; Seizures; Subarachnoid Hemorrhage; Treatment Outcome | 2011 |
Levetiracetam in primary orthostatic tremor: a double-blind placebo-controlled crossover study.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Cross-Over Studies; Dizziness; Double-Blind Method; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Placebos; Treatment Outcome; Tremor | 2011 |
Canine status epilepticus: a translational platform for human therapeutic trials.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Levetiracetam; Phenytoin; Pilot Projects; Piracetam; Reproducibility of Results; Status Epilepticus | 2011 |
A prehospital randomized trial in convulsive status epilepticus.
Topics: Adult; Anticonvulsants; Clonazepam; Double-Blind Method; Drug Therapy, Combination; Emergency Medical Services; Female; Humans; Injections, Intravenous; Levetiracetam; Male; Piracetam; Status Epilepticus; Time Factors; Treatment Outcome | 2011 |
Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
Topics: Adolescent; Adult; Anticonvulsants; Anxiety; Child; Child, Preschool; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Seizures; Sleep Initiation and Maintenance Disorders; Time Factors; Treatment Outcome; Young Adult | 2012 |
A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients.
Topics: Adult; Affect; Aged; Alcoholism; Anticonvulsants; Anxiety; Breath Tests; Delayed-Action Preparations; Depression; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Levetiracetam; Male; Middle Aged; Neuropsychological Tests; Patient Compliance; Piracetam; Quality of Life; Socioeconomic Factors; Treatment Outcome | 2012 |
A randomized, placebo-controlled trial of levetiracetam in central pain in multiple sclerosis.
Topics: Adult; Analgesics; Anticonvulsants; Chronic Pain; Cross-Over Studies; Female; Humans; Hyperalgesia; Levetiracetam; Male; Middle Aged; Multiple Sclerosis; Neuralgia; Pain Threshold; Patient Satisfaction; Piracetam; Placebos; Treatment Failure | 2012 |
Bioequivalence of a novel minitablet formulation of levetiracetam.
Topics: Adult; Anticonvulsants; Area Under Curve; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cross-Over Studies; Electroencephalography; Female; Half-Life; Humans; Levetiracetam; Male; Piracetam; Tablets; Therapeutic Equivalency; Young Adult | 2012 |
The anticonvulsant levetiracetam potentiates alcohol consumption in non-treatment seeking alcohol abusers.
Topics: Alcohol Drinking; Alcoholism; Anticonvulsants; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Levetiracetam; Male; Piracetam | 2012 |
The effect of levetiracetam on focal nocturnal epileptiform activity during sleep--a placebo-controlled double-blind cross-over study.
Topics: Analysis of Variance; Anticonvulsants; Child; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Electroencephalography; Epilepsies, Myoclonic; Female; Humans; Levetiracetam; Male; Piracetam; Sleep Wake Disorders; Treatment Outcome | 2012 |
Levetiracetam extended release conversion to monotherapy for the treatment of patients with partial-onset seizures: a double-blind, randomised, multicentre, historical control study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Child; Double-Blind Method; Epilepsies, Partial; Female; Humans; Kaplan-Meier Estimate; Levetiracetam; Male; Middle Aged; Piracetam; Sample Size; Treatment Outcome; Young Adult | 2012 |
Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Amnesia; Brain Mapping; Case-Control Studies; Choice Behavior; Cognitive Dysfunction; Double-Blind Method; Female; Hippocampus; Humans; Image Processing, Computer-Assisted; Levetiracetam; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Oxygen; Photic Stimulation; Piracetam; Statistics as Topic | 2012 |
The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study.
Topics: Adolescent; Adult; Anticonvulsants; Child; Early Diagnosis; Epilepsy; Female; Humans; Lamotrigine; Levetiracetam; Male; Middle Aged; Piracetam; Quality of Life; Triazines | 2012 |
Efficacy and safety of levetiracetam for the prevention of alcohol relapse in recently detoxified alcohol-dependent patients: a randomized trial.
Topics: Adolescent; Adult; Aged; Alcoholism; Anticonvulsants; Behavior, Addictive; Female; Humans; Levetiracetam; Male; Medication Adherence; Middle Aged; Piracetam; Secondary Prevention | 2012 |
Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anticonvulsants; Craniotomy; Female; Humans; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Seizures | 2013 |
Results of phase II pharmacokinetic study of levetiracetam for prevention of post-traumatic epilepsy.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Anticonvulsants; Area Under Curve; Brain Injuries; Child; Creatinine; Epilepsy; Female; Follow-Up Studies; Glasgow Coma Scale; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Protein Kinases; Saliva; Young Adult | 2012 |
Results of phase 2 safety and feasibility study of treatment with levetiracetam for prevention of posttraumatic epilepsy.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Brain Injuries; Child; Chromatography, High Pressure Liquid; Epilepsy; Feasibility Studies; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Patient Compliance; Phenytoin; Piracetam; Survival Analysis; Tandem Mass Spectrometry; Time Factors; Young Adult | 2012 |
Levetiracetam in patients with central neuropathic post-stroke pain--a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Anticonvulsants; Cross-Over Studies; Double-Blind Method; Female; Humans; Levetiracetam; Male; Middle Aged; Neuralgia; Pain Measurement; Piracetam; Placebos; Stroke | 2013 |
KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Electroencephalography; Epilepsies, Partial; Epilepsy, Generalized; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Levetiracetam; Male; Middle Aged; Patient Dropouts; Piracetam; Quality of Life; Signal Processing, Computer-Assisted; Valproic Acid | 2013 |
Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project).
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Seizures; Stroke; Treatment Outcome | 2012 |
Reduced immunoglobulin levels in epilepsy patients treated with levetiracetam, lamotrigine, or carbamazepine.
Topics: Adolescent; Adult; Anticonvulsants; Body Mass Index; Carbamazepine; Double-Blind Method; Epilepsy; Female; Humans; Immunoglobulins; Lamotrigine; Levetiracetam; Male; Middle Aged; Piracetam; Statistics, Nonparametric; Triazines; Young Adult | 2013 |
Subclinical epileptiform activity in children with electrical status epilepticus during sleep: effects on cognition and behavior before and after treatment with levetiracetam.
Topics: Action Potentials; Anticonvulsants; Child; Child Behavior; Child, Preschool; Cognition Disorders; Double-Blind Method; Electroencephalography; Female; Humans; Learning; Levetiracetam; Male; Memory; Neuropsychological Tests; Piracetam; Sleep; Status Epilepticus | 2013 |
A prospective multicenter comparison of levetiracetam versus phenytoin for early posttraumatic seizure prophylaxis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Brain Injuries; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Length of Stay; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Prospective Studies; Seizures; Survival Rate; Trauma Centers; Treatment Outcome; United States; Young Adult | 2013 |
Ineffectiveness of topiramate and levetiracetam in infantile spasms non-responsive to steroids. Open labeled randomized prospective study.
Topics: Anticonvulsants; Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Fructose; Humans; Infant; Infant, Newborn; Levetiracetam; Male; Piracetam; Prednisone; Prospective Studies; Retreatment; Spasms, Infantile; Topiramate; Treatment Failure | 2013 |
Effect of switching hepatic enzyme-inducer antiepileptic drug to levetiracetam on bone mineral density, 25 hydroxyvitamin D, and parathyroid hormone in young adult patients with epilepsy.
Topics: Adult; Anticonvulsants; Bone Density; Epilepsy; Female; Femur; Humans; Levetiracetam; Lumbar Vertebrae; Male; Parathyroid Hormone; Phenytoin; Piracetam; Vitamin D; Young Adult | 2013 |
Levetiracetam vs. sulthiame in benign epilepsy with centrotemporal spikes in childhood: a double-blinded, randomized, controlled trial (German HEAD Study).
Topics: Anticonvulsants; Child; Double-Blind Method; Drug Therapy, Combination; Epilepsy; Female; Humans; Levetiracetam; Male; Piracetam; Prospective Studies; Secondary Prevention; Thiazines; Treatment Failure; Treatment Outcome | 2013 |
[Dynamics of cognitive and emotional-volitional disorders in children and adolescents with refractory epilepsy during the treatment with levetiracetam].
Topics: Adolescent; Affective Symptoms; Child; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Emotions; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Nootropic Agents; Piracetam; Treatment Outcome | 2013 |
Effects of levetiracetam monotherapy on the cognitive function of epilepsy patients.
Topics: Adolescent; Adult; Anticonvulsants; Child; Cognition; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Neuropsychological Tests; Piracetam; Young Adult | 2013 |
Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Bayes Theorem; Child; Child, Preschool; Comparative Effectiveness Research; Early Termination of Clinical Trials; Emergency Service, Hospital; Humans; Intention to Treat Analysis; Levetiracetam; Middle Aged; Models, Statistical; Phenytoin; Piracetam; Randomized Controlled Trials as Topic; Research Design; Status Epilepticus; Treatment Outcome; Valproic Acid; Young Adult | 2013 |
Results of phase II levetiracetam trial following acute head injury in children at risk for posttraumatic epilepsy.
Topics: Adolescent; Anticonvulsants; Brain Injuries; Child; Craniocerebral Trauma; Epilepsy, Post-Traumatic; Female; Humans; Irritable Mood; Levetiracetam; Male; Piracetam; Prospective Studies; Risk Factors; Treatment Outcome | 2013 |
The established status epilepticus trial 2013.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Child; Child, Preschool; Double-Blind Method; Humans; Levetiracetam; Middle Aged; Phenytoin; Piracetam; Research Design; Status Epilepticus; Treatment Outcome; Valproic Acid; Young Adult | 2013 |
[Efficacy and safety of levetiracetam as adjunctive therapy in Japanese children with uncontrolled partial-onset seizures: multicenter and open-label study (N01223), short term evaluation].
Topics: Adolescent; Asian People; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levetiracetam; Male; Nootropic Agents; Piracetam; Seizures; Treatment Outcome | 2013 |
Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study.
Topics: Anticonvulsants; Brain Neoplasms; Epilepsy; Female; Follow-Up Studies; gamma-Aminobutyric Acid; Humans; Levetiracetam; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Piracetam; Pregabalin; Prognosis; Survival Rate | 2014 |
Efficacy of levetiracetam in electrical status epilepticus during sleep of children: a multicenter experience.
Topics: Anticonvulsants; Brain; Child; Child, Preschool; Electroencephalography; Female; Follow-Up Studies; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Piracetam; Retrospective Studies; Seizures; Sleep; Status Epilepticus; Time Factors; Treatment Outcome | 2014 |
Effects of marketed antiepileptic drugs and placebo in the human photosensitivity screening protocol.
Topics: Anticonvulsants; Carbamazepine; Double-Blind Method; Epilepsy, Reflex; Female; Humans; Levetiracetam; Light; Male; Piracetam; Placebo Effect | 2014 |
Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: a randomized, double-blind, noninferiority trial.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Female; gamma-Aminobutyric Acid; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Pregabalin; Treatment Outcome; Young Adult | 2014 |
Adjunctive levetiracetam treatment in pediatric Lennox-Gastaut syndrome.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Lennox Gastaut Syndrome; Levetiracetam; Male; Piracetam; Treatment Outcome | 2014 |
Pharmacokinetics of the antiepileptic drug levetiracetam in healthy Japanese and Caucasian volunteers following intravenous administration.
Topics: Administration, Intravenous; Adult; Anticonvulsants; Asian People; Cross-Over Studies; Female; Healthy Volunteers; Humans; Levetiracetam; Male; Middle Aged; Piracetam; White People; Young Adult | 2015 |
Levetiracetam pharmacokinetics in Japanese subjects with renal impairment.
Topics: Adult; Aged; Animals; Case-Control Studies; Dose-Response Relationship, Drug; Humans; Japan; Kidney Failure, Chronic; Levetiracetam; Male; Middle Aged; Piracetam; Renal Insufficiency; Young Adult | 2014 |
Determining the polymer threshold amount for achieving robust drug release from HPMC and HPC matrix tablets containing a high-dose BCS class I model drug: in vitro and in vivo studies.
Topics: Adolescent; Adult; Cellulose; Chemistry, Pharmaceutical; Cross-Over Studies; Drug Liberation; Excipients; Humans; Hypromellose Derivatives; Levetiracetam; Male; Middle Aged; Piracetam; Polymers; Solubility; Tablets; Therapeutic Equivalency; Viscosity; Young Adult | 2015 |
Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders.
Topics: Adult; Aged; Alcohol Drinking; Alcohol-Related Disorders; Anticonvulsants; Cognition Disorders; Double-Blind Method; Female; Fructose; Humans; Isoxazoles; Levetiracetam; Male; Middle Aged; Neuropsychological Tests; Piracetam; Topiramate; Treatment Outcome; Young Adult; Zonisamide | 2015 |
Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: a phase II prospective, randomised study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Brain Neoplasms; Cohort Studies; Craniotomy; Female; Humans; Levetiracetam; Male; Middle Aged; Neurosurgical Procedures; Phenytoin; Piracetam; Postoperative Complications; Prospective Studies; Seizures; Treatment Outcome; Young Adult | 2015 |
The efficacy of levetiracetam for focal seizures and its blood levels in children.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Infant, Newborn; Levetiracetam; Piracetam; Prospective Studies; Seizures; Treatment Outcome | 2015 |
A single preoperative dose of levetiracetam has no effect on pain or analgesic requirements after laparoscopic cholecystectomy.
Topics: Analgesics, Opioid; Cholecystectomy, Laparoscopic; Double-Blind Method; Humans; India; Levetiracetam; Pain, Postoperative; Piracetam; Premedication; Prospective Studies; Time Factors; Tramadol; Treatment Outcome | 2015 |
Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance.
Topics: Aged; Anticonvulsants; Cognitive Dysfunction; Cross-Over Studies; Dentate Gyrus; Female; Humans; Image Processing, Computer-Assisted; Levetiracetam; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Neuropsychological Tests; Piracetam; Temporal Lobe | 2015 |
Efficacy and tolerability of levetiracetam as adjunctive therapy in Japanese patients with uncontrolled partial-onset seizures.
Topics: Adolescent; Adult; Anticonvulsants; Double-Blind Method; Epilepsies, Partial; Female; Humans; Japan; Levetiracetam; Male; Middle Aged; Molecular Sequence Data; Piracetam; Placebo Effect; Treatment Outcome; Young Adult | 2015 |
Levetiracetam versus phenytoin in management of status epilepticus.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Anticonvulsants; Disease Management; Female; Hospitalization; Humans; Levetiracetam; Male; Middle Aged; Patient Discharge; Phenytoin; Piracetam; Prospective Studies; Status Epilepticus; Young Adult | 2015 |
New onset paediatric epilepsy in 1-5 years age group children--approach to management in a tertiary care centre with newer anti-epileptic levetiracetam.
Topics: Age Factors; Anticonvulsants; Child, Preschool; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy, Tonic-Clonic; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Tertiary Care Centers | 2014 |
Neuropsychological effects of levetiracetam and carbamazepine in children with focal epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child Behavior; Child, Preschool; Epilepsies, Partial; Female; Follow-Up Studies; Humans; Intelligence; Levetiracetam; Male; Piracetam; Social Skills; Treatment Outcome | 2015 |
Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam--Pilot study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Drug Therapy, Combination; Electroencephalography; Epilepsy, Generalized; Female; Follow-Up Studies; Humans; Injections, Intravenous; Levetiracetam; Lorazepam; Male; Middle Aged; Phenytoin; Pilot Projects; Piracetam; Prognosis; Prospective Studies; Status Epilepticus; Treatment Outcome; Valproic Acid; Young Adult | 2015 |
Pharmacokinetics, Safety and Bioequivalence of Levetiracetam Intravenous Infusion and Oral Tablets in Healthy Chinese Subjects.
Topics: Administration, Oral; Adult; Cross-Over Studies; Double-Blind Method; Female; Healthy Volunteers; Humans; Infusions, Intravenous; Levetiracetam; Male; Piracetam; Tablets; Therapeutic Equivalency | 2015 |
Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures.
Topics: Aged; Anticonvulsants; Carbamates; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Kaplan-Meier Estimate; Lamotrigine; Levetiracetam; Male; Middle Aged; Oxcarbazepine; Phenylenediamines; Piracetam; Seizures; Treatment Outcome; Triazines; Valproic Acid | 2015 |
An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam.
Topics: Adolescent; Adult; Anticonvulsants; Epilepsy; Female; Humans; Levetiracetam; Male; Mental Disorders; Middle Aged; Piracetam; Prospective Studies; Pyrrolidinones; Quality of Life; Suicidal Ideation; Suicide, Attempted; Treatment Outcome; Young Adult | 2015 |
A comparison of four antiepileptic drugs in status epilepticus: experience from India.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Child; Child, Preschool; Female; Humans; India; Infant; Levetiracetam; Lorazepam; Male; Middle Aged; Outcome Assessment, Health Care; Phenytoin; Piracetam; Status Epilepticus; Valproic Acid; Young Adult | 2016 |
[Effects of Long-Term Treatment with Levetiracetam as an Adjunctive Therapy in Japanese Children with Uncontrolled Partial-Onset Seizures: A Multicenter, Open-Label Study].
Topics: Adolescent; Anticonvulsants; Asian People; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Piracetam; Seizures; Time; Treatment Outcome | 2015 |
Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial.
Topics: Adult; Aged; Anticonvulsants; Clonazepam; Double-Blind Method; Drug Therapy, Combination; Emergency Medical Services; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Placebo Effect; Prospective Studies; Status Epilepticus; Treatment Outcome | 2016 |
A single-blinded phenobarbital-controlled trial of levetiracetam as mono-therapy in dogs with newly diagnosed epilepsy.
Topics: Animals; Anticonvulsants; Dog Diseases; Dogs; Epilepsy; Female; Levetiracetam; Male; Phenobarbital; Piracetam; Prospective Studies; Seizures; Single-Blind Method | 2016 |
Brivaracetam in Unverricht-Lundborg disease (EPM1): Results from two randomized, double-blind, placebo-controlled studies.
Topics: Adolescent; Adult; Anticonvulsants; Clonazepam; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Fructose; Humans; Isoxazoles; Levetiracetam; Male; Middle Aged; Phenobarbital; Piracetam; Pyrrolidinones; Topiramate; Treatment Outcome; Unverricht-Lundborg Syndrome; Valproic Acid; Young Adult; Zonisamide | 2016 |
Levetiracetam extended release for the treatment of patients with partial-onset seizures: A long-term, open-label follow-up study.
Topics: Adult; Anticonvulsants; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Piracetam; Seizures; Treatment Outcome | 2016 |
Cognitive effects of adjunctive perampanel for partial-onset seizures: A randomized trial.
Topics: Acetamides; Adolescent; Anticonvulsants; Attention; Carbamazepine; Child; Cognition; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Female; Fructose; Humans; Lacosamide; Lamotrigine; Levetiracetam; Male; Memory, Short-Term; Neuropsychological Tests; Nitriles; Oxcarbazepine; Piracetam; Pyridones; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2016 |
Monotherapy with Levetiracetam Versus Older AEDs: A Randomized Comparative Trial of Effects on Bone Health.
Topics: Absorptiometry, Photon; Adult; Aged; Anticonvulsants; Bone and Bones; Bone Density; Bone Remodeling; Carbamazepine; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Tomography, X-Ray Computed; Valproic Acid | 2016 |
Randomized Comparative Bioavailability of a Novel Three-Dimensional Printed Fast-Melt Formulation of Levetiracetam Following the Administration of a Single 1000-mg Dose to Healthy Human Volunteers Under Fasting and Fed Conditions.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Drug Compounding; Female; Half-Life; Healthy Volunteers; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Printing, Three-Dimensional; Tablets; Tandem Mass Spectrometry; Therapeutic Equivalency; Young Adult | 2016 |
Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Pyrrolidinones; Seizures; Young Adult | 2016 |
Efficacy and safety of levetiracetam in the management of seizures in neonates.
Topics: Anticonvulsants; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Iran; Levetiracetam; Male; Phenobarbital; Phenytoin; Piracetam; Seizures; Treatment Outcome | 2016 |
Changes in hormone and lipid levels in male patients with focal seizures when switched from carbamazepine to lacosamide as adjunctive treatment to levetiracetam: A small phase IIIb, prospective, multicenter, open-label trial.
Topics: Acetamides; Adult; Anticonvulsants; Carbamazepine; Cholesterol; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Epilepsies, Partial; Humans; Lacosamide; Levetiracetam; Lipids; Lipoproteins, LDL; Male; Piracetam; Progesterone; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Thyroxine; Treatment Outcome | 2016 |
An exploratory evaluation of Take Control: A novel computer-delivered behavioral platform for placebo-controlled pharmacotherapy trials for alcohol use disorder.
Topics: Adult; Alcohol-Related Disorders; Antidiuretic Hormone Receptor Antagonists; Behavior Therapy; Combined Modality Therapy; Double-Blind Method; Female; Humans; Levetiracetam; Male; Medication Adherence; Middle Aged; Piracetam; Placebos; Quetiapine Fumarate; Research Design; Software; Varenicline | 2016 |
Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Seizures; Valproic Acid | 2016 |
Effect of anticonvulsive treatment on neuropsychological performance in children with BECTS.
Topics: Anticonvulsants; Child; Child Behavior; Cognition; Double-Blind Method; Epilepsy, Rolandic; Executive Function; Female; Humans; Intelligence Tests; Language; Levetiracetam; Male; Memory; Mental Recall; Neuropsychological Tests; Piracetam; Psychomotor Performance; Space Perception; Thiazines | 2016 |
Lacosamide and sodium channel-blocking antiepileptic drug cross-titration against levetiracetam background therapy.
Topics: Acetamides; Adult; Anticonvulsants; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Lacosamide; Levetiracetam; Male; Middle Aged; Piracetam; Sodium Channel Blockers | 2017 |
Lack of efficacy of levetiracetam in oromandibular and cranial dystonia.
Topics: Adult; Aged; Anticonvulsants; Cross-Over Studies; Double-Blind Method; Dystonic Disorders; Facial Muscles; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Skull; Treatment Outcome | 2017 |
Lamotrigine and levetiracetam exert a similar modulation of TMS-evoked EEG potentials.
Topics: Adult; Analysis of Variance; Anticonvulsants; Brain Mapping; Cross-Over Studies; Double-Blind Method; Electroencephalography; Electromyography; Evoked Potentials, Motor; Female; Healthy Volunteers; Humans; Lamotrigine; Levetiracetam; Male; Piracetam; Statistics as Topic; Statistics, Nonparametric; Transcranial Magnetic Stimulation; Triazines; Young Adult | 2017 |
[Efficacy and Safety of Levetiracetam as an Add-on Therapy for Symptomatic Refractory Epilepsy Treated in a Department of Neurosurgery].
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Quality of Life; Treatment Outcome | 2016 |
Clinical features of benign epilepsy of childhood with centrotemporal spikes in chinese children.
Topics: Adolescent; Age of Onset; Anticonvulsants; Brain; Carbamazepine; Child; Child, Preschool; China; Drug Therapy, Combination; Electroencephalography; Epilepsy, Rolandic; Female; Humans; Levetiracetam; Male; Oxcarbazepine; Piracetam; Valproic Acid; Young Adult | 2017 |
Prophylactic Levetiracetam for Seizure Control After Cranioplasty: A Multicenter Prospective Controlled Study.
Topics: Adult; Anticonvulsants; Craniotomy; Electroencephalography; Female; Humans; Intracranial Hypertension; Kaplan-Meier Estimate; Levetiracetam; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Piracetam; Prospective Studies; Retrospective Studies; Seizures; Surgery, Plastic; Tomography Scanners, X-Ray Computed | 2017 |
Levetiracetam in Compare to Sodium Valproate for Prophylaxis in Chronic Migraine Headache: A Randomized Double-Blind Clinical Trial.
Topics: Adolescent; Adult; Analgesics; Chronic Disease; Disability Evaluation; Double-Blind Method; Female; Humans; Iran; Levetiracetam; Male; Middle Aged; Migraine Disorders; Pain Measurement; Piracetam; Severity of Illness Index; Time Factors; Treatment Outcome; Valproic Acid; Young Adult | 2017 |
Brand-to-generic levetiracetam switch in patients with epilepsy in a routine clinical setting.
Topics: Adult; Anticonvulsants; Drug Substitution; Drugs, Generic; Epilepsy; Female; Humans; Levetiracetam; Male; Piracetam; Prospective Studies; Therapeutic Equivalency; Treatment Outcome | 2017 |
Comparison of levetiracetam and oxcarbazepine monotherapy among Korean patients with newly diagnosed focal epilepsy: A long-term, randomized, open-label trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epilepsies, Partial; Female; Humans; Levetiracetam; Longitudinal Studies; Male; Middle Aged; Oxcarbazepine; Piracetam; Republic of Korea; Treatment Outcome; Young Adult | 2017 |
Levetiracetam Alters Oscillatory Connectivity in Alzheimer's Disease.
Topics: Alzheimer Disease; Analysis of Variance; Brain Mapping; Brain Waves; Cognition; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Female; Fourier Analysis; Humans; Levetiracetam; Male; Mental Recall; Nootropic Agents; Piracetam | 2017 |
Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: A prospective, randomized study.
Topics: Adult; Anticonvulsants; Female; Humans; Infusions, Intravenous; Levetiracetam; Male; Phenytoin; Piracetam; Prospective Studies; Seizures; Status Epilepticus | 2017 |
Emergency treatment with levetiracetam or phenytoin in status epilepticus in children-the EcLiPSE study: study protocol for a randomised controlled trial.
Topics: Adolescent; Age Factors; Anticonvulsants; Child; Child, Preschool; Clinical Protocols; Emergencies; Female; Humans; Infant; Infusions, Intravenous; Intention to Treat Analysis; Ireland; Levetiracetam; Male; Phenytoin; Piracetam; Research Design; Status Epilepticus; Time Factors; Treatment Outcome; United Kingdom | 2017 |
A multicentre randomised controlled trial of levetiracetam versus phenytoin for convulsive status epilepticus in children (protocol): Convulsive Status Epilepticus Paediatric Trial (ConSEPT) - a PREDICT study.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Clinical Protocols; Emergencies; Emergency Service, Hospital; Female; Follow-Up Studies; Humans; Infant; Infusions, Intravenous; Levetiracetam; Male; Phenytoin; Piracetam; Prospective Studies; Single-Blind Method; Status Epilepticus; Treatment Outcome | 2017 |
A randomized, double-blind, placebo-controlled crossover study of the effects of levetiracetam on cognition, mood, and balance in healthy older adults.
Topics: Affect; Aged; Aged, 80 and over; Cognition; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Humans; Levetiracetam; Male; Nootropic Agents; Piracetam; Postural Balance | 2017 |
Can Matching-Adjusted Indirect Comparison Methods Mitigate Placebo Response Differences Among Patient Populations in Adjunctive Trials of Brivaracetam and Levetiracetam?
Topics: Adult; Anticonvulsants; Databases, Bibliographic; Double-Blind Method; Epilepsies, Partial; Female; Humans; Levetiracetam; Longitudinal Studies; Male; Middle Aged; Piracetam; Placebo Effect; Pyrrolidinones; Retrospective Studies; Treatment Outcome | 2017 |
Pharmacokinetics of the anticonvulsant levetiracetam in neonatal foals.
Topics: Administration, Oral; Animals; Anticonvulsants; Area Under Curve; Cross-Over Studies; Half-Life; Horses; Injections, Intravenous; Levetiracetam; Piracetam | 2018 |
Effects of Levetiracetam and Sulthiame on EEG in benign epilepsy with centrotemporal spikes: A randomized controlled trial.
Topics: Anticonvulsants; Brain Waves; Child; Double-Blind Method; Electroencephalography; Epilepsy, Rolandic; Female; Germany; Humans; Levetiracetam; Male; Piracetam; Retrospective Studies; Statistics, Nonparametric; Thiazines; Treatment Outcome | 2018 |
Pharmacokinetics of rectal levetiracetam as add-on treatment in dogs affected by cluster seizures or status epilepticus.
Topics: Administration, Rectal; Animals; Anticonvulsants; Dog Diseases; Dogs; Female; Levetiracetam; Male; Pilot Projects; Piracetam; Seizures; Status Epilepticus | 2018 |
Efficacy of levetiracetam on upper limb movement in multiple sclerosis patients with cerebellar signs: a multicenter double-blind, placebo-controlled, crossover study.
Topics: Adult; Anticonvulsants; Cross-Over Studies; Double-Blind Method; Humans; Levetiracetam; Middle Aged; Multiple Sclerosis; Piracetam; Treatment Outcome; Upper Extremity | 2020 |
Pyridoxine for treatment of levetiracetam-induced behavioral adverse events: A randomized double-blind placebo-controlled trial.
Topics: Adult; Anticonvulsants; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Humans; Levetiracetam; Piracetam; Pyridoxine; Treatment Outcome | 2022 |
1281 other study(ies) available for piracetam and levetiracetam
| Article | Year |
|---|---|
Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity.
Topics: Acoustic Stimulation; Amides; Animals; Anticonvulsants; Binding Sites; Butyrates; Caco-2 Cells; Cerebral Cortex; Crystallography, X-Ray; Female; Humans; In Vitro Techniques; Levetiracetam; Male; Mice; Mice, Inbred DBA; Microsomes, Liver; Models, Molecular; Molecular Conformation; Piracetam; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Seizures; Structure-Activity Relationship | 2004 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
ucb L059, a novel anti-convulsant drug: pharmacological profile in animals.
Topics: Acoustic Stimulation; Animals; Anticonvulsants; Convulsants; Dizocilpine Maleate; Female; Kindling, Neurologic; Levetiracetam; Male; Mice; Mice, Inbred DBA; Motor Activity; N-Methylaspartate; Piracetam; Rats; Rats, Sprague-Dawley; Seizures | 1992 |
Facilitation of calcium-dependent cholinergic function by ucb L059, a new "second generation" nootropic agent.
Topics: Animals; Calcium; Female; Guinea Pigs; Ileum; In Vitro Techniques; Levetiracetam; Male; Muscle Contraction; Muscle, Smooth; Parasympathetic Nervous System; Piracetam; Pyrrolidinones; Stereoisomerism | 1989 |
Topographic approaches in human quantitative pharmaco-electroencephalography.
Topics: Anti-Anxiety Agents; Benzodiazepines; Dose-Response Relationship, Drug; Electroencephalography; Ethosuximide; Evoked Potentials; Flurazepam; Humans; Levetiracetam; Piracetam; Psychotropic Drugs; Valproic Acid | 1983 |
Memory retrieval deficits: alleviation by etiracetam, a nootropic drug.
Topics: Animals; Avoidance Learning; Electroshock; Food; Food Deprivation; Handling, Psychological; Hypoxia; Levetiracetam; Male; Memory; Piracetam; Prejudice; Pyrrolidinones; Rats; Time Factors | 1980 |
Behavioural effects of etiracetam in rats.
Topics: Animals; Avoidance Learning; Behavior, Animal; Discrimination, Psychological; Electroshock; Levetiracetam; Male; Motor Activity; Piracetam; Pyrrolidinones; Rats; Rats, Inbred Strains; Sensory Thresholds | 1981 |
High-performance liquid chromatographic and megabore gas-liquid chromatographic determination of levetiracetam (ucb L059) in human serum after solid-phase extraction.
Topics: Autoanalysis; Chromatography, Gas; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Levetiracetam; Nootropic Agents; Piracetam; Quality Control; Spectrophotometry, Ultraviolet | 1994 |
Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats.
Topics: Amygdala; Animals; Anticonvulsants; Behavior, Animal; Dose-Response Relationship, Drug; Electrodes; Electroshock; Epilepsies, Partial; Epilepsy, Generalized; Female; Kindling, Neurologic; Levetiracetam; Male; Mice; Myoclonus; Pentylenetetrazole; Piracetam; Postural Balance; Psychomotor Performance; Rats; Rats, Wistar; Stereotaxic Techniques | 1993 |
The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes.
Topics: Animals; Anticonvulsants; Binding Sites; Brain; Levetiracetam; Male; Piracetam; Rats; Rats, Sprague-Dawley | 1995 |
ucb L059, a novel anticonvulsant, reduces bicuculline-induced hyperexcitability in rat hippocampal CA3 in vivo.
Topics: Animals; Anticonvulsants; Bicuculline; GABA-A Receptor Antagonists; Hippocampus; Levetiracetam; Male; Piracetam; Rats; Rats, Sprague-Dawley; Receptors, GABA-A | 1995 |
A micromethod for the determination of the new antiepileptic drug levetiracetam (ucb LO59) in serum or plasma by high performance liquid chromatography.
Topics: Anticonvulsants; Chromatography, High Pressure Liquid; Humans; Levetiracetam; Piracetam | 1996 |
The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata.
Topics: 4-Aminobutyrate Transaminase; Aminooxyacetic Acid; Animals; Anticonvulsants; Brain; Electrophysiology; Female; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Levetiracetam; Neurons; Piracetam; Rats; Rats, Wistar; Substantia Nigra; Tissue Distribution | 1996 |
Progress report on new antiepileptic drugs: a summary of the Third Eilat Conference.
Topics: Acetamides; Animals; Anticonvulsants; Azetidines; Carbamates; Drug Evaluation, Preclinical; Drugs, Investigational; Epilepsy; Humans; Israel; Levetiracetam; Nipecotic Acids; Phenylenediamines; Piracetam; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Thiazoles; Tiagabine; Triazoles | 1996 |
Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy.
Topics: Acoustic Stimulation; Animals; Anticonvulsants; Behavior, Animal; Electroencephalography; Epilepsies, Partial; Epilepsy; Epilepsy, Absence; Epilepsy, Tonic-Clonic; Female; Levetiracetam; Male; Piracetam; Rats; Rats, Inbred Strains; Rats, Wistar | 1995 |
Neurochemical studies with the novel anticonvulsant levetiracetam in mouse brain.
Topics: 4-Aminobutyrate Transaminase; Animals; Anticonvulsants; Brain; Drug Administration Schedule; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Glutamic Acid; Glutamine; Levetiracetam; Male; Mice; Mice, Inbred ICR; Piracetam | 1997 |
Inhibition by levetiracetam of a non-GABAA receptor-associated epileptiform effect of bicuculline in rat hippocampus.
Topics: Animals; Anticonvulsants; Bicuculline; Convulsants; Flunarizine; GABA Antagonists; Hippocampus; Levetiracetam; Male; Piracetam; Pyridazines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Seizures | 1997 |
Levetiracetam (ucb LO59) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission.
Topics: Animals; Anticonvulsants; Bicuculline; Drug Interactions; Electric Stimulation; Epilepsy; GABA Antagonists; Levetiracetam; Male; Membrane Potentials; Models, Biological; Piracetam; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Synaptic Transmission | 1997 |
Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy.
Topics: Animals; Anticonvulsants; Behavior, Animal; Epilepsy; Female; Kindling, Neurologic; Levetiracetam; Piracetam; Rats; Rats, Wistar | 1998 |
Validation of corneally kindled mice: a sensitive screening model for partial epilepsy in man.
Topics: Amygdala; Animals; Anticonvulsants; Carbamazepine; Cornea; Disease Models, Animal; Dizocilpine Maleate; Drug Evaluation, Preclinical; Electric Stimulation; Electroshock; Epilepsies, Partial; gamma-Aminobutyric Acid; Kindling, Neurologic; Levetiracetam; Male; Mice; Piracetam; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Retina; Seizures; Sensitivity and Specificity; Time Factors; Valproic Acid; Vigabatrin | 1998 |
Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
Topics: Amygdala; Animals; Anticonvulsants; Behavior, Animal; Carbolines; Convulsants; Diazepam; Disease Models, Animal; Electroconvulsive Therapy; Epilepsy; Excitatory Amino Acid Agonists; Flumazenil; GABA-A Receptor Antagonists; Kindling, Neurologic; Levetiracetam; Male; Mice; Pentylenetetrazole; Piracetam; Rats; Rats, Sprague-Dawley; Seizures | 1998 |
In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent.
Topics: Animals; Anticonvulsants; Biomarkers; Butyrates; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Enzyme Inhibitors; Epoxide Hydrolases; Glucuronosyltransferase; Humans; In Vitro Techniques; Levetiracetam; Liver; Male; Microsomes, Liver; Piracetam; Pyrrolidinones; Rats; Rats, Sprague-Dawley | 1999 |
Blood and cerebrospinal fluid pharmacokinetics of the novel anticonvulsant levetiracetam (ucb L059) in the rat.
Topics: Animals; Anticonvulsants; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Levetiracetam; Male; Osmolar Concentration; Piracetam; Rats; Rats, Sprague-Dawley; Time Factors | 1999 |
Piracetam and levetiracetam, two pyrrolidone derivatives, exert antidystonic activity in a hamster model of paroxysmal dystonia.
Topics: Animals; Anticonvulsants; Cricetinae; Dystonia; Levetiracetam; Mutation; Nootropic Agents; Piracetam | 2000 |
Anticonvulsant efficacy of gabapentin and levetiracetam in phenytoin-resistant kindled rats.
Topics: Acetates; Amines; Animals; Anticonvulsants; Cyclohexanecarboxylic Acids; Drug Evaluation; Drug Resistance; Female; Gabapentin; gamma-Aminobutyric Acid; Kindling, Neurologic; Levetiracetam; Phenytoin; Piracetam; Rats; Rats, Wistar; Seizures | 2000 |
Two new drugs for epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Clinical Trials as Topic; Drug Interactions; Epilepsy; Humans; Intestinal Absorption; Isoxazoles; Levetiracetam; Nootropic Agents; Oxcarbazepine; Piracetam; Sodium Channel Blockers; Zonisamide | 2000 |
Absence of pharmacokinetic drug interaction of levetiracetam with phenytoin in patients with epilepsy determined by new technique.
Topics: Adult; Anticonvulsants; Drug Interactions; Drug Therapy, Combination; Epilepsy; Humans; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam | 2000 |
Linezolid, Alosetron, Levetiracetam.
Topics: Acetamides; Adult; Anti-Infective Agents; Anticonvulsants; Carbolines; Colonic Diseases, Functional; Contraindications; Drug Interactions; Female; Humans; Levetiracetam; Linezolid; Oxazolidinones; Piracetam; Serotonin Antagonists | 2000 |
Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs.
Topics: Animals; Anticonvulsants; Calcium; Carbamazepine; Clonazepam; Electrophysiology; Epilepsy; Evoked Potentials; Hippocampus; In Vitro Techniques; Levetiracetam; Male; Neurons; Piracetam; Potassium; Rats; Rats, Sprague-Dawley; Valproic Acid | 2000 |
Enantioselective analysis of levetiracetam and its enantiomer R-alpha-ethyl-2-oxo-pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detection.
Topics: Animals; Dogs; Gas Chromatography-Mass Spectrometry; Levetiracetam; Piracetam; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism | 2000 |
[Clinical utilization of new anti-epileptic agents].
Topics: Acetates; Amines; Anemia, Aplastic; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Drug Tolerance; Epilepsy; Felbamate; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Phenylcarbamates; Piracetam; Propylene Glycols; Tiagabine; Topiramate; Triazines; Vigabatrin; Visual Fields | 2000 |
Development of tolerance during chronic treatment of kindled rats with the novel antiepileptic drug levetiracetam.
Topics: Amygdala; Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Epilepsy, Temporal Lobe; Female; Kindling, Neurologic; Levetiracetam; Piracetam; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2000 |
Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.
Topics: Adult; Aged; Female; Humans; Hypoxia, Brain; Levetiracetam; Male; Middle Aged; Myoclonus; Piracetam; Time Factors | 2001 |
Antimyoclonic effect of levetiracetam.
Topics: Adult; Anticonvulsants; Epilepsies, Myoclonic; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Severity of Illness Index | 2000 |
Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurones of rat hippocampal slices.
Topics: Animals; Anticonvulsants; Cadmium; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Epilepsy; Hippocampus; Levetiracetam; Male; Membrane Potentials; Nimodipine; omega-Conotoxin GVIA; Organ Culture Techniques; Patch-Clamp Techniques; Piracetam; Pyramidal Cells; Rats | 2001 |
Effects of antiepileptic drugs on cognition.
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Cognition; Cognition Disorders; Cyclohexanecarboxylic Acids; Epilepsy; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Piracetam; Tiagabine; Topiramate; Triazines; Triazoles; Vigabatrin | 2001 |
Long-term continuation of levetiracetam in patients with refractory epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Time Factors | 2001 |
A microdialysis study of the novel antiepileptic drug levetiracetam: extracellular pharmacokinetics and effect on taurine in rat brain.
Topics: Amino Acids; Animals; Anticonvulsants; Brain; Extracellular Space; Frontal Lobe; Hippocampus; Levetiracetam; Male; Microdialysis; Piracetam; Rats; Rats, Sprague-Dawley; Taurine; Time Factors | 2001 |
Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents.
Topics: Animals; Calcium Channels, T-Type; Corpus Striatum; gamma-Aminobutyric Acid; Hippocampus; Levetiracetam; Neurons; Nootropic Agents; Piracetam; Rats; Rats, Wistar; Sodium Channels; Substantia Nigra; Thalamus | 2001 |
Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia.
Topics: Animals; Anticonvulsants; Arterial Occlusive Diseases; Body Temperature; Brain; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Dizocilpine Maleate; Levetiracetam; Male; Middle Cerebral Artery; N-Methylaspartate; Neuroprotective Agents; Piracetam; Rats; Rats, Wistar | 2001 |
Pharmacokinetics of levetiracetam and its enantiomer (R)-alpha-ethyl-2-oxo-pyrrolidine acetamide in dogs.
Topics: Animals; Anticonvulsants; Chromatography, High Pressure Liquid; Dogs; Half-Life; Levetiracetam; Male; Piracetam; Stereoisomerism | 2001 |
Effect of levetiracetam on human corticospinal excitability.
Topics: Adult; Anticonvulsants; Double-Blind Method; Electromagnetic Phenomena; Electromyography; Evoked Potentials, Motor; Female; Humans; Levetiracetam; Male; Piracetam; Pyramidal Tracts | 2001 |
The place of levetiracetam in the treatment of epilepsy.
Topics: Adult; Animals; Anticonvulsants; Drug Approval; Epilepsies, Partial; Epilepsy; Humans; Levetiracetam; Piracetam; United States | 2001 |
Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.
Topics: Anticonvulsants; Dose-Response Relationship, Drug; Encephalitis; Epilepsies, Myoclonic; Humans; Hypoxia, Brain; Levetiracetam; Piracetam; Treatment Outcome; Unverricht-Lundborg Syndrome | 2001 |
[Levetiracetam].
Topics: Adult; Animals; Anticonvulsants; Drug Interactions; Epilepsies, Partial; Humans; Learning; Levetiracetam; Memory; Molecular Structure; Piracetam | 2001 |
Levetiracetam for acute mania.
Topics: Acute Disease; Adult; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Levetiracetam; Male; Piracetam; Psychiatric Status Rating Scales; Treatment Outcome | 2002 |
Levetiracetam psychosis in children with epilepsy.
Topics: Acute Disease; Adolescent; Anticonvulsants; Child, Preschool; Comorbidity; Drug Administration Schedule; Epilepsy; Female; Humans; Learning Disabilities; Levetiracetam; Male; Mental Disorders; Piracetam; Psychoses, Substance-Induced; Remission, Spontaneous | 2001 |
Selective blockade of N-type calcium channels by levetiracetam.
Topics: Animals; Anticonvulsants; Calcium Channel Blockers; Calcium Channels, N-Type; Dose-Response Relationship, Drug; Electric Stimulation; Epilepsy; Hippocampus; Kinetics; Levetiracetam; Neurons; Nifedipine; omega-Conotoxin GVIA; Patch-Clamp Techniques; Piracetam; Rats; Rats, Wistar | 2002 |
Levetiracetam opposes the action of GABAA antagonists in hypothalamic neurones.
Topics: Action Potentials; Animals; Anticonvulsants; Female; GABA Antagonists; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Guinea Pigs; Hypothalamus; Levetiracetam; Neurons; Piracetam; Receptors, GABA-A | 2002 |
Carbamazepine toxicity during combination therapy with levetiracetam: a pharmacodynamic interaction.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam | 2002 |
A comparison of the efficacy of carbamazepine and the novel anti-epileptic drug levetiracetam in the tetanus toxin model of focal complex partial epilepsy.
Topics: Animals; Anticonvulsants; Carbamazepine; Epilepsy, Complex Partial; Levetiracetam; Male; Piracetam; Rats; Rats, Sprague-Dawley; Tetanus Toxin | 2002 |
Suppression of cortical myoclonus by levetiracetam.
Topics: Adolescent; Anticonvulsants; Cerebral Cortex; Dominance, Cerebral; Drug Therapy, Combination; Epilepsy, Post-Traumatic; Humans; Levetiracetam; Male; Myoclonic Epilepsy, Juvenile; Piracetam | 2002 |
The new antiepileptic drug levetiracetam normalises chlordiazepoxide withdrawal-induced anxiety in mice.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Chlordiazepoxide; Dose-Response Relationship, Drug; Female; Levetiracetam; Maze Learning; Mice; Mice, Inbred Strains; Piracetam; Substance Withdrawal Syndrome | 2002 |
Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy.
Topics: Animals; Anticonvulsants; Epilepsy, Temporal Lobe; Female; Infusion Pumps; Levetiracetam; Muscarinic Agonists; Pilocarpine; Piracetam; Rats; Rats, Wistar; Time Factors | 2002 |
The clinical challenge of posthypoxic myoclonus.
Topics: 5-Hydroxytryptophan; Anticonvulsants; Clonazepam; Humans; Hypoxia; Levetiracetam; Myoclonus; Neuroprotective Agents; Piracetam | 2002 |
The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents.
Topics: Allosteric Regulation; Animals; Animals, Newborn; Anticonvulsants; Cells, Cultured; Embryo, Mammalian; Female; GABA Modulators; Ion Channel Gating; Levetiracetam; Mice; Neural Inhibition; Neurons; Piracetam; Rats; Receptors, GABA-A; Receptors, Glycine | 2002 |
Aggravation of partial seizures by antiepileptic drugs: is there evidence from clinical trials?
Topics: Anticonvulsants; Epilepsies, Partial; Epilepsy, Generalized; Fructose; Humans; Levetiracetam; Nipecotic Acids; Piracetam; Randomized Controlled Trials as Topic; Retrospective Studies; Tiagabine; Topiramate | 2002 |
Levetiracetam in the treatment of paroxysmal kinesiogenic choreoathetosis.
Topics: Adult; Anticonvulsants; Athetosis; Chorea; Female; Humans; Levetiracetam; Piracetam; Treatment Outcome | 2002 |
The 'number needed to treat' with levetiracetam (LEV): comparison with the other new antiepileptic drugs (AEDs).
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Epilepsies, Partial; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Piracetam; Tiagabine; Topiramate; Triazines; Vigabatrin; Zonisamide | 2002 |
Amelioration of spinal myoclonus with levetiracetam.
Topics: Anticonvulsants; Child; Female; Herpes Zoster; Humans; Levetiracetam; Male; Middle Aged; Myelitis; Myelitis, Transverse; Myoclonus; Piracetam; Severity of Illness Index; Spinal Cord Compression; Treatment Outcome | 2002 |
Improvement of a patient with stuttering on levetiracetam.
Topics: Adult; Female; Humans; Levetiracetam; Piracetam; Stuttering | 2002 |
Effect of levetiracetam on epileptiform discharges in human neocortical slices.
Topics: Adolescent; Adult; Anticonvulsants; Bicuculline; Child; Child, Preschool; Culture Media; Culture Techniques; Electric Stimulation; Electroencephalography; Epilepsy; Evoked Potentials; Female; Humans; Infant; Levetiracetam; Magnesium; Male; Middle Aged; Neocortex; Piracetam | 2002 |
Levetiracetam may be more effective for late-onset partial epilepsy.
Topics: Adult; Age of Onset; Anticonvulsants; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Neuropsychological Tests; Piracetam; Postoperative Period; Preoperative Care; Retrospective Studies; Verbal Learning | 2002 |
Effect of levetiracetam on rapid motor learning in humans.
Topics: Adult; Analysis of Variance; Evoked Potentials, Motor; Female; Humans; Learning; Levetiracetam; Male; Motor Skills; Piracetam; Statistics, Nonparametric | 2002 |
A case of levetiracetam (Keppra) poisoning with clinical and toxicokinetic data.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Drug Overdose; Female; Half-Life; Humans; Levetiracetam; Neurologic Examination; Piracetam; Poisoning; Respiration, Artificial; Respiratory Insufficiency; Suicide, Attempted | 2002 |
Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation.
Topics: Acetates; Amines; Animals; Anticonvulsants; Carbamates; Carbamazepine; Cell Death; Cells, Cultured; Chlordiazepoxide; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Ethosuximide; Felbamate; Gabapentin; gamma-Aminobutyric Acid; Glucose; Hippocampus; Hypoxia; Ischemia; Lamotrigine; Levetiracetam; Midazolam; Neurons; Neuroprotective Agents; Nipecotic Acids; Oxcarbazepine; Phenobarbital; Phenylcarbamates; Phenylenediamines; Phenytoin; Piracetam; Propylene Glycols; Rats; Rats, Wistar; Tiagabine; Triazines; Valproic Acid | 2003 |
Correlation of levetiracetam concentrations between serum and saliva.
Topics: Adolescent; Adult; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Levetiracetam; Linear Models; Male; Middle Aged; Piracetam; Saliva; Statistics, Nonparametric | 2003 |
Levetiracetam efficacy in refractory partial-onset seizures, especially after failed epilepsy surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electroencephalography; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Postoperative Complications; Retrospective Studies; Treatment Failure; Treatment Outcome | 2003 |
Electrophysiological, neurochemical and regional effects of levetiracetam in the rat pilocarpine model of temporal lobe epilepsy.
Topics: Animals; Anticonvulsants; Aspartic Acid; Clonazepam; Electroencephalography; Epilepsy, Temporal Lobe; gamma-Aminobutyric Acid; Hippocampus; Injections, Intraperitoneal; Levetiracetam; Male; Microinjections; Phenobarbital; Pilocarpine; Piracetam; Rats; Rats, Sprague-Dawley; Valproic Acid | 2003 |
Effects of lamotrigine and levetiracetam on seizure development in a rat amygdala kindling model.
Topics: Amygdala; Animals; Anticonvulsants; Behavior, Animal; Electric Stimulation; Electrodes, Implanted; Kindling, Neurologic; Lamotrigine; Levetiracetam; Male; Models, Neurological; Piracetam; Rats; Seizures; Triazines | 2003 |
Successful treatment of pharmacoresistent continuous spike wave activity during slow sleep with levetiracetam.
Topics: Child, Preschool; Drug Therapy, Combination; Electroencephalography; Epilepsies, Partial; Humans; Levetiracetam; Male; Nootropic Agents; Piracetam; Sleep | 2003 |
Levetiracetam reduces caffeine-induced Ca2+ transients and epileptiform potentials in hippocampal neurons.
Topics: Animals; Anticonvulsants; Caffeine; Calcium; Cells, Cultured; Central Nervous System Stimulants; Electrophysiology; Epilepsy; Hippocampus; In Vitro Techniques; Levetiracetam; Neurons; Piracetam; Rats; Rats, Sprague-Dawley | 2003 |
Levetiracetam control of myoclonus in a patient with Creutzfeldt-Jakob disease.
Topics: Adult; Anticonvulsants; Creutzfeldt-Jakob Syndrome; Humans; Levetiracetam; Male; Myoclonus; Piracetam; Treatment Outcome | 2003 |
Clinically relevant reduction of lamotrigine concentrations by carbamazepine.
Topics: Aged; Anticonvulsants; Carbamazepine; Drug Antagonism; Drug Therapy, Combination; Epilepsy; Humans; Lamotrigine; Levetiracetam; Male; Piracetam; Treatment Outcome; Triazines | 2003 |
Levetiracetam monotherapy for primary generalised epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Dose-Response Relationship, Drug; Epilepsy, Generalized; Humans; Levetiracetam; Male; Middle Aged; Piracetam | 2003 |
Levetiracetam monotherapy for newly diagnosed epilepsy patients.
Topics: Adolescent; Adult; Age of Onset; Aged; Anticonvulsants; Drug Therapy, Combination; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Middle Aged; Piracetam; Retrospective Studies; Treatment Outcome | 2003 |
Levetiracetam for benign epilepsy of childhood with centrotemporal spikes-three cases.
Topics: Anticonvulsants; Child; Child, Preschool; Dose-Response Relationship, Drug; Epilepsy, Rolandic; Female; Humans; Levetiracetam; Neurologic Examination; Piracetam | 2003 |
Microemulsion electrokinetic chromatography applied for separation of levetiracetam from other antiepileptic drugs in polypharmacy.
Topics: Anticonvulsants; Chromatography, Micellar Electrokinetic Capillary; Drug Combinations; Emulsions; Humans; Hydrogen-Ion Concentration; Levetiracetam; Osmolar Concentration; Piracetam; Solvents; Surface-Active Agents | 2003 |
Dramatic effect of levetiracetam on epileptic negative myoclonus.
Topics: Anticonvulsants; Electroencephalography; Epilepsies, Myoclonic; Female; Humans; Levetiracetam; Middle Aged; Piracetam | 2003 |
Levetiracetam has no significant gamma-aminobutyric acid-related effect on paired-pulse interaction in the dentate gyrus of rats.
Topics: Animals; Anticonvulsants; Baclofen; Bicuculline; Clonazepam; Convulsants; Dentate Gyrus; Diazepam; Electric Stimulation; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Levetiracetam; Male; Phenobarbital; Piracetam; Rats; Rats, Sprague-Dawley; Receptors, GABA; Synaptic Transmission; Time Factors | 2003 |
Efficacy of levetiracetam in a patient with Unverricht-Lundborg progressive myoclonic epilepsy.
Topics: Adult; Amino Acid Substitution; Anticonvulsants; Chromosomes, Human, Pair 21; Cystatin B; Cystatins; Drug Evaluation; Female; Heterozygote; Humans; Levetiracetam; Minisatellite Repeats; Mutation, Missense; Myoclonic Epilepsies, Progressive; Piracetam; Point Mutation; Promoter Regions, Genetic | 2003 |
Expression of brain-derived neurotrophic factor (BDNF) and inducible nitric oxide synthase (iNOS) in rat astrocyte cultures treated with Levetiracetam.
Topics: Animals; Anticonvulsants; Astrocytes; Brain-Derived Neurotrophic Factor; Cells, Cultured; Immunohistochemistry; Levetiracetam; Lipopolysaccharides; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Piracetam; Rats; Rats, Wistar | 2003 |
Anxiolytic profile of the antiepileptic drug levetiracetam in the Vogel conflict test in the rat.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Conflict, Psychological; Electric Stimulation; Levetiracetam; Male; Piracetam; Rats; Rats, Sprague-Dawley | 2003 |
Effect of levetiracetam in refractory childhood epilepsy syndromes.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Administration Schedule; Epilepsies, Partial; Epilepsy, Generalized; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Syndrome | 2003 |
[Levetiracetam in the treatment of epilepsy].
Topics: Adolescent; Adult; Aged; Anticonvulsants; Drug Interactions; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Myoclonic Epilepsy, Juvenile; Piracetam | 2003 |
Desynchronizing effect of levetiracetam on epileptiform responses in rat hippocampal slices.
Topics: Action Potentials; Animals; Hippocampus; In Vitro Techniques; Levetiracetam; Male; Piracetam; Rats; Rats, Sprague-Dawley | 2003 |
Levetiracetam monotherapy for liver transplant patients with seizures.
Topics: Anticonvulsants; Hepatitis C; Humans; Levetiracetam; Liver Cirrhosis, Alcoholic; Liver Transplantation; Male; Middle Aged; Piracetam; Postoperative Complications; Treatment Outcome | 2003 |
Levetiracetam in the treatment of rapid cycling bipolar disorder.
Topics: Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Valproic Acid | 2003 |
Acute psychosis associated with levetiracetam.
Topics: Anticonvulsants; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetiracetam; Piracetam; Psychoses, Substance-Induced; Valproic Acid | 2003 |
Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats.
Topics: Acute Disease; Analgesics; Animals; Carbamazepine; Chronic Disease; Constriction, Pathologic; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Hyperalgesia; Injections, Intraperitoneal; Levetiracetam; Male; Morphine; Pain; Pain Measurement; Peripheral Nervous System Diseases; Piracetam; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Vocalization, Animal | 2003 |
Levetiracetam monotherapy during pregnancy: a case series.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Epilepsy; Female; Humans; Infant, Newborn; Levetiracetam; Piracetam; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Treatment Outcome | 2003 |
Levetiracetam as a treatment for tardive dyskinesia: a case report.
Topics: Adrenergic alpha-Agonists; Anticonvulsants; Antidepressive Agents; Chronic Disease; Clonidine; Depression; Dyskinesia, Drug-Induced; Female; Humans; Hypotension; Levetiracetam; Lithium Carbonate; Middle Aged; Piracetam | 2003 |
Meeting the challenge of treating epilepsy.
Topics: Anticonvulsants; Epilepsy; Humans; Levetiracetam; Neuroprotective Agents; Piracetam | 2003 |
Analysis of the antiepileptic drug keppra by capillary electrophoresis.
Topics: Anticonvulsants; Chromatography, High Pressure Liquid; Electrophoresis, Capillary; Humans; Levetiracetam; Piracetam; Reference Standards; Reproducibility of Results | 2003 |
Reduction of voltage-operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action?
Topics: 4-Aminopyridine; Action Potentials; Animals; Anticonvulsants; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Guinea Pigs; Hippocampus; In Vitro Techniques; Levetiracetam; Neural Conduction; Neurons; Patch-Clamp Techniques; Piracetam; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Wistar; Sodium Channel Blockers; Tetraethylammonium; Tetrodotoxin | 2003 |
Psychiatric adverse events during levetiracetam therapy.
Topics: Adult; Anticonvulsants; Female; Humans; Levetiracetam; Male; Piracetam; Prevalence; Psychoses, Substance-Induced; Risk Factors | 2003 |
Developmental outcome of levetiracetam, its major metabolite in humans, 2-pyrrolidinone N-butyric acid, and its enantiomer (R)-alpha-ethyl-oxo-pyrrolidine acetamide in a mouse model of teratogenicity.
Topics: Animals; Butyrates; Disease Models, Animal; Female; Fetus; Levetiracetam; Mice; Piracetam; Pregnancy; Prenatal Exposure Delayed Effects; Pyrrolidines; Pyrrolidinones; Teratogens | 2003 |
Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases.
Topics: Adult; Aged; Aggression; Anticonvulsants; Drug Resistance; Drug Therapy, Combination; Epilepsy; Female; Humans; Irritable Mood; Levetiracetam; Magnetic Resonance Imaging; Male; Middle Aged; Patient Compliance; Piracetam; Retrospective Studies | 2003 |
Landau-Kleffner syndrome responsive to levetiracetam.
Topics: Anticonvulsants; Child, Preschool; Electroencephalography; Female; Humans; Landau-Kleffner Syndrome; Language Tests; Levetiracetam; Memory, Short-Term; Piracetam; Valproic Acid | 2003 |
Pharmacokinetics and metabolism of 14C-levetiracetam, a new antiepileptic agent, in healthy volunteers.
Topics: Adult; Anticonvulsants; Area Under Curve; Carbon Radioisotopes; Half-Life; Humans; Hydrolysis; In Vitro Techniques; Levetiracetam; Male; Middle Aged; Piracetam; Stereoisomerism | 2003 |
Binding characteristics of [3H]ucb 30889 to levetiracetam binding sites in rat brain.
Topics: Animals; Anticonvulsants; Azides; Binding, Competitive; Brain; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Levetiracetam; Male; Piracetam; Pyrrolidines; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tritium | 2003 |
Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell lines.
Topics: Animals; Binding Sites; Brain; Cell Line; Chlorocebus aethiops; COS Cells; Cricetinae; Dose-Response Relationship, Drug; Levetiracetam; Male; Mice; Neurons; Photoaffinity Labels; Piracetam; Rats; Rats, Sprague-Dawley; Synaptic Vesicles | 2003 |
Drug points: Weight loss associated with levetiracetam.
Topics: Adult; Anticonvulsants; Body Weight; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Weight Loss | 2003 |
Discontinuation of levetiracetam because of behavioral side effects: a case-control study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Behavioral Symptoms; Case-Control Studies; Child; Dose-Response Relationship, Drug; Epilepsy; Female; Humans; Incidence; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Risk Factors; Sex Factors | 2003 |
Levetiracetam: preliminary experience in patients with primary brain tumours.
Topics: Brain Neoplasms; Follow-Up Studies; Glioma; Humans; Levetiracetam; Piracetam; Prospective Studies; Seizures | 2003 |
Levetiracetam in clinical use--a prospective observational study.
Topics: Adolescent; Adult; Aged; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Residential Facilities | 2003 |
Levetiracetam treatment of idiopathic generalised epilepsy.
Topics: Adolescent; Adult; Aged; Epilepsy, Generalized; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam | 2003 |
Unidirectional cross-tolerance from levetiracetam to carbamazepine in amygdala-kindled seizures.
Topics: Amygdala; Animals; Anticonvulsants; Carbamazepine; Drug Tolerance; Electroencephalography; Injections, Intraperitoneal; Kindling, Neurologic; Levetiracetam; Long-Term Care; Male; Piracetam; Rats; Rats, Sprague-Dawley | 2003 |
Anxiolytic effects of the novel anti-epileptic drug levetiracetam in the elevated plus-maze test in the rat.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Buspirone; Chlordiazepoxide; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Levetiracetam; Male; Maze Learning; Piracetam; Rats; Rats, Sprague-Dawley | 2003 |
Serum concentrations of Levetiracetam in epileptic patients: the influence of dose and co-medication.
Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Regression Analysis | 2003 |
Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anticonvulsants; Antiparkinson Agents; Callithrix; Dopamine Agents; Drug Synergism; Drug Therapy, Combination; Female; Indoles; Levetiracetam; Levodopa; Male; Parkinsonian Disorders; Piracetam | 2003 |
Tolerability of levetiracetam in elderly patients with CNS disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Anticonvulsants; Anxiety Disorders; Central Nervous System Diseases; Cognition Disorders; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam | 2003 |
Levetiracetam for phasic spasticity in multiple sclerosis.
Topics: Adult; Anticonvulsants; Dose-Response Relationship, Drug; Female; Humans; Levetiracetam; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Piracetam; Retrospective Studies; Severity of Illness Index | 2003 |
Levetiracetam reduces spike-wave density and duration during continuous EEG monitoring in patients with idiopathic generalized epilepsy.
Topics: Action Potentials; Electroencephalography; Epilepsy, Generalized; Humans; Levetiracetam; Monitoring, Physiologic; Piracetam; Statistics, Nonparametric | 2004 |
Levetiracetam protects against kainic acid-induced toxicity.
Topics: Animals; Behavior, Animal; Brain; Cells, Cultured; Cerebral Cortex; Diencephalon; DNA Primers; Excitatory Amino Acid Agonists; Glutathione; Inflammation; Interleukin-1; Kainic Acid; Levetiracetam; Lipid Peroxidation; Macrophages; Male; Malondialdehyde; Neurons; Neurotoxicity Syndromes; Nootropic Agents; Piracetam; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA | 2004 |
The antiepileptic drug levetiracetam selectively modifies kindling-induced alterations in gene expression in the temporal lobe of rats.
Topics: Animals; Anticonvulsants; Brain Chemistry; Female; Gene Expression Regulation; Kindling, Neurologic; Levetiracetam; Piracetam; Rats; Rats, Wistar; Temporal Lobe | 2004 |
[Levetiracetam hepatitis].
Topics: Anticonvulsants; Chemical and Drug Induced Liver Injury; Humans; Levetiracetam; Male; Middle Aged; Piracetam | 2004 |
Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam.
Topics: Adult; Analysis of Variance; Anticonvulsants; Behavioral Symptoms; Chi-Square Distribution; Epilepsy; Female; Humans; Learning Disabilities; Levetiracetam; Male; Piracetam; Prevalence; Regression Analysis | 2004 |
Levetiracetam monotherapy for elderly patients with epilepsy.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Dose-Response Relationship, Drug; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies | 2004 |
Levetiracetam improves paroxysmal symptoms in a patient with stiff-person syndrome.
Topics: Female; GABA Agonists; Humans; Immunoglobulins, Intravenous; Levetiracetam; Middle Aged; Muscle Spasticity; Piracetam; Stiff-Person Syndrome; Valproic Acid | 2004 |
Levetiracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque.
Topics: Animals; Chorea; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Levetiracetam; Levodopa; Macaca fascicularis; MPTP Poisoning; Piracetam | 2004 |
High-performance liquid chromatographic determination of Levetiracetam in human plasma: comparison of different sample clean-up procedures.
Topics: Anticonvulsants; Chromatography, High Pressure Liquid; Humans; Levetiracetam; Piracetam; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Levetiracetam in progressive myoclonic epilepsy: an exploratory study in 9 patients.
Topics: Activities of Daily Living; Adolescent; Anticonvulsants; Child; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Levetiracetam; Male; MERRF Syndrome; Piracetam; Treatment Outcome; Unverricht-Lundborg Syndrome | 2004 |
Levetiracetam potentiates the antidyskinetic action of amantadine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease.
Topics: Amantadine; Animals; Anticonvulsants; Antiparkinson Agents; Callithrix; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Dyskinesias; Female; Levetiracetam; Levodopa; Male; MPTP Poisoning; Piracetam | 2004 |
Efficacy and tolerability of levetiracetam in children aged 10 years and younger: a clinical experience.
Topics: Age Factors; Child; Child, Preschool; Epilepsy; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Retrospective Studies | 2004 |
Efficacy and tolerability of levetiracetam in patients with therapy-resistant epilepsy and learning disabilities.
Topics: Adolescent; Adult; Aged; Epilepsy; Female; Humans; Learning Disabilities; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies | 2004 |
FDA notifications. UCB Pharma and FDA issue advisory letter.
Topics: Anticonvulsants; Drug Industry; Drug Interactions; HIV Infections; HIV Protease Inhibitors; Humans; Levetiracetam; Lopinavir; Piracetam; Pyrimidinones; United States; United States Food and Drug Administration | 2004 |
Efficacy and safety of levetiracetam in pediatric migraine.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Female; Humans; Levetiracetam; Male; Migraine Disorders; Piracetam; Recurrence; Retrospective Studies; Treatment Outcome | 2004 |
[Levetiracetam in combined therapy for focal epilepsy: experience with 80 patients].
Topics: Adult; Anticonvulsants; Combined Modality Therapy; Disease-Free Survival; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Piracetam; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2004 |
Levetiracetam in the treatment of Lennox-Gastaut syndrome.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Female; Humans; Intellectual Disability; Levetiracetam; Male; Myoclonic Epilepsy, Juvenile; Piracetam; Retrospective Studies; Syndrome | 2004 |
Levetiracetam in focal epilepsy and hepatic porphyria: a case report.
Topics: Acute Disease; Adult; Anticonvulsants; Comorbidity; Epilepsies, Partial; Female; Humans; Levetiracetam; Piracetam; Porphyrias, Hepatic; Primidone; Valproic Acid | 2004 |
Inhibition of multidrug transporters by verapamil or probenecid does not alter blood-brain barrier penetration of levetiracetam in rats.
Topics: Animals; ATP-Binding Cassette Transporters; Blood-Brain Barrier; Levetiracetam; Piracetam; Probenecid; Rats; Rats, Wistar; Verapamil | 2004 |
Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus.
Topics: Action Potentials; Animals; Anticonvulsants; Diazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electric Stimulation; Levetiracetam; Male; Piracetam; Rats; Status Epilepticus | 2004 |
Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing propert
Topics: Affect; Amygdala; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Electroencephalography; Escape Reaction; Gene Expression Regulation; Hippocampus; Kindling, Neurologic; Levetiracetam; Male; Motivation; Neuropeptide Y; Piracetam; Rats; Rats, Wistar; Receptors, Neuropeptide Y; RNA, Messenger | 2004 |
Levetiracetam in adult patients with and without learning disability: focus on behavioral adverse effects.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy, Generalized; Female; Humans; Intellectual Disability; Levetiracetam; Male; Mental Disorders; Middle Aged; Myoclonic Epilepsy, Juvenile; Piracetam; Retrospective Studies | 2004 |
Aromatase inhibition, testosterone, and seizures.
Topics: Anticonvulsants; Aromatase Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroencephalography; Epilepsy, Temporal Lobe; Erectile Dysfunction; Estradiol; Follicle Stimulating Hormone; Humans; Letrozole; Levetiracetam; Libido; Luteinizing Hormone; Male; Middle Aged; Nitriles; Piracetam; Quality of Life; Sex Hormone-Binding Globulin; Testosterone; Triazoles | 2004 |
Enterocolitis: an adverse event in refractory epilepsy patients treated with levetiracetam?
Topics: Adult; Anticonvulsants; Electroencephalography; Enterocolitis; Epilepsy; Female; Hippocampus; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Middle Aged; Piracetam | 2004 |
Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy.
Topics: Adolescent; Adult; Chi-Square Distribution; Child; Child, Preschool; Epilepsy; Female; Follow-Up Studies; Humans; Infant; Levetiracetam; Male; Piracetam; Prospective Studies; Statistics, Nonparametric | 2004 |
"Mu rhythm status" and clinical correlates.
Topics: Diagnosis, Differential; Electroencephalography; Epilepsy, Rolandic; Female; Humans; Levetiracetam; Middle Aged; Motor Cortex; Piracetam; Statistics as Topic | 2004 |
Levetiracetam in the treatment of idiopathic hemifacial spasm.
Topics: Anticonvulsants; Calcium Channel Blockers; Calcium Channels, N-Type; Female; Hemifacial Spasm; Humans; Levetiracetam; Middle Aged; Piracetam; Remission Induction | 2004 |
Comparative pharmacokinetics and metabolism of levetiracetam, a new anti-epileptic agent, in mouse, rat, rabbit and dog.
Topics: Administration, Oral; Animals; Anticonvulsants; Biotransformation; Carbon Isotopes; Dogs; Female; Half-Life; Hydrolysis; In Vitro Techniques; Levetiracetam; Male; Mass Spectrometry; Mice; Piracetam; Rabbits; Rats; Sex Factors; Species Specificity; Tissue Distribution | 2004 |
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.
Topics: Animals; Anticonvulsants; Binding Sites; Brain; Fibroblasts; Gene Deletion; Humans; Inhibitory Concentration 50; Intracellular Membranes; Levetiracetam; Membrane Glycoproteins; Mice; Mice, Knockout; Molecular Weight; Nerve Tissue Proteins; Photoaffinity Labels; Piracetam; Precipitin Tests; Protein Binding; Rats; Seizures; Synaptic Vesicles | 2004 |
Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine.
Topics: 4-Aminopyridine; Animals; Anticonvulsants; Bicuculline; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, N-Type; Dose-Response Relationship, Drug; Epilepsy; Lamotrigine; Levetiracetam; Male; Membrane Potentials; Neocortex; Patch-Clamp Techniques; Piracetam; Pyramidal Cells; Rats; Rats, Wistar; Triazines | 2004 |
The activity of antiepileptic drugs as histone deacetylase inhibitors.
Topics: Acetylation; Anticonvulsants; Biotransformation; Butyrates; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Fructose; HeLa Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Levetiracetam; Piracetam; Pyrrolidinones; Topiramate; Valproic Acid | 2004 |
Levetiracetam-induced thrombocytopenia.
Topics: Anticonvulsants; Epilepsy; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Sweden; Thrombocytopenia | 2004 |
Levetiracetam inhibits Na+-dependent Cl-/HCO3- exchange of adult hippocampal CA3 neurons from guinea-pigs.
Topics: Action Potentials; Animals; Anticonvulsants; Buffers; Cations, Monovalent; Chloride-Bicarbonate Antiporters; Guinea Pigs; Hippocampus; Hydrogen-Ion Concentration; In Vitro Techniques; Levetiracetam; Neurons; Piracetam; Sodium; Time Factors | 2004 |
Future Pain Drugs - Europe 2003. 15-16 September 2003, London, UK.
Topics: Acetaminophen; Acetates; Amines; Analgesics; Animals; Cyclohexanecarboxylic Acids; Disease Models, Animal; Drug Delivery Systems; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Levetiracetam; Nitrates; Pain; Peripheral Nervous System Diseases; Piracetam; Pregabalin; Topiramate | 2003 |
A validated chiral LC method for the enantioselective analysis of Levetiracetam and its enantiomer R-alpha-ethyl-2-oxo-pyrrolidine acetamide on amylose-based stationary phase.
Topics: Amides; Amylose; Anticonvulsants; Butyrates; Chromatography, Liquid; Levetiracetam; Molecular Structure; Piracetam; Pyrrolidinones; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism | 2004 |
Psychopharmacology of anticonvulsants: levetiracetam as a synaptic vesicle protein modulator.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Exocytosis; Humans; Levetiracetam; Membrane Glycoproteins; Mice; Mice, Knockout; Nerve Tissue Proteins; Neurotransmitter Agents; Piracetam; Protein Binding; Seizures; Synaptic Transmission; Synaptic Vesicles | 2004 |
Substantial improvement in a Meige's syndrome patient with levetiracetam treatment.
Topics: Anticonvulsants; Female; Humans; Levetiracetam; Meige Syndrome; Middle Aged; Piracetam; Severity of Illness Index; Treatment Outcome | 2004 |
Acute repetitive pilomotor seizures (goose bumps) in a patient with right mesial temporal sclerosis.
Topics: Acute Disease; Adult; Electroencephalography; Epilepsy, Temporal Lobe; Female; Humans; Levetiracetam; Piloerection; Piracetam | 2004 |
Levetiracetam induces a rapid and sustained reduction of generalized spike-wave and clinical absence.
Topics: Adult; Anticonvulsants; Delta Rhythm; Dose-Response Relationship, Drug; Drug Administration Schedule; Electroencephalography; Female; Fructose; Humans; Lamotrigine; Levetiracetam; Piracetam; Retrospective Studies; Seizures; Topiramate; Triazines | 2004 |
Effects of levetiracetam on spike and wave discharges in WAG/Rij rats.
Topics: Animals; Anticonvulsants; Electroencephalography; Epilepsy, Absence; Levetiracetam; Male; Piracetam; Rats | 2004 |
Levetiracetam in the treatment of vascular chorea: a case report.
Topics: Aged; Anticonvulsants; Chorea; Drug Administration Schedule; Female; Humans; Levetiracetam; Piracetam; Treatment Outcome; Vascular Diseases | 2005 |
Monotherapy treatment of bipolar disorder with levetiracetam.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Female; Humans; Levetiracetam; MEDLINE; Piracetam; Review Literature as Topic; Treatment Outcome | 2004 |
Levetiracetam in refractory epilepsy: a prospective observational study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Drug Resistance; Drug Therapy, Combination; Electroencephalography; Epilepsies, Partial; Epilepsy, Generalized; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Treatment Outcome | 2005 |
Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electroencephalography; Epilepsies, Myoclonic; Epilepsies, Partial; Epilepsy, Absence; Epilepsy, Generalized; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Prospective Studies; Syndrome; Treatment Outcome | 2005 |
The antiepileptic drug levetiracetam decreases the inositol 1,4,5-trisphosphate-dependent [Ca2+]I increase induced by ATP and bradykinin in PC12 cells.
Topics: Adenosine Triphosphate; Animals; Anticonvulsants; Bradykinin; Calcium; Dose-Response Relationship, Drug; Inositol 1,4,5-Trisphosphate; Levetiracetam; PC12 Cells; Piracetam; Rats | 2005 |
Drug-induced psychosis after long-term treatment with levetiracetam.
Topics: Adult; Female; Humans; Levetiracetam; Nootropic Agents; Piracetam; Psychoses, Substance-Induced; Time | 2004 |
Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Electroencephalography; Epilepsies, Partial; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Video Recording | 2005 |
Levetiracetam in the treatment of infantile spasms.
Topics: Anticonvulsants; Electroencephalography; Humans; Infant; Levetiracetam; Male; Piracetam; Spasms, Infantile | 2005 |
Retrospective study of the use of levetiracetam in childhood seizure disorders.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsy; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Retrospective Studies; Treatment Outcome | 2004 |
Continued use of zonisamide following development of renal calculi.
Topics: Adult; Anticonvulsants; Calcium Citrate; Carbamazepine; Drug Therapy, Combination; Fluid Therapy; Humans; Isoxazoles; Kidney Calculi; Levetiracetam; Male; Oxcarbazepine; Piracetam; Recurrence; Ultrasonography; Ureteral Calculi; Zonisamide | 2005 |
Effects of levetiracetam on the production of nitric oxide--an in vivo study.
Topics: Analysis of Variance; Animals; Anticonvulsants; Cerebellum; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Levetiracetam; Male; Microdialysis; N-Methylaspartate; NG-Nitroarginine Methyl Ester; Nitric Oxide; Piracetam; Quinoxalines; Rats; Rats, Wistar; Time Factors | 2005 |
Chorea in a patient with cerebral palsy: treatment with levetiracetam.
Topics: Adult; Anticonvulsants; Cerebral Palsy; Chorea; Female; Humans; Levetiracetam; Piracetam; Treatment Outcome | 2005 |
Levetiracetam for the treatment of essential tremor.
Topics: Anticonvulsants; Essential Tremor; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Randomized Controlled Trials as Topic; Severity of Illness Index | 2005 |
Determination of levetiracetam in human plasma with minimal sample pretreatment.
Topics: Anticonvulsants; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Epilepsy; Humans; Lamotrigine; Levetiracetam; Phenobarbital; Piracetam; Primidone; Triazines | 2005 |
Levetiracetam as an adjunctive analgesic in neoplastic plexopathies: case series and commentary.
Topics: Adult; Aged; Analgesics, Opioid; Anticonvulsants; Brachial Plexus Neuropathies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levetiracetam; Lumbosacral Plexus; Male; Middle Aged; Neoplasms; Pain; Peripheral Nervous System Diseases; Piracetam | 2005 |
Hypersomnia in an epilepsy patient treated with levetiracetam.
Topics: Adult; Anticonvulsants; Disorders of Excessive Somnolence; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetiracetam; Piracetam | 2005 |
Levetiracetam concentrations in serum and in breast milk at birth and during lactation.
Topics: Anticonvulsants; Breast Feeding; Epilepsy; Female; Fetal Blood; Humans; Infant, Newborn; Lactation; Levetiracetam; Maternal-Fetal Exchange; Milk, Human; Parturition; Piracetam; Pregnancy; Pregnancy Complications | 2005 |
Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain.
Topics: Age Factors; Animals; Animals, Newborn; Brain; Cell Death; Dose-Response Relationship, Drug; Female; Levetiracetam; Male; Nerve Degeneration; Neurotoxins; Piracetam; Rats; Rats, Wistar; Thiazines | 2005 |
Nonconvulsive status epilepticus on treatment with levetiracetam.
Topics: Adult; Aged; Anticonvulsants; Electroencephalography; Humans; Levetiracetam; Male; Piracetam; Status Epilepticus; Treatment Outcome | 2005 |
Economic evaluation of levetiracetam as an add-on therapy in patients with refractory epilepsy.
Topics: Anticonvulsants; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Epilepsy; Humans; Levetiracetam; Models, Economic; Piracetam | 2005 |
Levetiracetam selectively potentiates the acute neurotoxic effects of topiramate and carbamazepine in the rotarod test in mice.
Topics: Animals; Anticonvulsants; Brain; Carbamazepine; Dose-Response Relationship, Drug; Drug Synergism; Electroshock; Fructose; Levetiracetam; Male; Mice; Piracetam; Postural Balance; Psychomotor Performance; Topiramate | 2005 |
Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroshock; Levetiracetam; Male; Mice; Nootropic Agents; Pentylenetetrazole; Piracetam; Pyrrolidinones; Rats; Rats, Wistar; Seizures | 2005 |
Hyponatremia associated with repeated use of levetiracetam.
Topics: Aged; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Levetiracetam; Piracetam; Sodium | 2005 |
The effect of levetiracetam on levodopa induced dyskinesia in patients with Parkinson's disease.
Topics: Aged; Anticonvulsants; Antiparkinson Agents; Dyskinesia, Drug-Induced; Female; Humans; Levetiracetam; Levodopa; Male; Middle Aged; Parkinson Disease; Piracetam | 2005 |
Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease.
Topics: Aged; Anticonvulsants; Antiparkinson Agents; Dyskinesia, Drug-Induced; Female; Humans; Levetiracetam; Levodopa; Male; Middle Aged; Parkinson Disease; Pilot Projects; Piracetam | 2005 |
Evaluation of levetiracetam effects on pilocarpine-induced seizures: cholinergic muscarinic system involvement.
Topics: Animals; Anticonvulsants; Convulsants; Disease Models, Animal; Hippocampus; Levetiracetam; Male; Mice; Muscarinic Agonists; Oxotremorine; Pilocarpine; Piracetam; Receptors, Muscarinic; Seizures | 2005 |
Levetiracetam for the treatment of generalized dystonia.
Topics: Anticonvulsants; Blepharospasm; Dystonia; Female; Humans; Levetiracetam; Middle Aged; Piracetam | 2005 |
Levetiracetam for agitated Alzheimer's disease patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Behavior; Cognition; Female; Humans; Interpersonal Relations; Levetiracetam; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Piracetam; Treatment Outcome | 2005 |
Effects of anticonvulsants on soman-induced epileptiform activity in the guinea-pig in vitro hippocampus.
Topics: Amines; Animals; Anticonvulsants; Carbamates; Carbamazepine; Chlormethiazole; Clozapine; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Epilepsy; Felbamate; Fructose; Gabapentin; gamma-Aminobutyric Acid; Guinea Pigs; Hippocampus; In Vitro Techniques; Levetiracetam; Male; Phenylcarbamates; Phenylenediamines; Piracetam; Propylene Glycols; Soman; Topiramate | 2005 |
Separation of antiepileptogenic and antiseizure effects of levetiracetam in the spontaneously epileptic rat (SER).
Topics: Animals; Animals, Newborn; Anticonvulsants; Disease Models, Animal; Drug Administration Schedule; Electrodes, Implanted; Electroencephalography; Epilepsy; Female; Frontal Lobe; Hippocampus; Injections, Intraperitoneal; Levetiracetam; Male; Piracetam; Rats; Rats, Mutant Strains; Seizures | 2005 |
An audit of lamotrigine, levetiracetam and topiramate usage for epilepsy in a district general hospital.
Topics: Adult; Aged; Anticonvulsants; Cohort Studies; Drug Utilization; Epilepsy; Epilepsy, Generalized; Female; Fructose; Hospitals, General; Humans; Knowledge Bases; Lamotrigine; Learning Disabilities; Levetiracetam; Male; Medical Audit; Middle Aged; Patient Dropouts; Piracetam; Topiramate; Triazines; United Kingdom | 2005 |
Chronic levetiracetam treatment early in life decreases epileptiform events in young GAERS, but does not prevent the expression of spike and wave discharges during adulthood.
Topics: Aging; Animals; Anticonvulsants; Brain; Electrodes, Implanted; Electroencephalography; Epilepsy; Levetiracetam; Piracetam; Rats; Rats, Inbred Strains | 2005 |
Levetiracetam in the treatment of status epilepticus in adults: a study of 13 episodes.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Status Epilepticus; Treatment Outcome | 2005 |
Characterization of [(3)H]ucb 30889 binding to synaptic vesicle protein 2A in the rat spinal cord.
Topics: Animals; Anticonvulsants; Azides; Binding Sites; Binding, Competitive; Dose-Response Relationship, Drug; Kinetics; Levetiracetam; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam; Pyrrolidines; Rats; Rats, Sprague-Dawley; Spinal Cord; Synaptic Vesicles | 2005 |
Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
Topics: Animals; Anticonvulsants; Behavior, Animal; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; Epilepsy, Absence; Epilepsy, Generalized; Female; Injections, Intraperitoneal; Levetiracetam; Male; Piracetam; Rats; Rats, Mutant Strains; Time Factors | 2005 |
Efficacy of levetiracetam at 12 months in children classified by seizure type, cognitive status, and previous anticonvulsant drug use.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Cognition; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy, Generalized; Female; Follow-Up Studies; Humans; Infant; Isoxazoles; Levetiracetam; Male; Piracetam; Retrospective Studies; Treatment Outcome; Zonisamide | 2005 |
Broad-spectrum efficacy of zonisamide at 12 months in children with intractable epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Cognition; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy, Generalized; Female; Follow-Up Studies; Humans; Infant; Isoxazoles; Levetiracetam; Male; Piracetam; Retrospective Studies; Treatment Outcome; Zonisamide | 2005 |
Therapeutic approach in a case of Pearson's syndrome.
Topics: Acidosis, Lactic; Bone Marrow Diseases; Calcium; Child, Preschool; Disease Progression; DNA, Mitochondrial; Ergocalciferols; Fanconi Syndrome; Female; Humans; Kearns-Sayre Syndrome; Levetiracetam; Neutropenia; Nootropic Agents; Pancreas, Exocrine; Pancreatic Diseases; Piracetam; Sodium Bicarbonate; Thrombocytopenia | 2005 |
Effects of Nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats.
Topics: Administration, Oral; Amygdala; Animals; Anticonvulsants; Behavior, Animal; Disease Models, Animal; Electric Stimulation; Electrodes, Implanted; Electroencephalography; Epilepsy, Complex Partial; Humans; Kindling, Neurologic; Levetiracetam; Male; Nootropic Agents; Piracetam; Pyrrolidinones; Rats; Rats, Wistar; Seizures | 2005 |
Levetiracetam for mood stabilization and maintenance of seizure control following multiple treatment failures.
Topics: Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Female; Fructose; Humans; Levetiracetam; Middle Aged; Mood Disorders; Oxcarbazepine; Piracetam; Seizures; Topiramate; Treatment Outcome; Valproic Acid | 2005 |
New antiepileptic drugs in practice--how do they perform in the real world?
Topics: Amines; Anticonvulsants; Controlled Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Epilepsy; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Levetiracetam; Long-Term Care; Patient Dropouts; Piracetam; Topiramate; Treatment Outcome; Triazines | 2005 |
Antiepileptic drug discovery: lessons from the past and future challenges.
Topics: Animals; Anticonvulsants; Brain; Dose-Response Relationship, Drug; Epilepsy; Forecasting; GABA Agonists; Humans; Levetiracetam; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam; Synapses; Treatment Outcome | 2005 |
Catatonia induced by levetiracetam.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Catatonia; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetiracetam; Paranoid Disorders; Piracetam; Risperidone | 2006 |
Rapid kindling in preclinical anti-epileptic drug development: the effect of levetiracetam.
Topics: Animals; Anticonvulsants; Convulsants; Electric Stimulation; Electrodes, Implanted; Electroencephalography; Hippocampus; Kindling, Neurologic; Levetiracetam; Male; Pentylenetetrazole; Piracetam; Rats; Rats, Wistar; Seizures | 2005 |
Idiopathic generalized epilepsies: a review and modern approach.
Topics: Anticonvulsants; Brain; Child; Diagnosis, Differential; Electroencephalography; Epilepsy, Generalized; Female; Humans; Levetiracetam; Magnetic Resonance Imaging; Piracetam | 2005 |
Levetiracetam in the treatment of idiopathic generalized epilepsies.
Topics: Adult; Animals; Anticonvulsants; Child; Disease Models, Animal; Epilepsy, Generalized; Female; Humans; Levetiracetam; Piracetam; Treatment Outcome | 2005 |
Treatment of chorea with levetiracetam.
Topics: Acute Disease; Adult; Anticonvulsants; Chorea; Diabetes Mellitus, Type 1; Female; Humans; Levetiracetam; Piracetam | 2006 |
The long term retention of levetiracetam in a large cohort of patients with epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Cohort Studies; Dose-Response Relationship, Drug; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Time Factors | 2006 |
Cortical laminar necrosis related to prolonged focal status epilepticus.
Topics: Adult; Anticonvulsants; Aphasia, Wernicke; Brain Diseases; Cerebral Cortex; Functional Laterality; Hemianopsia; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Paresis; Phenytoin; Piracetam; Status Epilepticus; Tomography, Emission-Computed, Single-Photon | 2006 |
Levetiracetam in a neonate with malignant migrating partial seizures.
Topics: Anticonvulsants; Electroencephalography; Epilepsies, Partial; Humans; Infant, Newborn; Levetiracetam; Male; Piracetam | 2006 |
Hyponatremia from oxcarbazepine and carbamazepine.
Topics: Adult; Age Factors; Aging; Anticonvulsants; Carbamazepine; Databases, Factual; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Hyponatremia; Levetiracetam; Male; Middle Aged; Oxcarbazepine; Piracetam; Prevalence; Sex Factors; Sodium | 2005 |
Antimyoclonic effect of levetiracetam in MERRF syndrome.
Topics: Activities of Daily Living; Anticonvulsants; Atrophy; Brain; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Humans; Levetiracetam; MERRF Syndrome; Middle Aged; Mitochondria; Muscle, Skeletal; Mutation; Myoclonus; Phenylalanine; Piracetam; Quality of Life; RNA, Transfer; Treatment Outcome; Ubiquinone; Valproic Acid | 2006 |
Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis.
Topics: Animals; Anticonvulsants; Behavior, Animal; Brain; Carbamazepine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Electroshock; Epilepsy; Humans; Levetiracetam; Male; Memory; Mice; Motor Activity; Oxcarbazepine; Piracetam; Seizures | 2006 |
Post-anoxic myoclonus: a case presentation and review of management in the rehabilitation setting.
Topics: Anticonvulsants; Clonazepam; Diazepam; Female; Heart Arrest; Humans; Hypoxia, Brain; Isoxazoles; Levetiracetam; Middle Aged; Myoclonus; Phenobarbital; Piracetam; Valproic Acid; Zonisamide | 2006 |
The use of levetiracetam in refractory status epilepticus.
Topics: Adolescent; Adult; Aged, 80 and over; Anticonvulsants; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Status Epilepticus | 2006 |
Nonconvulsive status epilepticus due to ifosfamide.
Topics: Anticonvulsants; Antineoplastic Agents, Alkylating; Diazepam; Female; Humans; Ifosfamide; Levetiracetam; Middle Aged; Neoplasms; Piracetam; Status Epilepticus | 2006 |
The impact of levetiracetam on challenging behavior.
Topics: Adult; Anticonvulsants; Behavior; Epilepsy; Female; Humans; Intellectual Disability; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Surveys and Questionnaires | 2006 |
Re: Drug-induced psychosis with levetiracetam.
Topics: Acute Disease; Anticonvulsants; Humans; Levetiracetam; Piracetam; Psychoses, Substance-Induced; Seizures | 2005 |
Determinants of success in the use of oral levetiracetam in status epilepticus.
Topics: Administration, Oral; Anticonvulsants; Dose-Response Relationship, Drug; Female; Humans; Intubation, Gastrointestinal; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Retrospective Studies; Status Epilepticus; Treatment Outcome | 2006 |
Effects of intermittent levetiracetam dosing in a patient with refractory daily seizures.
Topics: Adult; Anticonvulsants; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levetiracetam; Piracetam; Seizures | 2006 |
Levetiracetam suppresses long-loop reflexes at the cortical level.
Topics: Coma; Evoked Potentials, Somatosensory; H-Reflex; Humans; Hypoxia, Brain; Levetiracetam; Male; Middle Aged; Nootropic Agents; Piracetam; Reflex, Startle; Somatosensory Cortex | 2006 |
Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus.
Topics: Aconitate Hydratase; Animals; Anticonvulsants; Chromatography, High Pressure Liquid; Citrate (si)-Synthase; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Electroencephalography; Epilepsy; Glutathione; Hippocampus; Levetiracetam; Male; Mitochondria; Mitochondrial Diseases; Neurons; Neuroprotective Agents; Perforant Pathway; Piracetam; Rats; Rats, Sprague-Dawley; Status Epilepticus | 2006 |
Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Brain Neoplasms; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Seizures | 2006 |
Levetiracetam can be effective in the treatment of restless legs syndrome with periodic limb movements in sleep: report of two cases.
Topics: Adult; Anticonvulsants; Drug Administration Schedule; Female; Humans; Levetiracetam; Male; Middle Aged; Nocturnal Myoclonus Syndrome; Piracetam; Restless Legs Syndrome; Treatment Outcome | 2006 |
Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trial.
Topics: Adolescent; Adult; Anorexia; Anticonvulsants; Behavioral Symptoms; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gait Disorders, Neurologic; Humans; Infant; Levetiracetam; Male; Piracetam; Retrospective Studies; Seizures; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Tuberous Sclerosis | 2006 |
Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein.
Topics: Animals; Azides; Binding Sites; Binding, Competitive; Brain; Cerebellum; Cerebral Cortex; CHO Cells; Cricetinae; Cricetulus; Female; Gene Expression; Hippocampus; Humans; Kinetics; Levetiracetam; Male; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam; Pyrrolidines; Recombinant Proteins; Tritium | 2006 |
Effect of levetiracetam on truncal tic in neuroacanthocytosis.
Topics: Adult; Chorea; Electromyography; Female; gamma-Aminobutyric Acid; Humans; Levetiracetam; Magnetic Resonance Imaging; Piracetam; Tic Disorders | 2006 |
Language-induced epilepsy, acquired stuttering, and idiopathic generalized epilepsy: phenotypic study of one family.
Topics: Adolescent; Age of Onset; Anticonvulsants; Comorbidity; Electroencephalography; Electromyography; Epilepsy, Generalized; Epilepsy, Reflex; Family; Female; France; Genetic Heterogeneity; Humans; Language Disorders; Levetiracetam; Male; Pedigree; Phenotype; Piracetam; Polysomnography; Stuttering; Treatment Outcome; Videotape Recording | 2006 |
Levetiracetam for cerebellar tremor in multiple sclerosis: an open-label pilot tolerability and efficacy study.
Topics: Activities of Daily Living; Adult; Anticonvulsants; Cerebellar Neoplasms; Disability Evaluation; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Multiple Sclerosis; Pilot Projects; Piracetam; Severity of Illness Index; Statistics, Nonparametric | 2006 |
Predicting drug-resistant patients who respond to add-on therapy with levetiracetam.
Topics: Anticonvulsants; Drug Resistance; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy, Generalized; Female; Humans; Levetiracetam; Male; Piracetam; Remission Induction | 2006 |
Levetiracetam in Meige's syndrome.
Topics: Anticonvulsants; Botulinum Toxins, Type A; Brain; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Electromyography; Facial Muscles; Female; Humans; Ion Channels; Levetiracetam; Meige Syndrome; Middle Aged; Molecular Chaperones; Piracetam; Treatment Outcome | 2006 |
[Experience with levetiracetam in childhood epilepsy].
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Child; Child, Preschool; Epilepsy; Female; Humans; Infant; Intellectual Disability; Levetiracetam; Male; Piracetam; Retrospective Studies; Treatment Outcome | 2006 |
The role of hippocampal sclerosis in antiepileptic drug-related depression in patients with epilepsy: a study on levetiracetam.
Topics: Adult; Anticonvulsants; Cognition Disorders; Depression; Epilepsy, Temporal Lobe; Female; Hippocampus; Humans; Levetiracetam; Male; Piracetam; Sclerosis | 2006 |
Levetiracetam pharmacokinetics in neonates at birth.
Topics: Amniotic Fluid; Anticonvulsants; Epilepsy, Complex Partial; Female; Fetal Blood; Half-Life; Humans; Infant, Newborn; Levetiracetam; Maternal-Fetal Exchange; Piracetam; Pregnancy; Pregnancy Complications; Twins | 2006 |
Levetiracetam reduces frequency and duration of epileptic activity in patients with refractory primary generalized epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Drug Therapy, Combination; Electroencephalography; Epilepsy, Generalized; Female; Humans; Levetiracetam; Male; Piracetam; Retrospective Studies; Seizures | 2006 |
Neocortical hyperexcitability in a genetic model of absence seizures and its reduction by levetiracetam.
Topics: 4-Aminopyridine; Age Factors; Animals; Anticonvulsants; Disease Models, Animal; Electric Stimulation; Electrodes, Implanted; Epilepsy, Absence; Image Enhancement; In Vitro Techniques; Levetiracetam; Models, Genetic; Neocortex; Oscillometry; Piracetam; Rats; Rats, Inbred Strains; Rats, Wistar; Signal Processing, Computer-Assisted; Somatosensory Cortex; Videotape Recording | 2006 |
Levetiracetam-induced depression in a healthy adult.
Topics: Adult; Anticonvulsants; Clinical Protocols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Levetiracetam; Piracetam; Research Subjects | 2006 |
Determination of levetiracetam in human plasma/serum/saliva by liquid chromatography-electrospray tandem mass spectrometry.
Topics: Anticonvulsants; Chromatography, High Pressure Liquid; Humans; Levetiracetam; Piracetam; Reproducibility of Results; Saliva; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2007 |
[The results of the two-year experience of using keppra in therapy of adult patients with epilepsy].
Topics: Adult; Anticonvulsants; Electroencephalography; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prognosis; Time Factors | 2006 |
In vivo characterisation of the small-conductance KCa (SK) channel activator 1-ethyl-2-benzimidazolinone (1-EBIO) as a potential anticonvulsant.
Topics: Animals; Anticonvulsants; Benzimidazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Levetiracetam; Male; Mice; Motor Activity; Pentylenetetrazole; Phenytoin; Pilocarpine; Piracetam; Seizures; Sensory Thresholds; Small-Conductance Calcium-Activated Potassium Channels | 2006 |
Long-term levetiracetam treatment of epilepsy patients: clinical audit.
Topics: Anticonvulsants; Chi-Square Distribution; Drug Therapy, Combination; Epilepsy; Humans; Kaplan-Meier Estimate; Levetiracetam; Piracetam; Retrospective Studies; Statistics, Nonparametric | 2006 |
Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.
Topics: Anticonvulsants; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Huntington Disease; Levetiracetam; Male; Middle Aged; Pilot Projects; Piracetam; Severity of Illness Index | 2006 |
Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: a comparative short-term study.
Topics: Adult; Anticonvulsants; Anxiety; Depression; Epilepsies, Partial; Female; gamma-Aminobutyric Acid; Humans; Levetiracetam; Male; Memory; Middle Aged; Neuropsychological Tests; Piracetam; Pregabalin | 2006 |
Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage.
Topics: Animals; Disease Models, Animal; Drug Administration Schedule; Head Injuries, Closed; Injections, Intravenous; Levetiracetam; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Piracetam; Random Allocation; Subarachnoid Hemorrhage; Time Factors; Vasospasm, Intracranial | 2006 |
Comparison of reproductive effects of levetiracetam and valproate studied in prepubertal porcine ovarian follicular cells.
Topics: Animals; Anticonvulsants; Dose-Response Relationship, Drug; Estradiol; Estrus; Female; Levetiracetam; Ovarian Follicle; Ovary; Piracetam; Swine; Testosterone; Theca Cells; Valproic Acid | 2006 |
Levetiracetam-induced myoclonic status epilepticus in myoclonic-astatic epilepsy: a case report.
Topics: Anticonvulsants; Behavior; Child, Preschool; Electroencephalography; Electromyography; Epilepsies, Myoclonic; Ethosuximide; Humans; Levetiracetam; Male; Piracetam; Status Epilepticus | 2006 |
Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.
Topics: Adolescent; Adolescent Behavior; Anticonvulsants; Autistic Disorder; Child; Child Behavior; Child, Preschool; Double-Blind Method; Female; Humans; Levetiracetam; Male; Piracetam; Placebos; Psychiatric Status Rating Scales; Treatment Outcome | 2006 |
Effect of levetiracetam on visual-spatial memory following status epilepticus.
Topics: Animals; Anticonvulsants; Behavior, Animal; Cell Death; Disease Models, Animal; Electroencephalography; Hippocampus; Levetiracetam; Male; Maze Learning; Memory Disorders; Pilocarpine; Piracetam; Random Allocation; Rats; Rats, Sprague-Dawley; Status Epilepticus; Swimming; Water | 2007 |
Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.
Topics: Analysis of Variance; Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Biological Transport; Carbamazepine; Cell Line; Cyclosporine; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Gene Expression; Humans; Levetiracetam; Mice; Phenytoin; Piracetam; Transfection | 2007 |
The actions of lamotrigine and levetiracetam on the conduction properties of isolated rat sciatic nerve.
Topics: 4-Aminopyridine; Action Potentials; Animals; Anticonvulsants; Dose-Response Relationship, Drug; Electrophysiology; Female; In Vitro Techniques; Lamotrigine; Levetiracetam; Neural Conduction; Patch-Clamp Techniques; Piracetam; Potassium Channel Blockers; Rats; Rats, Wistar; Sciatic Nerve; Triazines | 2006 |
The use of levetiracetam to decrease mania in elderly bipolar patients.
Topics: Aged; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levetiracetam; Male; Middle Aged; Pilot Projects; Piracetam; Psychiatric Status Rating Scales; Treatment Outcome | 2006 |
Administration of levetiracetam after prolonged status epilepticus does not protect from mitochondrial dysfunction in a rodent model.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Electric Stimulation; Electroencephalography; Levetiracetam; Mitochondria; Neuroprotective Agents; Piracetam; Rats; Rats, Sprague-Dawley; Status Epilepticus; Time Factors | 2007 |
The Effect of Antiepileptic Drugs on Cognition: Patient Perceived Cognitive Problems of Topiramate versus Levetiracetam in Clinical Practice.
Topics: Adult; Anticonvulsants; Attitude to Health; Child; Cognition Disorders; Drug Utilization; Epilepsy; Female; Follow-Up Studies; Fructose; Humans; Levetiracetam; Male; Patient Dropouts; Piracetam; Topiramate | 2006 |
In situ metabolism of levetiracetam in blood of patients with epilepsy.
Topics: Adult; Aged; Anticonvulsants; Blood Specimen Collection; Chromatography, High Pressure Liquid; Drug Monitoring; Enzyme Inhibitors; Epilepsy; Esterases; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Time Factors | 2006 |
Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register.
Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Body Weight; Epilepsy; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Levetiracetam; Piracetam; Pregnancy; Prenatal Exposure Delayed Effects; Prospective Studies; Registries; United Kingdom | 2006 |
Zonisamide or levetiracetam for adults with cyclic vomiting syndrome: a case series.
Topics: Adult; Aged; Anticonvulsants; Antidepressive Agents, Tricyclic; Female; Humans; Interviews as Topic; Isoxazoles; Levetiracetam; Male; Middle Aged; Periodicity; Piracetam; Remission Induction; Retrospective Studies; Syndrome; Treatment Outcome; Vomiting; Zonisamide | 2007 |
Levetiracetam as a treatment option in non-convulsive status epilepticus.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Electroencephalography; Epilepsies, Partial; Female; Follow-Up Studies; Humans; Levetiracetam; Middle Aged; Piracetam; Retrospective Studies; Status Epilepticus | 2007 |
Levetiracetam in idiopathic generalised epilepsy and porphyria cutanea tarda.
Topics: Administration, Oral; Anticonvulsants; Clonazepam; Drug Therapy, Combination; Epilepsy, Tonic-Clonic; Humans; Lamotrigine; Levetiracetam; Male; Middle Aged; Nootropic Agents; Piracetam; Porphyria Cutanea Tarda; Time Factors; Treatment Outcome; Triazines | 2006 |
Levetiracetam reduces anesthetic-induced hyperalgesia in rats.
Topics: Anesthesia; Animals; Anticonvulsants; Hyperalgesia; Levetiracetam; Male; Models, Animal; Pain Threshold; Piracetam; Rats; Rats, Sprague-Dawley | 2007 |
Use of levetiracetam in hospitalized patients.
Topics: Adult; Aged; Anticonvulsants; Comorbidity; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Female; Hospitalization; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Secondary Prevention; Seizures; Status Epilepticus; Treatment Outcome | 2006 |
Levetiracetam monotherapy for children and adolescents with benign rolandic seizures.
Topics: Adolescent; Anticonvulsants; Child; Electroencephalography; Epilepsy, Rolandic; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Piracetam; Prospective Studies; Treatment Outcome | 2007 |
Effects of levetiracetam in lipid peroxidation level, nitrite-nitrate formation and antioxidant enzymatic activity in mice brain after pilocarpine-induced seizures.
Topics: Animals; Anticonvulsants; Antioxidants; Brain; Catalase; Glutathione; Levetiracetam; Lipid Peroxidation; Male; Malondialdehyde; Mice; Nitrates; Nitrites; Pilocarpine; Piracetam; Seizures; Thiobarbituric Acid Reactive Substances | 2007 |
Clinical development of levetiracetam for amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Anticonvulsants; Clinical Trials as Topic; Humans; Levetiracetam; Muscle Cramp; Muscle Spasticity; Neuroprotective Agents; Piracetam | 2006 |
Orofacial dystonia related to Sjogren's syndrome.
Topics: Adrenal Cortex Hormones; Brain; Clonazepam; Dystonia; Dystonic Disorders; Face; Female; Humans; Levetiracetam; Magnetic Resonance Imaging; Middle Aged; Piracetam; Remission Induction; Sjogren's Syndrome; Treatment Outcome | 2007 |
Levetiracetam in three cases of progressive myoclonus epilepsy.
Topics: Activities of Daily Living; Adult; Anticonvulsants; Drug Therapy, Combination; Female; Humans; Levetiracetam; Male; Piracetam; Quality of Life; Severity of Illness Index; Treatment Outcome; Unverricht-Lundborg Syndrome | 2007 |
Retention rate of levetiracetam in children with intractable epilepsy at 1 year.
Topics: Adolescent; Adolescent Behavior; Anticonvulsants; Child; Child Behavior; Child, Preschool; Drug Therapy, Combination; Epilepsy; Female; Humans; Infant; Levetiracetam; Male; Outcome Assessment, Health Care; Patient Compliance; Patient Dropouts; Piracetam; Retrospective Studies | 2007 |
Anticonvulsants in sports: ethical considerations.
Topics: Anticonvulsants; Doping in Sports; Humans; Lamotrigine; Levetiracetam; Nipecotic Acids; Piracetam; Tiagabine; Triazines | 2007 |
Translocation-positive acute myeloid leukemia associated with valproic acid therapy.
Topics: Acute Disease; Anticonvulsants; Cell Differentiation; Cell Division; Child, Preschool; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 8; Clone Cells; Cocarcinogenesis; Drug Therapy, Combination; Epilepsy, Absence; Female; Humans; Isoxazoles; Lamotrigine; Leukemia, Myeloid; Levetiracetam; Neoplastic Stem Cells; Oncogene Proteins, Fusion; Phenobarbital; Piracetam; Translocation, Genetic; Triazines; Valproic Acid; Zonisamide | 2008 |
MERRF syndrome without ragged-red fibers: the need for molecular diagnosis.
Topics: Adolescent; Adult; Child; Humans; Levetiracetam; Male; MERRF Syndrome; Muscle Fibers, Fast-Twitch; Piracetam | 2007 |
Modulation of AMPA receptors in cultured cortical neurons induced by the antiepileptic drug levetiracetam.
Topics: Action Potentials; Animals; Anticonvulsants; Cells, Cultured; Cerebral Cortex; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Kainic Acid; Levetiracetam; Mice; Neurons; Patch-Clamp Techniques; Piracetam; Receptors, AMPA; Receptors, Kainic Acid | 2007 |
Levetiracetam and felbamate interact both pharmacodynamically and pharmacokinetically: an isobolographic analysis in the mouse maximal electroshock model.
Topics: Animals; Anticonvulsants; Behavior, Animal; Brain; Chromatography, High Pressure Liquid; Disease Models, Animal; Drug Synergism; Electroshock; Epilepsy; Felbamate; Humans; Levetiracetam; Male; Mice; Motor Activity; Phenylcarbamates; Piracetam; Propylene Glycols; Seizures | 2007 |
Enantiomeric impurity determination of levetiracetam using capillary electrochromatography.
Topics: Calibration; Chromatography, Micellar Electrokinetic Capillary; Levetiracetam; Piracetam; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism | 2006 |
Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Epilepsy; Female; Follow-Up Studies; Humans; Infant; Levetiracetam; Male; Mental Disorders; Middle Aged; Piracetam; Referral and Consultation; Seizures; Survival Analysis | 2007 |
Psychic disturbances associated with sodium valproate plus levetiracetam.
Topics: Anticonvulsants; Anxiety; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetiracetam; Middle Aged; Piracetam; Psychomotor Agitation; Sleep Initiation and Maintenance Disorders; Valproic Acid | 2007 |
Tuberous sclerosis successfully treated with levetiracetam monotherapy: 18 months of follow-up.
Topics: Anticonvulsants; Child; Follow-Up Studies; Humans; Levetiracetam; Male; Piracetam; Seizures; Tuberous Sclerosis | 2007 |
Termination of complex partial status epilepticus by intravenous levetiracetam.
Topics: Adult; Anticonvulsants; Electroencephalography; Female; Humans; Infusions, Intravenous; Levetiracetam; Phenytoin; Piracetam; Status Epilepticus | 2009 |
Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy.
Topics: Anticonvulsants; Child, Preschool; Epilepsy; Female; Humans; Infant; Infant, Newborn; Levetiracetam; Male; Piracetam; Retrospective Studies | 2007 |
Dramatic response to levetiracetam in post-ischaemic Holmes' tremor.
Topics: Brain Ischemia; Cerebral Hemorrhage; Humans; Infarction; Levetiracetam; Male; Middle Aged; Nootropic Agents; Piracetam; Treatment Outcome; Tremor | 2007 |
Levetiracetam prophylaxis in pediatric migraine--an open-label study.
Topics: Adolescent; Anticonvulsants; Child; Female; Humans; Levetiracetam; Male; Migraine Disorders; Piracetam; Prospective Studies; Treatment Outcome | 2007 |
Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation.
Topics: Anticonvulsants; Breast Feeding; Delivery, Obstetric; Epilepsy; Female; Fetal Blood; Half-Life; Humans; Infant, Newborn; Lactation; Levetiracetam; Maternal-Fetal Exchange; Milk, Human; Piracetam; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Prospective Studies; Puerperal Disorders | 2007 |
The effect of levetiracetam in startle disease.
Topics: Acoustic Stimulation; Anticonvulsants; Brain Stem; Dose-Response Relationship, Drug; Epilepsy; Female; Humans; Levetiracetam; Middle Aged; Muscle, Skeletal; Neural Pathways; Noise; Piracetam; Reflex, Abnormal; Reflex, Startle; Treatment Outcome | 2007 |
Effect of levetiracetam on molecular regulation of hippocampal glutamate and GABA transporters in rats with chronic seizures induced by amygdalar FeCl3 injection.
Topics: Amino Acid Transport System X-AG; Amygdala; Analysis of Variance; Animals; Anticonvulsants; Dose-Response Relationship, Drug; Ferric Compounds; GABA Plasma Membrane Transport Proteins; Gene Expression Regulation; Hippocampus; Levetiracetam; Male; Microdialysis; Piracetam; Rats; Rats, Wistar; Seizures | 2007 |
The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate.
Topics: Adult; Anticonvulsants; Case-Control Studies; Cognition; Electroencephalography; Epilepsy; Female; Fructose; Humans; Intelligence; Levetiracetam; Male; Memory, Short-Term; Middle Aged; Multivariate Analysis; Neuropsychological Tests; Piracetam; Topiramate; Visual Perception | 2007 |
Adjuvant levetiracetam in adolescent mania.
Topics: Acute Disease; Adolescent; Anticonvulsants; Bipolar Disorder; Dose-Response Relationship, Drug; Female; Humans; Levetiracetam; Piracetam; Psychiatric Status Rating Scales; Remission Induction; Treatment Outcome | 2007 |
Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
Topics: Age Factors; Anticonvulsants; Child Behavior; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy; Female; Follow-Up Studies; Humans; Infant; Irritable Mood; Levetiracetam; Male; Patient Dropouts; Piracetam; Proportional Hazards Models; Retrospective Studies; Sleep Wake Disorders; Survival Analysis; Treatment Outcome | 2007 |
Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors.
Topics: Adult; Aged; Anticonvulsants; Brain Neoplasms; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Seizures | 2007 |
[Clinical experience with levetiracetam for adults with epilepsy].
Topics: Adult; Aged; Anticonvulsants; Drug Resistance; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Recurrence; Retrospective Studies; Syndrome; Treatment Outcome | 2007 |
Levetiracetam monotherapy in children with epilepsy.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Epilepsies, Partial; Epilepsy, Generalized; Female; Humans; Levetiracetam; Male; Piracetam; Retrospective Studies; Treatment Outcome | 2007 |
Pharmacokinetics of levetiracetam in infants and young children with epilepsy.
Topics: Administration, Oral; Age Factors; Anticonvulsants; Child, Preschool; Dose-Response Relationship, Drug; Epilepsy; Female; Half-Life; Humans; Infant; Levetiracetam; Male; Piracetam | 2007 |
Juvenile myoclonic epilepsy: a benign disorder? Personality traits and psychiatric symptoms.
Topics: Adolescent; Adult; Anticonvulsants; Child; Ethosuximide; Female; Fructose; Humans; Lamotrigine; Levetiracetam; Male; Mental Disorders; Myoclonic Epilepsy, Juvenile; Personality; Personality Tests; Piracetam; Psychiatric Status Rating Scales; Surveys and Questionnaires; Topiramate; Triazines; Valproic Acid | 2007 |
The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs.
Topics: Animals; Anticonvulsants; Bromides; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsy; Female; Levetiracetam; Male; Phenobarbital; Piracetam; Retrospective Studies; Treatment Outcome | 2008 |
Role of intravenous levetiracetam in status migrainosus.
Topics: Adult; Anticonvulsants; Female; Humans; Infusions, Intravenous; Levetiracetam; Migraine Disorders; Piracetam | 2007 |
Prolonged exposure to levetiracetam reveals a presynaptic effect on neurotransmission.
Topics: Animals; Anticonvulsants; Dose-Response Relationship, Drug; Electric Stimulation; Evoked Potentials; Excitatory Postsynaptic Potentials; Hippocampus; Levetiracetam; Male; Models, Animal; Piracetam; Presynaptic Terminals; Pyridinium Compounds; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; Receptors, Presynaptic; Synaptic Transmission | 2007 |
The antiepileptic drug levetiracetam stabilizes the human epileptic GABAA receptors upon repetitive activation.
Topics: Adult; Aged; Animals; Anticonvulsants; Brain Tissue Transplantation; Cell Membrane; Child; Epilepsy, Temporal Lobe; Female; gamma-Aminobutyric Acid; Hippocampus; Humans; Levetiracetam; Male; Microelectrodes; Neocortex; Neural Inhibition; Patch-Clamp Techniques; Piracetam; Pyramidal Cells; Receptors, GABA-A; Synaptic Transmission; Xenopus | 2007 |
Status gelasticus associated with levetiracetam as add-on treatment.
Topics: Anticonvulsants; Brain; Child, Preschool; Electroencephalography; Epilepsies, Partial; Female; Humans; Laughter; Levetiracetam; Magnetic Resonance Imaging; Piracetam; Seizures; Stereotyped Behavior | 2007 |
Levetiracetam for the treatment of epilepsy among adults with intellectual disabilities.
Topics: Adolescent; Adult; Anticonvulsants; Epilepsy; Female; Humans; Intellectual Disability; Levetiracetam; Male; Piracetam | 2007 |
Suicidal ideation in epilepsy and levetiracetam therapy.
Topics: Adult; Affective Symptoms; Anticonvulsants; Epilepsy; Female; Humans; Levetiracetam; Male; Mood Disorders; Piracetam; Retrospective Studies; Self-Injurious Behavior; Suicide, Attempted | 2007 |
Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice.
Topics: Acoustic Stimulation; Animals; Anticonvulsants; Ataxia; Behavior, Animal; Body Temperature; Brain; Dose-Response Relationship, Drug; Drug Interactions; Epilepsy, Reflex; Levetiracetam; Mice; Mice, Inbred DBA; Motor Activity; Piloerection; Piracetam; Postural Balance; Posture | 2007 |
Effect of age and comedication on levetiracetam pharmacokinetics and tolerability.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ambulatory Care; Anticonvulsants; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Induction; Epilepsy; Female; Humans; Levetiracetam; Male; Metabolic Clearance Rate; Middle Aged; Piracetam; Retrospective Studies | 2007 |
Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats.
Topics: Amygdala; Analysis of Variance; Animals; Anticonvulsants; Behavior, Animal; Brain Damage, Chronic; Diazepam; Disease Models, Animal; Drug Administration Schedule; Electric Stimulation; Exploratory Behavior; Female; Hippocampus; Hyperkinesis; Levetiracetam; Maze Learning; Piracetam; Rats; Rats, Sprague-Dawley; Status Epilepticus; Swimming; Time Factors | 2007 |
Levetiracetam use in critically ill patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Brain Diseases; Brain Neoplasms; Cerebral Hemorrhage; Comorbidity; Critical Illness; Epilepsy; Humans; Intensive Care Units; Length of Stay; Levetiracetam; Middle Aged; Piracetam; Retrospective Studies; Stroke; Treatment Outcome | 2007 |
Levetiracetam for the treatment of neonatal seizures.
Topics: Anticonvulsants; Electroencephalography; Female; Humans; Infant; Infant, Newborn; Levetiracetam; Male; Piracetam; Seizures | 2007 |
Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
Topics: Adolescent; Adult; Age of Onset; Aged; Anticonvulsants; Child; Child, Preschool; Cognition; Epilepsy; Female; Fructose; Humans; Infant; Levetiracetam; Long-Term Care; Magnetic Resonance Imaging; Male; Middle Aged; Piracetam; Tomography, X-Ray Computed; Topiramate | 2008 |
No kinetic interaction between levetiracetam and cyclosporine: a case report.
Topics: Adolescent; Anticonvulsants; Cardiomyopathy, Dilated; Cyclosporine; Enzyme Inhibitors; Epilepsy; Female; Heart Transplantation; Humans; Levetiracetam; Piracetam | 2007 |
Levetiracetam attenuates spontaneous spike-and-wave discharges in DBA/2J mice.
Topics: Animals; Anticonvulsants; Electroencephalography; Epilepsy, Absence; Ethosuximide; Injections, Intraperitoneal; Levetiracetam; Male; Mice; Mice, Inbred DBA; Piracetam; Valproic Acid | 2007 |
Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism.
Topics: Animals; Anticonvulsants; Biomarkers; Biomechanical Phenomena; Bone and Bones; Bone Density; Compressive Strength; Dose-Response Relationship, Drug; Female; Femur Neck; Levetiracetam; Models, Animal; Osteogenesis; Phenytoin; Piracetam; Rats; Rats, Wistar; Valproic Acid | 2007 |
Antiepileptic drug-induced neuronal cell death in the immature brain: effects of carbamazepine, topiramate, and levetiracetam as monotherapy versus polytherapy.
Topics: Animals; Animals, Newborn; Anticonvulsants; Brain; Carbamazepine; Cell Death; Drug Synergism; Drug Therapy, Combination; Female; Fructose; In Situ Nick-End Labeling; Levetiracetam; Male; Neurons; Piracetam; Rats; Rats, Sprague-Dawley; Topiramate | 2007 |
Current treatment of myoclonic astatic epilepsy: clinical experience at the Children's Hospital of Philadelphia.
Topics: Age of Onset; Anticonvulsants; Child; Cognition Disorders; Dietary Fats; Electroencephalography; Epilepsies, Myoclonic; Ethosuximide; Female; Hospitals, Pediatric; Humans; Ketones; Ketosis; Lamotrigine; Levetiracetam; Male; Pennsylvania; Piracetam; Retrospective Studies; Survival Analysis; Syndrome; Triazines | 2007 |
IV levetiracetam in the management of non-convulsive status epilepticus.
Topics: Aged, 80 and over; Anticonvulsants; Electroencephalography; Humans; Infusions, Intravenous; Levetiracetam; Male; Piracetam; Status Epilepticus | 2007 |
[Probable levetiracetam-induced psychosis].
Topics: Anticonvulsants; Dose-Response Relationship, Drug; Epilepsy; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Psychoses, Substance-Induced | 2007 |
Levetiracetam as adjunctive therapy for refractory anxiety disorders.
Topics: Adult; Aged; Anticonvulsants; Anxiety Disorders; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Treatment Outcome | 2007 |
Levetiracetam-induced diffuse interstitial lung disease.
Topics: Anticonvulsants; Child; Epilepsy; Female; Humans; Levetiracetam; Lung Diseases, Interstitial; Piracetam | 2007 |
Levetiracetam in nonconvulsive status epilepticus in childhood: a case report.
Topics: Anticonvulsants; Child; Electroencephalography; Humans; Levetiracetam; Male; Piracetam; Status Epilepticus | 2007 |
Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsies, Myoclonic; Heart Arrest; Hypoxia; Levetiracetam; Piracetam; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Seizures | 2007 |
Levetiracetam monotherapy in juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Child; Data Interpretation, Statistical; Electroencephalography; Female; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Myoclonic Epilepsy, Juvenile; Piracetam; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Accidental overdosage of levetiracetam in two children caused no side effects.
Topics: Anticonvulsants; Child, Preschool; Drug Overdose; Female; Humans; Levetiracetam; Piracetam; Seizures | 2007 |
Coexistence of epileptic nocturnal wanderings and an arachnoid cyst.
Topics: Adolescent; Anticonvulsants; Arachnoid Cysts; Electroencephalography; Epilepsy, Frontal Lobe; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Piracetam; Polysomnography; Somnambulism; Temporal Lobe; Tomography, Emission-Computed, Single-Photon; Valproic Acid | 2007 |
Are psychiatric adverse events of antiepileptic drugs a unique entity? A study on topiramate and levetiracetam.
Topics: Adult; Anticonvulsants; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Epilepsy; Female; Fructose; Humans; Levetiracetam; Male; Mental Disorders; Netherlands; Piracetam; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Registries; Retrospective Studies; Seizures, Febrile; Topiramate | 2007 |
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.
Topics: Anticonvulsants; Bias; Carbamazepine; Clinical Trials as Topic; Conflict of Interest; Disclosure; Drug Industry; Epilepsy; Humans; Levetiracetam; Neurology; Neuropharmacology; Piracetam; Reproducibility of Results; Treatment Outcome | 2007 |
Comparison of motor activity and sleep in patients with complex partial seizures on levetiracetam treatment and a group of healthy subjects.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Disorders of Excessive Somnolence; Electroencephalography; Epilepsy, Complex Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Motor Activity; Piracetam; Prospective Studies; Severity of Illness Index; Sleep; Sleep Stages; Surveys and Questionnaires; Wakefulness | 2007 |
Dramatic weight loss with levetiracetam.
Topics: Adult; Age of Onset; Anticonvulsants; Body Mass Index; Epilepsy; Feeding Behavior; Female; Humans; Levetiracetam; Male; Middle Aged; Obesity; Overweight; Piracetam; Risk Factors; Sex Factors; Weight Loss | 2008 |
Modeling and simulation of intravenous levetiracetam pharmacokinetic profiles in children to evaluate dose adaptation rules.
Topics: Adolescent; Anticonvulsants; Area Under Curve; Child; Child, Preschool; Computer Simulation; Dose-Response Relationship, Drug; Drug Dosage Calculations; Humans; Injections, Intravenous; Levetiracetam; Piracetam | 2007 |
Levetiracetam in the treatment of antipsychotics-resistant Tourette syndrome.
Topics: Adrenergic alpha-Agonists; Adult; Anti-Dyskinesia Agents; Anticonvulsants; Antipsychotic Agents; Clonidine; Drug Resistance; Female; Haloperidol; Humans; Levetiracetam; Pimozide; Piracetam; Tourette Syndrome; Treatment Outcome | 2008 |
Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Female; Humans; Levetiracetam; Male; Piracetam; Prospective Studies; Seizures | 2007 |
Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticonvulsants; Benzodiazepines; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Electroencephalography; Epilepsy, Complex Partial; Female; Humans; Infusions, Intravenous; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Status Epilepticus | 2008 |
Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epil
Topics: Adolescent; Adult; Aged; Anticonvulsants; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Resistance; Epilepsy; Female; Humans; Levetiracetam; Male; Medical Records; Middle Aged; Piracetam; Predictive Value of Tests; Retrospective Studies; ROC Curve; Severity of Illness Index; Spectrophotometry, Ultraviolet | 2007 |
Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain.
Topics: Animals; Animals, Newborn; Anticonvulsants; Apoptosis; Basal Ganglia; Behavior, Animal; Body Weight; Brain; Dizocilpine Maleate; Electroshock; Levetiracetam; Piracetam; Rats; Rats, Sprague-Dawley; Seizures; Thalamus | 2007 |
Seizure-freedom with combination therapy in localization-related epilepsy.
Topics: Adult; Anticonvulsants; Brain; Carbamazepine; Drug Therapy, Combination; Female; Frontal Lobe; Fructose; Humans; Lamotrigine; Levetiracetam; Male; Nipecotic Acids; Occipital Lobe; Oxcarbazepine; Parietal Lobe; Piracetam; Seizures; Temporal Lobe; Tiagabine; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2008 |
[DRESS syndrome after carbamazepine].
Topics: Anticonvulsants; Carbamazepine; Child; Drug Eruptions; Eosinophilia; Epilepsy, Complex Partial; Female; Humans; Levetiracetam; Piracetam; Syndrome; Time Factors | 2007 |
[Effect of levetiracetam on the sodium currents of rat hippocampal neurons exposed to coriaria lactone].
Topics: Action Potentials; Animals; Anticonvulsants; Cells, Cultured; Hippocampus; Lactones; Levetiracetam; Neurons; Patch-Clamp Techniques; Piracetam; Rats; Rats, Sprague-Dawley; Sodium Channels | 2007 |
Drug monitoring: simultaneous analysis of lamotrigine, oxcarbazepine, 10-hydroxycarbazepine, and zonisamide by HPLC-UV and a rapid GC method using a nitrogen-phosphorus detector for levetiracetam.
Topics: Anticonvulsants; Carbamazepine; Chromatography, Gas; Chromatography, High Pressure Liquid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Nitrogen; Oxcarbazepine; Phosphorus; Piracetam; Reproducibility of Results; Triazines; Ultraviolet Rays; Zonisamide | 2007 |
Treatment of tardive dyskinesia with levetiracetam in a transplant patient.
Topics: Aged; Anticonvulsants; Antiemetics; Dyskinesia, Drug-Induced; Female; Humans; Levetiracetam; Metoclopramide; Piracetam | 2008 |
[Use of levetiracetam in the management of post-anoxic myoclonias. A report of two cases].
Topics: Adult; Anticonvulsants; Humans; Hypoxia, Brain; Levetiracetam; Male; Myoclonus; Piracetam | 2007 |
Switching from branded to generic antiepileptic drugs as a confounding factor and unpredictable diagnostic pitfall in epilepsy management.
Topics: Adult; Anticonvulsants; Ataxia; Carbamazepine; Drugs, Generic; Electroencephalography; Epilepsy; Female; Humans; Levetiracetam; Magnetic Resonance Imaging; Piracetam | 2007 |
The effect of anticonvulsant drugs on the fibrinolytic activity of tissue plasminogen activator.
Topics: Adult; Anticonvulsants; Blood Coagulation; Drug Interactions; Erythropoietin; Female; Fibrinolytic Agents; Humans; In Vitro Techniques; Levetiracetam; Male; Phenobarbital; Phenytoin; Piracetam; Recombinant Proteins; Tissue Plasminogen Activator; Valproic Acid | 2008 |
Encephalopathy induced by levetiracetam added to valproate.
Topics: Adult; Anticonvulsants; Brain Diseases; Electroencephalography; Epilepsy; Humans; Levetiracetam; Male; Piracetam; Valproic Acid | 2008 |
Long-term levetiracetam treatment affects reproductive endocrine function in female Wistar rats.
Topics: Administration, Oral; Analysis of Variance; Animals; Anticonvulsants; Corpus Luteum; Dose-Response Relationship, Drug; Endocrine System; Female; Gonadotropins, Pituitary; Levetiracetam; Menstrual Cycle; Ovary; Piracetam; Radioimmunoassay; Rats; Rats, Wistar; Statistics, Nonparametric; Time Factors | 2008 |
Antiepileptic drugs and brain maturation: fetal exposure to lamotrigine generates cortical malformations in rats.
Topics: Animals; Anticonvulsants; Brain; Cell Count; Cell Movement; Dose-Response Relationship, Drug; Female; Fructose; Hippocampus; Immunohistochemistry; Lamotrigine; Levetiracetam; Litter Size; Malformations of Cortical Development; Neurons; Phenobarbital; Piracetam; Pregnancy; Rats; Rats, Wistar; Teratogens; Topiramate; Triazines; Weight Gain | 2008 |
Serum concentration/dose ratio of levetiracetam before, during and after pregnancy.
Topics: Adult; Anticonvulsants; Epilepsy; Female; Humans; Levetiracetam; Piracetam; Pregnancy; Retrospective Studies; Time Factors | 2008 |
Intravenous levetiracetam terminates refractory focal status epilepticus.
Topics: Anticonvulsants; Humans; Infusions, Intravenous; Levetiracetam; Male; Piracetam; Status Epilepticus; Young Adult | 2009 |
Exacerbations of seizures by levetiracetam.
Topics: Acute Disease; Adult; Dose-Response Relationship, Drug; Epilepsy; Epilepsy, Complex Partial; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Piracetam | 2008 |
The use of levetiracetam in a child with nonconvulsive status epilepticus.
Topics: Anticonvulsants; Child; Female; Humans; Immunosuppressive Agents; Levetiracetam; Liver Transplantation; Piracetam; Status Epilepticus; Tacrolimus; Treatment Outcome | 2008 |
Sporadic multiple cerebral cavernomatosis: report of a case and review of literature.
Topics: Adult; Anticonvulsants; Brain; Cerebral Hemorrhage; Chromosomes, Human, Pair 7; Epilepsy; Family Health; Female; Genetic Predisposition to Disease; Hemangioma, Cavernous, Central Nervous System; Humans; KRIT1 Protein; Levetiracetam; Magnetic Resonance Imaging; Male; Microtubule-Associated Proteins; Middle Aged; Mutation; Neoplasms, Multiple Primary; Neurosurgical Procedures; Piracetam; Proto-Oncogene Proteins; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Development of tolerance to levetiracetam in rats with chronic epilepsy.
Topics: Animals; Anticonvulsants; Chromatography, Gas; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Electrodes, Implanted; Electroencephalography; Epilepsy, Temporal Lobe; Infusion Pumps; Levetiracetam; Male; Phenytoin; Piracetam; Rats; Rats, Sprague-Dawley; Temporal Lobe; Videotape Recording | 2008 |
HIF-1-regulated vasoactive systems are differentially involved in acute hypoxic stress responses of the developing brain of newborn mice and are not affected by levetiracetam.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Brain; Disease Models, Animal; Gene Expression Regulation, Developmental; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Levetiracetam; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Nitric Oxide Synthase Type II; Nootropic Agents; Piracetam; Vascular Endothelial Growth Factor A | 2008 |
Rapid dosage titration of levetiracetam in children.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Demography; Drug Administration Schedule; Epilepsy; Female; Humans; Infant; Levetiracetam; Magnetic Resonance Imaging; Male; Piracetam; Retrospective Studies; Treatment Outcome | 2008 |
Effects of uridine on kindling.
Topics: Analysis of Variance; Animals; Anticonvulsants; Electric Stimulation; Electroencephalography; Hippocampus; Kindling, Neurologic; Levetiracetam; Male; Piracetam; Rats; Rats, Sprague-Dawley; Uridine | 2008 |
Contraindications to phenytoin in emergency department patients with seizures.
Topics: Anticonvulsants; Contraindications; Emergency Service, Hospital; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Pregnancy; Retrospective Studies; Valproic Acid | 2009 |
New antiepileptic drugs in pediatric epilepsy.
Topics: Amines; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cyclohexanecarboxylic Acids; Epilepsy; Felbamate; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Levetiracetam; Pediatrics; Phenylcarbamates; Piracetam; Practice Guidelines as Topic; Propylene Glycols; Topiramate; Triazines; Vigabatrin | 2008 |
Implications of antiinflammatory properties of the anticonvulsant drug levetiracetam in astrocytes.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Astrocytes; Cells, Cultured; Coculture Techniques; Levetiracetam; Piracetam; Rats; Rats, Wistar | 2008 |
Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy.
Topics: Animals; Anticonvulsants; Cat Diseases; Cats; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Female; Half-Life; Levetiracetam; Male; Phenobarbital; Piracetam; Treatment Outcome | 2008 |
Pharmaco-EEG-based assessment of interaction between ethanol and levetiracetam.
Topics: Animals; Drug Interactions; Electroencephalography; Ethanol; Female; Frontal Lobe; Hippocampus; Levetiracetam; Male; Piracetam; Rabbits; Receptors, GABA-A; Reticular Formation | 2008 |
[Dynamics of clinical, neurophysiological and radiological indices as a criterion for evaluation of treatment quality of symptomatic epilepsy with keppra and topamax].
Topics: Adolescent; Adult; Anticonvulsants; Blood Flow Velocity; Cerebrovascular Circulation; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroencephalography; Epilepsy; Female; Follow-Up Studies; Fructose; Humans; Infant; Levetiracetam; Male; Neuroprotective Agents; Piracetam; Tomography, Emission-Computed, Single-Photon; Topiramate; Treatment Outcome | 2007 |
Anticonvulsive and antiepileptogenic effects of levetiracetam in the audiogenic kindling model.
Topics: Acoustic Stimulation; Animals; Anticonvulsants; Dose-Response Relationship, Drug; Epilepsy, Tonic-Clonic; Female; Injections, Intraperitoneal; Kindling, Neurologic; Levetiracetam; Piracetam; Rats; Time Factors | 2008 |
Retrospective population pharmacokinetic analysis of levetiracetam in children and adolescents with epilepsy: dosing recommendations.
Topics: Adolescent; Algorithms; Anticonvulsants; Child; Child, Preschool; Databases, Factual; Epilepsy; Humans; Infant; Levetiracetam; Nonlinear Dynamics; Piracetam; Population; Retrospective Studies | 2008 |
Levetiracetam inhibits both ryanodine and IP3 receptor activated calcium induced calcium release in hippocampal neurons in culture.
Topics: Animals; Animals, Newborn; Bradykinin; Caffeine; Calcium; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Hippocampus; Inositol 1,4,5-Trisphosphate Receptors; Levetiracetam; Neurons; Nootropic Agents; Phosphodiesterase Inhibitors; Piracetam; Rats; Rats, Sprague-Dawley; Ryanodine Receptor Calcium Release Channel | 2008 |
Should we accept the status quo? Time for new trials in status epilepticus.
Topics: Adult; Anticonvulsants; Electroencephalography; Epilepsy, Complex Partial; Humans; Infusions, Intravenous; Levetiracetam; Lorazepam; Piracetam; Retrospective Studies; Status Epilepticus; Treatment Outcome | 2008 |
An in vivo [18F]MK-9470 microPET study of type 1 cannabinoid receptor binding in Wistar rats after chronic administration of valproate and levetiracetam.
Topics: Animals; Anticonvulsants; Binding, Competitive; Cerebral Cortex; Female; Fluorine Radioisotopes; Image Processing, Computer-Assisted; Levetiracetam; Piracetam; Positron-Emission Tomography; Pyridines; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Valproic Acid | 2008 |
Thrombocytopenia during levetiracetam therapy.
Topics: Anticonvulsants; Epilepsy, Complex Partial; Female; Humans; Levetiracetam; Middle Aged; Piracetam; Thrombocytopenia | 2008 |
Use of propofol anesthesia and adjunctive treatment with levetiracetam and gabapentin in managing status epilepticus in a patient of acute intermittent porphyria.
Topics: Amines; Anesthetics, Intravenous; Anticonvulsants; Child; Comorbidity; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Levetiracetam; Male; Piracetam; Porphyria, Acute Intermittent; Propofol; Status Epilepticus | 2008 |
Cognitive fMRI and soluble telencephalin assessment in patients with localization-related epilepsy.
Topics: Adult; Anticonvulsants; Biomarkers; Brain; Cell Adhesion Molecules; Epilepsies, Partial; Female; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Tissue Proteins; Neuropsychological Tests; Pilot Projects; Piracetam | 2008 |
Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics.
Topics: Absorption; Administration, Oral; Animals; Anticonvulsants; Area Under Curve; Biological Availability; Dogs; Drug-Related Side Effects and Adverse Reactions; Female; Half-Life; Injections, Intramuscular; Injections, Intravenous; Levetiracetam; Male; Metabolic Clearance Rate; Piracetam | 2008 |
Antinociceptive efficacy of levetiracetam in a mice model for painful diabetic neuropathy.
Topics: Analgesics; Animals; Anticonvulsants; Behavior, Animal; Diabetic Neuropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Hot Temperature; Levetiracetam; Male; Mice; Mice, Inbred BALB C; Pain; Pain Measurement; Piracetam; Time Factors; Treatment Outcome | 2008 |
The risk of paradoxical levetiracetam effect is increased in mentally retarded patients.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Child; Disorders of Excessive Somnolence; Dizziness; Drug Interactions; Epilepsy; Female; Humans; Intellectual Disability; Irritable Mood; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Risk Factors | 2008 |
Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Electroshock; Epilepsy; Hippocampus; Levetiracetam; Ligands; Male; Membrane Glycoproteins; Mice; Nerve Tissue Proteins; Piracetam; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Seizures | 2008 |
Levetiracetam prevents kindling-induced asymmetric accumulation of hippocampal 7S SNARE complexes.
Topics: Amygdala; Analysis of Variance; Animals; Anticonvulsants; Disease Models, Animal; Electric Stimulation; Gene Expression Regulation; Hippocampus; Kindling, Neurologic; Levetiracetam; Male; Membrane Glycoproteins; N-Ethylmaleimide-Sensitive Proteins; Nerve Tissue Proteins; Piracetam; R-SNARE Proteins; Rats; Rats, Sprague-Dawley; Seizures; SNARE Proteins; Time Factors | 2008 |
Hemodiafiltration and high-flux hemodialysis significantly reduce serum valproate levels inducing epileptic seizures: case report.
Topics: Adult; Epilepsy; Female; Hemodiafiltration; Humans; Levetiracetam; Piracetam; Renal Dialysis; Valproic Acid | 2008 |
PKA-mediated phosphorylation is a novel mechanism for levetiracetam, an antiepileptic drug, activating ROMK1 channels.
Topics: Animals; Anticonvulsants; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Hydrogen-Ion Concentration; Levetiracetam; Mutagenesis, Site-Directed; Oocytes; Patch-Clamp Techniques; Phosphatidylinositol 4,5-Diphosphate; Phosphorylation; Piracetam; Potassium Channels, Inwardly Rectifying; RNA, Messenger; Xenopus | 2008 |
Brivaracetam: a rational drug discovery success story.
Topics: Animals; Anticonvulsants; Binding Sites; Disease Models, Animal; Drug Delivery Systems; Drug Design; Epilepsy; Humans; Levetiracetam; Piracetam | 2008 |
Emesis responsive to levetiracetam.
Topics: Aged; Anticonvulsants; Brain Neoplasms; Female; Humans; Levetiracetam; Papilloma, Choroid Plexus; Piracetam; Vomiting | 2008 |
Levetiracetam-associated hyponatremia.
Topics: Aged; Anticonvulsants; Epilepsy, Complex Partial; Humans; Hyponatremia; Levetiracetam; Male; Piracetam; Water-Electrolyte Imbalance | 2008 |
Impending status epilepticus and anxiety in a pregnant woman treated with levetiracetam.
Topics: Administration, Oral; Adult; Anticonvulsants; Anxiety; Epilepsy, Frontal Lobe; Fear; Female; Humans; Levetiracetam; Piracetam; Pregnancy; Pregnant Women | 2008 |
Quantification of levetiracetam in human plasma by liquid chromatography-tandem mass spectrometry: application to therapeutic drug monitoring.
Topics: Adenosine; Anticonvulsants; Calibration; Chromatography, Liquid; Drug Monitoring; Drug Stability; Drug Storage; Epilepsy; Freezing; Humans; Levetiracetam; Metabolic Clearance Rate; Piracetam; Quality Control; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Time Factors | 2008 |
Retention rates of new antiepileptic drugs in localization-related epilepsy: a single-center study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amines; Anticonvulsants; Child; Cyclohexanecarboxylic Acids; Epilepsy; Female; Finland; Fructose; Gabapentin; gamma-Aminobutyric Acid; Half-Life; Humans; Lamotrigine; Levetiracetam; Licensure, Pharmacy; Male; Middle Aged; Nipecotic Acids; Piracetam; Retrospective Studies; Tiagabine; Topiramate; Treatment Outcome; Triazines; Young Adult | 2009 |
Termination of absence status epilepticus by low-dose intravenous levetiracetam.
Topics: Adult; Anticonvulsants; Drug Administration Schedule; Electroencephalography; Humans; Injections, Intravenous; Levetiracetam; Male; Piracetam; Status Epilepticus | 2008 |
Off-label use of antiepileptic drugs for the treatment of neonatal seizures.
Topics: Anticonvulsants; Drug Utilization; Guidelines as Topic; Health Surveys; Humans; Infant, Newborn; Levetiracetam; Piracetam; Practice Patterns, Physicians'; Seizures; Surveys and Questionnaires | 2008 |
Phenobarbital withdrawal seizures may occur over several weeks before remitting: human data and hypothetical mechanism.
Topics: Anticonvulsants; Data Collection; Female; Humans; Lamotrigine; Levetiracetam; Middle Aged; Phenobarbital; Piracetam; Seizures; Substance Withdrawal Syndrome; Time Factors; Triazines | 2009 |
Reversible panhypogammaglobulinemia associated with the antiepileptic agent levetiracetam.
Topics: Adult; Agammaglobulinemia; Anticonvulsants; Brain Abscess; Humans; Immunoglobulins; Levetiracetam; Male; Piracetam; Seizures | 2008 |
Levetiracetam (keppra) in the treatment of refractory status epilepticus.
Topics: Adult; Anticonvulsants; Electroencephalography; Humans; Levetiracetam; Male; Piracetam; Refractory Period, Electrophysiological; Status Epilepticus | 2007 |
Visualization of SV2A conformations in situ by the use of Protein Tomography.
Topics: Animals; Anticonvulsants; Brain Chemistry; Immunohistochemistry; Levetiracetam; Membrane Glycoproteins; Mice; Microscopy, Electron, Transmission; Microscopy, Immunoelectron; Nerve Tissue Proteins; Piracetam; Protein Conformation | 2008 |
Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy.
Topics: Adolescent; Adult; Animals; Anticonvulsants; Blotting, Western; Child; Disease Models, Animal; Epilepsy, Temporal Lobe; Female; Hippocampus; Humans; Infant; Levetiracetam; Male; Membrane Glycoproteins; Microscopy, Confocal; Middle Aged; Nerve Tissue Proteins; Piracetam; Rats; Sclerosis; Status Epilepticus; Young Adult | 2009 |
Effects of chronic treatment with levetiracetam on hippocampal field responses after pilocarpine-induced status epilepticus in rats.
Topics: Animals; Anticonvulsants; Dose-Response Relationship, Drug; Hippocampus; Humans; Levetiracetam; Male; Membrane Potentials; Muscarinic Agonists; Pilocarpine; Piracetam; Rats; Rats, Sprague-Dawley; Status Epilepticus | 2008 |
Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Brain; Brain Injuries; Drug Tolerance; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Neurosurgical Procedures; Phenytoin; Piracetam; Postoperative Complications; Retrospective Studies; Supratentorial Neoplasms; Treatment Outcome | 2008 |
Levetiracetam as a possible cause of fulminant liver failure.
Topics: Adult; Anticonvulsants; Brain; Epilepsy; Humans; Levetiracetam; Liver; Liver Failure, Acute; Liver Function Tests; Liver Transplantation; Male; Neurocysticercosis; Phenytoin; Piracetam; Treatment Outcome | 2008 |
Perspectives on interactions between antiepileptic drugs (AEDs) and antimicrobial agents.
Topics: Aged; Anti-Infective Agents; Anticonvulsants; Brain Abscess; Drug Interactions; Epilepsy; Female; Heart Block; HIV Infections; Humans; Levetiracetam; Neurocysticercosis; Piracetam; Valproic Acid | 2008 |
Simple and validated HPLC-UV analysis of levetiracetam in deproteinized plasma of patients with epilepsy.
Topics: Chromatography, High Pressure Liquid; Epilepsy; Humans; Levetiracetam; Piracetam; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Retention of new AEDs in institutionalized intellectually disabled patients with epilepsy.
Topics: Adolescent; Adult; Amines; Anticonvulsants; Child; Cyclohexanecarboxylic Acids; Drug Utilization Review; Epilepsy; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Institutionalization; Intellectual Disability; Lamotrigine; Levetiracetam; Middle Aged; Piracetam; Retrospective Studies; Topiramate; Triazines | 2009 |
Successful treatment of Holmes tremor by levetiracetam.
Topics: Anticonvulsants; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Piracetam; Tremor; Young Adult | 2008 |
Rapid effect of levetiracetam in a case of juvenile myoclonic epilepsy.
Topics: Adult; Anticonvulsants; Electroencephalography; Epilepsy, Tonic-Clonic; Female; Humans; Levetiracetam; Magnetic Resonance Imaging; Myoclonic Epilepsy, Juvenile; Piracetam | 2009 |
Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury.
Topics: Adult; Brain Injuries; Cohort Studies; Electroencephalography; Epilepsy, Post-Traumatic; Female; Humans; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Prospective Studies; Young Adult | 2008 |
Levetiracetam for seizures in children with brain tumors and other cancers.
Topics: Adolescent; Anticonvulsants; Brain Neoplasms; Child; Drug Evaluation; Female; Humans; Levetiracetam; Male; Neoplasms; Piracetam; Retrospective Studies; Seizures; Treatment Outcome | 2009 |
Effects of levetiracetam on generalized discharges monitored with ambulatory EEG in epileptic patients.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Drug Therapy, Combination; Electroencephalography; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Monitoring, Ambulatory; Piracetam | 2009 |
Physiology-based simulations of a pathological condition: prediction of pharmacokinetics in patients with liver cirrhosis.
Topics: Alfentanil; Humans; Levetiracetam; Lidocaine; Liver Cirrhosis; Models, Biological; Piracetam; Theophylline | 2008 |
Levetiracetam-induced depression in a 5-year-old child with partial epilepsy.
Topics: Anticonvulsants; Child, Preschool; Depression; Epilepsies, Partial; Humans; Levetiracetam; Male; Piracetam | 2009 |
Levetiracetam in children with refractory status epilepticus.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Resistance; Electroencephalography; Female; Humans; Infant; Injections, Intravenous; Intubation, Gastrointestinal; Levetiracetam; Male; Piracetam; Status Epilepticus | 2009 |
Antiemetic properties of the antiepileptic drug levetiracetam.
Topics: Age Factors; Anticonvulsants; Antiemetics; Antineoplastic Agents; Brain Neoplasms; Glioblastoma; Humans; Levetiracetam; Logistic Models; Nausea; Piracetam; Retrospective Studies; Vomiting | 2008 |
Intravenous levetiracetam for epileptic seizure emergencies in older people.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Drug Tolerance; Emergencies; Epilepsy; Epilepsy, Complex Partial; Female; Humans; Infusions, Intravenous; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Status Epilepticus | 2009 |
Treatment of seizures in a patient with Batten's disease.
Topics: Anticonvulsants; Child; Drug Therapy, Combination; Epilepsy, Tonic-Clonic; Humans; Isoxazoles; Levetiracetam; Male; Neuronal Ceroid-Lipofuscinoses; Piracetam; Quality of Life; Zonisamide | 2008 |
No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy.
Topics: Adult; Anticonvulsants; Cohort Studies; Epilepsy; Epilepsy, Temporal Lobe; Female; Genetic Predisposition to Disease; Genetic Variation; Genotype; Hippocampus; Humans; Ireland; Levetiracetam; Male; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam; Polymorphism, Genetic; Synaptic Vesicles; United Kingdom | 2009 |
Partial seizures and atypical absence seizures as a single ictal event in a patient with Lennox-Gastaut syndrome.
Topics: Adolescent; Epilepsy; Epilepsy, Absence; Humans; Intellectual Disability; Levetiracetam; Male; Piracetam | 2008 |
A new method for quantification and assessment of epileptiform activity in EEG with special reference to focal nocturnal epileptiform activity.
Topics: Algorithms; Anticonvulsants; Brain; Child; Cognition; Electroencephalography; Epilepsy; Humans; Levetiracetam; Linear Models; Piracetam; Reproducibility of Results; Signal Processing, Computer-Assisted; Sleep; Time Factors | 2009 |
[Use of keppra during the radiotherapy in patients with brain tumors and epileptic seizures after surgical treatment].
Topics: Administration, Oral; Adolescent; Adult; Anticonvulsants; Brain Neoplasms; Child; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; Female; Follow-Up Studies; Glioma; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Middle Aged; Piracetam; Postoperative Period; Treatment Outcome; Young Adult | 2008 |
Levetiractam in the treatment of two children with myoclonic status epilepticus.
Topics: Anticonvulsants; Child; Electroencephalography; Humans; Infant; Levetiracetam; Male; Piracetam; Status Epilepticus | 2009 |
Brivaracetam and seletracetam, two new SV2A ligands, improve paroxysmal dystonia in the dt sz mutant hamster.
Topics: Animals; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Dystonia; Humans; Levetiracetam; Ligands; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam; Pyrrolidinones; Severity of Illness Index | 2008 |
Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study.
Topics: Adult; Aged; Anticonvulsants; Cognition; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Neuropsychological Tests; Piracetam; Prospective Studies; Quality of Life; Seizures; Young Adult | 2008 |
Levetiracetam therapy for treatment of choreoathetosis in dyskinetic cerebral palsy.
Topics: Anticonvulsants; Athetosis; Cerebral Palsy; Child; Child, Preschool; Chorea; Female; Humans; Levetiracetam; Motor Skills; Piracetam | 2009 |
An unusual cause of collapse and neck pain.
Topics: Anticonvulsants; Humans; Levetiracetam; Male; Neck Pain; Neurofibromatosis 1; Piracetam; Seizures; Soft Tissue Neoplasms; Young Adult | 2008 |
Seletracetam (ucb 44212) inhibits high-voltage-activated Ca2+ currents and intracellular Ca2+ increase in rat cortical neurons in vitro.
Topics: 4-Aminopyridine; Animals; Anticonvulsants; Bicuculline; Biophysics; Calcium; Calcium Channel Blockers; Calcium Channels; Dose-Response Relationship, Drug; GABA Antagonists; In Vitro Techniques; Levetiracetam; Magnesium; Male; Membrane Potentials; Neocortex; Neural Inhibition; Neurons; Patch-Clamp Techniques; Piracetam; Potassium Channel Blockers; Pyrrolidinones; Rats; Rats, Wistar | 2009 |
Electrochemical determination of levetiracetam by screen-printed based biosensors.
Topics: Biosensing Techniques; Electrochemistry; Electrodes; Enzymes, Immobilized; Levetiracetam; Peroxidase; Piracetam | 2009 |
Initial management of epilepsy.
Topics: Anticonvulsants; Drug Approval; Drug Labeling; Epilepsy; Humans; Levetiracetam; Piracetam; United States; United States Food and Drug Administration | 2008 |
The role of the newer antiepileptic drugs in the treatment of generalized convulsive status epilepticus.
Topics: Anticonvulsants; Humans; Levetiracetam; Piracetam; Status Epilepticus; Valproic Acid | 2008 |
[Follow-up study on levetiracetam monotherapy in children with epilepsy].
Topics: Anticonvulsants; Child; Child, Preschool; Epilepsy; Female; Follow-Up Studies; Humans; Infant; Levetiracetam; Male; Piracetam | 2008 |
Preemptive levetiracetam decreases postoperative pain in rats.
Topics: Analgesics; Analysis of Variance; Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Levetiracetam; Male; Morphine; Pain, Postoperative; Piracetam; Premedication; Preoperative Care; Random Allocation; Rats; Rats, Wistar; Statistics, Nonparametric; Treatment Outcome | 2008 |
Symptomatic complex partial status epilepticus manifesting as utilization behavior of a mobile phone.
Topics: Anticonvulsants; Benzodiazepines; Brain Neoplasms; Cell Phone; Clobazam; Electroencephalography; Epilepsy, Complex Partial; Female; Frontal Lobe; Glioblastoma; Humans; Levetiracetam; Magnetic Resonance Imaging; Middle Aged; Piracetam; Status Epilepticus; Tomography, X-Ray Computed | 2009 |
Successful treatment of encephalopathy and myoclonus with levetiracetam in a case of subacute sclerosing panencephalitis.
Topics: Anticonvulsants; Blood Chemical Analysis; Brain; Cerebrospinal Fluid; Child; Electroencephalography; Humans; Levetiracetam; Male; Myoclonus; Piracetam; Subacute Sclerosing Panencephalitis | 2009 |
Effect of antiepileptic agent, levetiracetam, on urodynamic parameters and neurogenic bladder overactivity in chronically paraplegic rats.
Topics: Animals; Anticonvulsants; Chronic Disease; Dose-Response Relationship, Drug; Female; Levetiracetam; Paraplegia; Piracetam; Rats; Rats, Sprague-Dawley; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Urodynamics | 2009 |
Pharmacodynamic and pharmacokinetic interaction profiles of levetiracetam in combination with gabapentin, tiagabine and vigabatrin in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis.
Topics: Amines; Animals; Anticonvulsants; Brain; Cyclohexanecarboxylic Acids; Disease Models, Animal; Drug Interactions; Drug Synergism; Gabapentin; gamma-Aminobutyric Acid; Levetiracetam; Male; Mice; Nipecotic Acids; Pentylenetetrazole; Piracetam; Seizures; Tiagabine; Tissue Distribution; Vigabatrin | 2009 |
Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Electrochemistry; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Models, Biological; Piracetam; Population; Prospective Studies; Reference Values; Reproducibility of Results; Time Factors | 2009 |
Safety and efficacy of levetiracetam for critically ill patients with seizures.
Topics: Adult; Aged; Anticonvulsants; Critical Care; Critical Illness; Epilepsy; Female; Humans; Kidney; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies | 2009 |
Levetiracetam as monotherapy for seizures in a neonate with acute lymphoblastic leukemia.
Topics: Anticonvulsants; Electroencephalography; Humans; Infant, Newborn; Levetiracetam; Magnetic Resonance Imaging; Male; Piracetam; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Seizures | 2010 |
[New antiepileptic drugs].
Topics: Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Epilepsies, Partial; Epilepsy; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Oxcarbazepine; Piracetam; Pregabalin; Triazines; Zonisamide | 2009 |
Levetiracetam accumulation in renal failure causing myoclonic encephalopathy with triphasic waves.
Topics: Aged, 80 and over; Anticonvulsants; Electroencephalography; Epilepsies, Myoclonic; Female; Humans; Levetiracetam; Piracetam; Renal Insufficiency | 2009 |
Brivaracetam inhibits spreading depression in rat neocortical slices in vitro.
Topics: Animals; Anticonvulsants; Cortical Spreading Depression; Dose-Response Relationship, Drug; In Vitro Techniques; Levetiracetam; Male; Neocortex; Piracetam; Potassium Chloride; Pyrrolidinones; Rats; Rats, Sprague-Dawley | 2009 |
[Levetiracetam use in the post-hypoxic myoclonic status].
Topics: Anticonvulsants; Epilepsies, Myoclonic; Humans; Hypoxia, Brain; Levetiracetam; Piracetam; Prospective Studies | 2009 |
Epilepsia partialis continua successfully treated with levetiracetam.
Topics: Adult; Anticonvulsants; Brain; Cerebral Hemorrhage, Traumatic; Epilepsia Partialis Continua; Humans; Levetiracetam; Male; Piracetam; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Levetiracetam enhances endogenous antioxidant in the hippocampus of rats: in vivo evaluation by brain microdialysis combined with ESR spectroscopy.
Topics: alpha-Tocopherol; Amino Acid Transport System y+; Amino Acid Transport Systems, Acidic; Amino Acids; Animals; Antioxidants; Ascorbic Acid; Blotting, Western; Electron Spin Resonance Spectroscopy; Hippocampus; Levetiracetam; Male; Microdialysis; Neuroprotective Agents; Nitric Oxide Synthase Type II; Nitrogen Oxides; Piracetam; Rats; Rats, Wistar | 2009 |
Post-hypoxic myoclonic status: the prognosis is not always hopeless.
Topics: Aged; Anticonvulsants; Critical Care; Female; Heart Arrest; Humans; Hypoxia; Levetiracetam; Myoclonus; Piracetam; Prognosis | 2009 |
[When a seizure occurs...].
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Fructose; Humans; Lamotrigine; Levetiracetam; Piracetam; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2009 |
Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures.
Topics: Acute Disease; Adolescent; Anticonvulsants; Child; Child, Preschool; Cohort Studies; Critical Illness; Electroencephalography; Humans; Infant; Infusions, Intravenous; Levetiracetam; Piracetam; Retrospective Studies; Seizures; Status Epilepticus | 2009 |
Anticonvulsant hypersensitivity syndrome presenting as aseptic meningitis.
Topics: Anti-Bacterial Agents; Anticonvulsants; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Fever; Headache; Humans; Lamotrigine; Levetiracetam; Meninges; Meningitis, Aseptic; Middle Aged; Myoclonic Epilepsy, Juvenile; Nausea; Piracetam; Steroids; Triazines | 2009 |
Levetiracetam plasma level monitoring during pregnancy, delivery, and postpartum: clinical and outcome implications.
Topics: Adult; Anticonvulsants; Epilepsy; Female; Follow-Up Studies; Humans; Lamotrigine; Levetiracetam; Maternal-Fetal Exchange; Piracetam; Postpartum Period; Pregnancy; Pregnancy Complications; Triazines | 2009 |
Behavioral effects of levetiracetam mitigated by pyridoxine.
Topics: Anticonvulsants; Behavioral Symptoms; Child; Drug Therapy, Combination; Humans; Levetiracetam; Male; Piracetam; Pyridoxine; Seizures; Vitamin B Complex | 2009 |
Linezolid-induced complex partial seizures in a patient with epilepsy.
Topics: Acetamides; Aged; Anti-Infective Agents; Epilepsy; Epilepsy, Complex Partial; Humans; Levetiracetam; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Piracetam; Staphylococcal Infections; Ulcer | 2009 |
Charles Bonnet syndrome disappearing with carbamazepine and valproic acid but not with levetiracetam.
Topics: Aged, 80 and over; Anticonvulsants; Carbamazepine; Female; Hallucinations; Humans; Levetiracetam; Piracetam; Valproic Acid | 2009 |
Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study.
Topics: Activities of Daily Living; Adult; Aged; Anticonvulsants; Blood Cell Count; Brain Neoplasms; Combined Modality Therapy; Epilepsy; Female; Humans; Karnofsky Performance Status; Levetiracetam; Logistic Models; Male; Middle Aged; Neuropsychological Tests; Personal Autonomy; Piracetam; Quality of Life; Seizures; Surveys and Questionnaires; Young Adult | 2009 |
Levetiracetam-induced pancytopenia.
Topics: Aged; Anticonvulsants; Female; Humans; Levetiracetam; Pancytopenia; Piracetam; Status Epilepticus | 2009 |
Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome.
Topics: Anticonvulsants; Child; Drug Therapy, Combination; Electroencephalography; Epilepsies, Partial; Female; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Piracetam; Status Epilepticus; Syndrome; Valproic Acid | 2009 |
Efficacy of anti-epileptic drugs in patients with gliomas and seizures.
Topics: Adult; Anticonvulsants; Brain Neoplasms; Carbamazepine; Drug Therapy, Combination; Female; Follow-Up Studies; Glioma; Humans; Kaplan-Meier Estimate; Lamotrigine; Levetiracetam; Male; Middle Aged; Neoplasm Staging; Piracetam; Seizures; Time Factors; Treatment Outcome; Triazines; Valproic Acid | 2009 |
Epileptic negative myoclonus: SPECT, PET, and video/EEG studies and the dramatic effects of levetiracetam.
Topics: Adolescent; Anticonvulsants; Electroencephalography; Epilepsy; Female; Humans; Levetiracetam; Piracetam; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon | 2009 |
Levetiracetam-induced platelet dysfunction.
Topics: Aged; Anticonvulsants; Blood Platelet Disorders; Clopidogrel; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Piracetam; Platelet Aggregation; Platelet Aggregation Inhibitors; Seizures; Ticlopidine | 2009 |
Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Status Epilepticus; Survival Rate; Treatment Outcome | 2009 |
Hemiballismus in subthalamic haemorrhage: efficacy of levetiracetam.
Topics: Aged; Anti-Dyskinesia Agents; Anticonvulsants; Antihypertensive Agents; Ataxia; Cerebellum; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesias; Haloperidol; Hemangioma, Cavernous, Central Nervous System; Humans; Hypertension; Intracranial Hemorrhage, Hypertensive; Levetiracetam; Lorazepam; Magnetic Resonance Imaging; Male; Piracetam; Recurrence; Subthalamic Nucleus; Treatment Outcome; Vomiting | 2009 |
Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options.
Topics: Adolescent; Adult; Angelman Syndrome; Anticonvulsants; Child; Child, Preschool; Clonazepam; Comorbidity; Drug Administration Schedule; Drug Resistance; Epilepsy; Epilepsy, Generalized; Female; Humans; Infant; Lamotrigine; Levetiracetam; Male; Middle Aged; Piracetam; Surveys and Questionnaires; Syndrome; Treatment Outcome; Triazines; Vagus Nerve Stimulation; Valproic Acid | 2009 |
Intravenous levetiracetam as treatment for status epilepticus.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Female; Humans; Injections, Intravenous; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Status Epilepticus; Time Factors; Treatment Outcome; Young Adult | 2009 |
Levetiracetam decreases the seizure activity and blood-brain barrier permeability in pentylenetetrazole-kindled rats with cortical dysplasia.
Topics: Animals; Anticonvulsants; Blood-Brain Barrier; Brain; Capillary Permeability; Endothelium; Fluorescein; Glial Fibrillary Acidic Protein; Levetiracetam; Malformations of Cortical Development; Membrane Proteins; Occludin; Pentylenetetrazole; Pinocytosis; Piracetam; Proto-Oncogene Proteins c-fos; Random Allocation; Rats; Rats, Sprague-Dawley; Seizures; Tight Junctions | 2009 |
Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam.
Topics: Amygdala; Animals; Anticonvulsants; Binding Sites; Brain; Disease Models, Animal; Electroshock; Epilepsy; Kainic Acid; Kindling, Neurologic; Levetiracetam; Male; Membrane Glycoproteins; Mice; Mice, Knockout; Nerve Tissue Proteins; Pentylenetetrazole; Pharmacogenetics; Phenotype; Piracetam | 2009 |
Effects of levetiracetam and valproate on reproductive endocrine function studied in human ovarian follicular cells.
Topics: Adult; Anticonvulsants; Aromatase; Caspase 3; Cells, Cultured; Dose-Response Relationship, Drug; Estradiol; Female; Follicle Stimulating Hormone; Granulosa Cells; Humans; In Vitro Techniques; Levetiracetam; Ovary; Piracetam; Valproic Acid | 2009 |
Effect of prenatal levetiracetam exposure on motor and cognitive functions of rat offspring.
Topics: Animals; Anticonvulsants; Avoidance Learning; Cognition; Exploratory Behavior; Female; Learning; Levetiracetam; Male; Motor Activity; Piracetam; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Performance; Rats; Rats, Sprague-Dawley | 2010 |
Olfactory disturbance in Parkinson disease.
Topics: Aged; Anticonvulsants; Antiparkinson Agents; Antipsychotic Agents; Aripiprazole; Biomarkers; Brain; Cognition Disorders; Constipation; Diagnosis, Differential; Disease Progression; Electroencephalography; Hallucinations; Humans; Levetiracetam; Lewy Body Disease; Male; Olfactory Pathways; Parkinson Disease; Piperazines; Piracetam; Quinolones; REM Sleep Behavior Disorder; Treatment Failure; Tremor | 2009 |
Role of intravenous levetiracetam in acute seizure management of children.
Topics: Adolescent; Anticonvulsants; Brain; Chemotherapy, Adjuvant; Child; Child, Preschool; Electroencephalography; Female; Humans; Infant; Infusions, Intravenous; Levetiracetam; Male; Piracetam; Retrospective Studies; Seizures; Status Epilepticus; Treatment Outcome | 2009 |
Levetiracetam induced interstitial nephritis and renal failure.
Topics: Adolescent; Adrenal Cortex Hormones; Anticonvulsants; Contraindications; Female; Humans; Kidney; Levetiracetam; Nephritis, Interstitial; Piracetam; Renal Insufficiency; Seizures | 2009 |
Intravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancy.
Topics: Ammonia; Anticonvulsants; Blood Cell Count; Creatine; Drug Administration Schedule; Electroencephalography; Epilepsy, Partial, Sensory; Follow-Up Studies; Humans; Infant; Infusions, Intravenous; Lactic Acid; Levetiracetam; Liver; Male; Piracetam; Status Epilepticus | 2009 |
In the rat maximal dentate activation model of partial complex epilepsy, the anticonvulsant activity of levetiracetam is modulated by nitric oxide-active drugs.
Topics: Animals; Anticonvulsants; Arginine; Dentate Gyrus; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Epilepsy, Complex Partial; Indazoles; Levetiracetam; Male; Nitric Oxide; Nitric Oxide Synthase Type I; Piracetam; Rats; Rats, Wistar | 2009 |
Is levetiracetam a treatment option for dyskinetic cerebral palsy?
Topics: Anticonvulsants; Cerebral Palsy; Child; Humans; Levetiracetam; Piracetam | 2009 |
Differential effects of antiepileptic drugs on steroidogenesis in a human in vitro cell model.
Topics: Anticonvulsants; Carbamazepine; Cell Line, Tumor; Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Endocrine Disruptors; Estradiol; Humans; Hydroxymethylglutaryl CoA Reductases; Levetiracetam; Phosphoproteins; Piracetam; Progesterone; Radioimmunoassay; Reverse Transcriptase Polymerase Chain Reaction; Steroid Hydroxylases; Steroids; Testosterone; Valproic Acid | 2009 |
A family with paroxysmal nonkinesigenic dyskinesia: genetic and treatment issues.
Topics: Adult; Anticonvulsants; Base Sequence; Child; Child, Preschool; Chorea; Diazepam; DNA Mutational Analysis; Family; Female; Humans; Levetiracetam; Male; Middle Aged; Molecular Sequence Data; Muscle Proteins; Mutation; Pedigree; Penetrance; Phenotype; Piracetam | 2009 |
Isobolographic characterization of interactions of levetiracetam with the various antiepileptic drugs in the mouse 6 Hz psychomotor seizure model.
Topics: Animals; Anticonvulsants; Clonazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Electroshock; Epilepsy; Levetiracetam; Male; Mice; Phenobarbital; Piracetam; Psychomotor Performance; Valproic Acid | 2009 |
Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.
Topics: Anticonvulsants; Brain; Humans; Levetiracetam; Phenytoin; Piracetam; Seizures | 2009 |
Levetiracetam in nonconvulsive status epilepticus in a child with Angelman syndrome.
Topics: Angelman Syndrome; Anticonvulsants; Brain; Child; Electroencephalography; Humans; Levetiracetam; Male; Piracetam; Status Epilepticus; Treatment Outcome | 2010 |
Two years of experience in the treatment of status epilepticus with intravenous levetiracetam.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Cerebrovascular Disorders; Epilepsies, Myoclonic; Epilepsies, Partial; Female; Germany; Humans; Injections, Intravenous; Levetiracetam; Male; Middle Aged; Piracetam; Status Epilepticus | 2009 |
Isobolographic characterization of the anticonvulsant interaction profiles of levetiracetam in combination with clonazepam, ethosuximide, phenobarbital and valproate in the mouse pentylenetetrazole-induced seizure model.
Topics: Animals; Anticonvulsants; Clonazepam; Convulsants; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Ethosuximide; Levetiracetam; Male; Mice; Pentylenetetrazole; Phenobarbital; Piracetam; Seizures; Valproic Acid | 2009 |
Levetiracetam has a time- and stimulation-dependent effect on synaptic transmission.
Topics: Animals; Anticonvulsants; Excitatory Postsynaptic Potentials; Hippocampus; Levetiracetam; Male; Organ Culture Techniques; Patch-Clamp Techniques; Piracetam; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Time | 2009 |
The use of antiepileptic drugs in pediatric brain tumor patients.
Topics: Anticonvulsants; Antineoplastic Agents; Brain Neoplasms; Carbamazepine; Child; Drug Interactions; Follow-Up Studies; Glioma; Humans; Levetiracetam; Oxcarbazepine; Phenytoin; Piracetam; Retrospective Studies; Seizures; Supratentorial Neoplasms; Treatment Outcome | 2009 |
Horseradish peroxidase covalent grafting onto screen-printed carbon electrodes for levetiracetam chronoamperometric determination.
Topics: Anticonvulsants; Biosensing Techniques; Calibration; Carbon; Diazonium Compounds; Electrochemical Techniques; Enzymes, Immobilized; Horseradish Peroxidase; Hydrogen Peroxide; Hydrogen-Ion Concentration; Indicators and Reagents; Levetiracetam; Linear Models; Microelectrodes; Piracetam; Reproducibility of Results; Silver; Surface Properties; Transducers | 2009 |
Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
Topics: Animals; Anticonvulsants; Dentate Gyrus; Disease Models, Animal; Drug Administration Schedule; Drug Resistance; Drug Tolerance; Electric Stimulation; Electroencephalography; Epilepsy; Epilepsy, Temporal Lobe; Humans; Levetiracetam; Male; Piracetam; Rats; Rats, Sprague-Dawley; Status Epilepticus; Treatment Outcome; Valproic Acid | 2010 |
Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.
Topics: Acetamides; Adult; Anticonvulsants; Diazepam; Drug Resistance; Drug Therapy, Combination; Epilepsy; Etomidate; Humans; Lacosamide; Levetiracetam; Male; Midazolam; Piracetam; Practice Guidelines as Topic; Status Epilepticus; Treatment Outcome | 2010 |
[Limbic encephalitis associated to voltage dependent potassium channel antibodies: report of one case].
Topics: Aged; Autoantibodies; Electroencephalography; Glucocorticoids; Humans; Levetiracetam; Limbic Encephalitis; Magnetic Resonance Imaging; Male; Piracetam; Potassium Channels, Voltage-Gated; Prednisone; Tomography, X-Ray Computed; Valproic Acid | 2009 |
Levetiracetam reduces myoclonus in corticobasal degeneration: report of two cases.
Topics: Anticonvulsants; Female; Humans; Levetiracetam; Male; Middle Aged; Myoclonus; Neurodegenerative Diseases; Piracetam; Severity of Illness Index; Treatment Outcome | 2009 |
Ion chromatographic determination of residual phase transfer catalyst in active pharmaceutical ingredient.
Topics: Catalysis; Chromatography, Liquid; Levetiracetam; Piracetam; Quaternary Ammonium Compounds; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
Topics: Anticonvulsants; Child, Preschool; Drug Therapy, Combination; Epilepsy; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Seizures; Time Factors; Treatment Outcome | 2010 |
[Levetiracetam-associated hyponatremia].
Topics: Aged; Anticonvulsants; Female; Humans; Hyponatremia; Levetiracetam; Piracetam | 2010 |
Pancytopenia associated with levetiracetam treatment.
Topics: Aged; Anticonvulsants; Female; Humans; Levetiracetam; Pancytopenia; Piracetam | 2009 |
Epilepsia partialis continua responsive to intravenous levetiracetam.
Topics: Anticonvulsants; Brain Neoplasms; Epilepsies, Partial; Female; Humans; Injections, Intravenous; Levetiracetam; Middle Aged; Oligodendroglioma; Piracetam; Speech Disorders | 2009 |
Experience with intravenous levetiracetam in status epilepticus: a retrospective case series.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Child; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Status Epilepticus; Treatment Outcome; Young Adult | 2009 |
Sequential intrarectal diazepam and intravenous levetiracetam in treating acute repetitive and prolonged seizures.
Topics: Acute Disease; Administration, Rectal; Adult; Aged; Diazepam; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Intellectual Disability; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Seizures; Treatment Outcome; Young Adult | 2010 |
Blood pressure changes after intravenous fosphenytoin and levetiracetam in patients with acute cerebral symptoms.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Chi-Square Distribution; Female; Humans; Hypotension; Levetiracetam; Male; Medical Records; Middle Aged; Patient Selection; Phenytoin; Piracetam; Regression Analysis; Retrospective Studies; Seizures; Treatment Outcome | 2009 |
Utility of levetiracetam in patients with subarachnoid hemorrhage.
Topics: Adult; Aged; Anticonvulsants; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Retrospective Studies; Subarachnoid Hemorrhage; Treatment Outcome | 2009 |
Effects of levetiracetam on hippocampal kindling in Noda epileptic rats.
Topics: Animals; Anticonvulsants; Brain Stem; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Electric Stimulation; Epilepsy; Functional Laterality; Genetic Predisposition to Disease; Hippocampus; Kindling, Neurologic; Levetiracetam; Male; Neural Inhibition; Neural Pathways; Piracetam; Rats; Rats, Mutant Strains; Rats, Wistar; Treatment Outcome | 2010 |
Levetiracetam inhibits glutamate transmission through presynaptic P/Q-type calcium channels on the granule cells of the dentate gyrus.
Topics: Animals; Anticonvulsants; Calcium Channels, P-Type; Calcium Channels, Q-Type; Dentate Gyrus; Excitatory Postsynaptic Potentials; Glutamic Acid; In Vitro Techniques; Levetiracetam; Male; Patch-Clamp Techniques; Piracetam; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2009 |
LC method for therapeutic drug monitoring of levetiracetam: evaluation of the assay performance and validation of its application in the routine area.
Topics: Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Levetiracetam; Limit of Detection; Linear Models; Piracetam; Quality Control; Risk Factors; Validation Studies as Topic | 2010 |
Levetiracetam inhibits kindling-induced synaptic potentiation in the dentate gyrus of freely moving rats.
Topics: Analysis of Variance; Animals; Anticonvulsants; Dentate Gyrus; Electric Stimulation; Electrodes, Implanted; Kindling, Neurologic; Levetiracetam; Male; Neural Inhibition; Neuronal Plasticity; Perforant Pathway; Piracetam; Rats; Rats, Wistar; Synapses; Synaptic Transmission; Time Factors | 2010 |
Vomiting due to intravenous levetiracetam in a case of Creutzfeldt-Jakob disease.
Topics: Anticonvulsants; Creutzfeldt-Jakob Syndrome; Female; Humans; Injections, Intravenous; Levetiracetam; Middle Aged; Piracetam; Vomiting | 2010 |
Efficacy of levetiracetam in the treatment of drug-resistant Rett syndrome.
Topics: Adolescent; Analysis of Variance; Anticonvulsants; Child; Drug Administration Schedule; Electroencephalography; Female; Humans; Levetiracetam; Methyl-CpG-Binding Protein 2; Patient Selection; Piracetam; Prospective Studies; Quality of Life; Rett Syndrome; Seizures; Treatment Outcome; Young Adult | 2010 |
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy.
Topics: Age Factors; Analysis of Variance; Animals; Anticonvulsants; Chromatography, High Pressure Liquid; Disease Models, Animal; Epilepsy, Absence; Ethosuximide; Levetiracetam; Male; Piracetam; Rats; Rats, Mutant Strains; Time Factors | 2010 |
Seizure risk in brain tumor patients with conversion to generic levetiracetam.
Topics: Adult; Anticonvulsants; Brain Neoplasms; Drugs, Generic; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Seizures | 2010 |
Simultaneous determination of levetiracetam and its acid metabolite (ucb L057) in serum/plasma by liquid chromatography tandem mass spectrometry.
Topics: Chromatography, Liquid; Humans; Levetiracetam; Piracetam; Reference Standards; Tandem Mass Spectrometry | 2010 |
Probable levetiracetam-associated depression in the elderly: two case reports.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Chronic Disease; Depression; Epilepsies, Partial; Female; Follow-Up Studies; Humans; Kidney Diseases; Levetiracetam; Male; Piracetam | 2009 |
Correspondence on ''the unrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production''.
Topics: Anticonvulsants; Brain; Child; Cognition; Cognition Disorders; Developmental Disabilities; Electroencephalography; Epilepsy; Evoked Potentials; Humans; Levetiracetam; Neuropsychological Tests; Nootropic Agents; Piracetam; Recovery of Function | 2009 |
Face-related ictal hallucinations and illusions and reflex-type phenomena.
Topics: Adult; Anticonvulsants; Cerebral Cortex; Electroencephalography; Epilepsy, Complex Partial; Face; Female; Fructose; Hallucinations; Humans; Illusions; Levetiracetam; Magnetic Resonance Imaging; Piracetam; Reflex; Topiramate; Valproic Acid | 2009 |
Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Chemotherapy, Adjuvant; Cohort Studies; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Seizures; Time Factors; Treatment Outcome; Young Adult | 2010 |
Effects of levetiracetam and valproic acid monotherapy on sex-steroid hormones in prepubertal children--results from a pilot study.
Topics: Analysis of Variance; Anticonvulsants; Child; Cohort Studies; Cross-Sectional Studies; Epilepsy; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Levetiracetam; Male; Pilot Projects; Piracetam; Sex Factors; Valproic Acid | 2010 |
Treatment strategies targeting excess hippocampal activity benefit aged rats with cognitive impairment.
Topics: Age Factors; Aging; Animals; Anticonvulsants; CA3 Region, Hippocampal; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Levetiracetam; Male; Maze Learning; Neuropeptide Y; Peptide Fragments; Piracetam; Rats; Rats, Long-Evans; Space Perception; Transduction, Genetic; Valproic Acid | 2010 |
[Levetiracetam (keppra) in the treatment of different epileptic syndromes in adults].
Topics: Adolescent; Adult; Aged; Anticonvulsants; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Middle Aged; Piracetam; Quality of Life; Syndrome; Treatment Outcome; Young Adult | 2009 |
Discovery of indolone acetamides as novel SV2A ligands with improved potency toward seizure suppression.
Topics: Acetamides; Animals; Anticonvulsants; Disease Models, Animal; Indoles; Levetiracetam; Ligands; Membrane Glycoproteins; Mice; Nerve Tissue Proteins; Piracetam; Pyrrolidinones; Rats; Seizures; Synaptic Vesicles | 2010 |
Levetiracetam as add-on therapy in different subgroups of "benign" idiopathic focal epilepsies in childhood.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Cognition Disorders; Electroencephalography; Epilepsies, Partial; Female; Humans; Landau-Kleffner Syndrome; Language Disorders; Language Tests; Levetiracetam; Male; Neuropsychological Tests; Piracetam; Severity of Illness Index | 2010 |
Experimental and simulation studies on the mechanisms of levetiracetam-mediated inhibition of delayed-rectifier potassium current (KV3.1): contribution to the firing of action potentials.
Topics: Action Potentials; Animals; Anticonvulsants; Cell Differentiation; Cell Line, Tumor; Cerebellum; Computer Simulation; Delayed Rectifier Potassium Channels; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; Gene Expression Regulation; Ion Channel Gating; KATP Channels; Levetiracetam; Neural Conduction; Neurons; Piracetam; Rats; Rats, Wistar; Shaw Potassium Channels; Sodium Channels | 2009 |
Transient improvement after brief antiepileptic drug withdrawal in the epilepsy monitoring unit--possible relationship to AED tolerance.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Administration Schedule; Drug Resistance; Drug Tolerance; Electroencephalography; Epilepsy; Female; Follow-Up Studies; Humans; Lamotrigine; Levetiracetam; Male; Oxcarbazepine; Piracetam; Severity of Illness Index; Substance Withdrawal Syndrome; Treatment Outcome; Triazines | 2010 |
Levetiracetam inhibits interleukin-1 beta inflammatory responses in the hippocampus and piriform cortex of epileptic rats.
Topics: Animals; Anticonvulsants; Astrocytes; Chronic Disease; Epilepsy; Gliosis; Hippocampus; Interleukin-1beta; Levetiracetam; Male; Microglia; Olfactory Pathways; Pilocarpine; Piracetam; Rats; Rats, Sprague-Dawley; Receptors, Interleukin-1 Type I; Valproic Acid | 2010 |
Levetiracetam attenuates hippocampal expression of synaptic plasticity-related immediate early and late response genes in amygdala-kindled rats.
Topics: Amygdala; Animals; Anticonvulsants; Disease Models, Animal; Electric Stimulation; Epilepsy, Temporal Lobe; Gene Expression; Genes, Immediate-Early; Hippocampus; Levetiracetam; Male; Neuronal Plasticity; Piracetam; Rats; Rats, Wistar; RNA, Messenger; Seizures; Synapses; Synaptic Transmission; Time Factors | 2010 |
[Which factors have an impact on levetiracetam serum concentrations? An analysis in 163 patients with epilepsy].
Topics: Adult; Analysis of Variance; Anticonvulsants; Biological Availability; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Levetiracetam; Linear Models; Male; Metabolic Clearance Rate; Piracetam; Statistics as Topic | 2010 |
Efficacy and safety of adjunctive levetiracetam therapy in pediatric intractable epilepsy.
Topics: Adolescent; Age Factors; Aggression; Child; Child, Preschool; Epilepsy; Female; Humans; Infant; Irritable Mood; Levetiracetam; Male; Piracetam; Retrospective Studies; Treatment Outcome | 2010 |
Antiepileptogenic and anticonvulsive actions of levetiracetam in a pentylenetetrazole kindling model.
Topics: Animals; Anticonvulsants; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Injections, Intraperitoneal; Kindling, Neurologic; Levetiracetam; Male; Mice; Mice, Inbred Strains; Pentylenetetrazole; Piracetam; Seizures; Treatment Outcome; Valproic Acid | 2010 |
Quantification of levetiracetam in plasma of neonates by ultra performance liquid chromatography-tandem mass spectrometry.
Topics: Anticonvulsants; Chromatography, High Pressure Liquid; Drug Stability; Humans; Infant, Newborn; Levetiracetam; Linear Models; Methanol; Piracetam; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2010 |
Unexpected gamma glutamyltransferase rise increase during levetiracetam monotherapy.
Topics: Anticonvulsants; Drug Monitoring; Epilepsies, Partial; Female; gamma-Glutamyltransferase; Humans; Levetiracetam; Liver; Middle Aged; Piracetam; Treatment Outcome | 2010 |
High-dose intravenous levetiracetam for acute seizure exacerbation in children with intractable epilepsy.
Topics: Child; Child, Preschool; Epilepsy; Female; Humans; Infant; Injections, Intravenous; Levetiracetam; Male; Piracetam; Seizures; Time Factors; Treatment Outcome | 2010 |
Heavy metals testing in active pharmaceutical ingredients: an alternate approach.
Topics: Acids; Catalysis; Europe; Hydrogen Peroxide; Indicators and Reagents; Levetiracetam; Metals, Heavy; Microwaves; Nitric Oxide; Pharmaceutical Preparations; Pharmacopoeias as Topic; Piracetam; Reference Standards; Solutions; Spectrometry, X-Ray Emission; United States | 2010 |
Levetiracetam pharmacokinetics in healthy dogs following oral administration of single and multiple doses.
Topics: Administration, Oral; Animals; Anticonvulsants; Area Under Curve; Chromatography, High Pressure Liquid; Dogs; Half-Life; Kinetics; Levetiracetam; Metabolic Clearance Rate; Piracetam | 2010 |
Efficacy and safety of levetiracetam in patients with glioma: a clinical prospective study.
Topics: Adult; Aged; Anticonvulsants; Brain Neoplasms; Dose-Response Relationship, Drug; Epilepsy; Female; Glioma; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Severity of Illness Index | 2010 |
Thrombocytopenia as an adverse effect of levetiracetam therapy in a child.
Topics: Anticonvulsants; Child; Epilepsy; Humans; Levetiracetam; Male; Piracetam; Sinus Thrombosis, Intracranial; Thrombocytopenia | 2009 |
Seizure management in a complex hospice patient.
Topics: Anti-Retroviral Agents; Anticonvulsants; Drug Interactions; Female; HIV Infections; Hospice Care; Humans; Levetiracetam; Piracetam; Seizures; Young Adult | 2010 |
Region-specific changes in gene expression in rat brain after chronic treatment with levetiracetam or phenytoin.
Topics: Animals; Anticonvulsants; Brain; Female; Frontal Lobe; Gene Expression Regulation; Hippocampus; Levetiracetam; Medulla Oblongata; Models, Animal; Oligonucleotide Array Sequence Analysis; Phenytoin; Piracetam; Pons; Rats; Rats, Wistar; RNA, Messenger; Tissue Distribution | 2010 |
Alterations of intracerebral γ-aminobutyric acid (GABA) levels by titration with levetiracetam in patients with focal epilepsies.
Topics: Adult; Anticonvulsants; Creatine; Electroencephalography; Electrons; Epilepsies, Partial; Female; gamma-Aminobutyric Acid; Humans; Levetiracetam; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Occipital Lobe; Piracetam; Protons; Radionuclide Imaging; Young Adult | 2010 |
Efficacy and tolerability of levetiracetam in children with epilepsy.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Epilepsy; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Levetiracetam; Male; Piracetam; Retrospective Studies; Time Factors | 2011 |
Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy.
Topics: Adult; Aged; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Resistance; Epilepsy; Female; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Levetiracetam; Male; Middle Aged; Oxcarbazepine; Phenytoin; Piracetam; Retrospective Studies; Topiramate; Treatment Outcome; Triazines | 2010 |
Levetiracetam in submaximal subcutaneous pentylentetrazol-induced seizures in rats.
Topics: Animals; Anticonvulsants; Convulsants; Dose-Response Relationship, Drug; Electroshock; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Injections, Subcutaneous; Levetiracetam; Male; Pentylenetetrazole; Piracetam; Rats; Rats, Wistar; Seizures; Valproic Acid | 2010 |
Intravenous levetiracetam in children with seizures: a prospective safety study.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Humans; Infant; Infusions, Intravenous; Levetiracetam; Male; Piracetam; Prospective Studies; Regression Analysis; Seizures; Time Factors; Treatment Outcome | 2010 |
[Efficacy and safety of adjunctive levetiracetam in children younger than 4 years with refractory epilepsy].
Topics: Anticonvulsants; Child, Preschool; Epilepsy; Female; Humans; Infant; Levetiracetam; Male; Piracetam | 2010 |
Generalized seizures aggravated by levetiracetam in an adult patient with phenylketonuria.
Topics: Anticonvulsants; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; Female; Fructose; Humans; Levetiracetam; Phenylalanine; Phenylketonurias; Piracetam; Topiramate; Treatment Outcome; Young Adult | 2010 |
Effect of levetiracetam on hippocampal protein expression and cell proliferation in rats.
Topics: Animals; Anticonvulsants; Bromodeoxyuridine; Cell Proliferation; Databases, Protein; Electrophoresis, Gel, Two-Dimensional; Female; Gene Expression Regulation; Hippocampus; Levetiracetam; Mass Spectrometry; Multivariate Analysis; Piracetam; Principal Component Analysis; Rats; Rats, Sprague-Dawley | 2010 |
Separate episodes of delirium associated with levetiracetam and amiodarone treatment in an elderly woman.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Anticonvulsants; Delirium; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Levetiracetam; Piracetam | 2010 |
In reference to Usery JB et al. (J Neuro-oncol. 2010 Feb 10).
Topics: Brain Neoplasms; Humans; Levetiracetam; Nootropic Agents; Piracetam; Prospective Studies | 2010 |
The tolerability and efficacy of levetiracetam.
Topics: Anticonvulsants; Epilepsy; Humans; Levetiracetam; Piracetam; Treatment Outcome | 2010 |
Levetiracetam in clinical practice: efficacy and tolerability in epilepsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Child; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Logistic Models; Male; Middle Aged; Piracetam; Retrospective Studies; Treatment Outcome; Young Adult | 2010 |
Improvement of myoclonic epilepsy in Down syndrome treated with levetiracetam.
Topics: Adult; Alzheimer Disease; Anticonvulsants; Disease Progression; Dose-Response Relationship, Drug; Down Syndrome; Drug Administration Schedule; Electroencephalography; Epilepsies, Myoclonic; Humans; Levetiracetam; Middle Aged; Piracetam; Signal Processing, Computer-Assisted | 2010 |
Levetiracetam-induced seizure aggravation associated with continuous spikes and waves during slow sleep in children with refractory epilepsies.
Topics: Anticonvulsants; Child; Drug Therapy, Combination; Electroencephalography; Epilepsies, Myoclonic; Epilepsies, Partial; Epilepsy, Tonic-Clonic; Evoked Potentials; Female; Humans; Levetiracetam; Male; Piracetam; Seizures; Sleep; Syndrome | 2010 |
BsmI vitamin D receptor's polymorphism and bone mineral density in men and premenopausal women on long-term antiepileptic therapy.
Topics: Absorptiometry, Photon; Adolescent; Adult; Alleles; Anticonvulsants; Bone Density; Calcium, Dietary; Carbamazepine; Cross-Sectional Studies; Epilepsy; Female; Genotype; Humans; Levetiracetam; Male; Middle Aged; Oxcarbazepine; Piracetam; Polymorphism, Genetic; Premenopause; Receptors, Calcitriol; Regression Analysis; Statistics, Nonparametric; Valproic Acid | 2011 |
Efficacy and safety of levetiracetam for outpatient alcohol detoxification.
Topics: Adolescent; Adult; Aged; Alcohol Drinking; Alcoholism; Ambulatory Care; Anticonvulsants; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Psychotherapy; Recurrence; Substance Withdrawal Syndrome; Temperance; Treatment Outcome; Young Adult | 2010 |
Dose-related levetiracetam-induced reticulated drug eruption.
Topics: Anticonvulsants; Dose-Response Relationship, Drug; Drug Eruptions; Female; Humans; Levetiracetam; Middle Aged; Piracetam | 2010 |
Rapid improvement of neuroleptic-induced tardive dyskinesia with levetiracetam in an interictal psychotic patient.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Levetiracetam; Middle Aged; Piracetam; Psychotic Disorders; Time Factors; Treatment Outcome | 2010 |
Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide.
Topics: Anticonvulsants; Antineoplastic Agents; Blotting, Western; Cell Proliferation; Chromatin Immunoprecipitation; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Gene Expression; Glioblastoma; Humans; Levetiracetam; Piracetam; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Temozolomide; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2010 |
Perioperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Female; Humans; Levetiracetam; Male; Middle Aged; Neurosurgical Procedures; Perioperative Period; Piracetam; Postoperative Complications; Retrospective Studies; Seizures; Supratentorial Neoplasms | 2011 |
Reversible blindness: simple partial seizures presenting as ictal and postictal hemianopsia.
Topics: Adult; Anticonvulsants; Brain; Electroencephalography; Epilepsies, Partial; Female; Hemianopsia; Humans; Illusions; Levetiracetam; Liver Diseases; Liver Transplantation; Magnetic Resonance Imaging; Piracetam; Visual Field Tests | 2010 |
Seizures in patients with glioma treated with phenytoin and levetiracetam.
Topics: Adult; Aged; Anticonvulsants; Female; Glioma; Humans; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Retrospective Studies; Seizures | 2010 |
Levetiracetam-mediated emotional behavior in heterozygous rolling Nagoya Ca(V)2.1 channel mutant mice.
Topics: Animals; Anticonvulsants; Anxiety; Blotting, Western; Brain Stem; Calcium Channels, N-Type; Dopamine; Emotions; Exploratory Behavior; Genotype; Hindlimb Suspension; Levetiracetam; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Mutation; Piracetam; Serotonin; Swimming; Synapses; Tryptophan Hydroxylase | 2010 |
Decrease in propagation of interictal epileptiform activity after introduction of levetiracetam visualized with electric source imaging.
Topics: Anticonvulsants; Brain Mapping; Child; Child, Preschool; Diagnostic Imaging; Electroencephalography; Epilepsy; Female; Humans; Levetiracetam; Male; Piracetam; Time Factors | 2010 |
Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Cardiovascular Diseases; Comorbidity; Epilepsy; Female; Humans; Lamotrigine; Levetiracetam; Male; Middle Aged; Piracetam; Risk Factors; Triazines; Young Adult | 2010 |
Levetiracetam suppresses development of spontaneous EEG seizures and aberrant neurogenesis following kainate-induced status epilepticus.
Topics: Animals; Animals, Newborn; Bromodeoxyuridine; Dentate Gyrus; Disease Models, Animal; Electroencephalography; Homeodomain Proteins; Immunohistochemistry; Kainic Acid; Levetiracetam; Neurons; Nootropic Agents; Piracetam; Rats; Seizures; Status Epilepticus; Tetanus Toxin; Time Factors; Tumor Suppressor Proteins | 2010 |
[Myoclonias with a propiospinal and radicular origin: their response to levetiracetam].
Topics: Anticonvulsants; Epilepsies, Myoclonic; Female; Humans; Levetiracetam; Piracetam; Young Adult | 2010 |
Intravenous levetiracetam in the management of acute seizures in children.
Topics: Acute Disease; Adolescent; Anticonvulsants; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Injections, Intravenous; Levetiracetam; Male; Piracetam; Retrospective Studies; Seizures; Time Factors; Treatment Outcome | 2010 |
Efficacy of levetiracetam in children with refractory epilepsy as an add-on trial.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Epilepsy; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Prospective Studies; Treatment Outcome | 2010 |
[Prophylactic efficacy of levetiracetam, valproate or phenobarbital on febrile convulsions in rats].
Topics: Animals; Anticonvulsants; Levetiracetam; Male; Phenobarbital; Piracetam; Rats; Recurrence; Seizures, Febrile; Valproic Acid | 2010 |
Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy.
Topics: Administration, Oral; Adolescent; Age Factors; Anticonvulsants; Child; Child, Preschool; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; Female; Humans; Infant; Levetiracetam; Male; Mental Disorders; Piracetam; Retrospective Studies; Treatment Outcome; Young Adult | 2010 |
Subthreshold pharmacological and genetic approaches to analyzing CaV2.1-mediated NMDA receptor signaling in short-term memory.
Topics: Animals; Calcium Channels, N-Type; Heterozygote; Hippocampus; Levetiracetam; Male; Maze Learning; Memory, Short-Term; Mice; Mice, Mutant Strains; Piperazines; Piracetam; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Signal Transduction; Space Perception | 2010 |
Catatonia after right temporal lobe resection.
Topics: Adult; Anticonvulsants; Catatonia; Epilepsy, Temporal Lobe; Humans; Levetiracetam; Lorazepam; Male; Neurosurgical Procedures; Piracetam; Temporal Lobe; Treatment Outcome | 2010 |
Tuberous sclerosis.
Topics: Adult; Anticonvulsants; Carbamazepine; Female; Humans; Levetiracetam; Mutation; Piracetam; Tuberous Sclerosis; Tuberous Sclerosis Complex 1 Protein; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins | 2010 |
The effect of valproate and levetiracetam on steroidogenesis in forskolin-stimulated H295R cells.
Topics: Adrenal Gland Neoplasms; Anticonvulsants; Aromatase; Cell Line, Tumor; Colforsin; Cytochrome P-450 CYP1A1; DAX-1 Orphan Nuclear Receptor; Dose-Response Relationship, Drug; Estradiol; Gene Expression; Humans; In Vitro Techniques; Levetiracetam; Piracetam; Polymerase Chain Reaction; Progesterone; Steroidogenic Factor 1; Stimulation, Chemical; Testosterone; Valproic Acid | 2010 |
The antihyperalgesic effect of levetiracetam in an inflammatory model of pain in rats: mechanism of action.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Disease Models, Animal; Hyperalgesia; Levetiracetam; Male; Narcotic Antagonists; Pain; Piracetam; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, GABA-A; Receptors, Opioid; Receptors, Serotonin | 2010 |
Cortico-hippocampal hyperexcitability in synapsin I/II/III knockout mice: age-dependency and response to the antiepileptic drug levetiracetam.
Topics: 4-Aminopyridine; Aging; Analysis of Variance; Animals; Anticonvulsants; Cerebral Cortex; Disease Models, Animal; Drug Interactions; Electrodes; Epilepsy, Tonic-Clonic; Evoked Potentials; Gene Expression Regulation; Hippocampus; In Vitro Techniques; Levetiracetam; Membrane Glycoproteins; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Tissue Proteins; Neurons; Patch-Clamp Techniques; Piracetam; Potassium Channel Blockers; Synapsins; Synaptophysin | 2010 |
Inhibitory effects of levetiracetam on absence seizures in a novel absence-like epilepsy animal model, Groggy rat.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Electroencephalography; Epilepsy, Absence; Levetiracetam; Piracetam; Rats; Rats, Mutant Strains; Rats, Wistar | 2010 |
[Levetiracetam modifies the pattern of audiogenic locomotive response in Wistar and Krushinsky-Molodkina strain rats].
Topics: Acoustic Stimulation; Animals; Anticonvulsants; Levetiracetam; Male; Motor Activity; Piracetam; Rats; Rats, Wistar; Reaction Time; Seizures; Species Specificity | 2010 |
Juvenile myoclonic epilepsy.
Topics: Anticonvulsants; Electroencephalography; Family Health; Humans; Levetiracetam; Mutation; Myoclonic Epilepsy, Juvenile; Piracetam; Receptors, GABA-A; Seizures | 2010 |
Age and comedications influence levetiracetam pharmacokinetics in children.
Topics: Adolescent; Age Factors; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Infant; Lamotrigine; Levetiracetam; Male; Metabolic Clearance Rate; Oxcarbazepine; Phenytoin; Piracetam; Retrospective Studies; Triazines; Valproic Acid | 2010 |
Probable psychosis associated with levetiracetam: a case report.
Topics: Anticonvulsants; Epilepsies, Partial; Epilepsy, Tonic-Clonic; Humans; Levetiracetam; Male; Piracetam; Psychoses, Substance-Induced; Young Adult | 2011 |
Improvement of early diagnosed post-anoxic myoclonus with levetiracetam.
Topics: Adolescent; Anticonvulsants; Early Diagnosis; Female; Humans; Hypoxia, Brain; Levetiracetam; Male; Middle Aged; Myoclonus; Piracetam | 2011 |
Effects of levetiracetam on blood-brain barrier disturbances following hyperthermia-induced seizures in rats with cortical dysplasia.
Topics: Animals; Anticonvulsants; Blood-Brain Barrier; Disease Models, Animal; Female; Fever; Fluorescein; Gamma Rays; Levetiracetam; Male; Malformations of Cortical Development; Microscopy, Electron; Piracetam; Pregnancy; Rats; Rats, Sprague-Dawley; Seizures; Tight Junctions | 2010 |
11-Deoxycortisol impedes GABAergic neurotransmission and induces drug-resistant status epilepticus in mice.
Topics: Animals; Anticonvulsants; Cerebellum; Cortodoxone; Dose-Response Relationship, Drug; Drug Resistance; Electroencephalography; Epilepsy; Hippocampus; Inhibitory Postsynaptic Potentials; Levetiracetam; Male; Mice; Mice, Inbred C57BL; Piracetam; Receptors, GABA-A; Status Epilepticus | 2011 |
Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
Topics: Adolescent; Adult; Aged; Amines; Anticonvulsants; Carbamazepine; Chi-Square Distribution; Child; China; Clonazepam; Cyclohexanecarboxylic Acids; Exanthema; Female; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Levetiracetam; Male; Medicine, Chinese Traditional; Middle Aged; Phenobarbital; Phenytoin; Piracetam; Retrospective Studies; Topiramate; Triazines; Valproic Acid; Young Adult | 2010 |
Levetiracetam is associated with improved cognitive outcome for patients with intracranial hemorrhage.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Cognition Disorders; Female; Humans; Intracranial Hemorrhages; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Retrospective Studies; Seizures; Young Adult | 2011 |
Increased compactibility of acetames after roll compaction.
Topics: Central Nervous System Agents; Chemical Phenomena; Drug Compounding; Levetiracetam; Particle Size; Piracetam; Powders; Pressure; Pyrrolidinones; Surface Properties; Tablets | 2011 |
Nonepileptic seizures under levetiracetam therapy.
Topics: Adult; Anticonvulsants; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Seizures | 2010 |
Restless Leg Syndrome in ADHD children: levetiracetam as a reasonable therapeutic option.
Topics: Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Comorbidity; Electroencephalography; Humans; Levetiracetam; Male; Piracetam; Restless Legs Syndrome; Sleep; Surveys and Questionnaires | 2011 |
Anti-inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia are mediated via TGFβ1 regulation.
Topics: Animals; Anti-Inflammatory Agents; Anticonvulsants; Astrocytes; Coculture Techniques; Electrophysiological Phenomena; Interleukin-1beta; Levetiracetam; Membrane Potentials; Microglia; Patch-Clamp Techniques; Piracetam; Rats; Rats, Wistar; Transforming Growth Factor beta1 | 2011 |
Epilepsy and trimethylaminuria: A new case report and literature review.
Topics: Anticonvulsants; Child; Comorbidity; Electroencephalography; Epilepsy; Female; Humans; Levetiracetam; Metabolism, Inborn Errors; Methylamines; Neuropsychological Tests; Piracetam | 2011 |
Non-convulsive status epilepticus in the postanesthesia care unit following meningioma excision.
Topics: Aged, 80 and over; Anticonvulsants; Craniotomy; Electroencephalography; Female; Humans; Levetiracetam; Meningeal Neoplasms; Meningioma; Piracetam; Postoperative Complications; Recovery Room; Status Epilepticus | 2011 |
Acceptability and tolerability of levetiracetam oral solution for the treatment of partial-onset seizures: the SOLUCIÓN study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Cross-Sectional Studies; Female; Humans; Levetiracetam; Male; Middle Aged; Patient Compliance; Patient Preference; Pharmaceutical Solutions; Piracetam; Seizures; Taste; Young Adult | 2010 |
A case of levetiracetam-induced thrombocytopenia.
Topics: Anticonvulsants; Brain Neoplasms; Epilepsies, Partial; Female; Frontal Lobe; Glioblastoma; Humans; Levetiracetam; Middle Aged; Piracetam; Platelet Count; Thrombocytopenia; Treatment Outcome | 2010 |
Nocturnal frontal lobe epilepsy presenting with restless leg syndrome-like symptoms.
Topics: Anticonvulsants; Brain Diseases; Carbamazepine; Electroencephalography; Epilepsy; Epilepsy, Frontal Lobe; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Malformations of Cortical Development; Malformations of Cortical Development, Group I; Piracetam; Restless Legs Syndrome; Young Adult | 2011 |
Levetiracetam: safety and efficacy in neonatal seizures.
Topics: Administration, Oral; Anticonvulsants; Feasibility Studies; Female; Humans; Infant, Newborn; Infant, Premature; Injections, Intravenous; Levetiracetam; Male; Piracetam; Prospective Studies; Seizures | 2011 |
Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeks.
Topics: Anticonvulsants; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsies, Partial; Female; Follow-Up Studies; Humans; Infant; Levetiracetam; Male; Piracetam; Prospective Studies; Retrospective Studies; Time Factors; Treatment Outcome | 2010 |
Anti-convulsants and gene expression in malignant gliomas.
Topics: Brain Neoplasms; Convulsants; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Glioma; Humans; Levetiracetam; Piracetam; Time Factors | 2010 |
Successful treatment of refractory simple motor status epilepticus with lacosamide and levetiracetam.
Topics: Acetamides; Anticonvulsants; Humans; Lacosamide; Levetiracetam; Magnetic Resonance Imaging; Male; Middle Aged; Piracetam; Status Epilepticus | 2011 |
The EULEV cohort study: rates of and factors associated with continuation of levetiracetam after 1 year.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Cohort Studies; Epilepsy; Female; France; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Time Factors; Treatment Outcome; Young Adult | 2011 |
Efficacy of intravenous levetiracetam as an add-on treatment in status epilepticus: a multicentric observational study.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Female; Humans; Injections, Intravenous; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Status Epilepticus; Time Factors; Treatment Outcome; Young Adult | 2011 |
Status epilepticus.
Topics: Anticonvulsants; Benzodiazepines; Child; Clinical Protocols; Fructose; GABA Modulators; Humans; Ketamine; Levetiracetam; Midazolam; Pentobarbital; Phenobarbital; Phenytoin; Piracetam; Propofol; Status Epilepticus; Thiopental; Topiramate; Valproic Acid | 2011 |
Performance characteristics of a new levetiracetam immunoassay and method comparison with a high-performance liquid chromatography method.
Topics: Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Immunoassay; Levetiracetam; Nootropic Agents; Piracetam; Quality Control | 2011 |
Elderly patient with acquired long QT syndrome secondary to Levetiracetam.
Topics: Aged, 80 and over; Anticonvulsants; Female; Humans; Levetiracetam; Long QT Syndrome; Piracetam | 2011 |
Role of Ca(V)2.1-mediated NMDA receptor signaling in the nucleus accumbens in spatial short-term memory.
Topics: Analysis of Variance; Animals; Calcium Channels, N-Type; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Exploratory Behavior; Levetiracetam; Maze Learning; Memory, Short-Term; Mice; Mice, Neurologic Mutants; N-Methylaspartate; Nucleus Accumbens; Piracetam; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Space Perception | 2011 |
Recurrent sinus arrest and asystole due to breath-holding spell in a toddler; recovery with levetiracetam-therapy.
Topics: Anticonvulsants; Electrocardiography; European Union; Female; Heart Arrest; Humans; Infant; Levetiracetam; Piracetam; Recurrence; Respiration; Sinus Arrest, Cardiac; Treatment Outcome | 2010 |
Effect of levetiracetam on testosterone levels in male patients.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Epilepsy; Follicle Stimulating Hormone; Humans; Levetiracetam; Luteinizing Hormone; Middle Aged; Piracetam; Reference Values; Sex Hormone-Binding Globulin; Testosterone; Young Adult | 2010 |
Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol preferring rats chronically treated with levetiracetam: a preliminary study.
Topics: Alcohol Drinking; Alcoholism; Animals; Anticonvulsants; beta-Endorphin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethanol; Female; Humans; Levetiracetam; Piracetam; Rats; Rats, Inbred Strains; Self Administration; Substance Withdrawal Syndrome | 2011 |
Higher evening antiepileptic drug dose for nocturnal and early-morning seizures.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Diethylcarbamazine; Dose-Response Relationship, Drug; Drug Chronotherapy; Electroencephalography; Electronic Health Records; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Seizures; Statistics, Nonparametric; Treatment Outcome | 2011 |
Levetiracetam-induced thrombocytopenia among inpatients: a retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Blood Platelets; Drug Therapy, Combination; Epilepsy, Generalized; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Thrombocytopenia | 2010 |
Acute levetiracetam overdose presented with mild adverse events.
Topics: Adult; Humans; Levetiracetam; Male; Neurotoxicity Syndromes; Piracetam; Seizures | 2010 |
Early valproic acid exposure alters functional organization in the primary visual cortex.
Topics: Age Factors; Animals; Animals, Newborn; Female; Ferrets; Levetiracetam; Orientation; Piracetam; Sensory Deprivation; Valproic Acid; Visual Cortex | 2011 |
Levetiracetam for treatment of neonatal seizures.
Topics: Anticonvulsants; Child, Preschool; Electroencephalography; Female; Gestational Age; Humans; Levetiracetam; Male; Piracetam; Retrospective Studies; Seizures; Treatment Outcome | 2011 |
Levetiracetam in children and adolescents with epilepsy and hemiplegic cerebral palsy.
Topics: Adolescent; Anticonvulsants; Cerebral Palsy; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy; Female; Hemiplegia; Humans; Levetiracetam; Male; Outcome Assessment, Health Care; Piracetam | 2011 |
Clinical diagnosis and successful treatment of inflammatory cerebral amyloid angiopathy.
Topics: Aged; Anticonvulsants; Apolipoprotein E4; Brain Edema; Cerebral Amyloid Angiopathy, Familial; Diffusion Magnetic Resonance Imaging; Drug Therapy, Combination; Genotype; Humans; Image Processing, Computer-Assisted; Immunosuppressive Agents; Levetiracetam; Magnetic Resonance Imaging; Male; Neurologic Examination; Neuropsychological Tests; Occipital Lobe; Piracetam; Prednisone; Temporal Lobe | 2011 |
The use of lacosamide in refractory status epilepticus.
Topics: Acetamides; Aged; Aged, 80 and over; Angioedema; Anticonvulsants; Drug Administration Schedule; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Intensive Care Units; Lacosamide; Levetiracetam; Male; Middle Aged; Piracetam; Status Epilepticus | 2011 |
Child development following in utero exposure: levetiracetam vs sodium valproate.
Topics: Anticonvulsants; Child Development; Child, Preschool; Cognition; Epilepsy; Female; Humans; Infant; Levetiracetam; Maternal Exposure; Maternal-Fetal Exchange; Piracetam; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Retrospective Studies; Valproic Acid | 2011 |
Carbamazepine in pregnancy: Levetiracetam and lamotrigine are better options.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Contraindications; Epilepsy; Female; Humans; Lamotrigine; Levetiracetam; Piracetam; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Triazines | 2011 |
Suspected phenobarbital-induced pseudolymphoma in a cat.
Topics: Animals; Anticonvulsants; Cat Diseases; Cats; Epilepsy; Female; Levetiracetam; Phenobarbital; Piracetam; Pseudolymphoma | 2011 |
Simultaneous quantification of levetiracetam and gabapentin in plasma by ultra-pressure liquid chromatography coupled with tandem mass spectrometry detection.
Topics: Amines; Anticonvulsants; Chromatography, Liquid; Cyclohexanecarboxylic Acids; Drug Monitoring; Gabapentin; gamma-Aminobutyric Acid; Humans; Levetiracetam; Piracetam; Reproducibility of Results; Tandem Mass Spectrometry | 2011 |
[Transient splenial lesion in influenza A H1N1 2009 infection].
Topics: Acyclovir; Anticonvulsants; Antiviral Agents; Child; Corpus Callosum; Diffusion Magnetic Resonance Imaging; Drug Therapy, Combination; Encephalitis, Viral; Epilepsy, Tonic-Clonic; Follow-Up Studies; Humans; Image Enhancement; Image Processing, Computer-Assisted; Influenza A Virus, H1N1 Subtype; Influenza, Human; Levetiracetam; Magnetic Resonance Imaging; Male; Oseltamivir; Pandemics; Piracetam; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Safety of non-therapeutic levetiracetam ingestions--a poison center based study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Child; Child, Preschool; Databases, Factual; Drug Overdose; Female; Humans; Infant; Levetiracetam; Male; Middle Aged; Piracetam; Poison Control Centers; Retrospective Studies; Young Adult | 2011 |
Effect of valproate, lamotrigine and levetiracetam on excitability and firing properties of CA1 neurons in rat brain slices.
Topics: Action Potentials; Animals; Bicuculline; CA1 Region, Hippocampal; Female; In Vitro Techniques; Lamotrigine; Levetiracetam; Male; Neurons; Piracetam; Rats; Rats, Sprague-Dawley; Triazines; Valproic Acid | 2011 |
Levetiracetam efficacy in patients with Lennox-Gastaut syndrome. Presentation of a case.
Topics: Anticonvulsants; Child, Preschool; Humans; Intellectual Disability; Lennox Gastaut Syndrome; Levetiracetam; Male; Piracetam; Spasms, Infantile | 2011 |
Protein kinase inhibitor as a potential candidate for epilepsy treatment.
Topics: 4-Aminopyridine; Animals; Anticonvulsants; Carbamazepine; Carbenoxolone; Cerebral Cortex; Electroencephalography; Epilepsy; Female; Heart Rate; Levetiracetam; Male; Piracetam; Premedication; Protein Kinase Inhibitors; Rats; Rats, Wistar; Signal Processing, Computer-Assisted | 2011 |
The efficacy of bromides, stiripentol and levetiracetam in two patients with malignant migrating partial seizures in infancy.
Topics: Anticonvulsants; Bromides; Dioxolanes; Drug Therapy, Combination; Electroencephalography; Epilepsies, Partial; Female; Humans; Infant; Infant, Newborn; Levetiracetam; Piracetam; Sodium Compounds; Treatment Outcome | 2011 |
Use of intravenous levetiracetam for management of acute seizures in neonates.
Topics: Anticonvulsants; Female; Follow-Up Studies; Humans; Infant; Injections, Intravenous; Levetiracetam; Male; Piracetam; Retrospective Studies; Seizures; Treatment Outcome | 2011 |
Clinical experience with generic levetiracetam in people with epilepsy.
Topics: Adult; Anticonvulsants; Cohort Studies; Drug Substitution; Drugs, Generic; Epilepsy; Female; Hospitalization; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Seizures; Treatment Failure | 2011 |
Clinical and neuropsychological considerations in a case of unrecognized myoclonic epileptic jerks dramatically controlled by levetiracetam.
Topics: Anticonvulsants; Child; Cognition Disorders; Electroencephalography; Epilepsies, Myoclonic; Female; Humans; Levetiracetam; Myoclonus; Neuropsychological Tests; Piracetam; Treatment Outcome | 2010 |
Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam.
Topics: Aged; Analysis of Variance; Anticonvulsants; Chi-Square Distribution; Female; Humans; Levetiracetam; Logistic Models; Male; Middle Aged; Multivariate Analysis; Phenytoin; Piracetam; Retrospective Studies; Status Epilepticus; Treatment Failure; Valproic Acid | 2011 |
Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis?
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Electroencephalography; Encephalitis; Female; Humans; Intracellular Signaling Peptides and Proteins; Lamotrigine; Levetiracetam; Middle Aged; Phenytoin; Piracetam; Proteins; Seizures; Triazines | 2011 |
Prophylactic anticonvulsants after subarachnoid hemorrhage.
Topics: Anticonvulsants; Epilepsy; Humans; Incidence; Levetiracetam; Phenytoin; Piracetam; Subarachnoid Hemorrhage | 2011 |
Comparison of short-duration levetiracetam with extended-course phenytoin for seizure prophylaxis after subarachnoid hemorrhage.
Topics: Adult; Aged; Anticonvulsants; Databases, Factual; Delayed-Action Preparations; Disease-Free Survival; Epilepsy; Female; Humans; Incidence; Inpatients; Intensive Care Units; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Subarachnoid Hemorrhage | 2011 |
The effects of valproic acid and levetiracetam on chicken embryos.
Topics: Animals; Anticonvulsants; Chick Embryo; Developmental Disabilities; Dose-Response Relationship, Drug; Levetiracetam; Piracetam; Time Factors; Valproic Acid | 2011 |
Conclusions of the available meta-analyses exploring the efficacy of levetiracetam.
Topics: Anticonvulsants; Epilepsy; Humans; Levetiracetam; Meta-Analysis as Topic; Piracetam | 2011 |
Generic substitution of levetiracetam resulting in increased incidence of breakthrough seizures.
Topics: Adult; Aged, 80 and over; Anticonvulsants; Drug Substitution; Drugs, Generic; Female; Humans; Incidence; Levetiracetam; Male; Middle Aged; Piracetam; Seizures; Treatment Failure; Young Adult | 2011 |
Levetiracetam protects hippocampal neurons in culture against hypoxia-induced injury.
Topics: Animals; Cell Death; Cell Hypoxia; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Hippocampus; L-Lactate Dehydrogenase; Levetiracetam; Neurons; Neuroprotective Agents; Piracetam; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2011 |
Abnormal facilitatory mechanisms in motor cortex of migraine with aura.
Topics: Adult; Electromyography; Evoked Potentials, Motor; Female; Humans; Levetiracetam; Male; Migraine with Aura; Motor Cortex; Nerve Net; Neurons; Piracetam; Transcranial Magnetic Stimulation | 2011 |
Levetiracetam monotherapy--outcomes from an epilepsy clinic.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Child; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Scotland; Treatment Outcome | 2011 |
Effects of antiepileptic drugs on GABA release from rat and human neocortical synaptosomes.
Topics: Adolescent; Adult; Aged; Amines; Animals; Anticonvulsants; Calcium; Carbamazepine; Child; Child, Preschool; Cyclohexanecarboxylic Acids; Female; GABA Antagonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Infant; Lamotrigine; Levetiracetam; Male; Middle Aged; Neocortex; Nipecotic Acids; Oximes; Phenytoin; Piracetam; Potassium; Pregabalin; Rats; Rats, Wistar; Synaptosomes; Tetanus Toxin; Tetrodotoxin; Triazines; Valproic Acid; Veratridine; Young Adult | 2011 |
Childhood febrile convulsions and déjà vu in adulthood.
Topics: Adult; Anticonvulsants; Deja Vu; Epilepsy, Temporal Lobe; Epilepsy, Tonic-Clonic; Female; Humans; Levetiracetam; Piracetam; Seizures, Febrile; Treatment Outcome | 2011 |
No effect of oral contraceptives on the metabolism of levetiracetam.
Topics: Adolescent; Adult; Anticonvulsants; Contraceptives, Oral; Dose-Response Relationship, Drug; Epilepsy; Female; Humans; Levetiracetam; Middle Aged; Piracetam; Pregnancy; Young Adult | 2011 |
Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
Topics: Adult; Anticonvulsants; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Epilepsies, Partial; Female; gamma-Aminobutyric Acid; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Placebos; Pregabalin; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Failure; Treatment Outcome | 2011 |
Enhanced efficacy of anticonvulsants when combined with levetiracetam in soman-exposed rats.
Topics: Animals; Anticonvulsants; Antidotes; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterase Reactivators; Cyclopentanes; Disease Models, Animal; Drug Therapy, Combination; Lethal Dose 50; Levetiracetam; Male; Motor Activity; Muscimol; Nicotinic Antagonists; Piracetam; Procyclidine; Quinoxalines; Rats; Rats, Wistar; Reaction Time; Seizures; Soman; Time Factors | 2011 |
[Effects of levetiracetam on the expression of NCAM and GAP-43 mRNA in the hippocampus of rats with epilepsy].
Topics: Animals; Anticonvulsants; Epilepsy; GAP-43 Protein; Hippocampus; Levetiracetam; Male; Neural Cell Adhesion Molecules; Piracetam; Rats; Rats, Wistar; RNA, Messenger | 2011 |
Pharmacokinetics of levetiracetam in neonates with seizures.
Topics: Anticonvulsants; Body Weight; Chromatography, Liquid; Creatinine; Female; Half-Life; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Levetiracetam; Male; Multivariate Analysis; Piracetam; Prospective Studies; Seizures; Tandem Mass Spectrometry | 2011 |
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model.
Topics: Animals; Anticonvulsants; Brain; Carbamazepine; Depression; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy, Absence; Ethosuximide; Isoxazoles; Levetiracetam; Male; Piracetam; Rats; Rats, Wistar; Seizures; Zonisamide | 2011 |
A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam.
Topics: Animals; Anticonvulsants; Excitatory Postsynaptic Potentials; Hippocampus; Levetiracetam; Organ Culture Techniques; Piracetam; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Synaptic Vesicles | 2011 |
Neuroprotective effect of levetiracetam on hippocampal sclerosis-like change in spontaneously epileptic rats.
Topics: Animals; Anticonvulsants; Brain-Derived Neurotrophic Factor; Hippocampus; Levetiracetam; Neurons; Neuroprotective Agents; Piracetam; Placebos; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley; Sclerosis; Seizures | 2011 |
Aggravation of absence seizure related to levetiracetam.
Topics: Anticonvulsants; Child; Child, Preschool; Electroencephalography; Epilepsy, Absence; Female; France; Humans; Levetiracetam; Male; Piracetam; Retrospective Studies | 2011 |
Levetiracetam reduces the frequency of interictal epileptiform discharges during NREM sleep in children with ADHD.
Topics: Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Child; Electroencephalography; Epilepsy; Female; Humans; Levetiracetam; Male; Piracetam; Retrospective Studies; Sleep Stages; Wakefulness | 2011 |
Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage.
Topics: Administration, Oral; Aged; Aneurysm, Ruptured; Anti-Bacterial Agents; Anticonvulsants; Biological Availability; Brain Ischemia; Critical Care; Drug Interactions; Enteral Nutrition; Epilepsy; Female; Humans; Intensive Care Units; Levetiracetam; Male; Meropenem; Middle Aged; Piracetam; Prospective Studies; Seizures; Subarachnoid Hemorrhage; Thienamycins; Valproic Acid | 2011 |
Haematological side effects of antiepileptic drug treatment in patients with epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Blood Platelets; Carbamazepine; Cross-Sectional Studies; Epilepsy; Female; Humans; Lamotrigine; Leukocytes; Levetiracetam; Male; Middle Aged; Piracetam; Platelet Count; Triazines; Valproic Acid | 2011 |
[The effectiveness of levetiracetam in the treatment of neuropathic pain].
Topics: Anticonvulsants; Clinical Trials as Topic; Humans; Levetiracetam; Neuralgia; Piracetam; PubMed; Review Literature as Topic; Treatment Outcome | 2011 |
A prospective study of levetiracetam efficacy in epileptic syndromes with continuous spikes-waves during slow sleep.
Topics: Action Potentials; Adolescent; Anticonvulsants; Brain Waves; Child; Child, Preschool; Electroencephalography; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Piracetam; Prospective Studies; Sleep; Syndrome; Treatment Outcome | 2011 |
Postpartum cerebral venous thrombosis.
Topics: Anticoagulants; Anticonvulsants; Brain; Female; Heparin; Humans; Hypertension; Levetiracetam; Magnesium Sulfate; Magnetic Resonance Imaging; Piracetam; Postpartum Period; Pregnancy; Pregnancy Complications, Hematologic; Seizures; Sinus Thrombosis, Intracranial; Stroke; Tomography, X-Ray Computed; Treatment Outcome; Venous Thrombosis; Young Adult | 2011 |
Pregnancy complicated by recurrent brain abscess after extraction of an infected tooth.
Topics: Adult; Anti-Bacterial Agents; Anticonvulsants; Brain Abscess; Cefotaxime; Cesarean Section; Dexamethasone; Drug Therapy, Combination; Female; Focal Infection, Dental; Humans; Infant, Newborn; Levetiracetam; Male; Meningoencephalitis; Metronidazole; Molar, Third; Piracetam; Pregnancy; Pregnancy Complications, Infectious; Radiography; Streptococcal Infections; Tooth Extraction; Treatment Outcome; Ultrasonography, Prenatal; Viridans Streptococci | 2011 |
A combination of levetiracetam and tiapride for outpatient alcohol detoxification: a case series.
Topics: Adult; Aged; Alcoholism; Dopamine Antagonists; Drug Therapy, Combination; Female; Humans; Levetiracetam; Male; Middle Aged; Nootropic Agents; Outpatients; Piracetam; Substance Withdrawal Syndrome; Tiapamil Hydrochloride; Treatment Outcome; Young Adult | 2011 |
Study on the absolute configuration of levetiracetam via density functional theory calculations of electronic circular dichroism and optical rotatory dispersion.
Topics: Anticonvulsants; Circular Dichroism; Levetiracetam; Models, Chemical; Models, Molecular; Molecular Conformation; Optical Rotatory Dispersion; Piracetam | 2011 |
Synaptic vesicle protein 2A predicts response to levetiracetam in patients with glioma.
Topics: Adult; Aged; Blotting, Western; Brain Neoplasms; Cohort Studies; Epilepsy; False Positive Reactions; Female; Follow-Up Studies; Glioma; Humans; Immunohistochemistry; Levetiracetam; Male; Membrane Glycoproteins; Middle Aged; Nerve Tissue Proteins; Nootropic Agents; Piracetam; Predictive Value of Tests; Prospective Studies; Treatment Outcome; Young Adult | 2011 |
[Paroxysmal tonic upward gaze deviation triggered by valproic acid within the context of focal epilepsy].
Topics: Anticonvulsants; Child, Preschool; Epilepsies, Partial; Female; Humans; Levetiracetam; Ocular Motility Disorders; Piracetam; Valproic Acid | 2011 |
Tissue distribution of newer anticonvulsant drugs in postmortem cases.
Topics: Adult; Anticonvulsants; Autopsy; Carbamazepine; Chromatography, Gas; Fatal Outcome; Female; Fructose; Humans; Kidney; Levetiracetam; Liver; Male; Middle Aged; Oxcarbazepine; Piracetam; Tissue Distribution; Topiramate; Young Adult | 2010 |
Curing of oscillating larynx by levetiracetam.
Topics: Anticonvulsants; Fluoroscopy; Humans; Laryngeal Diseases; Laryngeal Muscles; Levetiracetam; Male; Middle Aged; Myoclonus; Piracetam; Treatment Outcome | 2011 |
Cost-utility analysis of levetiracetam and phenytoin for posttraumatic seizure prophylaxis.
Topics: Adult; Anticonvulsants; Brain Injuries; Cost-Benefit Analysis; Decision Trees; Female; Glasgow Outcome Scale; Humans; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Seizures; Treatment Outcome | 2011 |
Development and validation of an analytical method based on high performance thin layer chromatography for the simultaneous determination of lamotrigine, zonisamide and levetiracetam in human plasma.
Topics: Anticonvulsants; Calibration; Chromatography, Thin Layer; Drug Monitoring; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Linear Models; Mass Spectrometry; Piracetam; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Triazines; Zonisamide | 2011 |
Ventricular fibrillation in loop recorder memories in a patient with early repolarization syndrome.
Topics: Adolescent; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Cyanosis; Defibrillators, Implantable; Electrocardiography; Humans; Levetiracetam; Male; Piracetam; Quinidine; Syncope; Treatment Outcome; Ventricular Fibrillation | 2012 |
Perioral myoclonia with absences and myoclonic status aggravated by oxcarbazepine.
Topics: Anticonvulsants; Brain; Carbamazepine; Child; Electroencephalography; Epilepsies, Myoclonic; Epilepsy, Absence; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Oxcarbazepine; Piracetam | 2011 |
Pharmacokinetics of levetiracetam after oral and intravenous administration of a single dose to clinically normal cats.
Topics: Administration, Oral; Animals; Anticonvulsants; Cats; Chromatography, High Pressure Liquid; Cross-Over Studies; Female; Half-Life; Injections, Intravenous; Levetiracetam; Linear Models; Male; Piracetam; Prospective Studies; Random Allocation; Time Factors | 2011 |
Phenytoin, levetiracetam, and pregabalin in the acute management of refractory status epilepticus in patients with brain tumors.
Topics: Acute Disease; Aged; Anticonvulsants; Brain Neoplasms; Drug Therapy, Combination; Female; gamma-Aminobutyric Acid; Humans; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Pregabalin; Retrospective Studies; Status Epilepticus; Treatment Outcome | 2012 |
Amelioration of disabling myoclonus in a case of DRPLA by levetiracetam.
Topics: Adolescent; Anticonvulsants; Epilepsies, Myoclonic; Humans; Levetiracetam; Male; Myoclonic Epilepsies, Progressive; Myoclonus; Piracetam; Treatment Outcome | 2012 |
Short report: A calcified Taenia solium granuloma associated with recurrent perilesional edema causing refractory seizures: histopathological features.
Topics: Albendazole; Animals; Anthelmintics; Anticonvulsants; Calcinosis; Edema; Granuloma; Humans; Levetiracetam; Male; Neurocysticercosis; Piracetam; Seizures; Taenia solium; Valproic Acid; Young Adult | 2011 |
[Clinical characteristics and treatment for new onset epilepsy in the elderly].
Topics: Aged; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Diagnostic Imaging; Electroencephalography; Epilepsy; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Levetiracetam; Patient Education as Topic; Piracetam; Social Support; Triazines | 2010 |
Combining modelling and mutagenesis studies of synaptic vesicle protein 2A to identify a series of residues involved in racetam binding.
Topics: Alanine; Amino Acid Sequence; Animals; Anticonvulsants; Binding Sites; Humans; Levetiracetam; Membrane Glycoproteins; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutagenesis, Site-Directed; Nerve Tissue Proteins; Piracetam; Protein Binding; Rats; Sequence Alignment | 2011 |
Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsy.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Epilepsy; Female; Geriatrics; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Retrospective Studies | 2012 |
Interactions of pregabalin with gabapentin, levetiracetam, tiagabine and vigabatrin in the mouse maximal electroshock-induced seizure model: a type II isobolographic analysis.
Topics: Amines; Animals; Anticonvulsants; Avoidance Learning; Confidence Intervals; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Electroshock; Gabapentin; gamma-Aminobutyric Acid; Hand Strength; Levetiracetam; Male; Mice; Motor Activity; Piracetam; Pregabalin; Seizures; Vigabatrin | 2012 |
Off-label gabapentin masking ictal triphasic waves: case analysis of neuropsychiatric and electrographic correlates.
Topics: Administration, Oral; Aged; Amines; Anticonvulsants; Brain Waves; Cyclohexanecarboxylic Acids; Electroencephalography; Epilepsy; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Levetiracetam; Piracetam; Psychotic Disorders | 2011 |
[Frontal lobe nocturnal epilepsy in an adult with Gilles de la Tourette syndrome].
Topics: Adult; Anticonvulsants; Epilepsy, Frontal Lobe; Humans; Levetiracetam; Male; Piracetam; Polysomnography; Sleep Wake Disorders; Tourette Syndrome | 2011 |
Probable psychosis associated with levetiracetam: a case report.
Topics: Anticonvulsants; Humans; Levetiracetam; Male; Piracetam; Psychotic Disorders; Seizures; Young Adult | 2011 |
Modulation of abnormal synaptic transmission in hippocampal CA3 neurons of spontaneously epileptic rats (SERs) by levetiracetam.
Topics: Action Potentials; Animals; Anticonvulsants; CA3 Region, Hippocampal; Calcium; Electrophysiology; Humans; Levetiracetam; Membrane Potentials; Mossy Fibers, Hippocampal; Neurons; Piracetam; Rats; Rats, Mutant Strains; Rats, Wistar; Seizures; Sodium Channels; Synaptic Transmission | 2011 |
Self-reported symptoms in patients on antiepileptic drugs in monotherapy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Epilepsy; Female; Humans; Lamotrigine; Levetiracetam; Male; Middle Aged; Outcome Assessment, Health Care; Piracetam; Self Report; Triazines; Young Adult | 2011 |
Status epilepticus-induced hyperemia and brain tissue hypoxia after cardiac arrest.
Topics: Aged, 80 and over; Body Temperature; Brain; Cerebrovascular Circulation; Electroencephalography; Humans; Hyperemia; Hypothermia, Induced; Hypoxia, Brain; Injections, Intravenous; Intracranial Pressure; Levetiracetam; Lorazepam; Male; Out-of-Hospital Cardiac Arrest; Piracetam; Status Epilepticus | 2011 |
Effect of levetiracetam monotherapy on background EEG activity and cognition in drug-naïve epilepsy patients.
Topics: Adolescent; Adult; Anticonvulsants; Brain Mapping; Brain Waves; Cognition; Electroencephalography; Epilepsy; Executive Function; Female; Follow-Up Studies; Fourier Analysis; Humans; Levetiracetam; Linear Models; Male; Middle Aged; Neuropsychological Tests; Piracetam; Retrospective Studies; Verbal Learning; Young Adult | 2012 |
Levetiracetam exhibits protective properties on rat Schwann cells in vitro.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blotting, Western; Cells, Cultured; Glutamic Acid; In Vitro Techniques; Levetiracetam; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neuroprotective Agents; Oxidative Stress; Piracetam; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Schwann Cells | 2011 |
Epileptic seizures after octreotide administration in a 6.5-year-old female with ALL and L-asparaginase associated pancreatitis: a possible drug interaction.
Topics: Acute Disease; Anticonvulsants; Asparaginase; Child; Diagnosis, Differential; Drug Interactions; Electroencephalography; Epilepsy; Female; Humans; Levetiracetam; Octreotide; Pancreatitis; Piracetam; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2011 |
Treatment with levetiracetam in a patient with pervasive developmental disorders, severe intellectual disability, self-injurious behavior, and seizures: a case report.
Topics: Anticonvulsants; Child; Child Development Disorders, Pervasive; Humans; Intellectual Disability; Levetiracetam; Male; Piracetam; Seizures; Self-Injurious Behavior; Treatment Outcome; Young Adult | 2012 |
Levetiracetam-induced interstitial nephritis in a patient with glioma.
Topics: Acute Kidney Injury; Anticonvulsants; Astrocytoma; Brain Neoplasms; Humans; Levetiracetam; Male; Middle Aged; Nephritis, Interstitial; Piracetam; Seizures | 2012 |
Teratogenicity of the newer antiepileptic drugs--the Australian experience.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Australia; Drug Administration Schedule; Female; Fructose; Humans; Lamotrigine; Levetiracetam; Piracetam; Pregnancy; Registries; Topiramate; Triazines | 2012 |
[Treating Neonates with Levetiracetam: a survey among German University Hospitals].
Topics: Anticonvulsants; Drug Utilization; Germany; Health Surveys; Hospitals, University; Humans; Infant, Newborn; Infant, Newborn, Diseases; Levetiracetam; Off-Label Use; Piracetam; Spasms, Infantile | 2011 |
In vivo biocompatibility and in vitro characterization of poly-lactide-co-glycolide structures containing levetiracetam, for the treatment of epilepsy.
Topics: Animals; Anticonvulsants; Brain; Epilepsy; Glial Fibrillary Acidic Protein; Lactic Acid; Levetiracetam; Male; Materials Testing; Microscopy, Electron, Scanning; Piracetam; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Time Factors | 2012 |
Positive impact of levetiracetam on emotional learning and memory in naive mice.
Topics: Analysis of Variance; Animals; Anticonvulsants; Avoidance Learning; Behavior, Animal; Epilepsy; Humans; Levetiracetam; Male; Maze Learning; Memory; Mice; Mice, Inbred BALB C; Piracetam; Reaction Time | 2012 |
Levetiracetam compared to phenytoin for the prevention of postoperative seizures after craniotomy for intracranial tumours in patients without epilepsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Child; Contraindications; Craniotomy; Female; Humans; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Postoperative Complications; Retrospective Studies; Seizures; Young Adult | 2012 |
Performance characteristics and patient comparison of the ARK Diagnostics levetiracetam immunoassay with an ultra-high performance liquid chromatography with tandem mass spectrometry detection method.
Topics: Chromatography, High Pressure Liquid; Humans; Immunoassay; Levetiracetam; Piracetam; Reproducibility of Results; Tandem Mass Spectrometry | 2012 |
[Experience with levetiracetam in the treatment of childhood refractory epilepsy].
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Epilepsy; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Quality of Life; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult | 2012 |
Effects of valproic acid (VPA) and levetiracetam (LEV) on proliferation, apoptosis and hormone secretion of the human choriocarcinoma BeWo cell line.
Topics: Anticonvulsants; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Dose-Response Relationship, Drug; Estradiol; Fluorometry; Humans; Levetiracetam; Piracetam; Progesterone; Valproic Acid | 2011 |
Optimized and validated flow-injection spectrophotometric analysis of topiramate, piracetam and levetiracetam in pharmaceutical formulations.
Topics: Chemistry, Pharmaceutical; Flow Injection Analysis; Fructose; Levetiracetam; Piracetam; Reproducibility of Results; Spectrophotometry, Ultraviolet; Topiramate | 2011 |
Levetiracetam reverses synaptic deficits produced by overexpression of SV2A.
Topics: Animals; Green Fluorescent Proteins; Levetiracetam; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Tissue Proteins; Neurons; Neurotransmitter Agents; Phenotype; Piracetam; Presynaptic Terminals; Protein Transport; Rats; Recombinant Fusion Proteins; Synapses; Synaptotagmins | 2011 |
A case of physical and mental adverse drug reactions associated with levetiracetam in post-stroke epilepsy.
Topics: Aged; Anticonvulsants; Cognition; Disease Progression; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Follow-Up Studies; Humans; Levetiracetam; Male; Motor Activity; Piracetam; Stroke | 2012 |
Seizures as a manifestation of multiple sclerosis.
Topics: Adult; Anticonvulsants; Brain; Electroencephalography; Epilepsy, Tonic-Clonic; Female; Humans; Levetiracetam; Magnetic Resonance Imaging; Multiple Sclerosis; Piracetam; Seizures; Vitamin B 12; Vitamin B 6; Vitamins | 2011 |
Early-onset childhood absence epilepsy: is it a distinct entity?
Topics: Age Factors; Age of Onset; Anticonvulsants; Child; Child Development; Child, Preschool; Cohort Studies; Disease Progression; Drug Therapy, Combination; Electroencephalography; Epilepsy, Absence; Ethosuximide; Female; Follow-Up Studies; Humans; Lamotrigine; Language Development Disorders; Levetiracetam; Male; Piracetam; Prognosis; Prospective Studies; Sex Factors; Treatment Outcome; Triazines | 2011 |
Pancytopenia associated with levetiracetam treatment in Lafora's disease.
Topics: Adolescent; Aged; Anticonvulsants; Female; Humans; Lafora Disease; Levetiracetam; Pancytopenia; Piracetam | 2012 |
Levetiracetam has an activity-dependent effect on inhibitory transmission.
Topics: Animals; Anticonvulsants; CA1 Region, Hippocampal; Levetiracetam; Neural Inhibition; Neurons; Organ Culture Techniques; Piracetam; Rats; Rats, Sprague-Dawley; Synaptic Transmission | 2012 |
Leukoencephalopathy, cerebral calcifications, and cysts: case report.
Topics: Adult; Anticonvulsants; Basal Ganglia Diseases; Brain; Calcinosis; Central Nervous System Cysts; Dystonia; Female; Gait Disorders, Neurologic; Humans; Infant, Newborn; Infant, Premature; Leukoencephalopathies; Levetiracetam; Magnetic Resonance Imaging; Muscle Spasticity; Neurologic Examination; Piracetam; Seizures; Spinal Puncture; Tomography, X-Ray Computed | 2012 |
A cost-minimization analysis of phenytoin versus levetiracetam for early seizure pharmacoprophylaxis after traumatic brain injury.
Topics: Adult; Anticonvulsants; Brain Injuries; Cost Control; Cost-Benefit Analysis; Decision Trees; Drug Costs; Humans; Levetiracetam; Monte Carlo Method; Phenytoin; Piracetam; Seizures | 2012 |
Sensitivity of computed tomography angiography vs catheter angiography in the detection of a ruptured intracranial infectious aneurysm in a pregnant woman.
Topics: Adult; Aneurysm, Infected; Aneurysm, Ruptured; Anti-Bacterial Agents; Anticonvulsants; Brain; Catheters; Cerebral Angiography; Cesarean Section; Clindamycin; Female; Humans; Infant, Newborn; Intracranial Aneurysm; Levetiracetam; Nimodipine; Piracetam; Pregnancy; Pregnancy Outcome; Tomography, X-Ray Computed; Vancomycin; Vasodilator Agents | 2012 |
Determination of ng/mL levetiracetam using ultra-high-performance liquid chromatography-photodiode absorbance.
Topics: Blood Proteins; Chromatography, High Pressure Liquid; Epilepsy; Humans; Hydrogen-Ion Concentration; Levetiracetam; Limit of Detection; Linear Models; Liquid-Liquid Extraction; Piracetam; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Temperature | 2012 |
Initial EEG predicts outcomes in a trial of levetiracetam vs. fosphenytoin for seizure prevention.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Brain Injuries; Disability Evaluation; Electroencephalography; Female; Glasgow Outcome Scale; Humans; Levetiracetam; Linear Models; Male; Middle Aged; Phenytoin; Piracetam; Randomized Controlled Trials as Topic; Seizures; Statistics, Nonparametric; Subarachnoid Hemorrhage; Young Adult | 2012 |
Recurrent seizures in a levetiracetam-treated patient after subarachnoid hemorrhage: a matter of enhanced renal function?
Topics: Anticonvulsants; Female; Humans; Levetiracetam; Middle Aged; Piracetam; Recurrence; Seizures; Subarachnoid Hemorrhage; Time Factors | 2012 |
Levetiracetam for busulfan-induced seizure prophylaxis in children undergoing hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Anticonvulsants; Busulfan; Child; Child, Preschool; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Levetiracetam; Phenytoin; Piracetam; Seizures; Transplantation Conditioning; Young Adult | 2012 |
A lamotrigine induced toxic epidermal necrolysis in a child.
Topics: Anticonvulsants; Child; Drug Combinations; Epilepsy; Female; Humans; Lamotrigine; Levetiracetam; Piracetam; Stevens-Johnson Syndrome; Triazines | 2013 |
New observations in primary and secondary reading epilepsy: excellent response to levetiracetam and early spontaneous remission.
Topics: Adolescent; Adult; Anticonvulsants; Electroencephalography; Epilepsy, Reflex; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Piracetam; Secondary Prevention | 2012 |
[Effect of levetiracetam on intractable secondarily generalized seizure and depression].
Topics: Anticonvulsants; Brain Injuries; Depression; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Seizures | 2012 |
Anxiety and predisposition to audiogenic epilepsy in rats of different genotypes.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Benzimidazoles; Epilepsy, Reflex; Genetic Predisposition to Disease; Injections, Intraperitoneal; Levetiracetam; Male; Maze Learning; Morpholines; Motor Activity; Piracetam; Rats; Rats, Inbred Strains; Rats, Long-Evans; Rats, Wistar; Severity of Illness Index | 2011 |
Levetiracetam may favorably affect seizure outcome after temporal lobectomy.
Topics: Adolescent; Adult; Aged; Anterior Temporal Lobectomy; Anticonvulsants; Child; Child, Preschool; Epilepsy; Female; Humans; Levetiracetam; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Piracetam; Positron-Emission Tomography; Postoperative Complications; Recurrence; Retrospective Studies; Seizures; Statistics, Nonparametric; Survival Analysis; Treatment Outcome; Young Adult | 2012 |
Modulation of action potential and calcium signaling by levetiracetam in rat sensory neurons.
Topics: Action Potentials; Analgesics; Animals; Anticonvulsants; Calcium; Dose-Response Relationship, Drug; Electrophysiology; Epilepsy; Fluorescent Dyes; Fura-2; Ganglia, Spinal; Levetiracetam; Neurons; Pain; Patch-Clamp Techniques; Piracetam; Rats; Sensory Receptor Cells | 2012 |
[Two cases of autoimmune encephalitis with antibodies to N-methyl-D-aspartate receptor in intensive care].
Topics: Adrenal Cortex Hormones; Adult; Anticonvulsants; Autoimmune Diseases of the Nervous System; Critical Care; Early Diagnosis; Electroencephalography; Female; Glasgow Coma Scale; Humans; Immunization, Passive; Levetiracetam; Limbic Encephalitis; Magnetic Resonance Imaging; Marijuana Smoking; Mental Disorders; Nervous System Diseases; Ovarian Neoplasms; Piracetam; Receptors, N-Methyl-D-Aspartate; Teratoma; Tomography, X-Ray Computed | 2012 |
Levetiracetam.
Topics: Anticonvulsants; Drug Interactions; Epilepsy; Humans; India; Levetiracetam; Piracetam; Treatment Outcome | 2011 |
Levetiracetam inhibits neurotransmitter release associated with CICR.
Topics: Animals; Anticonvulsants; Chromatography, High Pressure Liquid; Inositol 1,4,5-Trisphosphate Receptors; Levetiracetam; Male; Microdialysis; Neurotransmitter Agents; Piracetam; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Ryanodine Receptor Calcium Release Channel; Synaptic Transmission | 2012 |
A seven-day study of the pharmacokinetics of intravenous levetiracetam in neonates: marked changes in pharmacokinetics occur during the first week of life.
Topics: Electroencephalography; Female; Gestational Age; Half-Life; Humans; Infant, Newborn; Injections, Intravenous; Levetiracetam; Male; Metabolic Clearance Rate; Piracetam; Seizures | 2012 |
Pilomotor seizure: when paroxysmal gooseflesh heralds brain tumor.
Topics: Aged; Amygdala; Anticonvulsants; Astrocytoma; Brain Neoplasms; Electroencephalography; Hippocampus; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Piloerection; Piracetam; Seizures; Temporal Lobe; Valproic Acid | 2012 |
[The retrospective study of efficacy and safety of levetiracetam as an add-on treatment of epilepsy in children].
Topics: Adolescent; Anticonvulsants; Brain; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Electroencephalography; Epilepsy; Humans; Infant; Levetiracetam; Male; Piracetam; Retrospective Studies; Treatment Outcome; Young Adult | 2011 |
[Transitory cognitive dysfunction in rolandic epilepsy].
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Cognition Disorders; Drug Therapy, Combination; Epilepsy, Rolandic; Ethosuximide; Female; Humans; Levetiracetam; Male; Piracetam; Recovery of Function; Remission Induction; Valproic Acid | 2011 |
Assessing adherence-based quality measures in epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Cohort Studies; Epilepsy; Female; Follow-Up Studies; Hospitalization; Humans; Levetiracetam; Male; Medication Adherence; Mental Disorders; Middle Aged; Odds Ratio; Phenytoin; Piracetam; Quality Indicators, Health Care; Retrospective Studies; Treatment Outcome; Young Adult | 2012 |
Levetiracetam induced angioedema in a patient with previous anticonvulsant hypersensitivity reaction to phenytoin and lamotrigine.
Topics: Adult; Angioedema; Anticonvulsants; Exanthema; Female; Humans; Lamotrigine; Levetiracetam; Phenytoin; Piracetam; Triazines | 2012 |
Phenytoin reduces 5-aminolevulinic acid-induced protoporphyrin IX accumulation in malignant glioma cells.
Topics: Aminolevulinic Acid; Anticonvulsants; Fluorescence; Glioma; Glutathione; Humans; Levetiracetam; Membrane Potential, Mitochondrial; Phenytoin; Photochemotherapy; Photosensitizing Agents; Piracetam; Protoporphyrins; Tumor Cells, Cultured | 2012 |
Bone mineral density in adult patients treated with various antiepileptic drugs.
Topics: Absorptiometry, Photon; Adolescent; Adult; Aged; Anticonvulsants; Bone Density; Carbamazepine; Cross-Sectional Studies; Drug Therapy, Combination; Female; Fructose; Humans; Incidence; Lamotrigine; Levetiracetam; Male; Middle Aged; Oxcarbazepine; Piracetam; Topiramate; Triazines; Valproic Acid; Young Adult | 2012 |
Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany--a nationwide population-based study in children and adults.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child; Databases, Factual; Epilepsy; Germany; Humans; Lamotrigine; Levetiracetam; Middle Aged; Piracetam; Population Surveillance; Prevalence; Retrospective Studies; Triazines; Valproic Acid; Young Adult | 2012 |
Rare protein sequence variation in SV2A gene does not affect response to levetiracetam.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Child; Child, Preschool; Epilepsy; Female; Genetic Variation; Humans; Levetiracetam; Male; Membrane Glycoproteins; Middle Aged; Nerve Tissue Proteins; Pharmacogenetics; Piracetam | 2012 |
The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca2+ channels through an intracellular pathway.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Intracellular Fluid; Levetiracetam; Ligands; Male; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam; Presynaptic Terminals; Rats; Rats, Wistar; Signal Transduction; Superior Cervical Ganglion | 2012 |
An acquired source of seizures.
Topics: Adult; Albendazole; Animals; Anti-Inflammatory Agents; Anticonvulsants; Antiparasitic Agents; Developing Countries; Diagnosis, Differential; Emigration and Immigration; Enzyme-Linked Immunosorbent Assay; Humans; Immunoblotting; Levetiracetam; Magnetic Resonance Imaging; Male; Muscle Weakness; Nepal; Neurocysticercosis; Piracetam; Prednisolone; Seizures; Spinal Puncture; Taenia solium; Tremor; United Kingdom | 2012 |
Levetiracetam-associated loss of libido and anhedonia.
Topics: Adult; Anhedonia; Anticonvulsants; Brain; Electroencephalography; Epilepsies, Myoclonic; Epilepsy, Complex Partial; Erectile Dysfunction; Gonadal Steroid Hormones; Humans; Lamotrigine; Levetiracetam; Libido; Magnetic Resonance Imaging; Male; Piracetam; Triazines; Valproic Acid; Young Adult | 2012 |
Practice variations in the management of status epilepticus.
Topics: Adult; Aged; Anticonvulsants; Benzodiazepines; Critical Care; Female; Humans; Levetiracetam; Male; Middle Aged; Multivariate Analysis; Phenytoin; Piracetam; Retrospective Studies; Risk Factors; Status Epilepticus; Treatment Outcome; United States | 2012 |
Gaucher disease: successful treatment of myoclonic status epilepticus with levetiracetam.
Topics: Adolescent; Anticonvulsants; Electroencephalography; Epilepsies, Myoclonic; Gaucher Disease; Humans; Levetiracetam; Male; Piracetam; Status Epilepticus | 2012 |
Effects of Levetiracetam on neural tube development and closure of the chick embryos in ovo.
Topics: Animals; Anticonvulsants; Cell Movement; Chick Embryo; Embryonic Development; Levetiracetam; Neural Tube; Neural Tube Defects; Neuroglia; Neurons; Piracetam; S100 Proteins; Tolonium Chloride | 2012 |
Effects of valproic acid and levetiracetam on viability and cell cycle regulatory genes expression in the OVCAR-3 cell line.
Topics: Anticonvulsants; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; G1 Phase; Gene Expression Regulation, Neoplastic; Genes, cdc; Humans; Levetiracetam; Ovarian Neoplasms; Piracetam; S Phase; Valproic Acid | 2012 |
A rat model for LGI1-related epilepsies.
Topics: Amino Acid Sequence; Animals; Anticonvulsants; Brain; Carbamazepine; Cells, Cultured; Chlorocebus aethiops; COS Cells; Disease Models, Animal; Electroencephalography; Epilepsies, Partial; Epilepsy; Epilepsy, Reflex; Ethosuximide; Heterozygote; Homozygote; Humans; Intercellular Signaling Peptides and Proteins; Levetiracetam; Molecular Sequence Data; Mutation, Missense; Neurons; Phenytoin; Piracetam; Proteins; Rats, Mutant Strains | 2012 |
The acute effects of levetiracetam on nocturnal sleep and daytime sleepiness in patients with partial epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Disorders of Excessive Somnolence; Electroencephalography; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Polysomnography; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Young Adult | 2012 |
[Idiopathic focal epilepsies of infancy and childhood].
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Electroencephalography; Epilepsies, Partial; Epilepsy, Rolandic; Ethosuximide; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Valproic Acid | 2011 |
[Therapeutic effects of levetiracetam on electrical status epilepticus during sleep in children].
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Electroencephalography; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Retrospective Studies; Status Epilepticus | 2012 |
Postmortem levetiracetam (Keppra®) data from North Carolina.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Cause of Death; Child; Child, Preschool; Drug Overdose; Female; Humans; Levetiracetam; Male; Middle Aged; North Carolina; Piracetam; Suicide; Young Adult | 2012 |
Increased levetiracetam clearance in pregnancy: is seizure frequency affected?
Topics: Anticonvulsants; Female; Humans; Levetiracetam; Piracetam; Pregnancy; Pregnancy Complications; Seizures | 2012 |
Population pharmacokinetics modeling of levetiracetam in Chinese children with epilepsy.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; China; Epilepsy; Humans; Infant; Levetiracetam; Models, Biological; Models, Statistical; Piracetam | 2012 |
Cortical blindness and posterior reversible encephalopathy syndrome in an older patient.
Topics: Accidental Falls; Aged, 80 and over; Anticonvulsants; Benzodiazepines; Blindness, Cortical; Clobazam; Diagnosis, Differential; Electroencephalography; Female; Humans; Levetiracetam; Magnetic Resonance Imaging; Piracetam; Posterior Leukoencephalopathy Syndrome | 2012 |
Quieting the overactive hippocampus restores memory in aging.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Cognitive Dysfunction; Hippocampus; Humans; Levetiracetam; Memory; Memory Disorders; Piracetam | 2012 |
Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression Regulation; Immunomodulation; Interleukin-1beta; Levetiracetam; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Neuroglia; Peptide Fragments; Piracetam; Transforming Growth Factor beta1 | 2012 |
Spectroscopic studies on the interaction of calf thymus DNA with the drug levetiracetam.
Topics: Animals; Binding, Competitive; Bisbenzimidazole; Cattle; Circular Dichroism; DNA; Kinetics; Levetiracetam; Methylene Blue; Nucleic Acid Denaturation; Piracetam; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Thermodynamics; Viscosity | 2012 |
Levetiracetam-induced reversible autistic regression.
Topics: Anticonvulsants; Autistic Disorder; Cerebral Palsy; Child; Cognition Disorders; Epilepsy; Female; Humans; Levetiracetam; Paraplegia; Piracetam; Regression, Psychology | 2012 |
Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Female; Hospitals, Pediatric; Humans; Infant; Infusions, Intravenous; Levetiracetam; Male; Piracetam; Seizures; Status Epilepticus | 2012 |
Paraneoplastic extralimbic encephalitis associated with thymoma and myastenia gravis: three years follow up.
Topics: Anticonvulsants; Cholinesterase Inhibitors; Electroencephalography; Follow-Up Studies; Levetiracetam; Magnetic Resonance Imaging; Myasthenia Gravis; Paraneoplastic Syndromes, Nervous System; Piracetam; Pyridostigmine Bromide; Seizures; Thymectomy; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Neurological picture. Transient high-intensity signal of heterotopia on DWI in an epilepsy patient.
Topics: Anticonvulsants; Brain; Carbamazepine; Choristoma; Consciousness Disorders; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Electroencephalography; Epilepsy; Female; Fluorodeoxyglucose F18; Frontal Lobe; Headache; Humans; Levetiracetam; Middle Aged; Oxcarbazepine; Piracetam; Positron-Emission Tomography; Radiopharmaceuticals; Status Epilepticus | 2012 |
Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Monitoring; Drug Therapy, Combination; Epilepsy; Female; Fructose; Humans; Lamotrigine; Levetiracetam; Male; Middle Aged; Oxcarbazepine; Piracetam; Topiramate; Triazines; Young Adult | 2012 |
Role of levetiracetam in refractory seizures due to a rare progressive myoclonic epilepsy: Lafora body disease.
Topics: Adolescent; Anticonvulsants; Biopsy; Fatal Outcome; Humans; Lafora Disease; Levetiracetam; Male; Piracetam; Skin | 2010 |
Neonatal status epilepticus controlled with levetiracetam at Sturge Weber syndrome.
Topics: Anticonvulsants; Electroencephalography; Female; Humans; Infant, Newborn; Levetiracetam; Magnetic Resonance Angiography; Piracetam; Status Epilepticus; Sturge-Weber Syndrome | 2013 |
Comparison of the effects of valproic acid and levetiracetam on apoptosis in the human ovarian cancer cell line OVCAR-3.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Far-Western; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; DNA Fragmentation; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; Levetiracetam; Ovarian Neoplasms; Piracetam; Time Factors; Valproic Acid | 2012 |
Levetiracetam in the treatment of alcohol dependence: toward the end of the story?
Topics: Alcoholism; Anticonvulsants; Baclofen; Double-Blind Method; GABA Agonists; Humans; Levetiracetam; Piracetam; Quality of Life; Randomized Controlled Trials as Topic | 2012 |
[Prolonged hemiplegia as the only symptom of a simple focal nonconvulsive status epilepticus].
Topics: Anticonvulsants; Bacteriuria; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Electroencephalography; Epilepsies, Partial; Facial Paralysis; Hemiplegia; Humans; Hydrocephalus; Levetiracetam; Male; Meningitis, Listeria; Middle Aged; Piracetam; Postoperative Complications; Status Epilepticus; Stroke; Ventriculoperitoneal Shunt | 2012 |
Solid-liquid phase diagrams for the determination of the solid state nature of both polymorphs of (RS)-2-(2-oxo-pyrrolidin-1-yl)-butyramide.
Topics: Levetiracetam; Phase Transition; Piracetam; Powder Diffraction; Stereoisomerism; Temperature; X-Ray Diffraction | 2012 |
Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Anticonvulsants; Blotting, Western; Cognition; Cognition Disorders; Electroencephalography; Humans; Immunohistochemistry; Levetiracetam; Maze Learning; Mice; Mice, Transgenic; Nerve Net; Piracetam; Synapses | 2012 |
Efficacy and safety of add-on levetiracetam in refractory childhood epilepsy.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Epilepsy; Female; Humans; Infant; Levetiracetam; Male; Outpatients; Piracetam; Treatment Outcome | 2013 |
Focal meningoencephalitis of hepatitis A: a clinico-radiologic picture.
Topics: Anticonvulsants; Brain; Child; Electroencephalography; Hepatitis A; Humans; Immunoglobulin M; Levetiracetam; Magnetic Resonance Imaging; Male; Meningoencephalitis; Piracetam; Radiography; Seizures | 2012 |
Quality of life, anxiety and depression in adult patients after add-on of levetiracetam and conversion to levetiracetam monotherapy.
Topics: Adult; Anticonvulsants; Anxiety; Depression; Drug Therapy, Combination; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Quality of Life; Treatment Outcome; Young Adult | 2013 |
Seizure freedom is not adversely affected by early discontinuation of concomitant anti-epileptic drugs in the EULEV cohort of levetiracetam users.
Topics: Adult; Anticonvulsants; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; France; Humans; Levetiracetam; Logistic Models; Male; Middle Aged; Multivariate Analysis; Pharmacoepidemiology; Piracetam; Propensity Score; Risk Factors; Seizures; Time Factors; Withholding Treatment | 2012 |
Acquired epileptiform opercular syndrome: F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) findings and efficacy of levetiracetam therapy.
Topics: Anticonvulsants; Child, Preschool; Deglutition Disorders; Dysarthria; Electroencephalography; Epilepsy, Generalized; Female; Fluorodeoxyglucose F18; Humans; Levetiracetam; Piracetam; Positron-Emission Tomography; Sialorrhea | 2012 |
[Complex therapy of idiopathic forms of epilepsy with small doses of valproates and levetiracetam].
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy, Absence; Epilepsy, Generalized; Female; Humans; Levetiracetam; Male; Myoclonic Epilepsy, Juvenile; Piracetam; Treatment Outcome; Valproic Acid; Young Adult | 2012 |
[The results of the use of levetiracetam (keppra) in post-stroke epilepsy].
Topics: Aged; Anticonvulsants; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Stroke; Treatment Outcome | 2012 |
[Idiopathic generalized epilepsy in young women: choise of treatment strategy].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsy, Generalized; Female; Fructose; Humans; Lamotrigine; Levetiracetam; Piracetam; Remission Induction; Topiramate; Triazines; Valproic Acid; Young Adult | 2012 |
[Latest news on the anti-alzheimer's front].
Topics: Alzheimer Disease; Animals; Antibodies, Monoclonal, Humanized; Anticonvulsants; Clinical Trials as Topic; Disease Models, Animal; Humans; Levetiracetam; Mice; Piracetam | 2012 |
Levetiracetam-associated aggravation of myoclonic seizure in children.
Topics: Anticonvulsants; Child; Electroencephalography; Epilepsies, Myoclonic; Humans; Levetiracetam; Male; Piracetam | 2012 |
Probable levetiracetam-related serum alkaline phosphatase elevation.
Topics: Alkaline Phosphatase; Anticonvulsants; Biomarkers; Chemical and Drug Induced Liver Injury; Child; Female; Humans; Levetiracetam; Piracetam; Treatment Outcome | 2012 |
[Levetiracetam-induced aggravation to non-convulsive status epilepticus in a boy with Lennox-Gastaut syndrome].
Topics: Anticonvulsants; Child; Humans; Intellectual Disability; Lennox Gastaut Syndrome; Levetiracetam; Male; Piracetam; Spasms, Infantile; Status Epilepticus | 2012 |
A case of levetiracetam induced bullous pemphigoid.
Topics: Aged; Anticonvulsants; Complement System Proteins; Female; Humans; Immunoglobulin G; Levetiracetam; Pemphigoid, Bullous; Piracetam | 2013 |
Effects of levetiracetam as a monotherapy on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Biomarkers; Bone Density; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Treatment Outcome; Young Adult | 2013 |
Stevens-Johnson syndrome induced by levetiracetam.
Topics: Anticonvulsants; Cardiovascular Surgical Procedures; Child, Preschool; Female; Heart Defects, Congenital; Humans; Levetiracetam; Piracetam; Postoperative Complications; Seizures; Stevens-Johnson Syndrome | 2012 |
[Clinical efficacy of the novel antiepileptic agent levetiracetam: evaluation in patients with localization-related epilepsy].
Topics: Adolescent; Adult; Anticonvulsants; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Japan; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Treatment Outcome; Young Adult | 2012 |
A case of amiodarone-associated myoclonus responsive to levetiracetam.
Topics: Aged, 80 and over; Amiodarone; Anticonvulsants; Humans; Levetiracetam; Male; Myoclonus; Piracetam | 2012 |
Levetiracetam-loaded biodegradable polymer implants in the tetanus toxin model of temporal lobe epilepsy in rats.
Topics: Absorbable Implants; Animals; Anticonvulsants; Disease Models, Animal; Drug Delivery Systems; Electroencephalography; Epilepsy, Temporal Lobe; Lactic Acid; Levetiracetam; Male; Neurotoxins; Piracetam; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Tetanus Toxin; Time Factors | 2013 |
Treatment of status epilepticus: an international survey of experts.
Topics: Administration, Intravenous; Adult; Anticonvulsants; Child; Consensus; Expert Testimony; Humans; Hypnotics and Sedatives; Levetiracetam; Lorazepam; Midazolam; Pentobarbital; Phenytoin; Piracetam; Propofol; Societies, Medical; Status Epilepticus; Surveys and Questionnaires; Valproic Acid | 2013 |
Inhibitory effects of levetiracetam on the high-voltage-activated L-type Ca²⁺ channels in hippocampal CA3 neurons of spontaneously epileptic rat (SER).
Topics: Animals; Anticonvulsants; Biophysics; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Electric Stimulation; Epilepsy; Female; Hippocampus; In Vitro Techniques; Levetiracetam; Male; Membrane Potentials; Neural Inhibition; Neurons; Nifedipine; Patch-Clamp Techniques; Piracetam; Rats; Rats, Mutant Strains; Rats, Wistar | 2013 |
[Epilepsies with electric status epilepticus in sleep: peculiarities of clinical course and rational approaches to treatment].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Resistance; Electricity; Electroencephalography; Ethosuximide; Female; Humans; Levetiracetam; Male; Piracetam; Sleep Stages; Sleep Wake Disorders; Status Epilepticus; Syndrome; Valproic Acid | 2011 |
The problem of non-superiority: what do we know after KOMET?
Topics: Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy, Generalized; Female; Humans; Levetiracetam; Male; Piracetam; Valproic Acid | 2013 |
Effects of levetiracetam on seizure frequency and neuropsychological impairments in children with refractory epilepsy with secondary bilateral synchrony.
Topics: Anticonvulsants; Child; Child, Preschool; Cognition Disorders; Electroencephalography; Electroencephalography Phase Synchronization; Epilepsy; Female; Humans; Levetiracetam; Male; Neuropsychological Tests; Piracetam; Sleep Stages | 2013 |
Drug-drug interaction between methotrexate and levetiracetam in a child treated for acute lymphoblastic leukemia.
Topics: Adolescent; Anticonvulsants; Antineoplastic Agents; Drug Interactions; Drug Therapy, Combination; Humans; Levetiracetam; Male; Methotrexate; Piracetam; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Seizures | 2013 |
Antiepileptic effects of levetiracetam in a rodent neonatal seizure model.
Topics: Animals; Animals, Newborn; Anticonvulsants; Blotting, Western; Brain; Immunohistochemistry; Kainic Acid; Levetiracetam; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam; Rats; Seizures | 2013 |
The local peripheral antihyperalgesic effect of levetiracetam and its mechanism of action in an inflammatory pain model.
Topics: Adenosine A1 Receptor Antagonists; Adrenergic alpha-Antagonists; Anesthetics, Local; Animals; Carrageenan; Drug Interactions; Edema; Foot; GABA Antagonists; Hindlimb; Hyperalgesia; Inflammation; Levetiracetam; Male; Pain; Peripheral Nerves; Piracetam; Plethysmography; Rats; Rats, Wistar; Receptors, Opioid; Serotonin Antagonists | 2012 |
Anticonvulsant treatment of compulsive sexual behavior.
Topics: Adult; Anticonvulsants; Compulsive Behavior; Exhibitionism; Fructose; Humans; Levetiracetam; Male; Piracetam; Sexual Dysfunctions, Psychological; Topiramate; Treatment Outcome | 2012 |
Functional neuroimages of cortical myoclonus altered by levetiracetam in a patient with sialidosis.
Topics: Adult; Cerebral Cortex; Humans; Levetiracetam; Male; Mucolipidoses; Myoclonus; Neuroimaging; Piracetam; Positron-Emission Tomography | 2013 |
Levetiracetam in children, adolescents and young adults with intractable epilepsy: efficacy, tolerability and effect on electroencephalogram--a pilot study.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Electroencephalography; Epilepsies, Partial; Epilepsy, Generalized; Female; Humans; Infant; Levetiracetam; Male; Pilot Projects; Piracetam; Retrospective Studies; Treatment Outcome; Young Adult | 2013 |
[New medications for dystonia].
Topics: Anticonvulsants; Dystonia; GABA-A Receptor Agonists; Humans; Levetiracetam; Piracetam; Pyridines; Zolpidem | 2012 |
[Clinical application of newer anti-epileptic drugs].
Topics: Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Epilepsy; Female; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Piracetam; Pregnancy; Pregnancy Complications; Topiramate; Triazines; Zonisamide | 2012 |
Hypersexuality in a patient with epilepsy during treatment of levetiracetam.
Topics: Adult; Anticonvulsants; Epilepsy; Female; Humans; Levetiracetam; Piracetam; Sexual Dysfunctions, Psychological; Treatment Outcome | 2013 |
Levetiracetam improves verbal memory in high-grade glioma patients.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Brain Neoplasms; Cognition Disorders; Female; Glioma; Humans; Levetiracetam; Male; Memory Disorders; Middle Aged; Neoplasm Grading; Neuropsychological Tests; Piracetam; Prognosis; Prospective Studies; Psychomotor Performance; Quality of Life; Verbal Learning; Young Adult | 2013 |
[A case with recurrent asystole due to breath-holding spells: successful treatment with levetiracetam].
Topics: Apnea; Autonomic Nervous System; Breath Holding; Female; Heart Arrest; Humans; Infant; Levetiracetam; Piracetam | 2012 |
Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study.
Topics: Adult; Aged; Anticonvulsants; Anxiety; Benzodiazepines; Brain Neoplasms; Carbamazepine; Clobazam; Drug Therapy, Combination; Epilepsy; Female; Fructose; gamma-Aminobutyric Acid; Humans; Lamotrigine; Levetiracetam; Male; Middle Aged; Oxcarbazepine; Phenobarbital; Pilot Projects; Piracetam; Pregabalin; Quality of Life; Topiramate; Treatment Outcome; Triazines; Valproic Acid; Young Adult | 2012 |
Successful treatment of POLG-related mitochondrial epilepsy with antiepileptic drugs and low glycaemic index diet.
Topics: Anticonvulsants; Diet, Ketogenic; DNA Polymerase gamma; DNA-Directed DNA Polymerase; Epilepsy; Female; Glycemic Index; Humans; Levetiracetam; Mitochondrial Diseases; Piracetam; Young Adult | 2012 |
Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report.
Topics: Acute Disease; Adolescent; Anticonvulsants; Autistic Disorder; Epilepsy; Humans; Levetiracetam; Male; Pancreatitis; Piracetam; Tomography, X-Ray Computed | 2013 |
Auto-antibody-negative limbic-like encephalitis as the first manifestation of Neurosyphilis.
Topics: Aged; Alcoholism; Anticonvulsants; Autoantibodies; Cognition Disorders; Epilepsy, Generalized; Humans; Levetiracetam; Limbic Encephalitis; Magnetic Resonance Imaging; Male; Neurosyphilis; Piracetam; Thiamine; Vitamins | 2013 |
The effect of levetiracetam on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury.
Topics: Analysis of Variance; Animals; Animals, Newborn; Apoptosis; Cerebral Cortex; Hippocampus; Histological Techniques; Hypoxia-Ischemia, Brain; In Situ Nick-End Labeling; Levetiracetam; Microscopy, Electron; Neurons; Neuroprotective Agents; Piracetam; Rats; Rats, Wistar | 2013 |
Seizure control with antiepileptic drug therapy in 517 consecutive adult outpatients at the Kork Epilepsy Centre.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anticonvulsants; Carbamazepine; Cross-Sectional Studies; Drug Therapy, Combination; Epilepsy; Female; Humans; Lamotrigine; Levetiracetam; Male; Middle Aged; Piracetam; Treatment Outcome; Triazines; Valproic Acid; Young Adult | 2012 |
Loss of the initial efficacy of levetiracetam in patients with refractory epilepsy.
Topics: Adult; Anticonvulsants; Drug Therapy, Combination; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Retreatment; Treatment Failure; Treatment Outcome | 2013 |
Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers.
Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Drug Therapy, Combination; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Female; Follow-Up Studies; Humans; Infant, Newborn; Ireland; Levetiracetam; Male; Piracetam; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Registries; Risk Factors; United Kingdom; Valproic Acid | 2013 |
Levetiracetam: a possible new inducer of toxic epidermal necrolysis and Stevens-Johnson syndrome in 2 cases.
Topics: Adult; Anticonvulsants; Female; Humans; Levetiracetam; Piracetam; Stevens-Johnson Syndrome; United States; United States Food and Drug Administration; Young Adult | 2013 |
Levetiracetam has opposite effects on alcohol- and cocaine-related behaviors in C57BL/6J mice.
Topics: Animals; Anticonvulsants; Central Nervous System Depressants; Central Nervous System Sensitization; Cocaine; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Excitatory Postsynaptic Potentials; Levetiracetam; Male; Mice; Motor Activity; Neurons; Nucleus Accumbens; Piracetam; Self Stimulation; Ventral Tegmental Area | 2013 |
Effects of levetiracetam, an antiepileptic drug, on memory impairments associated with aging and Alzheimer's disease in mice.
Topics: Aging; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Conditioning, Operant; Disease Models, Animal; Fear; Female; Levetiracetam; Male; Memory; Memory Disorders; Mice; Mice, Transgenic; Nootropic Agents; Piracetam | 2013 |
Asymptomatic elevation of liver enzymes due to levetiracetam: a case report.
Topics: Anticonvulsants; Female; Humans; Levetiracetam; Liver; Middle Aged; Piracetam | 2013 |
Acute generalized exanthematous pustulosis induced by levetiracetam.
Topics: Acute Generalized Exanthematous Pustulosis; Aged, 80 and over; Anticonvulsants; Epilepsy; Female; Fever; Humans; Levetiracetam; Piracetam | 2014 |
A case of erythema multiforme developing after levetiracetam therapy.
Topics: Adult; Anticonvulsants; Arm; Erythema Multiforme; Female; Humans; Levetiracetam; Piracetam | 2013 |
The effect of levetiracetam on status epilepticus-induced neuronal death in the rat hippocampus.
Topics: Animals; Behavior, Animal; Cell Death; Diazepam; Disease Models, Animal; Drug Therapy, Combination; Fluoresceins; Hippocampus; Levetiracetam; Neurons; Pilocarpine; Piracetam; Rats; Rats, Sprague-Dawley; Status Epilepticus; Valproic Acid | 2013 |
Levetiracetam-responsive myoclonus in spinocerebellar ataxia type 15.
Topics: Anticonvulsants; Female; Humans; Inositol 1,4,5-Trisphosphate Receptors; Levetiracetam; Mutation; Myoclonus; Piracetam; Spinocerebellar Ataxias; Young Adult | 2013 |
Symptomatic palatal tremor of cortical origin due to stroke.
Topics: Adult; Anticonvulsants; Electroencephalography; Humans; Infarction, Middle Cerebral Artery; Levetiracetam; Lorazepam; Male; Palate, Soft; Piracetam; Treatment Outcome; Tremor | 2013 |
Effects of levetiracetam on μ rhythm in persons with epilepsy.
Topics: Adult; Anticonvulsants; Brain Waves; Electroencephalography; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Neuropsychological Tests; Piracetam; Reaction Time; Treatment Outcome; Visual Perception; Young Adult | 2013 |
Long-term accidental overdose of levetiracetam in an infant.
Topics: Anticonvulsants; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Follow-Up Studies; Humans; Infant; Levetiracetam; Piracetam | 2014 |
Repeated use of subcutaneous levetiracetam in a palliative care patient.
Topics: Aged; Anticonvulsants; Brain Neoplasms; Dose-Response Relationship, Drug; Epilepsy; Female; Humans; Injections, Subcutaneous; Levetiracetam; Palliative Care; Piracetam; Treatment Outcome | 2013 |
Changing trends in the use of seizure prophylaxis after traumatic brain injury: a shift from phenytoin to levetiracetam.
Topics: Abbreviated Injury Scale; Adult; Anticonvulsants; Brain Injuries; Female; Humans; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Registries; Retrospective Studies; Seizures; Treatment Outcome | 2013 |
Survey of prophylactic antiseizure drug use for non-traumatic intracerebral hemorrhage.
Topics: Anticonvulsants; Brain; Cerebral Hemorrhage; Drug Prescriptions; Drug Utilization; Electroencephalography; Humans; Levetiracetam; Phenytoin; Piracetam; Practice Patterns, Physicians'; Seizures; Surveys and Questionnaires | 2013 |
Functional characterization of a CRH missense mutation identified in an ADNFLE family.
Topics: Analysis of Variance; Base Sequence; Blotting, Western; Corticotropin-Releasing Hormone; DNA Primers; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Epilepsy, Frontal Lobe; Genes, Dominant; Genetic Vectors; Heterozygote; Humans; Italy; Levetiracetam; Magnetic Resonance Imaging; Microscopy, Fluorescence; Molecular Sequence Data; Mutation, Missense; Pedigree; Piracetam; Real-Time Polymerase Chain Reaction; Sequence Analysis, DNA | 2013 |
[Successful treatment with levetiracetam in a case of Ohtahara syndrome caused by STXBP1 mutation].
Topics: Anticonvulsants; Epilepsy; Humans; Infant; Levetiracetam; Male; Munc18 Proteins; Mutation; Piracetam; Syndrome; Treatment Outcome | 2013 |
Phenytoin or levetiracetam for seizure prophylaxis in TBI.
Topics: Anticonvulsants; Brain Injuries; Humans; Levetiracetam; Phenytoin; Piracetam; Seizures | 2012 |
Levetiracetam but not valproate inhibits function of CD8+ T lymphocytes.
Topics: Adolescent; Adult; Anticonvulsants; Antigens, CD; Apoptosis; CD8-Positive T-Lymphocytes; Cell Proliferation; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Levetiracetam; Male; Membrane Glycoproteins; Middle Aged; Nerve Tissue Proteins; Perforin; Piracetam; Statistics, Nonparametric; Valproic Acid; Young Adult | 2013 |
Ictal bradycardia and asystole in an adult with a focal left insular lesion.
Topics: Anticonvulsants; Benzodiazepines; Bradycardia; Brain Diseases; Cerebral Cortex; Clobazam; Drug Resistance; Electroencephalography; Heart Arrest; Humans; Lamotrigine; Levetiracetam; Magnetic Resonance Imaging; Male; Middle Aged; Piracetam; Seizures; Triazines | 2013 |
Intravenous levetiracetam for treatment of neonatal seizures.
Topics: Administration, Intravenous; Anticonvulsants; Electroencephalography; Gestational Age; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Levetiracetam; Piracetam; Seizures; Treatment Outcome | 2013 |
Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Drug Therapy, Combination; Female; Follow-Up Studies; Glioblastoma; Humans; Levetiracetam; Male; Middle Aged; Neoplasm Recurrence, Local; Piracetam; Prognosis; Retrospective Studies; Seizures; Survival Rate; Temozolomide; Valproic Acid; Young Adult | 2013 |
Faciobrachial dystonic seizures arise from cortico-subcortical abnormal brain areas.
Topics: Adult; Anticonvulsants; Autoantibodies; Autoantigens; Brain; Dystonia; Female; Functional Laterality; Humans; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Levetiracetam; Magnetic Resonance Imaging; Methylprednisolone; Piracetam; Positron-Emission Tomography; Proteins; Seizures | 2013 |
West syndrome followed by juvenile myoclonic epilepsy: a coincidental occurrence?
Topics: Adolescent; Brain; Disease Progression; Humans; Infant; Levetiracetam; Magnetic Resonance Imaging; Male; Myoclonic Epilepsy, Juvenile; Piracetam; Spasms, Infantile | 2013 |
Encephalopathy induced by levetiracetam in an elderly woman.
Topics: Aged, 80 and over; Anticonvulsants; Female; Humans; Levetiracetam; Neurotoxicity Syndromes; Piracetam; Seizures | 2013 |
Hilar interneuron vulnerability distinguishes aged rats with memory impairment.
Topics: Aging; Animals; Antigens, Nuclear; Behavior, Animal; CA3 Region, Hippocampal; Cell Count; Cognition; Glutamate Decarboxylase; Hippocampus; Imaging, Three-Dimensional; Immunohistochemistry; Interneurons; Levetiracetam; Male; Memory Disorders; Nerve Tissue Proteins; Neuropeptide Y; Nootropic Agents; Perfusion; Piracetam; Rats; Rats, Long-Evans; Somatostatin | 2013 |
Levetiracetam add-on therapy in Japanese patients with refractory partial epilepsy.
Topics: Adult; Anticonvulsants; Benzodiazepines; Clobazam; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy, Complex Partial; Female; Fructose; Humans; Japan; Lamotrigine; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Retrospective Studies; Topiramate; Treatment Outcome; Triazines; Valproic Acid; Young Adult | 2013 |
Are we ready for a randomized trial of valproic acid in newly diagnosed glioblastoma?
Topics: Anticonvulsants; Brain Neoplasms; Female; Glioblastoma; Humans; Levetiracetam; Male; Neoplasm Recurrence, Local; Piracetam; Seizures; Valproic Acid | 2013 |
Pharmacological and neuroethological studies of three antiepileptic drugs in the Genetic Audiogenic Seizure Hamster (GASH:Sal).
Topics: Acoustic Stimulation; Animals; Anticonvulsants; Behavior, Animal; Chromatography, High Pressure Liquid; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy, Reflex; Homeodomain Proteins; Levetiracetam; Locomotion; Male; Mass Spectrometry; Phenobarbital; Piracetam; Time Factors; Transcription Factors; Valproic Acid | 2013 |
The importance of screening solid-state phases of a racemic modification of a chiral drug: thermodynamic and structural characterization of solid-state phases of etiracetam.
Topics: Calorimetry, Differential Scanning; Crystallography, X-Ray; Levetiracetam; Models, Molecular; Molecular Structure; Piracetam; Powder Diffraction; Stereoisomerism; Thermodynamics | 2013 |
Development of an integrated population pharmacokinetic model for oral levetiracetam in populations of various ages and ethnicities.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Anticonvulsants; Asian People; Black or African American; Child; Child, Preschool; Epilepsies, Partial; Female; Hispanic or Latino; Humans; Japan; Levetiracetam; Male; Middle Aged; Models, Biological; North America; Piracetam; White People; Young Adult | 2014 |
Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease.
Topics: Age of Onset; Aged; Alleles; Alzheimer Disease; Amyloid beta-Protein Precursor; Apolipoprotein E4; Brain; Cells, Cultured; Cerebral Cortex; Endocytosis; Epistasis, Genetic; Female; Fibroblasts; Gene Expression Profiling; Genome-Wide Association Study; Genome, Human; Genomics; Heterozygote; Humans; Levetiracetam; Membrane Glycoproteins; Nerve Tissue Proteins; Neurons; Phenotype; Piracetam; Polymorphism, Genetic; Proteolysis; Transcriptome | 2013 |
Antiepileptics topiramate and levetiracetam alleviate behavioral deficits and reduce neuropathology in APPswe/PS1dE9 transgenic mice.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Anticonvulsants; Brain; Cell Line, Tumor; Fructose; Humans; Levetiracetam; Maze Learning; Mice; Mice, Transgenic; Neuroprotective Agents; Piracetam; Presenilin-1; Topiramate | 2013 |
A new concept affecting restoration of inflammation-reactive astrocytes.
Topics: Actins; Analgesics, Opioid; Animals; Astrocytes; Calcium Signaling; Capillaries; Coculture Techniques; Cytokines; Cytoskeleton; Endothelial Cells; Glutamic Acid; Inflammation; Interleukin-1beta; Levetiracetam; Lipopolysaccharides; Male; Naloxone; Narcotic Antagonists; Nootropic Agents; Oligopeptides; Piracetam; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase | 2013 |
A simple assay for determination of levetiracetam in rat dried blood spots by LC-MS/MS.
Topics: Animals; Anticonvulsants; Calibration; Chromatography, Liquid; Dried Blood Spot Testing; Levetiracetam; Limit of Detection; Male; Piracetam; Rats; Rats, Sprague-Dawley; Reference Standards; Reproducibility of Results; Tandem Mass Spectrometry | 2013 |
Augmented renal clearance of vancomycin and levetiracetam in a traumatic brain injury patient.
Topics: Anti-Bacterial Agents; Anticonvulsants; Bacterial Infections; Brain Injuries; Drug Monitoring; Female; Humans; Kidney; Levetiracetam; Piracetam; Seizures; Urine; Vancomycin; Young Adult | 2013 |
A case of nonconvulsive status epilepticus with a reversible contralateral cerebellar lesion: temporal changes in magnetic resonance imaging and single-photon emission computed tomography finding.
Topics: Aged; Anticonvulsants; Brain Waves; Cerebellum; Cerebrovascular Circulation; Diffusion Magnetic Resonance Imaging; Electroencephalography; Female; Humans; Levetiracetam; Perfusion Imaging; Piracetam; Predictive Value of Tests; Status Epilepticus; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2013 |
Role of intravenous levetiracetam for acute seizure management in preterm neonates.
Topics: Acute Disease; Anticonvulsants; Electroencephalography; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Injections, Intravenous; Levetiracetam; Male; Piracetam; Retrospective Studies; Seizures | 2013 |
Levetiracetam compared with valproic acid for the prevention of postoperative seizures after supratentorial tumor surgery: a retrospective chart review.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Brain Neoplasms; Child; Child, Preschool; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Seizures; Supratentorial Neoplasms; Treatment Outcome; Valproic Acid; Young Adult | 2013 |
Initial anticonvulsant monotherapy in routine care of children and adolescents: levetiracetam fails more frequently than valproate and oxcarbazepine due to a lack of effectiveness.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Infant; Levetiracetam; Male; Oxcarbazepine; Piracetam; Retrospective Studies; Treatment Failure; Treatment Outcome; Valproic Acid | 2014 |
Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
Topics: Acetamides; Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Benzodiazepines; Female; Humans; Lacosamide; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Retreatment; Retrospective Studies; Status Epilepticus; Treatment Outcome; Young Adult | 2014 |
Can zinc depletion play a role in LEV-induced hair loss? Considerations from a case study.
Topics: Adult; Anticonvulsants; Epilepsy, Tonic-Clonic; Female; Hair Diseases; Hematologic Tests; Humans; Levetiracetam; Piracetam; Zinc | 2013 |
Effects of antiepileptic drugs on reproductive endocrine function, sexual function and sperm parameters in Chinese Han men with epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Asian People; Epilepsy; Erectile Dysfunction; Follicle Stimulating Hormone; Humans; Infertility, Male; Levetiracetam; Luteinizing Hormone; Male; Middle Aged; Piracetam; Spermatozoa; Testosterone; Valproic Acid; Young Adult | 2013 |
Levetiracetam interacts synergistically with nonsteroidal analgesics and caffeine to produce antihyperalgesia in rats.
Topics: Acetaminophen; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Caffeine; Celecoxib; Drug Synergism; Drug Therapy, Combination; Hyperalgesia; Ibuprofen; Inflammation; Levetiracetam; Male; Piracetam; Pyrazoles; Rats; Rats, Wistar; Sulfonamides | 2013 |
The beneficial effects of levetiracetam on polyneuropathy in the early stage of sepsis in rats: electrophysiological and biochemical evidence.
Topics: Action Potentials; Animals; Antioxidants; Electromyography; Levetiracetam; Male; Malondialdehyde; Muscles; Piracetam; Polyneuropathies; Rats; Rats, Sprague-Dawley; Sepsis; Tumor Necrosis Factor-alpha | 2013 |
Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Apolipoprotein A-I; Apolipoproteins B; Atherosclerosis; Biomarkers; Carbamazepine; Cholesterol, LDL; Epilepsy; Female; Fructose; Homocysteine; Humans; Levetiracetam; Male; Oxcarbazepine; Piracetam; Prospective Studies; Risk Factors; Topiramate | 2013 |
The long-term efficacy and safety of levetiracetam in a tertiary epilepsy centre.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Drug Therapy, Combination; Electroencephalography; Epilepsy; Female; Humans; Levetiracetam; Long-Term Care; Male; Middle Aged; Piracetam; Republic of Korea; Survival Analysis; Treatment Failure; Treatment Outcome; Young Adult | 2013 |
Levetiracetam resistance: Synaptic signatures & corresponding promoter SNPs in epileptic hippocampi.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Drug Resistance; Epilepsy; Female; Hexosyltransferases; Hippocampus; Humans; Infant; Levetiracetam; Male; Membrane Proteins; Middle Aged; Piracetam; Polymorphism, Single Nucleotide; Presynaptic Terminals; Promoter Regions, Genetic; Young Adult | 2013 |
A case of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) related to rufinamide.
Topics: Anti-Inflammatory Agents; Anticonvulsants; Child; Drug Hypersensitivity Syndrome; Epilepsy, Complex Partial; Fructose; Humans; Levetiracetam; Male; Piracetam; Prednisone; Topiramate; Triazoles | 2013 |
Capacities of metabotropic glutamate modulators in counteracting soman-induced seizures in rats.
Topics: Acetylcholinesterase; Animals; Anticonvulsants; Butyrylcholinesterase; Cyclopropanes; Drug Interactions; Glycine; Levetiracetam; Male; Oximes; Piracetam; Procyclidine; Pyridines; Pyridinium Compounds; Rats; Rats, Wistar; Receptor, Metabotropic Glutamate 5; Seizures; Soman | 2013 |
The effect of levetiracetam on rat bone mass, structure and metabolism.
Topics: Alkaline Phosphatase; Animals; Biomarkers; Body Composition; Bone and Bones; Bone Density; Bone Morphogenetic Protein 2; Collagen Type I; Levetiracetam; Male; Osteoprotegerin; Piracetam; Rats; Rats, Wistar | 2013 |
Continuation rates of levetiracetam in children from the EULEVp cohort study.
Topics: Anticonvulsants; Child; Epilepsy; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Levetiracetam; Male; Piracetam; Proportional Hazards Models; Treatment Outcome | 2014 |
Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures.
Topics: Anticonvulsants; Child Development; Child, Preschool; Cohort Studies; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Levetiracetam; Phenobarbital; Piracetam; Retrospective Studies; Seizures | 2013 |
Considerations in prophylaxis for tumor-associated epilepsy: prevention of status epilepticus and tolerability of newer generation AEDs.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Brain Neoplasms; Female; Humans; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Retrospective Studies; Risk Factors; Seizures; Status Epilepticus; Treatment Outcome | 2013 |
Postanoxic myoclonus: two case presentations and review of medical management.
Topics: Aged; Anticonvulsants; Clonazepam; Drug Therapy, Combination; Humans; Hypoxia; Levetiracetam; Male; Middle Aged; Myoclonus; Piracetam; Valproic Acid | 2014 |
Antihyperalgesic/antinociceptive effects of ceftriaxone and its synergistic interactions with different analgesics in inflammatory pain in rodents.
Topics: Acetaminophen; Analgesics; Analgesics, Non-Narcotic; Animals; Anti-Bacterial Agents; Ceftriaxone; Celecoxib; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Hyperalgesia; Ibuprofen; Inflammation; Levetiracetam; Male; Pain; Piracetam; Pyrazoles; Rats; Rats, Wistar; Sulfonamides | 2014 |
Inhibition of Ca(2+)-regulated exocytosis by levetiracetam, a ligand for SV2A, in antral mucous cells of guinea pigs.
Topics: Acetylcholine; Adenosine Triphosphate; Animals; Calcium; Exocytosis; Gastric Mucosa; Gene Expression Regulation; Guinea Pigs; Levetiracetam; Ligands; Male; Membrane Glycoproteins; Piracetam; Protein Transport | 2013 |
Additional antiepileptic mechanisms of levetiracetam in lithium-pilocarpine treated rats.
Topics: Animals; Anticonvulsants; Dinoprostone; Dopamine; Glutathione; Hippocampus; Interleukin-10; Levetiracetam; Lipid Peroxidation; Lithium Chloride; Male; Nitric Oxide; Norepinephrine; Peroxidase; Pilocarpine; Piracetam; Rats; Rats, Wistar; Seizures; Tumor Necrosis Factor-alpha | 2013 |
The effects of levetiracetam on neural tube development in the early stage of chick embryos.
Topics: Animals; Anticonvulsants; Chick Embryo; Dose-Response Relationship, Drug; Embryonic Development; Levetiracetam; Neural Tube; Neural Tube Defects; Piracetam | 2013 |
A method for actively tracking excitability of brain networks using a fully implantable monitoring system.
Topics: Animals; Anticonvulsants; Brain; Brain Mapping; Circadian Rhythm; Deep Brain Stimulation; Dogs; Drug Delivery Systems; Electrodes; Electrodes, Implanted; Epilepsy; Evoked Potentials; Hippocampus; Levetiracetam; Piracetam; Seizures; Signal Processing, Computer-Assisted; Thalamus | 2013 |
Early-onset absence epilepsy aggravated by valproic acid: a video-EEG report.
Topics: Age of Onset; Anticonvulsants; Child, Preschool; Electroencephalography; Epilepsy, Absence; Humans; Levetiracetam; Male; Piracetam; Seizures; Treatment Outcome; Valproic Acid | 2013 |
Valproic acid, but not levetiracetam, selectively decreases HDAC7 and HDAC2 expression in human ovarian cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Female; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Levetiracetam; Ovarian Neoplasms; Piracetam; Valproic Acid | 2014 |
[Epileptic encephalopathy associated with forced normalization after administration of levetiracetam].
Topics: Anticonvulsants; Brain Waves; Child; Electroencephalography; Epilepsy; Female; Humans; Levetiracetam; Piracetam; Treatment Outcome | 2013 |
Interactions of levetiracetam with carbamazepine, phenytoin, topiramate and vigabatrin in the mouse 6Hz psychomotor seizure model - a type II isobolographic analysis.
Topics: Animals; Anticonvulsants; Avoidance Learning; Carbamazepine; Disease Models, Animal; Drug Combinations; Drug Interactions; Fructose; Hand Strength; Levetiracetam; Male; Mice; Phenytoin; Piracetam; Psychomotor Performance; Seizures; Topiramate; Vigabatrin | 2014 |
The antiepileptic drug levetiracetam suppresses non-convulsive seizure activity and reduces ischemic brain damage in rats subjected to permanent middle cerebral artery occlusion.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Electroencephalography; Infarction, Middle Cerebral Artery; Levetiracetam; Male; Neuroprotective Agents; Piracetam; Rats; Seizures; Time Factors | 2013 |
Levetiracetam following liver and kidney failure in late-onset anticonvulsant hypersensitivity syndrome.
Topics: Anticonvulsants; Drug Hypersensitivity Syndrome; Epilepsy; Humans; Levetiracetam; Liver Failure; Male; Middle Aged; Piracetam; Renal Insufficiency | 2014 |
Drug-drug interaction between methotrexate and levetiracetam resulting in delayed methotrexate elimination.
Topics: Anticonvulsants; Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Interactions; Humans; Levetiracetam; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Osteosarcoma; Piracetam | 2014 |
Inhibition of excitatory synaptic transmission in hippocampal neurons by levetiracetam involves Zn²⁺-dependent GABA type A receptor-mediated presynaptic modulation.
Topics: Action Potentials; Animals; Anticonvulsants; CA3 Region, Hippocampal; Cells, Cultured; Chelating Agents; Evoked Potentials; Female; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; GABAergic Neurons; Levetiracetam; Male; Mossy Fibers, Hippocampal; Nerve Tissue Proteins; Neural Inhibition; Piracetam; Presynaptic Terminals; Rats; Receptors, GABA-A; Zinc | 2014 |
Levetiracetam-induced anaphylaxis in a neonate.
Topics: Anaphylaxis; Anticonvulsants; Asphyxia Neonatorum; Contraindications; Drug Eruptions; Exanthema; Face; Fetal Distress; Humans; Infant, Newborn; Infusions, Intravenous; Leg; Levetiracetam; Piracetam; Pneumothorax; Scalp; Seizures | 2014 |
Levetiracetam versus (fos)phenytoin for seizure prophylaxis in pediatric patients with intracranial hemorrhage.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Female; Humans; Incidence; Infant; Intracranial Hemorrhages; Levetiracetam; Male; Phenytoin; Piracetam; Primary Prevention; Retrospective Studies; Seizures; Treatment Outcome | 2014 |
Acute pancreatitis and elevated liver transaminases after rapid titration of oral levetiracetam.
Topics: Administration, Oral; Adult; Anticonvulsants; Female; Humans; Levetiracetam; Liver; Pancreatitis; Piracetam; Time Factors; Transaminases | 2014 |
[Efficacy and psychiatric adverse events as short-term adjunctive levetiracetam for epileptic children with refractory convulsive seizures].
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Female; Humans; Levetiracetam; Male; Piracetam; Quality of Life; Seizures; Time Factors; Treatment Outcome | 2013 |
Hair loss with levetiracetam in five patients with epilepsy.
Topics: Adult; Anticonvulsants; Epilepsy; Female; Follow-Up Studies; Humans; Hypotrichosis; Levetiracetam; Male; Piracetam; Time Factors; Young Adult | 2014 |
Levetiracetam results in increased and decreased alcohol drinking with different access procedures in C57BL/6J mice.
Topics: Alcohol Drinking; Animals; Anticonvulsants; Central Nervous System Depressants; Choice Behavior; Dose-Response Relationship, Drug; Drinking Behavior; Ethanol; Levetiracetam; Male; Mice; Mice, Inbred C57BL; Piracetam; Sucrose; Sweetening Agents | 2014 |
Teratogenic potential of antiepileptic drugs in the zebrafish model.
Topics: Acetamides; Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Ethosuximide; Female; Fructose; Humans; Lacosamide; Lamotrigine; Levetiracetam; Piracetam; Pregnancy; Teratogenesis; Topiramate; Triazines; United States; Valproic Acid; Zebrafish | 2013 |
The safety and tolerability of different intravenous administrations of levetiracetam, bolus versus infusion, in intensive care unit patients.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anticonvulsants; Female; Humans; Infusions, Intravenous; Intensive Care Units; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Seizures; Status Epilepticus; Treatment Outcome; Young Adult | 2014 |
Toothbrushing-induced seizures at onset of cryptogenic partial epilepsy: a case report.
Topics: Acetamides; Anticonvulsants; Electroencephalography; Epilepsies, Partial; Humans; Lacosamide; Levetiracetam; Magnetic Resonance Imaging; Male; Middle Aged; Neurologic Examination; Piracetam; Seizures; Toothbrushing | 2014 |
Synthesis, characterization, and DNA binding studies of a new Pt(II) complex containing the drug Levetiracetam: combining experimental and computational methods.
Topics: Animals; Anticonvulsants; Antineoplastic Agents; Binding Sites; Binding, Competitive; Bisbenzimidazole; Buffers; Cattle; Circular Dichroism; DNA; Intercalating Agents; Kinetics; Levetiracetam; Organoplatinum Compounds; Piracetam; Thermodynamics | 2014 |
Dress syndrome induced by levetiracetam.
Topics: Anticonvulsants; Drug Hypersensitivity Syndrome; Humans; Levetiracetam; Male; Middle Aged; Piracetam | 2015 |
Antiepileptic drugs and neurocognitive development.
Topics: Anticonvulsants; Child Development; Female; Humans; Language Development; Levetiracetam; Male; Piracetam; Pregnancy; Prenatal Exposure Delayed Effects; Valproic Acid | 2014 |
In utero exposure to levetiracetam vs valproate: development and language at 3 years of age.
Topics: Adult; Anticonvulsants; Child Development; Child, Preschool; Epilepsy; Female; Humans; Language Development; Levetiracetam; Male; Piracetam; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Prospective Studies; United Kingdom; Valproic Acid | 2014 |
Reproductive endocrine health in pubertal females with epilepsy on antiepileptic drugs: time to screen?
Topics: Adiposity; Adolescent; Anticonvulsants; Cohort Studies; Cross-Sectional Studies; Drug Evaluation, Preclinical; Endocrine Disruptors; Epilepsy; Female; Hirsutism; Humans; Hyperandrogenism; Lamotrigine; Levetiracetam; Piracetam; Reproductive Health; Triazines; Valproic Acid | 2014 |
Stability of levetiracetam oral solution repackaged in oral plastic syringes.
Topics: Administration, Oral; Anticonvulsants; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Packaging; Drug Stability; Drug Storage; Feasibility Studies; Hydrogen-Ion Concentration; Levetiracetam; Pharmaceutical Solutions; Piracetam; Polypropylenes; Syringes; Temperature; Time Factors | 2014 |
Efficacy of dexamethasone on penicillin-induced epileptiform activity in rats: an electrophysiological study.
Topics: Animals; Anticonvulsants; Brain; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; Glucocorticoids; Levetiracetam; Male; Penicillins; Phenytoin; Piracetam; Rats; Rats, Wistar; Time Factors; Treatment Outcome | 2014 |
Presumed mitochondrial disease manifesting with recurrent syncopes.
Topics: Aged; Anticonvulsants; Autonomic Nervous System Diseases; Biopsy; Catheter Ablation; Electrocardiography; Epilepsy, Tonic-Clonic; Humans; Levetiracetam; Male; Mitochondrial Diseases; Piracetam; Recurrence; Syncope; Tachycardia, Supraventricular; Treatment Outcome | 2014 |
Neuroprotective effect of levetiracetam on hypoxic ischemic brain injury in neonatal rats.
Topics: Animals; Animals, Newborn; Apoptosis; Brain Injuries; Caspase 3; Catalase; Cell Count; Dose-Response Relationship, Drug; Glutathione Peroxidase; Hypoxia-Ischemia, Brain; In Situ Nick-End Labeling; Levetiracetam; Malondialdehyde; Maze Learning; Neurons; Nootropic Agents; Piracetam; Rats; Superoxide Dismutase; Time Factors | 2014 |
Levetiracetam increases neonatal hypoxic-ischemic brain injury under normothermic, but not hypothermic conditions.
Topics: Animals; Apoptosis Inducing Factor; Caspase 3; Cell Count; Cell Death; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Embryo, Mammalian; Gene Expression Regulation; Glucose; Hippocampus; Hypothermia, Induced; Hypoxia; Hypoxia-Ischemia, Brain; Levetiracetam; Mice; Neurons; Neuroprotective Agents; Piracetam | 2014 |
Levetiracetam versus phenytoin: a comparison of efficacy of seizure prophylaxis and adverse event risk following acute or subacute subdural hematoma diagnosis.
Topics: Aged; Anticonvulsants; Female; Hematoma, Subdural; Humans; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Seizures | 2014 |
Generalised electrographic seizures presenting as perioral myoclonia.
Topics: Adult; Diagnosis, Differential; Electroencephalography; Humans; Levetiracetam; Male; Myoclonic Epilepsy, Juvenile; Piracetam; Seizures; Treatment Outcome; Video Recording | 2014 |
Therapeutic drug monitoring of levetiracetam: comparison of a novel immunoassay with an HPLC method.
Topics: Anticonvulsants; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Immunoassay; Levetiracetam; Piracetam | 2014 |
An atypical case of neuroleptic malignant syndrome precipitated by valproate.
Topics: Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Dopamine Agonists; Drug Therapy, Combination; Female; Fluid Therapy; Humans; Levetiracetam; Lorazepam; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Piracetam; Pramipexole; Psychotic Disorders; Valproic Acid | 2014 |
Short-term effect of levetiracetam monotherapy on haematological parameters in children with epilepsy: a prospective study.
Topics: Anticonvulsants; Blood Cell Count; Child; Child, Preschool; Epilepsy; Female; Hematocrit; Humans; Leukocytes; Levetiracetam; Male; Piracetam; Prospective Studies | 2014 |
Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs).
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Seizures; Valproic Acid; Young Adult | 2014 |
Busulfan triggers epileptic seizures under levetiracetam and valproic acid therapy.
Topics: Adolescent; Anticonvulsants; Busulfan; Drug Therapy, Combination; Epilepsy; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Levetiracetam; Piracetam; Transplantation Conditioning; Valproic Acid | 2014 |
[Therapeutic effect of levetiracetam add-on treatment for frontal lobe epilepsy in 105 children].
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Electroencephalography; Epilepsy, Frontal Lobe; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Prospective Studies; Treatment Outcome | 2014 |
Effect of levetiracetam on behavioral problems in pervasive developmental disorder children with epilepsy.
Topics: Adolescent; Anticonvulsants; Behavioral Symptoms; Brain Waves; Child; Developmental Disabilities; Electroencephalography; Epilepsy; Female; Humans; Levetiracetam; Male; Piracetam; Severity of Illness Index | 2014 |
A missed opportunity - consequences of unknown levetiracepam pharmacokinetics in a peritoneal dialysis patient.
Topics: Aged; Anticonvulsants; Fatigue; Humans; Levetiracetam; Male; Metabolic Clearance Rate; Peritoneal Dialysis; Piracetam; Renal Insufficiency, Chronic; Seizures; Treatment Outcome | 2014 |
'Dancing eyes, dancing feet syndrome' in small cell lung carcinoma.
Topics: Baclofen; Humans; Levetiracetam; Lung; Lung Neoplasms; Male; Middle Aged; Muscle Relaxants, Central; Opsoclonus-Myoclonus Syndrome; Piracetam; Radiography; Small Cell Lung Carcinoma | 2014 |
Phenytoin and sodium valproate but not levetiracetam induce bone alterations in female mice.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Anticonvulsants; Biomarkers; Bone Density; Calcium; Female; Hydroxyproline; Isoenzymes; Levetiracetam; Lumbar Vertebrae; Mice; Phenytoin; Piracetam; Tartrate-Resistant Acid Phosphatase; Valproic Acid | 2014 |
Cardiac involvement secondary to mediastinal lymphoma in a cat: regression with chemotherapy.
Topics: Animals; Anticonvulsants; Antineoplastic Agents; Asparaginase; Cat Diseases; Cats; Drug Therapy, Combination; Echocardiography; Euthanasia, Animal; Fatal Outcome; Heart Neoplasms; Levetiracetam; Lomustine; Lymphoma; Male; Mediastinal Neoplasms; Neoplasm Invasiveness; Piracetam; Seizures | 2014 |
Recurrent severe ulcers due to seizures.
Topics: Anticonvulsants; Electroencephalography; Female; Humans; Infant; Levetiracetam; Mouth Protectors; Oral Ulcer; Piracetam; Recurrence; Seizures | 2014 |
Levetiracetam as alternative treatment in Jeavons syndrome.
Topics: Adult; Anticonvulsants; Epilepsy, Absence; Female; Humans; Levetiracetam; Myoclonus; Piracetam | 2014 |
Management of Posterior Reversible Encephalopathy Syndrome Induced by Carfilzomib in a Patient With Multiple Myeloma.
Topics: Anticonvulsants; Antihypertensive Agents; Antineoplastic Agents; Biomarkers, Tumor; Bortezomib; Brain; Disease Management; Disease Progression; Female; Humans; Immunoglobulin kappa-Chains; Levetiracetam; Magnetic Resonance Imaging; Middle Aged; Multiple Myeloma; Neurologic Examination; Nimodipine; Nootropic Agents; Oligopeptides; Piracetam; Polyneuropathies; Posterior Leukoencephalopathy Syndrome; Secondary Prevention; Seizures | 2016 |
Increased levetiracetam clearance associated with a breakthrough seizure in a pregnant patient receiving once/day extended-release levetiracetam.
Topics: Adolescent; Anticonvulsants; Delayed-Action Preparations; Female; Humans; Infant, Newborn; Levetiracetam; Male; Piracetam; Pregnancy; Pregnancy Complications; Seizures | 2014 |
Effect of quercetin and rutin in some acute seizure models in mice.
Topics: Animals; Anticonvulsants; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electric Stimulation; Levetiracetam; Male; Memory, Long-Term; Mice; Muscle Strength; Pentylenetetrazole; Piracetam; Psychomotor Performance; Quercetin; Rutin; Seizures; Time Factors; Valproic Acid | 2014 |
Chronic valproate or levetiracetam treatment does not influence cytokine levels in humans.
Topics: Anticonvulsants; Blood Chemical Analysis; Cytokines; Enzyme-Linked Immunosorbent Assay; Epilepsy; Female; Flow Cytometry; Humans; Leukocyte Count; Levetiracetam; Lymphocytes; Male; Middle Aged; Neutrophils; Piracetam; Prospective Studies; Valproic Acid | 2014 |
Hypokalemia and hypomagnesaemia related to levetiracetam use.
Topics: Adult; Anticonvulsants; Humans; Hypokalemia; Lamotrigine; Levetiracetam; Magnesium; Male; Nephritis, Interstitial; Piracetam; Potassium; Risk Factors; Seizures; Triazines; Valproic Acid | 2014 |
Incidence of delayed seizures, delayed cerebral ischemia and poor outcome with the use of levetiracetam versus phenytoin after aneurysmal subarachnoid hemorrhage.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Brain Ischemia; Female; Follow-Up Studies; Hematoma; Humans; Incidence; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Seizures; Severity of Illness Index; Subarachnoid Hemorrhage; Time Factors; Treatment Outcome; Young Adult | 2014 |
A topical matter: toxic epidermal necrolysis.
Topics: Acetaminophen; Analgesics, Opioid; Anti-Inflammatory Agents; Anticonvulsants; Antiemetics; Antineoplastic Agents; Dacarbazine; Dexamethasone; Drug Combinations; Erythema; gamma-Globulins; Glioblastoma; Humans; Immunologic Factors; Levetiracetam; Male; Methylprednisolone; Middle Aged; Omeprazole; Oxycodone; Piperidines; Piracetam; Proton Pump Inhibitors; Quinazolines; Stevens-Johnson Syndrome; Temozolomide; Wound Healing | 2014 |
Levetiracetam as a possible contributor to acute kidney injury.
Topics: Acute Kidney Injury; Anticonvulsants; Female; Humans; Levetiracetam; Piracetam; Seizures; Young Adult | 2014 |
The efficacy of the newer antiepileptic drugs in controlling seizures in pregnancy.
Topics: Anticonvulsants; Female; Fructose; Humans; Lamotrigine; Levetiracetam; Piracetam; Pregnancy; Registries; Seizures; Topiramate; Treatment Outcome; Triazines; Victoria | 2014 |
Interaction of injectable neurotropic drugs with the red cell membrane.
Topics: Central Nervous System Agents; Chlorpromazine; Citalopram; Clomipramine; Clonazepam; Diazepam; Erythrocytes; Humans; Injections; Levetiracetam; Microscopy, Electron, Scanning; Neurotransmitter Agents; Phenobarbital; Phenytoin; Piracetam; Valproic Acid | 2014 |
Evaluation of levetiracetam and valproic acid as low-dose monotherapies for children with typical benign childhood epilepsy with centrotemporal spikes (BECTS).
Topics: Anticonvulsants; Brain Waves; Case-Control Studies; Child; Cohort Studies; Electroencephalography; Epilepsy, Rolandic; Female; Humans; Levetiracetam; Male; Piracetam; Valproic Acid | 2014 |
A young woman with seizures and psychosis.
Topics: Adult; Anticonvulsants; Epilepsy; Female; Hallucinations; Humans; Levetiracetam; Neuropsychological Tests; Phenytoin; Piracetam; Psychotic Disorders; Seizures; Treatment Outcome | 2014 |
Obsessive-compulsive behavior induced by levetiracetam.
Topics: Adolescent; Anticonvulsants; Epilepsy; Female; Humans; Levetiracetam; Obsessive-Compulsive Disorder; Piracetam | 2015 |
The teratogenicity of the newer antiepileptic drugs - an update.
Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Epilepsy; Female; Fetus; Fructose; Humans; Lamotrigine; Levetiracetam; Piracetam; Pregnancy; Registries; Risk; Topiramate; Triazines; Valproic Acid | 2014 |
Lacosamide-induced atrial tachycardia in a child with hypoplastic left-heart syndrome: the importance of assessing additional proarrhythmic risks.
Topics: Acetamides; Anticonvulsants; Arrhythmias, Cardiac; Child, Preschool; Comorbidity; Humans; Hypoplastic Left Heart Syndrome; Isoxazoles; Lacosamide; Levetiracetam; Male; Piracetam; Seizures; Tachycardia, Sinus; Treatment Outcome; Zonisamide | 2015 |
Effectiveness of intravenous levetiracetam as an adjunctive treatment in pediatric refractory status epilepticus.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Levetiracetam; Male; Piracetam; Status Epilepticus; Treatment Outcome | 2014 |
Zebrafish embryotoxicity test for developmental (neuro)toxicity: Demo case of an integrated screening approach system using anti-epileptic drugs.
Topics: Animals; Anticonvulsants; Brain; Carbamazepine; Dose-Response Relationship, Drug; Endpoint Determination; Ethosuximide; In Situ Hybridization; Levetiracetam; Piracetam; Toxicity Tests; Valproic Acid; Zebrafish | 2014 |
Development of new method for simultaneous analysis of piracetam and levetiracetam in pharmaceuticals and biological fluids: application in stability studies.
Topics: Adolescent; Adult; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Drug Contamination; Drug Stability; Humans; Levetiracetam; Linear Models; Male; Piracetam; Sensitivity and Specificity; Tablets; Young Adult | 2014 |
[Efficacy of levetiracetam combined with short-term clonazepam in treatment of electrical status epilepticus during sleep in children with benign childhood epilepsy with centrotemporal spikes].
Topics: Anticonvulsants; Child; Child, Preschool; Clonazepam; Drug Therapy, Combination; Electroencephalography; Epilepsy, Rolandic; Female; Humans; Levetiracetam; Male; Piracetam; Retrospective Studies; Sleep; Status Epilepticus | 2014 |
Levetiracetam as adjunctive therapy for acute alcohol withdrawal syndrome in hospitalized patients.
Topics: Adult; Alcoholism; Anticonvulsants; Benzodiazepines; Cohort Studies; Drug Therapy, Combination; Female; Hospitalization; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Substance Withdrawal Syndrome | 2014 |
Levetiracetam-induced neutropenia following traumatic brain injury.
Topics: Anticonvulsants; Brain Injuries; Humans; Levetiracetam; Male; Middle Aged; Neutropenia; Piracetam | 2015 |
Long-term comparison of GOS-E scores in patients treated with phenytoin or levetiracetam for posttraumatic seizure prophylaxis after traumatic brain injury.
Topics: Adult; Aged; Anticonvulsants; Brain Injuries; Female; Humans; Levetiracetam; Male; Mental Status Schedule; Middle Aged; Phenytoin; Piracetam; Prospective Studies; Seizures | 2014 |
Efficacy and safety of IV levetiracetam in children with acute repetitive seizures.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Electroencephalography; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Injections, Intravenous; Levetiracetam; Magnetic Resonance Imaging; Male; Piracetam; Retrospective Studies; ROC Curve; Seizures; Statistics, Nonparametric | 2014 |
Effect of levetiracetam in acute encephalitis with refractory, repetitive partial seizures during acute and chronic phase.
Topics: Acute Disease; Adolescent; Adult; Anticonvulsants; Bromides; Child; Chronic Disease; Encephalitis; Female; Humans; Levetiracetam; Male; Phenobarbital; Piracetam; Potassium Compounds; Retrospective Studies; Seizures; Status Epilepticus; Young Adult | 2015 |
Long term retention of retigabine in a cohort of people with drug resistant epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamates; Drug Resistance; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Phenylenediamines; Piracetam; Time; Treatment Outcome; Young Adult | 2014 |
Epilepsy in patients with gliomas: incidence and control of seizures.
Topics: Anticonvulsants; Antineoplastic Agents; Brain Neoplasms; Carbamazepine; Female; Glioma; Humans; Incidence; Japan; Levetiracetam; Male; Middle Aged; Neoplasm Grading; Phenytoin; Piracetam; Retrospective Studies; Seizures | 2015 |
Simultaneous analysis of 22 antiepileptic drugs in postmortem blood, serum and plasma using LC-MS-MS with a focus on their role in forensic cases.
Topics: Amines; Anticonvulsants; Carbamazepine; Chromatography, Liquid; Cyclohexanecarboxylic Acids; Drug Monitoring; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Levetiracetam; Limit of Detection; Nipecotic Acids; Oxcarbazepine; Phenytoin; Piracetam; Pregabalin; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Tiagabine; Topiramate; Triazines; Valproic Acid | 2014 |
Effect of levetiracetam on penicillin induced epileptic activity in rats.
Topics: Animals; Anticonvulsants; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; Female; Levetiracetam; Penicillins; Piracetam; Rats, Wistar | 2014 |
Development and validation of a GC/MS method for the simultaneous determination of levetiracetam and lamotrigine in whole blood.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Drug Monitoring; Female; Gas Chromatography-Mass Spectrometry; Humans; Lamotrigine; Levetiracetam; Limit of Detection; Male; Middle Aged; Piracetam; Solid Phase Extraction; Triazines; Young Adult | 2015 |
Profile of anticonvulsant action of levetiracetam, tiagabine and phenobarbital against seizures evoked by DMCM (methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate) in neonatal rats.
Topics: Animals; Animals, Newborn; Anticonvulsants; Carbolines; Levetiracetam; Male; Nipecotic Acids; Phenobarbital; Piracetam; Rats; Rats, Sprague-Dawley; Seizures; Tiagabine | 2014 |
Levetiracetam reduces abnormal network activations in temporal lobe epilepsy.
Topics: Adult; Anticonvulsants; Brain; Chi-Square Distribution; Epilepsy, Temporal Lobe; Female; Humans; Image Processing, Computer-Assisted; Levetiracetam; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Oxygen; Piracetam; Young Adult | 2014 |
Going beyond seizure control: can pharmacotherapy help to restore cognitive network function?
Topics: Anticonvulsants; Brain; Epilepsy, Temporal Lobe; Female; Humans; Levetiracetam; Male; Piracetam | 2014 |
Abbreviated levetiracetam treatment effects on behavioural and histological outcomes after experimental TBI.
Topics: Animals; Brain Injuries; Contusions; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Hippocampus; Levetiracetam; Male; Neurons; Neuroprotective Agents; Phenytoin; Piracetam; Random Allocation; Rats; Rats, Sprague-Dawley; Seizures; Spatial Learning; Treatment Outcome | 2015 |
Ictal asystole in epilepsy patients undergoing inpatient video-EEG monitoring.
Topics: Aged; Anticonvulsants; Bradycardia; Electroencephalography; Epilepsy, Temporal Lobe; Female; Heart Arrest; Humans; Inpatients; Levetiracetam; Middle Aged; Monitoring, Physiologic; Pacemaker, Artificial; Phenytoin; Piracetam; Syncope; Video Recording | 2014 |
Continuous subcutaneous use of levetiracetam: a retrospective review of tolerability and clinical effects.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Drug Therapy, Combination; Epilepsy; Female; Humans; Infusions, Subcutaneous; Levetiracetam; Male; Middle Aged; Pain; Piracetam; Retrospective Studies; Treatment Outcome | 2014 |
Levetiracetam effect on adult-onset temporal lobe epilepsy with positive voltage-gated potassium channel antibody.
Topics: Antibodies; Anticonvulsants; Brain; Epilepsy, Temporal Lobe; Female; Humans; Levetiracetam; Middle Aged; Piracetam; Positron-Emission Tomography; Potassium Channels, Voltage-Gated; Tomography, X-Ray Computed | 2015 |
The human synaptic vesicle protein, SV2A, functions as a galactose transporter in Saccharomyces cerevisiae.
Topics: Anticonvulsants; Biological Transport, Active; Galactose; Humans; Levetiracetam; Membrane Glycoproteins; Monosaccharide Transport Proteins; Nerve Tissue Proteins; Piracetam; Recombinant Proteins; Saccharomyces cerevisiae; Sequence Homology, Amino Acid; Synapses | 2014 |
Determination of a selection of anti-epileptic drugs and two active metabolites in whole blood by reversed phase UPLC-MS/MS and some examples of application of the method in forensic toxicology cases.
Topics: Amines; Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Cyclohexanecarboxylic Acids; Forensic Toxicology; Gabapentin; gamma-Aminobutyric Acid; Humans; Levetiracetam; Oxcarbazepine; Piracetam; Tandem Mass Spectrometry | 2015 |
Atherosclerotic effects of long-term old and new antiepileptic drugs monotherapy: a cross-sectional comparative study.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Carotid Arteries; Carotid Intima-Media Thickness; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Epilepsies, Partial; Epilepsy, Generalized; Female; Fructose; Humans; Intracranial Arteriosclerosis; Lamotrigine; Levetiracetam; Male; Piracetam; Topiramate; Triazines; Valproic Acid | 2015 |
Haematological toxicity of Valproic acid compared to Levetiracetam in patients with glioblastoma multiforme undergoing concomitant radio-chemotherapy: a retrospective cohort study.
Topics: Adult; Aged; Anticonvulsants; Blood Cell Count; Blood Cells; Brain Neoplasms; Chemoradiotherapy; Female; Glioblastoma; Hemoglobins; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Seizures; Valproic Acid; Young Adult | 2015 |
Rapid and simultaneous quantification of levetiracetam and its carboxylic metabolite in human plasma by liquid chromatography tandem mass spectrometry.
Topics: Chromatography, Liquid; Epilepsy; Humans; Levetiracetam; Limit of Detection; Piracetam; Reproducibility of Results; Tandem Mass Spectrometry | 2014 |
Increased levetiracetam clearance and breakthrough seizure in a pregnant patient successfully handled by intensive therapeutic drug monitoring.
Topics: Adult; Anticonvulsants; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Levetiracetam; Piracetam; Pregnancy; Seizures | 2015 |
Effects of phenobarbital and levetiracetam on PR and QTc intervals in patients with post-stroke seizure.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Female; Humans; Levetiracetam; Long QT Syndrome; Male; Middle Aged; Phenobarbital; Piracetam; Prospective Studies; Risk Factors; Seizures; Single-Blind Method; Stroke; Treatment Outcome | 2014 |
The temporal crescent syndrome.
Topics: Aged; Anticonvulsants; Cerebral Infarction; Epilepsy; Female; Humans; Levetiracetam; Piracetam; Syndrome; Vision Disorders; Visual Fields | 2015 |
Mechanistic and conformational studies on the interaction of a platinum(II) complex containing an antiepileptic drug, levetiracetam, with bovine serum albumin by optical spectroscopic techniques in aqueous solution.
Topics: Animals; Anticonvulsants; Binding Sites; Binding, Competitive; Cattle; Coordination Complexes; Humans; Hydrogen Bonding; Kinetics; Levetiracetam; Molecular Conformation; Piracetam; Platinum; Protein Binding; Pyrrolidines; Serum Albumin, Bovine; Thermodynamics | 2015 |
Interactions between levetiracetam and cardiovascular drugs against electroconvulsions in mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticonvulsants; Avoidance Learning; Cardiovascular Agents; Disease Models, Animal; Diuretics; Dose-Response Relationship, Drug; Drug Interactions; Electroshock; Injections, Intraperitoneal; Levetiracetam; Mice; Piracetam; Seizures | 2014 |
Nanocrystals of zeolite act as enhanced sensing interface for biosensing of leviteracetum.
Topics: Anticonvulsants; Biosensing Techniques; Chemistry, Pharmaceutical; Crystallography, X-Ray; Dielectric Spectroscopy; Electrochemical Techniques; Levetiracetam; Limit of Detection; Linear Models; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Nanotechnology; Piracetam; Reproducibility of Results; Surface Properties; Technology, Pharmaceutical; Time Factors; Zeolites | 2015 |
Effectiveness of levetiracetam use following resective surgery in patients with refractory epilepsy: a prospective observational study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Brain; Child; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Neurosurgical Procedures; Piracetam; Prognosis; Prospective Studies; Recurrence; Treatment Outcome; Young Adult | 2014 |
Inter-individual variation in the effect of antiepileptic drugs in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice.
Topics: Animals; Anticonvulsants; Carbamazepine; Diazepam; Disease Models, Animal; Drug Resistance; Electrodes, Implanted; Electroencephalography; Epilepsy, Temporal Lobe; Female; Hippocampus; Kainic Acid; Levetiracetam; Mice; Phenobarbital; Phenytoin; Piracetam; Seizures; Valproic Acid | 2015 |
Two patients with Hashimoto's encephalopathy and uncontrolled diabetes successfully treated with levetiracetam.
Topics: Adult; Anti-Inflammatory Agents; Anticonvulsants; Comorbidity; Diabetes Mellitus; Encephalitis; Female; Hashimoto Disease; Humans; Levetiracetam; Middle Aged; Piracetam | 2015 |
Levetiracetam as a possible cause of secondary graft failure after allogenic hematopoietic stem cell transplantation.
Topics: Adolescent; Anticonvulsants; Blood Cell Count; Graft Rejection; Hematopoietic Stem Cell Transplantation; Humans; Leukocyte Count; Levetiracetam; Male; Myelodysplastic Syndromes; Phenobarbital; Piracetam; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Seizures; Treatment Failure | 2015 |
Ammonia encephalopathy and awake craniotomy for brain language mapping: cause of failed awake craniotomy.
Topics: Anesthesia, General; Anesthesia, Local; Anticonvulsants; Aphasia; Benzodiazepines; Brain Diseases; Brain Mapping; Brain Neoplasms; Carnitine; Clobazam; Conscious Sedation; Consciousness Disorders; Craniotomy; Dominance, Cerebral; Frontal Lobe; Glioma; Humans; Hyperammonemia; Hypnotics and Sedatives; Intraoperative Complications; Language; Levetiracetam; Male; Middle Aged; Piperidines; Piracetam; Propofol; Remifentanil; Seizures; Temporal Lobe; Valproic Acid | 2015 |
Therapeutic Drug Monitoring of Levetiracetam and Lamotrigine: Is There a Need?
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Child; Child, Preschool; Cytochrome P-450 Enzyme Inducers; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Epilepsy; Female; Humans; Infant; Lamotrigine; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Triazines; Young Adult | 2015 |
Retention rates of levetiraceram in Chinese children and adolescents with epilepsy.
Topics: Adolescent; Anticonvulsants; Asian People; Child; Child, Preschool; Epilepsy; Female; Humans; Levetiracetam; Male; Medication Adherence; Piracetam | 2015 |
Cosmetic side effects of antiepileptic drugs in adults with epilepsy.
Topics: Acne Vulgaris; Adult; Alopecia; Anticonvulsants; Epilepsy; Female; gamma-Aminobutyric Acid; Gingival Diseases; Hirsutism; Humans; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Pregabalin; Risk Factors; Sex Factors; Valproic Acid; Weight Gain | 2015 |
Genetic background of mice strongly influences treatment resistance in the 6 Hz seizure model.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Electroshock; Levetiracetam; Male; Mice; Phenytoin; Piracetam; Psychomotor Performance; Seizures; Treatment Outcome | 2015 |
Efficacy and tolerability of the ketogenic diet in Dravet syndrome - Comparison with various standard antiepileptic drug regimen.
Topics: Adolescent; Anticonvulsants; Benzodiazepines; Bromides; Child; Child, Preschool; Clobazam; Diet, Ketogenic; Dioxolanes; Epilepsies, Myoclonic; Female; Fructose; Humans; Infant; Levetiracetam; Male; Piracetam; Retrospective Studies; Seizures; Topiramate; Treatment Outcome; Vagus Nerve Stimulation; Valproic Acid; Young Adult | 2015 |
[Successful treatment of epilepsy and circadian rhythm disturbance with levetiracetam in a patient with dentatorubral-pallidoluysian atrophy (DRPLA)].
Topics: Anticonvulsants; Circadian Rhythm; Electroencephalography; Humans; Levetiracetam; Male; Myoclonic Epilepsies, Progressive; Piracetam; Young Adult | 2014 |
Pretreatment with intravenous levetiracetam in the rhesus monkey Coriaria lactone-induced status epilepticus model.
Topics: Administration, Intravenous; Animals; Anticonvulsants; Disease Models, Animal; Humans; Lactones; Levetiracetam; Macaca mulatta; Male; Neurons; Piracetam; Status Epilepticus | 2015 |
Transient and reproducible loss of motor-evoked potential signals after intravenous levetiracetam in a child undergoing craniotomy for resection of astrocytoma.
Topics: Anticonvulsants; Astrocytoma; Brain Neoplasms; Child; Craniotomy; Evoked Potentials, Motor; Evoked Potentials, Somatosensory; Female; Humans; Infusions, Intravenous; Levetiracetam; Monitoring, Intraoperative; Piracetam | 2015 |
[Clinical efficacy of levetiracetam on bone mineral density and bone metabolism in middle-aged and elderly patients with generalized tonic-clonic seizures].
Topics: Aged; Alkaline Phosphatase; Anticonvulsants; Bone and Bones; Bone Density; Humans; Levetiracetam; Middle Aged; Parathyroid Hormone; Piracetam; Seizures; Treatment Outcome | 2014 |
Incidental rolandic spikes: long-term outcomes and impact of treatment.
Topics: Anticonvulsants; Child; Child, Preschool; Electroencephalography; Epilepsy, Rolandic; Female; Follow-Up Studies; Headache; Humans; Irritable Mood; Language Development Disorders; Learning Disabilities; Levetiracetam; Longitudinal Studies; Male; Piracetam; Retrospective Studies; Treatment Outcome | 2015 |
Levetiracetam efficacy in children with epilepsy with electrical status epilepticus in sleep.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; China; Epilepsy; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Seizures; Sleep Wake Disorders; Status Epilepticus; Treatment Outcome | 2015 |
Retention rate of zonisamide in intractable epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Denmark; Drug Therapy, Combination; Epilepsy; Female; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Male; Middle Aged; Norway; Patient Dropouts; Piracetam; Quality of Life; Sweden; Treatment Outcome; Triazines; Young Adult; Zonisamide | 2015 |
The anti-ictogenic effects of levetiracetam are mirrored by interictal spiking and high-frequency oscillation changes in a model of temporal lobe epilepsy.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Electrodes, Implanted; Electroencephalography; Epilepsy, Temporal Lobe; Hippocampus; Levetiracetam; Male; Periodicity; Pilocarpine; Piracetam; Rats, Sprague-Dawley; Seizures; Treatment Outcome; Video Recording | 2015 |
Myoclonic epilepsy in Down syndrome and Alzheimer disease.
Topics: Adult; Aged; Alzheimer Disease; Anticonvulsants; Down Syndrome; Electroencephalography; Epilepsies, Myoclonic; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Valproic Acid | 2017 |
Levetiracetam accelerates the onset of supply rate depression in synaptic vesicle trafficking.
Topics: Animals; Animals, Newborn; Hippocampus; Levetiracetam; Long-Term Synaptic Depression; Mice; Mice, Knockout; Organ Culture Techniques; Piracetam; Protein Transport; Synaptic Vesicles | 2015 |
Exploring the interaction of SV2A with racetams using homology modelling, molecular dynamics and site-directed mutagenesis.
Topics: Amino Acid Sequence; Anticonvulsants; Humans; Levetiracetam; Membrane Glycoproteins; Molecular Dynamics Simulation; Molecular Sequence Data; Mutagenesis, Site-Directed; Nerve Tissue Proteins; Piracetam; Protein Binding; Protein Structure, Secondary; Sequence Homology, Amino Acid | 2015 |
The effects of levetiracetam, sumatriptan, and caffeine in a rat model of trigeminal pain: interactions in 2-component combinations.
Topics: Analgesics; Animals; Behavior, Animal; Caffeine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Facial Neuralgia; Facial Pain; Formaldehyde; Levetiracetam; Male; Motor Activity; Nociception; Piracetam; Rats, Wistar; Sumatriptan; Time Factors; Trigeminal Nerve Diseases | 2015 |
Antiepileptic prophylaxis following severe traumatic brain injury within a military cohort.
Topics: Adult; Anticonvulsants; Brain Injuries; Carbamazepine; Case-Control Studies; Chemoprevention; Cohort Studies; Humans; Levetiracetam; Military Personnel; Phenytoin; Piracetam; Retrospective Studies; Seizures; Trauma Severity Indices; Valproic Acid | 2016 |
Study of the protective effects of nootropic agents against neuronal damage induced by amyloid-beta (fragment 25-35) in cultured hippocampal neurons.
Topics: Amyloid beta-Peptides; Animals; Apoptosis; Cell Death; Dose-Response Relationship, Drug; Hippocampus; L-Lactate Dehydrogenase; Levetiracetam; Neurons; Neuroprotective Agents; Nootropic Agents; Peptide Fragments; Piracetam; Primary Cell Culture; Rats | 2015 |
Successful immune moderation treatment for progressive encephalomyelitis with rigidity and myoclonus.
Topics: Azathioprine; Drug Therapy, Combination; Encephalomyelitis; Female; Humans; Immunoglobulins; Immunosuppressive Agents; Levetiracetam; Middle Aged; Muscle Rigidity; Piracetam | 2015 |
Sleep interacts with aβ to modulate intrinsic neuronal excitability.
Topics: Action Potentials; Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Anticonvulsants; Disease Models, Animal; Drosophila melanogaster; Humans; Levetiracetam; Neurons; Peptide Fragments; Piracetam; Sleep; Sleep Deprivation | 2015 |
Prevention of status epilepticus-induced brain edema and neuronal cell loss by repeated treatment with high-dose levetiracetam.
Topics: Animals; Anticonvulsants; Brain Edema; Cell Death; Disease Models, Animal; Levetiracetam; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred ICR; Muscarinic Agonists; Neurons; Pilocarpine; Piracetam; Status Epilepticus; Time Factors | 2015 |
[Dramatic seizure reduction with levetiracetam in adult Dravet syndrome: a case report].
Topics: Adult; Drug Therapy, Combination; Epilepsies, Myoclonic; Humans; Levetiracetam; Male; Piracetam; Status Epilepticus; Treatment Outcome; Valproic Acid | 2015 |
Correlation between efficacy of levetiracetam and serum levels among children with refractory epilepsy.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Databases, Factual; Drug Resistant Epilepsy; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Retrospective Studies; Young Adult | 2015 |
Intravenous levetiracetam in Thai children and adolescents with status epilepticus and acute repetitive seizures.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Levetiracetam; Male; Piracetam; Retrospective Studies; Seizures; Status Epilepticus; Thailand | 2015 |
Cross-species pharmacological characterization of the allylglycine seizure model in mice and larval zebrafish.
Topics: Allylglycine; Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Fructose; Levetiracetam; Male; Mice; Phenytoin; Piracetam; Seizures; Topiramate; Treatment Outcome; Valproic Acid; Zebrafish | 2015 |
Self-reported aggressiveness during treatment with levetiracetam correlates with depression.
Topics: Adult; Aggression; Anticonvulsants; Depressive Disorder, Major; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Self Report; Treatment Outcome | 2015 |
[Subcutaneous administration of levetiracetam in geriatrics].
Topics: Aged, 80 and over; Anticonvulsants; Arousal; Electroencephalography; Geriatrics; Humans; Injections, Subcutaneous; Levetiracetam; Male; Muscle Hypotonia; Myoclonus; Piracetam | 2015 |
Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer's disease.
Topics: Action Potentials; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain Waves; CA1 Region, Hippocampal; Dendrites; Female; Gene Expression Regulation; Humans; In Vitro Techniques; Levetiracetam; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neurons; Nootropic Agents; Piracetam; Shal Potassium Channels; tau Proteins | 2015 |
Paradoxical exacerbation of myoclonic-astatic seizures by levetiracetam in myoclonic astatic epilepsy.
Topics: Anticonvulsants; Child, Preschool; Epilepsies, Myoclonic; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Treatment Outcome | 2015 |
Assessment into the usage of levetiracetam in a canine epilepsy clinic.
Topics: Animals; Anticonvulsants; Dog Diseases; Dogs; Epilepsy; Female; Levetiracetam; Male; Piracetam; Retrospective Studies; Seizures; Treatment Outcome | 2015 |
Levetiracetam-associated Hypokalemia and Hypomagnesaemia among Two Patients Treated for Seizures.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Female; Humans; Hypokalemia; Levetiracetam; Magnesium Deficiency; Piracetam; Seizures | 2015 |
The first case of levetiracetam-induced and tolvaptan-resistant hyponatremia.
Topics: Aged; Anticonvulsants; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Epilepsy; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Levetiracetam; Male; Piracetam; Tolvaptan | 2015 |
[Protective effects of levetiracetam and simvastatin on pilocarpine-induced epilepsy in rat models].
Topics: Animals; Calpain; Disease Models, Animal; Epilepsy; Hippocampus; Levetiracetam; Pilocarpine; Piracetam; Rats; Seizures; Simvastatin | 2015 |
Combined administration of levetiracetam and valproic acid attenuates age-related hyperactivity of CA3 place cells, reduces place field area, and increases spatial information content in aged rat hippocampus.
Topics: Action Potentials; Aging; Animals; CA1 Region, Hippocampal; CA3 Region, Hippocampal; Central Nervous System Agents; Discrimination, Psychological; Drug Synergism; Exploratory Behavior; Levetiracetam; Male; Maze Learning; Neurons; Piracetam; Rats, Long-Evans; Space Perception; Spatial Memory; Valproic Acid | 2015 |
Epilepsy phenotypes in siblings with Norrie disease.
Topics: Anticonvulsants; Blindness; Chromosomes, Human, X; Electroencephalography; Epilepsy; Eye Proteins; Genetic Diseases, X-Linked; Humans; Lamotrigine; Levetiracetam; Nerve Tissue Proteins; Nervous System Diseases; Pedigree; Phenotype; Piracetam; Retinal Degeneration; Siblings; Spasms, Infantile; Triazines | 2015 |
Cardiac sodium channel blockade after an intentional ingestion of lacosamide, cyclobenzaprine, and levetiracetam: Case report.
Topics: Acetamides; Adolescent; Amitriptyline; Anticonvulsants; Drug Interactions; Drug Overdose; Electrocardiography; Epilepsy; Female; Heart Arrest; Humans; Lacosamide; Levetiracetam; Piracetam; Risk Factors; Sodium Bicarbonate; Sodium Channel Blockers; Sodium Channels; Suicide, Attempted; Tachycardia, Ventricular; Treatment Outcome | 2015 |
Levetiracetam synergises with common analgesics in producing antinociception in a mouse model of painful diabetic neuropathy.
Topics: Acetaminophen; Analgesics; Animals; Aspirin; Diabetic Neuropathies; Dose-Response Relationship, Drug; Drug Synergism; Hot Temperature; Ibuprofen; Levetiracetam; Male; Mice; Mice, Inbred C57BL; Pain; Pain Measurement; Pain Threshold; Physical Stimulation; Piracetam; Postural Balance | 2015 |
Epilepsy update, part 2: nursing care and evidence-based treatment.
Topics: Anticonvulsants; Brain; Cognition Disorders; Consumer Health Information; Diet, Ketogenic; Drug Resistance; Epilepsy; Evidence-Based Nursing; Fructose; Humans; Internet; Levetiracetam; Medical Marijuana; Parents; Piracetam; Topiramate | 2015 |
Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Chemotherapy, Adjuvant; Dacarbazine; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Levetiracetam; Male; Middle Aged; Piracetam; Proportional Hazards Models; Retrospective Studies; Temozolomide; Young Adult | 2015 |
Homozygous Mutation in Synaptic Vesicle Glycoprotein 2A Gene Results in Intractable Epilepsy, Involuntary Movements, Microcephaly, and Developmental and Growth Retardation.
Topics: Anticonvulsants; Child, Preschool; Developmental Disabilities; Dyskinesias; Epilepsy; Female; Growth Disorders; Humans; Levetiracetam; Membrane Glycoproteins; Microcephaly; Mutation; Nerve Tissue Proteins; Piracetam | 2015 |
Omega 3 polyunsaturated fatty acids enhance the protective effect of levetiracetam against seizures, cognitive impairment and hippocampal oxidative DNA damage in young kindled rats.
Topics: Animals; Anticonvulsants; Anxiety; Avoidance Learning; Cognition Disorders; Convulsants; DNA Damage; Drug Synergism; Fatty Acids, Omega-3; Hippocampus; Kindling, Neurologic; Levetiracetam; Male; Oxidative Stress; Pentylenetetrazole; Piracetam; Rats; Rats, Wistar; Seizures | 2015 |
Neutropenia secondary to exposure to levetiracetam.
Topics: Adenocarcinoma; Anticonvulsants; Brain Neoplasms; Craniotomy; Drug Administration Schedule; Humans; Levetiracetam; Lung Neoplasms; Male; Middle Aged; Neutropenia; Piracetam; Seizures | 2015 |
Synergistic Interaction of Retigabine with Levetiracetam in the Mouse Maximal Electroshock-Induced Seizure Model: A Type II Isobolographic Analysis.
Topics: Animals; Brain; Carbamates; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Electroshock; Levetiracetam; Male; Mice; Models, Statistical; Phenylenediamines; Piracetam; Seizures | 2015 |
Levetiracetam, Calcium Antagonism, and Bipolar Disorder.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Calcium; Calcium Channel Blockers; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam | 2015 |
[Adjunctive Therapy with Levetiracetam for Elderly Japanese with Partial Epilepsy: Effectiveness of Levetiracetam in Seizure Management of Epilepsy Patients with Advanced-age Onset in a Practical Setting].
Topics: Aged; Anticonvulsants; Data Collection; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies | 2015 |
Intravenous levetiracetam in clinical practice--Results from an independent registry.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Child; Child, Preschool; Female; Germany; Humans; Infant; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Registries; Status Epilepticus; Young Adult | 2015 |
QT interval prolongation in a patient with LQT2 on levetiracetam.
Topics: Anticonvulsants; Dose-Response Relationship, Drug; Electrocardiography; Epilepsy; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Female; Follow-Up Studies; Heart; Humans; Levetiracetam; Long QT Syndrome; Piracetam; Point Mutation; Young Adult | 2015 |
Intravenous levetiracetam treatment in status epilepticus: A prospective study.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Diazepam; Drug Resistant Epilepsy; Electroencephalography; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Status Epilepticus; Treatment Failure; Treatment Outcome; Young Adult | 2015 |
Status epilepticus induction has prolonged effects on the efficacy of antiepileptic drugs in the 6-Hz seizure model.
Topics: Animals; Anticonvulsants; Carbamazepine; Diazepam; Disease Models, Animal; Levetiracetam; Male; Mice; Phenytoin; Pilocarpine; Piracetam; Seizures; Status Epilepticus; Treatment Outcome | 2015 |
The Role of Levetiracetam in Treating Chronic Neuropathic Pain Symptoms.
Topics: Anticonvulsants; Diabetic Neuropathies; Humans; Levetiracetam; Neuralgia; Piracetam; Quality of Life; Symptom Assessment; Treatment Failure | 2015 |
Improvement of post-hypoxic action myoclonus with levetiracetam add-on therapy: A case report.
Topics: Accidents, Traffic; Anticonvulsants; Electroencephalography; Fracture Fixation, Internal; Humans; Hypoxia; Levetiracetam; Magnetic Resonance Imaging; Male; Middle Aged; Myoclonus; Piracetam; Zygoma | 2014 |
Lymphomatosis Cerebri: A Diagnostic Challenge.
Topics: Aged; Antineoplastic Agents; Brain Neoplasms; DNA-Binding Proteins; Female; Frontal Lobe; Humans; Immunocompetence; Levetiracetam; Lymphoma; Magnetic Resonance Imaging; Nootropic Agents; Piracetam; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Spasm | 2015 |
Intermittent levetiracetam treatment in five patients with catamenial epilepsy.
Topics: Adult; Anticonvulsants; Epilepsy; Female; Humans; Levetiracetam; Menstrual Cycle; Piracetam | 2015 |
Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies.
Topics: Alzheimer Disease; Animals; Behavior, Animal; In Vitro Techniques; Levetiracetam; Mice; Mice, Inbred C57BL; Nootropic Agents; Phenotype; Piracetam | 2015 |
Early pregnancy cerebral venous thrombosis and status epilepticus treated with levetiracetam and lacosamide throughout pregnancy.
Topics: Acetamides; Adult; Anticonvulsants; Female; Fetal Blood; Humans; Infant, Newborn; Lacosamide; Levetiracetam; Male; Milk, Human; Piracetam; Pregnancy; Status Epilepticus; Venous Thrombosis | 2015 |
Clinical features of long-term low-dose levetiracetam treatment for epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Dose-Response Relationship, Drug; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Piracetam; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult | 2016 |
Single-dose intravenous administration of antiepileptic drugs induces rapid and reversible remodeling in the brain: Evidence from a voxel-based morphometry evaluation of valproate and levetiracetam in rhesus monkeys.
Topics: Analysis of Variance; Animals; Anticonvulsants; Brain; Brain Mapping; Female; Imaging, Three-Dimensional; Injections, Intravenous; Levetiracetam; Macaca mulatta; Magnetic Resonance Imaging; Male; Piracetam; Valproic Acid | 2015 |
Pharmacokinetic evaluation of immediate- and extended-release formulations of levetiracetam in dogs.
Topics: Administration, Oral; Animals; Anticonvulsants; Area Under Curve; Chromatography, High Pressure Liquid; Cross-Over Studies; Delayed-Action Preparations; Dogs; Female; Levetiracetam; Male; Piracetam; Tablets; Tandem Mass Spectrometry | 2015 |
Dramatic effect of levetiracetam in early-onset epileptic encephalopathy due to STXBP1 mutation.
Topics: Age of Onset; Anticonvulsants; Brain; DNA Mutational Analysis; Electroencephalography; Epilepsy; Humans; Infant, Newborn; Levetiracetam; Male; Munc18 Proteins; Mutation; Piracetam; Treatment Outcome | 2016 |
A Man in His 40s With Headache, Lethargy, and Altered Mental Status.
Topics: Adult; Antineoplastic Agents, Hormonal; Craniotomy; Dexamethasone; DNA Nucleotidylexotransferase; Headache; Humans; Lethargy; Leukemia; Leukocytes, Mononuclear; Levetiracetam; Magnetic Resonance Imaging; Male; Mental Disorders; Nootropic Agents; Piracetam; Tomography, X-Ray Computed | 2015 |
A rare cause of status epilepticus; alpha lipoic acid intoxication, case report and review of the literature.
Topics: Anticonvulsants; Epilepsies, Myoclonic; Female; Humans; Infant; Levetiracetam; Midazolam; Piracetam; Respiration, Artificial; Seizures; Status Epilepticus; Thioctic Acid; Thiopental | 2015 |
Validation of the 6 Hz refractory seizure mouse model for intracerebroventricularly administered compounds.
Topics: Animals; Anticonvulsants; Blood-Brain Barrier; Capillary Permeability; Catheters, Indwelling; Cornea; Dentate Gyrus; Disease Models, Animal; Electric Stimulation; Immunohistochemistry; Injections, Intraventricular; Levetiracetam; Mice; Phenytoin; Piracetam; Proto-Oncogene Proteins c-fos; Seizures | 2015 |
Eosinophilia and Fever with Levetiracetam: A Case Report.
Topics: Anticonvulsants; Eosinophilia; Fever; Humans; Levetiracetam; Male; Piracetam; Seizures; Young Adult | 2015 |
Levetiracetam Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemofiltration and Venoarterial Extracorporeal Membrane Oxygenation.
Topics: Aged; Anticonvulsants; Critical Illness; Extracorporeal Membrane Oxygenation; Fatal Outcome; Hemofiltration; Humans; Levetiracetam; Male; Piracetam | 2015 |
De Novo Heterogeneous Mutations in SCN2A and GRIN2A Genes and Seizures With Ictal Vocalizations.
Topics: Anticonvulsants; Clonazepam; Diagnosis, Differential; Electroencephalography; Female; Fructose; Humans; Infant, Newborn; Levetiracetam; Mutation; NAV1.2 Voltage-Gated Sodium Channel; Phenobarbital; Phonation; Piracetam; Receptors, N-Methyl-D-Aspartate; Spasms, Infantile; Topiramate | 2016 |
Levetiracetam ameliorates ovarian function in streptozotocin-induced diabetic rats.
Topics: Animals; Anti-Mullerian Hormone; Blood Glucose; Diabetes Mellitus, Experimental; Female; Glutathione; Levetiracetam; Lipid Peroxidation; Malondialdehyde; Ovary; Oxidative Stress; Piracetam; Rats; Rats, Sprague-Dawley; Streptozocin | 2015 |
The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine.
Topics: Alkaline Phosphatase; Anticonvulsants; Bone Density; Calcium; Carbamazepine; Child; Child, Preschool; Female; Humans; Levetiracetam; Male; Parathyroid Hormone; Phosphorus; Piracetam; Valproic Acid; Vitamin D | 2015 |
Use of Levetiracetam in Neonates in Clinical Practice: A Retrospective Study at a German University Hospital.
Topics: Anticonvulsants; Female; Germany; Gestational Age; Hospitals, University; Humans; Infant, Newborn; Infant, Premature; Levetiracetam; Male; Piracetam; Retrospective Studies; Seizures; Treatment Outcome | 2015 |
Supralethal poisoning by any of the classical nerve agents is effectively counteracted by procyclidine regimens in rats.
Topics: Animals; Anticonvulsants; Antidotes; Body Weight; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Lethal Dose 50; Levetiracetam; Male; Nerve Agents; Organophosphate Poisoning; Organophosphates; Organophosphorus Compounds; Organothiophosphorus Compounds; Oximes; Piracetam; Procyclidine; Pyridinium Compounds; Rats; Rats, Wistar; Seizures; Soman | 2015 |
An Investigation into the Polymorphism and Crystallization of Levetiracetam and the Stability of its Solid Form.
Topics: Chemistry, Pharmaceutical; Crystallization; Drug Stability; Levetiracetam; Phase Transition; Piracetam; Powders; Solvents; Temperature; X-Ray Diffraction | 2015 |
[Effectiveness and safety of long-term levetiracetam treatment in patients with refractory epilepsy].
Topics: Adolescent; Adult; Aged; Anticonvulsants; Child; Child, Preschool; Epilepsy; Female; Humans; Infant; Levetiracetam; Long-Term Care; Male; Middle Aged; Piracetam; Treatment Outcome; Young Adult | 2015 |
Blockade of endothelin B receptor improves the efficacy of levetiracetam in chronic epileptic rats.
Topics: Animals; Anticonvulsants; Brain; Chronic Disease; Disease Models, Animal; Endothelin B Receptor Antagonists; Enzyme Inhibitors; Epilepsy; Imidazoles; Levetiracetam; Male; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Piperidines; Piracetam; Pyridines; Rats, Sprague-Dawley; Receptor, Endothelin B; Seizures; Treatment Outcome | 2015 |
[FOCAL MOTOR SEIZURES AND STATUS EPILEPTICUS PROVOKED BY MIRTAZAPINE].
Topics: Adult; Anticonvulsants; Antidepressive Agents, Tricyclic; Carbamazepine; Electroencephalography; Epilepsy, Partial, Motor; Humans; Levetiracetam; Male; Mianserin; Mirtazapine; Piracetam; Status Epilepticus; Video Recording | 2015 |
Acute rhabdomyolysis associated with levetiracetam therapy in a child.
Topics: Adolescent; Anticonvulsants; Female; Humans; Levetiracetam; Piracetam; Rhabdomyolysis; Seizures | 2016 |
Trends in Antiepileptic Drug Prescriptions for Childhood Epilepsy at a Tertiary Children's Hospital in Korea, 2001-2012.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Prescriptions; Epilepsy; Female; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Levetiracetam; Longitudinal Studies; Male; Oxcarbazepine; Piracetam; Republic of Korea; Tertiary Care Centers; Valproic Acid | 2015 |
Levetiracetam in the Treatment of Epileptic Seizures After Liver Transplantation.
Topics: Adult; Anticonvulsants; Drug Monitoring; End Stage Liver Disease; Female; Humans; Levetiracetam; Liver Transplantation; Male; Middle Aged; Piracetam; Retrospective Studies; Seizures; Taiwan; Treatment Outcome | 2015 |
Landau-Kleffner syndrome: an uncommon dealt with case in Southeast Asia.
Topics: Anticonvulsants; Aphasia; Asia, Southeastern; Child; Electroencephalography; Humans; Landau-Kleffner Syndrome; Levetiracetam; Magnetic Resonance Imaging; Male; Piracetam; Seizures; Steroids; Valproic Acid | 2015 |
[Position Statement of Hungarian Epilepsy League: The use of valproate preparations for epilepsy in pregnancy and in women of childbearing age].
Topics: Adolescent; Adult; Anticonvulsants; Cognition; Contraception; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsy; Female; Humans; Hungary; Insurance Coverage; Insurance, Health; Lamotrigine; Levetiracetam; Middle Aged; Piracetam; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Triazines; Valproic Acid; Young Adult | 2015 |
The Effect of Levetiracetam on Closure of the Midline in Early Chicken Embryos.
Topics: Animals; Anticonvulsants; Chick Embryo; Chickens; Levetiracetam; Neural Tube; Neural Tube Defects; Piracetam | 2015 |
First 3D-printed pill.
Topics: Drug Compounding; Drug Design; Humans; Levetiracetam; Piracetam; Printing, Three-Dimensional; Seizures; Tablets | 2015 |
[Efficacy of Levetiracetam as an Add-on Therapy in Children with Localization-related Epilepsy].
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy; Female; Humans; Levetiracetam; Male; Piracetam; Treatment Outcome | 2015 |
Antimuscarinic-induced convulsions in fasted animals after food intake: evaluation of the effects of levetiracetam, topiramate and different doses of atropine.
Topics: Animals; Anticonvulsants; Atropine; Eating; Fasting; Fructose; Levetiracetam; Male; Mice, Inbred BALB C; Muscarinic Antagonists; Piracetam; Seizures; Topiramate | 2016 |
Levetiracetam Prevents Perforin Mediated Neuronal Injury Induced by Acute Cerebral Ischemia Reperfusion.
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Female; Levetiracetam; Male; Mice, Inbred C57BL; Mice, Knockout; Neurons; Neuroprotection; Neuroprotective Agents; Perforin; Piracetam; Reperfusion Injury | 2016 |
Prolonged Cardiac Dysfunction After Intraparenchymal Hemorrhage and Neurogenic Stunned Myocardium.
Topics: Adult; Anesthesia, General; Cerebral Hemorrhage; Emergency Service, Hospital; Heart; Hemangioma, Cavernous, Central Nervous System; Humans; Hypertension; Hypotension; Levetiracetam; Male; Methamphetamine; Myocardial Stunning; Nicardipine; Perioperative Period; Phenylephrine; Piracetam; Seizures; Substance-Related Disorders; Takotsubo Cardiomyopathy | 2016 |
Neuroprotective effects of levetiracetam target xCT in astrocytes in parkinsonian mice.
Topics: Amino Acid Transport System y+; Animals; Astrocytes; Cells, Cultured; Drug Delivery Systems; Female; Levetiracetam; Male; Mice; Mice, Inbred ICR; Neuroprotective Agents; Parkinsonian Disorders; Piracetam; Pregnancy; Rats; Rats, Sprague-Dawley | 2016 |
[Efficacy and tolerability of topiramate, lamotrigine, and levetiracetam in children with refractory epilepsy].
Topics: Adolescent; Anticonvulsants; Child; Drug Resistant Epilepsy; Female; Fructose; Humans; Lamotrigine; Levetiracetam; Male; Piracetam; Retrospective Studies; Topiramate; Triazines | 2015 |
Safety of Overnight Switch from Brand-Name to Generic Levetiracetam.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Child; Drugs, Generic; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Young Adult | 2016 |
Brivaracetam augments short-term depression and slows vesicle recycling.
Topics: Animals; Anticonvulsants; CA1 Region, Hippocampal; Dose-Response Relationship, Drug; Electrophysiology; Hippocampus; Levetiracetam; Male; Microscopy, Fluorescence; Piracetam; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Synaptic Vesicles | 2015 |
"Herbal seizures"--atypical symptoms after ibogaine intoxication: a case report.
Topics: Adult; Anticonvulsants; Epilepsy, Tonic-Clonic; Hallucinogens; Humans; Hypnotics and Sedatives; Ibogaine; Levetiracetam; Magnetic Resonance Imaging; Male; Midazolam; Nausea; Piracetam; Treatment Outcome; Vomiting | 2015 |
[Cases of non-standard approach to treatment of super-refractory status epilepticus].
Topics: Adult; Anesthetics, Intravenous; Anticonvulsants; Clinical Protocols; Drug Therapy, Combination; Electroencephalography; Female; Humans; Intercellular Signaling Peptides and Proteins; Levetiracetam; Peptides; Piracetam; Propofol; Status Epilepticus; Thiopental; Treatment Outcome; Valproic Acid; Young Adult | 2015 |
Identifying clinical correlates for suicide among epilepsy patients in South Korea: A case-control study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Antidepressive Agents; Case-Control Studies; Epilepsy; Epilepsy, Temporal Lobe; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Republic of Korea; Risk Factors; Suicide; Young Adult | 2015 |
Neurofibromatosis 1-associated panhypopituitarism presenting as hypoglycaemic seizures and stroke-like symptoms.
Topics: Adult; Anti-Bacterial Agents; Anticonvulsants; Antiviral Agents; Brain Diseases; Cafe-au-Lait Spots; Diarrhea; Fluid Therapy; Functional Neuroimaging; Hormone Replacement Therapy; Humans; Hypopituitarism; Levetiracetam; Magnetic Resonance Imaging; Male; Nerve Sheath Neoplasms; Neurofibromatosis 1; Piracetam; Seizures; Stroke; Testosterone; Treatment Outcome | 2015 |
A Girl with Idiopathic Epilepsy Showing Forced Normalization after Levetiracetam Administration.
Topics: Anticonvulsants; Child; Electroencephalography; Epilepsy; Female; Humans; Levetiracetam; Piracetam; Treatment Outcome | 2015 |
Excellent response to levetiracetam in epilepsy with Wolf-Hirschhorn syndrome.
Topics: Anticonvulsants; Epilepsy; Female; Humans; Infant; Levetiracetam; Piracetam; Wolf-Hirschhorn Syndrome | 2016 |
Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Induced by Levetiracetam in a Pediatric Patient.
Topics: Anticonvulsants; Child; Drug Hypersensitivity Syndrome; Female; Humans; Levetiracetam; Piracetam | 2016 |
Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; China; Epilepsies, Partial; Female; Fructose; Humans; Lamotrigine; Levetiracetam; Male; Middle Aged; Oxcarbazepine; Piracetam; Retrospective Studies; Topiramate; Treatment Outcome; Triazines; Valproic Acid; Young Adult | 2015 |
Low-dose levetiracetam for seizure prophylaxis after traumatic brain injury.
Topics: Adult; Aged; Anticonvulsants; Brain Injuries, Traumatic; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Retrospective Studies; Seizures; Trauma Centers | 2016 |
WAVEFORM WINDOW #30. A Case of Nocturnal Episodes.
Topics: Aged, 80 and over; Alzheimer Disease; Anticonvulsants; Electroencephalography; Epilepsy, Frontal Lobe; Humans; Hypertension; Levetiracetam; Male; Night Terrors; Piracetam | 2015 |
A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam.
Topics: Adenosine Triphosphate; Aging; Alzheimer Disease; Animals; Brain; Cell Line; Cognition Disorders; Female; GAP-43 Protein; Gene Expression Regulation; Humans; Levetiracetam; Male; Membrane Glycoproteins; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Nerve Tissue Proteins; Nitroprusside; Nootropic Agents; Piracetam; Proteomics; Rats; RNA, Small Interfering | 2016 |
Dexamethasone alone and in combination with desipramine, phenytoin, valproic acid or levetiracetam interferes with 5-ALA-mediated PpIX production and cellular retention in glioblastoma cells.
Topics: Aminolevulinic Acid; Anti-Inflammatory Agents; Anticonvulsants; Desipramine; Dexamethasone; Drug Therapy, Combination; Enzyme Inhibitors; Fluorescence; Glioblastoma; Humans; Levetiracetam; Phenytoin; Photosensitizing Agents; Piracetam; Protoporphyrins; Valproic Acid | 2016 |
A Pilot Chemical and Physical Stability Study of Extemporaneously Compounded Levetiracetam Intravenous Solution.
Topics: Chromatography, High Pressure Liquid; Drug Stability; Drug Storage; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Levetiracetam; Pharmaceutical Solutions; Pilot Projects; Piracetam; Polyenes; Polypropylenes; Polyvinyl Chloride; Syringes | 2015 |
Simultaneous Quantitation of Lamotrigine, Levetiracetam, 10-Hydroxycarbazepine, Topiramate, and Zonisamide in Serum Using HPLC-MS/MS.
Topics: Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Drug Monitoring; Fructose; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Piracetam; Tandem Mass Spectrometry; Topiramate; Triazines; Zonisamide | 2016 |
Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action.
Topics: Animals; Anticonvulsants; Blood-Brain Barrier; Brain; Caco-2 Cells; Dogs; Epilepsy, Reflex; Humans; In Vitro Techniques; Levetiracetam; Macaca mulatta; Membrane Glycoproteins; Mice; Molecular Targeted Therapy; Nerve Tissue Proteins; Permeability; Piracetam; Positron-Emission Tomography; Pyrrolidinones; Rats | 2016 |
Prevalence of Early Posttraumatic Seizures in Children With Moderate to Severe Traumatic Brain Injury Despite Levetiracetam Prophylaxis.
Topics: Adolescent; Anticonvulsants; Brain Injuries; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Levetiracetam; Male; Piracetam; Prevalence; Prospective Studies; Seizures; Trauma Centers; Treatment Outcome | 2016 |
Levetiracetam Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy.
Topics: Animals; Biomarkers; Brain Injuries, Traumatic; Disease Models, Animal; Glial Fibrillary Acidic Protein; Levetiracetam; Male; Nootropic Agents; Piracetam; Rats; Rats, Sprague-Dawley; Recovery of Function; Ubiquitin Thiolesterase | 2016 |
Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
Topics: Adolescent; Adult; Anticonvulsants; Child; Comorbidity; Drug Resistant Epilepsy; Female; Follow-Up Studies; Humans; Lamotrigine; Levetiracetam; Male; Mental Disorders; Myoclonic Epilepsy, Juvenile; Piracetam; Retrospective Studies; Sex Factors; Treatment Outcome; Triazines; Valproic Acid; Young Adult | 2016 |
Axono-cortical evoked potentials: A proof-of-concept study.
Topics: Adult; Anomia; Anticonvulsants; Axons; Broca Area; Electrodiagnosis; Epilepsies, Partial; Evoked Potentials; Hemangioma, Cavernous, Central Nervous System; Hematoma; Humans; Language Tests; Levetiracetam; Magnetic Resonance Imaging; Male; Motor Cortex; Piracetam; Supratentorial Neoplasms; Temporal Lobe; Wakefulness; White Matter | 2016 |
Levetiracetam in the management of feline audiogenic reflex seizures: a randomised, controlled, open-label study.
Topics: Animals; Anticonvulsants; Cat Diseases; Cats; Epilepsies, Myoclonic; Epilepsy, Generalized; Female; Humans; Levetiracetam; Male; Piracetam; Prospective Studies; Seizures | 2017 |
Specific adverse effects of antiepileptic drugs--A true-to-life monotherapy study.
Topics: Adult; Aged; Anticonvulsants; Anxiety; Carbamazepine; Depression; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Fatigue; Female; Humans; Lamotrigine; Levetiracetam; Male; Middle Aged; Piracetam; Quality of Life; Triazines; Valproic Acid; Young Adult | 2016 |
Effect of levetiracetam versus gabapentin on peripheral neuropathy and sciatic degeneration in streptozotocin-diabetic mice: Influence on spinal microglia and astrocytes.
Topics: Amines; Animals; Astrocytes; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Levetiracetam; Male; Mice; Microglia; Nerve Degeneration; Nootropic Agents; Pain Measurement; Piracetam; Sciatic Neuropathy; Spinal Cord | 2016 |
Assessment of Noninvasive Regional Brain Oximetry in Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome.
Topics: Anticonvulsants; Blood Pressure; Blood Transfusion; Brain; Cerebral Angiography; Cerebrovascular Circulation; Female; Humans; Levetiracetam; Magnetic Resonance Imaging; Middle Aged; Oximetry; Piracetam; Posterior Leukoencephalopathy Syndrome; Treatment Outcome; Vasospasm, Intracranial | 2016 |
Click chemistry, 3D-printing, and omics: the future of drug development.
Topics: Anticonvulsants; Antineoplastic Agents; Click Chemistry; Computer Simulation; Genomics; Humans; Imaging, Three-Dimensional; Levetiracetam; Neoplasms; Piracetam; Precision Medicine; Printing, Three-Dimensional | 2016 |
Continuous subcutaneous levetiracetam in the management of seizures at the end of life: a case report.
Topics: Aged, 80 and over; Anticonvulsants; Brain Neoplasms; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Infusions, Subcutaneous; Levetiracetam; Male; Palliative Care; Piracetam; Quality of Life; Scalp; Seizures; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck; Terminal Care; Treatment Outcome | 2016 |
Preliminary evidence for gender effects of levetiracetam monotherapy duration on bone health of patients with epilepsy.
Topics: Adult; Anticonvulsants; Bone Density; Cohort Studies; Drug Administration Schedule; Epilepsy; Female; Health Status; Humans; Levetiracetam; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Piracetam; Radiography; Retrospective Studies; Sex Characteristics; Treatment Outcome; Young Adult | 2016 |
Spontaneous convexity subarachnoid haemorrhage: Clinical series of 3 patients with associated cerebral amyloid angiopathy.
Topics: Aged; Anticonvulsants; Brain; Cerebral Amyloid Angiopathy; Dexamethasone; Female; Glucocorticoids; Hemosiderosis; Humans; Levetiracetam; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Piracetam; Prednisone; Subarachnoid Hemorrhage; Tomography, X-Ray Computed | 2017 |
Effect of hydrophobic inclusions on polymer swelling kinetics studied by magnetic resonance imaging.
Topics: Delayed-Action Preparations; Drug Liberation; Hydrophobic and Hydrophilic Interactions; Hypromellose Derivatives; Kinetics; Levetiracetam; Magnetic Resonance Imaging; Models, Theoretical; Piracetam; Solubility; Tablets; Waxes | 2016 |
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Clinical Trials as Topic; Dacarbazine; Epilepsy; Female; Glioblastoma; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Prognosis; Survival Analysis; Temozolomide; Valproic Acid | 2016 |
Cardiovascular toxicity with levetiracetam overdose.
Topics: Adult; Atropine; Bradycardia; Cardiovascular System; Drug Overdose; Female; Humans; Hypotension; Levetiracetam; Oliguria; Piracetam | 2016 |
Neuroprotective effects of chronic administration of levetiracetam in a rat model of diabetic neuropathy.
Topics: Animals; Apoptosis; Caspase 3; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Electromyography; Electrophysiology; Immunoenzyme Techniques; Levetiracetam; Lipid Peroxides; Male; Neuroprotective Agents; Nootropic Agents; Oxidative Stress; Piracetam; Rats; Rats, Sprague-Dawley | 2016 |
Levetiracetam Pharmacokinetics During Continuous Venovenous Hemofiltration and Acute Liver Dysfunction.
Topics: Anticonvulsants; Hemofiltration; Humans; Levetiracetam; Liver Failure, Acute; Male; Middle Aged; Piracetam; Renal Insufficiency | 2016 |
Remember Keppra: seizure control with subcutaneous levetiracetam infusion.
Topics: Anticonvulsants; Drug Combinations; Female; Humans; Infusions, Subcutaneous; Levetiracetam; Middle Aged; Piracetam; Seizures | 2016 |
Case report: absence-status as late reexacerbation of genetic epilepsy of adolescence.
Topics: Adolescent; Age of Onset; Anticonvulsants; Electroencephalography; Epilepsy, Absence; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Status Epilepticus; Valproic Acid | 2016 |
Safety of levetiracetam among infants younger than 12 months--Results from a European multicenter observational study.
Topics: Anticonvulsants; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Europe; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Prospective Studies; Treatment Outcome | 2016 |
Neuroprotection and anti-seizure effects of levetiracetam in a rat model of penetrating ballistic-like brain injury.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Electroencephalography; Gait Disorders, Neurologic; Gene Expression Regulation; Head Injuries, Penetrating; Levetiracetam; Male; Maze Learning; Motor Activity; Neuroprotective Agents; Piracetam; Rats; Rats, Sprague-Dawley; Reaction Time; Seizures; Statistics, Nonparametric; Time Factors; Trauma Severity Indices; Treatment Outcome | 2016 |
Toxic epidermal necrolysis with isolated neutropenia related to the use of levetiracetam.
Topics: Adult; Anticonvulsants; Humans; Levetiracetam; Male; Neutropenia; Piracetam; Steroids; Stevens-Johnson Syndrome | 2016 |
Levetiracetam attenuates rotenone-induced toxicity: A rat model of Parkinson's disease.
Topics: Animals; Levetiracetam; Models, Animal; Neuroprotective Agents; Nootropic Agents; Piracetam; Random Allocation; Rats; Rats, Sprague-Dawley; Rotenone | 2016 |
Seizure and Fever.
Topics: Acyclovir; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antiviral Agents; Brain Neoplasms; Ceftriaxone; Dexamethasone; Diagnosis, Differential; Electroencephalography; Emergency Service, Hospital; Encephalitis, Herpes Simplex; Fever; Humans; Hypnotics and Sedatives; Infarction; Levetiracetam; Male; Massachusetts; Middle Aged; Phenytoin; Piracetam; Propofol; Status Epilepticus; Temporal Lobe; Tomography, X-Ray Computed; Unconsciousness; Vancomycin | 2016 |
Levetiracetam associated acute hepatic failure requiring liver transplantation: case report.
Topics: Anticonvulsants; Benzodiazepines; Epilepsy; Humans; Levetiracetam; Liver Failure, Acute; Liver Transplantation; Male; Middle Aged; Olanzapine; Piracetam | 2016 |
Aggravation of atonic seizures by rufinamide: A case report.
Topics: Anticonvulsants; Benzodiazepines; Brain; Child; Clobazam; Drug Resistant Epilepsy; Drug Therapy, Combination; Electroencephalography; Humans; Levetiracetam; Male; Piracetam; Seizures; Triazoles; Valproic Acid | 2016 |
Population Pharmacokinetic Modeling of Levetiracetam in Pediatric and Adult Patients With Epilepsy by Using Routinely Monitored Data.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Monitoring; Female; Glomerular Filtration Rate; Humans; Infant; Kidney Function Tests; Levetiracetam; Male; Middle Aged; Models, Biological; Nonlinear Dynamics; Piracetam; Retrospective Studies; Seizures; Young Adult | 2016 |
Effects of Different Doses of Levetiracetam on Aquaporin 4 Expression in Rats with Brain Edema Following Fluid Percussion Injury.
Topics: Animals; Aquaporin 4; Blotting, Western; Brain; Brain Edema; Brain Injuries; Dose-Response Relationship, Drug; Gene Expression Regulation; Immunohistochemistry; Levetiracetam; Male; Percussion; Piracetam; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA, Messenger; Water | 2016 |
Evaluation of the pentylenetetrazole seizure threshold test in epileptic mice as surrogate model for drug testing against pharmacoresistant seizures.
Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Drug Resistance; Epilepsy; GABA Antagonists; Levetiracetam; Male; Mice; Pentylenetetrazole; Phenobarbital; Pilocarpine; Piracetam; Rats; Seizures; Status Epilepticus; Valproic Acid | 2016 |
Intrapatient variation in antiepileptic drug plasma concentration after generic substitution vs stable brand-name drug regimens.
Topics: Adult; Anticonvulsants; Blood Chemical Analysis; Databases, Pharmaceutical; Drug Substitution; Drugs, Generic; Epilepsy; Female; Follow-Up Studies; Fructose; Humans; Inpatients; Lamotrigine; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Retrospective Studies; Topiramate; Triazines | 2016 |
Anti-epileptic drugs and bone loss: Phenytoin reduces pro-collagen I and alters the electrophoretic mobility of osteonectin in cultured bone cells.
Topics: Animals; Anticonvulsants; Blotting, Western; Bone and Bones; Carbamazepine; Cell Line; Collagen Type I; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Fluorescent Antibody Technique; Fructose; Gene Expression Profiling; Lamotrigine; Levetiracetam; Microscopy, Confocal; Osteoblasts; Osteonectin; Phenytoin; Piracetam; Procollagen; Real-Time Polymerase Chain Reaction; Topiramate; Triazines; Valproic Acid | 2016 |
The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
Topics: Adolescent; Anticonvulsants; Benzodiazepines; Carbamazepine; Child; Child, Preschool; Clobazam; Clonazepam; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Infant; Infant, Newborn; Isoxazoles; Japan; Lamotrigine; Levetiracetam; Male; Phenobarbital; Phenytoin; Piracetam; Triazines; Valproic Acid; Young Adult; Zonisamide | 2016 |
Ghost-Pill-Buster: A Case Study of Intact Levetiracetam Extended-Release Tablets after Dissolution Testing.
Topics: Administration, Oral; Capsules; Chemistry, Pharmaceutical; Delayed-Action Preparations; Humans; Levetiracetam; Piracetam; Solubility; Tablets; United States; United States Food and Drug Administration | 2016 |
A long-term noninterventional safety study of adjunctive lacosamide therapy in patients with epilepsy and uncontrolled partial-onset seizures.
Topics: Acetamides; Adult; Aged; Anticonvulsants; Combined Modality Therapy; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Lacosamide; Levetiracetam; Longitudinal Studies; Male; Middle Aged; Piracetam; Seizures; Treatment Outcome | 2016 |
Long-term effect of antiepileptic drug switch on serum lipids and C-reactive protein.
Topics: Anticonvulsants; Biomarkers; C-Reactive Protein; Carbamazepine; Drug Substitution; Drug Therapy, Combination; Epilepsies, Partial; Female; Fructose; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Lipids; Male; Middle Aged; Phenytoin; Piracetam; Time Factors; Topiramate; Treatment Outcome; Triazines; Zonisamide | 2016 |
A Comparison of Intravenous Levetiracetam and Valproate for the Treatment of Refractory Status Epilepticus in Children.
Topics: Administration, Intravenous; Adolescent; Anticonvulsants; Child; Child, Preschool; Clinical Protocols; Critical Care; Female; Humans; Infant; Intensive Care Units, Pediatric; Levetiracetam; Male; Patient Safety; Piracetam; Retrospective Studies; Status Epilepticus; Treatment Outcome; Valproic Acid | 2016 |
Levetiracetam prophylaxis ameliorates seizure epileptogenesis after fluid percussion injury.
Topics: Animals; Anticonvulsants; Brain Injuries, Traumatic; CA1 Region, Hippocampal; Disease Models, Animal; Drug Evaluation, Preclinical; Epilepsy, Post-Traumatic; Kainic Acid; Levetiracetam; Male; Neurons; Neuroprotective Agents; Piracetam; Rats, Sprague-Dawley; Seizures; Severity of Illness Index; Time Factors | 2016 |
Spectrofluorimetric Determination of Topiramate and Levetiracetam as Single Components in Tablet Formulations and in Human Plasma and Simultaneous Fourth Derivative Synchronous Fluorescence Determination of their Co-Adminstered Mixture in Human Plasma.
Topics: Fructose; Humans; Hydrogen-Ion Concentration; Levetiracetam; Male; Piracetam; Solvents; Spectrometry, Fluorescence; Tablets; Temperature; Time Factors; Topiramate | 2016 |
Levetiracetam-induced cutaneous adverse drug reactions were not associated with HLA genes in a small sample of Chinese patients with epilepsy.
Topics: Adult; Anticonvulsants; Asian People; Child; China; Epilepsy; Exanthema; Female; Gene Frequency; Genotyping Techniques; Heterozygote; HLA Antigens; Humans; Levetiracetam; Male; Middle Aged; Piracetam | 2016 |
Teaching NeuroImages: De novo absence status epilepticus in an adult.
Topics: Anticonvulsants; Benzodiazepines; Brain; Electroencephalography; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Status Epilepticus; Substance-Related Disorders | 2016 |
Levetiracetam mitigates doxorubicin-induced DNA and synaptic damage in neurons.
Topics: Animals; BRCA1 Protein; Cell Death; Cell Nucleus; Cell Survival; Cells, Cultured; Cerebral Cortex; DNA Breaks, Double-Stranded; DNA Damage; Down-Regulation; Doxorubicin; Levetiracetam; Neurites; Neurons; Neuroprotective Agents; Piracetam; Rats; Synapses; Tumor Suppressor p53-Binding Protein 1 | 2016 |
Levetiracetam inhibits oligomeric Aβ-induced glutamate release from human astrocytes.
Topics: Amyloid beta-Peptides; Astrocytes; Calcium; Cells, Cultured; Dose-Response Relationship, Drug; Glutamic Acid; HEK293 Cells; Humans; Levetiracetam; Luminescent Proteins; Microscopy, Fluorescence; Nootropic Agents; Peptide Fragments; Piracetam; Transfection | 2016 |
Rett syndrome: a concern for the anesthesiologists.
Topics: Adolescent; Anesthesia; Anesthetics, Inhalation; Anesthetics, Intravenous; Anticonvulsants; Atracurium; Female; Femoral Neck Fractures; Fentanyl; Humans; Isoflurane; Levetiracetam; Neuromuscular Nondepolarizing Agents; Piracetam; Propofol; Rett Syndrome | 2016 |
Levetiracetam for the prevention of busulfan-induced seizures in pediatric hematopoietic cell transplantation recipients.
Topics: Adolescent; Anticonvulsants; Busulfan; Child; Child, Preschool; Female; Graft Rejection; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Infant; Levetiracetam; Male; Myeloablative Agonists; Phenytoin; Piracetam; Recurrence; Retrospective Studies; Seizures; Transplantation Conditioning; Young Adult | 2017 |
Dose-dependent effects of levetiracetam after hypoxia and hypothermia in the neonatal mouse brain.
Topics: Animals; Animals, Newborn; Anticonvulsants; Anxiety; Apoptosis; Behavior, Animal; Brain; Brain Injuries; Dose-Response Relationship, Drug; Female; Hypothermia, Induced; Hypoxia; Levetiracetam; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Oligodendroglia; Piracetam; Recognition, Psychology; Rotarod Performance Test | 2016 |
[Treatment adherence with levetiracetam: a non-interventionist retrospective observation-based study].
Topics: Adult; Aged; Anticonvulsants; Female; Humans; Levetiracetam; Male; Medication Adherence; Middle Aged; Piracetam; Retrospective Studies | 2016 |
Comparison of body composition in persons with epilepsy on conventional & new antiepileptic drugs.
Topics: Adult; Anticonvulsants; Benzodiazepines; Body Composition; Body Water; Body Weight; Carbamazepine; Clobazam; Cross-Sectional Studies; Epilepsy; Female; Humans; Lamotrigine; Levetiracetam; Lipids; Male; Middle Aged; Piracetam; Triazines; Valproic Acid | 2016 |
Evaluation of apoptotic cell death on liver and kidney tissues following administration of levetiracetam during prenatal period.
Topics: Animals; Animals, Newborn; Anticonvulsants; Apoptosis; Chi-Square Distribution; DNA Nucleotidylexotransferase; Epilepsy; Female; In Situ Nick-End Labeling; Kidney; Levetiracetam; Liver; Piracetam; Pregnancy; Pregnancy Complications; Random Allocation; Rats; Rats, Sprague-Dawley | 2017 |
[(11)C]UCB-A, a novel PET tracer for synaptic vesicle protein 2A.
Topics: Animals; Brain; Carbon Radioisotopes; Levetiracetam; Male; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam; Positron-Emission Tomography; Rats; Swine; Tissue Distribution | 2016 |
Release of levetiracetam from extended-release tablets that appear intact in patient stool.
Topics: Anticonvulsants; Delayed-Action Preparations; Feces; Humans; Levetiracetam; Piracetam; Tablets | 2016 |
Spritam--a new formulation of levetiracetam for epilepsy.
Topics: Administration, Oral; Anticonvulsants; Brain; Brain Waves; Drug Administration Schedule; Drug Compounding; Epilepsy; Humans; Levetiracetam; Piracetam; Tablets; Treatment Outcome | 2016 |
Levetiracetam Prophylaxis for Post-traumatic Brain Injury Seizures is Ineffective: A Propensity Score Analysis.
Topics: Adolescent; Adult; Anticonvulsants; Brain Injuries, Traumatic; Chemoprevention; Databases, Factual; Female; Humans; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Propensity Score; Retrospective Studies; Seizures; Treatment Failure; Young Adult | 2016 |
Effect of low-frequency repetitive transcranial magnetic stimulation on sleep pattern and quality of life in patients with focal epilepsy.
Topics: Adult; Anticonvulsants; Electroencephalography; Epilepsies, Partial; Humans; Levetiracetam; Male; Piracetam; Polysomnography; Quality of Life; Sleep Stages; Surveys and Questionnaires; Transcranial Magnetic Stimulation | 2016 |
Use of Levetiracetam in Prophylaxis of Early Post-Traumatic Seizures.
Topics: Anticonvulsants; Epilepsy, Post-Traumatic; Humans; Levetiracetam; Outcome Assessment, Health Care; Phenytoin; Piracetam; Retrospective Studies | 2016 |
Osteochondral alteration in a child treated with levetiracetam: a rare case of juvenile osteochondritis dissecans of the talar head.
Topics: Analgesics; Anticonvulsants; Braces; Child; Conservative Treatment; Female; Humans; Levetiracetam; Magnetic Resonance Imaging; Osteochondritis Dissecans; Pediatrics; Piracetam; Range of Motion, Articular; Talus; Weight-Bearing | 2017 |
Chronic treatment with levetiracetam reverses deficits in hippocampal LTP in vivo in experimental temporal lobe epilepsy rats.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Epilepsy, Temporal Lobe; Hippocampus; Levetiracetam; Long-Term Potentiation; Male; Maze Learning; Muscarinic Agonists; Neuroprotective Agents; Pilocarpine; Piracetam; Rats; Rats, Sprague-Dawley; Spatial Memory | 2016 |
Effect of the antiepileptic therapy on olfactory disorders associated with mesial temporal sclerosis.
Topics: Anticonvulsants; Electroencephalography; Evoked Potentials; Female; Hippocampus; Humans; Levetiracetam; Magnetic Resonance Imaging; Middle Aged; Olfaction Disorders; Piracetam; Sclerosis; Temporal Lobe | 2016 |
The Effects of Levetiracetam on Cerebrospinal Fluid and Plasma NPY and GAL, and on the Components of Stress Response System, hs-CRP, and S100B Protein in Serum of Patients with Refractory Epilepsy.
Topics: Adolescent; Adult; Aryldialkylphosphatase; C-Reactive Protein; Enzyme-Linked Immunosorbent Assay; Epilepsy; Female; Galanin; Humans; Levetiracetam; Lipoproteins, LDL; Male; Middle Aged; Neuropeptide Y; Piracetam; Quality of Life; Radioimmunoassay; S100 Calcium Binding Protein beta Subunit; Young Adult | 2015 |
Patterns of antiepileptic drugs use in epileptic pediatric patients in Jordan.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cross-Sectional Studies; Drug Therapy, Combination; Epilepsy; Female; Fructose; Humans; Jordan; Levetiracetam; Male; Phenobarbital; Piracetam; Practice Patterns, Physicians'; Topiramate; Valproic Acid | 2016 |
Similarity of symptoms between transient epileptic amnesia and Lewy body disease.
Topics: 3-Iodobenzylguanidine; Aged; Amnesia; Anticonvulsants; Cognition Disorders; Electroencephalography; Female; Hallucinations; Humans; Levetiracetam; Lewy Body Disease; Myocardial Perfusion Imaging; Parkinsonian Disorders; Piracetam; Seizures; Tomography, Emission-Computed, Single-Photon | 2017 |
HyperCKemia induced by levetiracetam.
Topics: Adult; Anticonvulsants; Creatine Kinase; Humans; Levetiracetam; Male; Piracetam | 2016 |
The clinical efficacy and safety of levetiracetam add-on therapy for child refractory epilepsy.
Topics: Anticonvulsants; Child; Epilepsy; Humans; Levetiracetam; Piracetam; Treatment Outcome | 2016 |
Guideline conform initial monotherapy increases in patients with focal epilepsy: A population-based study on German health insurance data.
Topics: Anticonvulsants; Epilepsies, Partial; Female; Germany; Guidelines as Topic; Humans; Levetiracetam; Male; National Health Programs; Piracetam; Retrospective Studies | 2016 |
Comparative study of antiepileptic drug use during pregnancy over a period of 12 years in Spain. Efficacy of the newer antiepileptic drugs lamotrigine, levetiracetam, and oxcarbazepine.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Lamotrigine; Levetiracetam; Longitudinal Studies; Oxcarbazepine; Piracetam; Pregnancy; Seizures; Spain; Triazines | 2018 |
Charles Bonnet syndrome successfully treated with levetiracetam.
Topics: Aged; Brain; Female; Humans; Levetiracetam; Perceptual Disorders; Piracetam; Psychotropic Drugs; Syndrome | 2016 |
Effects of levetiracetam monotherapy on sperm parameters and sex hormones: Data from newly diagnosed patients with epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Epilepsy; Gonadal Steroid Hormones; Humans; Levetiracetam; Male; Piracetam; Sperm Count; Statistics as Topic; Testis; Ultrasonography, Doppler; Young Adult | 2016 |
Continuous electroencephalography in pediatric traumatic brain injury: Seizure characteristics and outcomes.
Topics: Adolescent; Brain; Brain Injuries, Traumatic; Child; Child, Preschool; Electroencephalography; Epilepsies, Partial; Female; Glasgow Outcome Scale; Humans; Infant; Infant, Newborn; Levetiracetam; Longitudinal Studies; Male; Piracetam; Prognosis; Prospective Studies; Seizures; Sleep | 2016 |
Methotrexate Elimination When Coadministered With Levetiracetam.
Topics: Adult; Anticonvulsants; Antimetabolites, Antineoplastic; Drug Interactions; Female; Humans; Levetiracetam; Logistic Models; Male; Metabolic Clearance Rate; Methotrexate; Middle Aged; Piracetam; Proportional Hazards Models; Retrospective Studies; Risk Factors | 2016 |
Serial Monitoring of Plasma Levetiracetam Levels in a Child With Epilepsy Undergoing Cord Blood Transplantation.
Topics: Adrenoleukodystrophy; Anticonvulsants; Child; Cord Blood Stem Cell Transplantation; Epilepsy; Glomerular Filtration Rate; Humans; Levetiracetam; Male; Monitoring, Physiologic; Piracetam | 2016 |
Resting-state fMRI revealed different brain activities responding to valproic acid and levetiracetam in benign epilepsy with central-temporal spikes.
Topics: Anticonvulsants; Brain; Child; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; Female; Frontal Lobe; Humans; Image Interpretation, Computer-Assisted; Levetiracetam; Magnetic Resonance Imaging; Male; Piracetam; Temporal Lobe; Thalamus; Valproic Acid | 2017 |
Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Study.
Topics: Adult; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Anticonvulsants; Cyclophosphamide; Fatal Outcome; Female; Headache; Humans; Immunologic Factors; Immunosuppressive Agents; Levetiracetam; Ovarian Neoplasms; Piracetam; Rituximab; Seizures | 2016 |
Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate.
Topics: Adult; Anticonvulsants; Child; Cognition Disorders; Cross-Sectional Studies; Epilepsy; Female; Follow-Up Studies; Fructose; Humans; Levetiracetam; Male; Piracetam; Pregnancy; Prenatal Exposure Delayed Effects; Topiramate; Valproic Acid; Young Adult | 2016 |
Intractable Seizures and Rehabilitation in Ciguatera Poisoning.
Topics: Adolescent; Animals; Anticonvulsants; Ciguatera Poisoning; Gait Disorders, Neurologic; Humans; Levetiracetam; Male; Neuropsychological Tests; Physical Therapy Modalities; Piracetam; Seizures | 2017 |
Epilepsy in Qatar: Causes, treatment, and outcome.
Topics: Adult; Anticonvulsants; Diagnosis, Differential; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Neurocysticercosis; Piracetam; Qatar; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
An effective and economical method for the storage of plasma samples using a novel freeze-drying device.
Topics: Chromatography, High Pressure Liquid; Freeze Drying; Levetiracetam; Piracetam; Plasma; Quality Control; Reproducibility of Results; Specimen Handling; Tandem Mass Spectrometry | 2016 |
Approved drugs are to be studied for use in Alzheimer's disease.
Topics: Alzheimer Disease; Drug Approval; Drug Repositioning; Humans; Levetiracetam; Nootropic Agents; Piracetam; Tadalafil; Vasodilator Agents | 2016 |
Sensitive inexpensive HPLC determination of four antiepileptic drugs in human plasma: application to PK studies.
Topics: Anticonvulsants; Blood Chemical Analysis; Calibration; Carbamazepine; Chromatography, High Pressure Liquid; Half-Life; Humans; Lamotrigine; Levetiracetam; Limit of Detection; Oxcarbazepine; Piracetam; Triazines | 2016 |
Levetiracetam treatment influences blood-brain barrier failure associated with angiogenesis and inflammatory responses in the acute phase of epileptogenesis in post-status epilepticus mice.
Topics: Acute Disease; Animals; Anticonvulsants; Astrocytes; Blood-Brain Barrier; Brain Edema; Capillary Permeability; Cytokines; Disease Models, Animal; Endothelial Cells; Gliosis; Hippocampus; Levetiracetam; Male; Mice, Inbred ICR; Microglia; Neovascularization, Pathologic; Piracetam; Status Epilepticus | 2016 |
An Unusual Side Effect Of A Commonly Used Antiepileptic Drug.
Topics: Agranulocytosis; Anticonvulsants; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Fever; Humans; Levetiracetam; Male; Piracetam | 2016 |
Physicochemical stability and compatibility testing of levetiracetam in all-in-one parenteral nutrition admixtures in daily practice.
Topics: Anticonvulsants; Chemical Phenomena; Drug Stability; Drug Storage; Fat Emulsions, Intravenous; Humans; Levetiracetam; Parenteral Nutrition; Piracetam | 2017 |
Efficacy and tolerability of levetiracetam for pediatric refractory epilepsy.
Topics: Administration, Oral; Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Resistant Epilepsy; Drug Therapy, Combination; Drug Tolerance; Epilepsy; Female; Humans; Levetiracetam; Male; Piracetam; Retrospective Studies; Treatment Outcome | 2017 |
Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Disorders of Excessive Somnolence; Drug Resistant Epilepsy; Female; Humans; Irritable Mood; Levetiracetam; Male; Middle Aged; Obsessive Behavior; Oxcarbazepine; Piracetam; Psychoses, Substance-Induced; Retrospective Studies; Young Adult | 2016 |
Efficacy and tolerability of anti-epileptic drugs-an internet study.
Topics: Adult; Anticonvulsants; Carbamazepine; Depression; Epilepsy; Female; Humans; Internet; Lamotrigine; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Seizures; Self Report; Treatment Outcome; Triazines; United Kingdom; Valproic Acid | 2017 |
Serious and reversible levetiracetam-induced psychiatric symptoms after resection of frontal low-grade glioma: two case histories.
Topics: Anticonvulsants; Brain Neoplasms; Craniotomy; Epilepsy; Frontal Lobe; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Mental Disorders; Middle Aged; Oligodendroglioma; Piracetam; Postoperative Complications; Valproic Acid | 2017 |
A New SV2A Ligand for Epilepsy.
Topics: Animals; Anticonvulsants; Binding Sites; Epilepsies, Partial; Epilepsy, Generalized; Humans; Levetiracetam; Ligands; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam; Protein Binding; Protein Conformation; Pyrrolidinones | 2016 |
Cytisine inhibits the protective activity of various classical and novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice.
Topics: Alkaloids; Animals; Anticonvulsants; Azocines; Dose-Response Relationship, Drug; Electroshock; Levetiracetam; Male; Memory, Long-Term; Mice; Nicotinic Agonists; Phenobarbital; Piracetam; Quinolizines; Seizures; Valproic Acid | 2017 |
Sprue-Like Enteropathy Associated With Oxcarbazepine.
Topics: Adult; Anticonvulsants; Carbamazepine; Celiac Disease; Diagnosis, Differential; Drug Substitution; Duodenal Diseases; Epilepsies, Partial; Humans; Levetiracetam; Male; Oxcarbazepine; Piracetam | 2016 |
Changing antiepileptic drug use for seizures in US neonatal intensive care units from 2005 to 2014.
Topics: Anticonvulsants; Child; Drug Utilization; Female; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Levetiracetam; Male; Phenobarbital; Phenytoin; Piracetam; Retrospective Studies; Seizures; Texas | 2017 |
Effect of lamotrigine, levetiracetam & topiramate on neurobehavioural parameters & oxidative stress in comparison with valproate in rats.
Topics: Animals; Brain; Fructose; Glutathione; Lamotrigine; Learning; Levetiracetam; Male; Malondialdehyde; Memory; Oxidative Stress; Piracetam; Rats; Superoxide Dismutase; Topiramate; Triazines; Valproic Acid | 2016 |
Marked EEG worsening following Levetiracetam overdose: How a pharmacological issue can confound coma prognosis.
Topics: Adult; Anticonvulsants; Coma; Drug Overdose; Electroencephalography; Female; Heart Arrest; Humans; Hypoxia; Levetiracetam; Piracetam | 2017 |
Dexamethasone and levetiracetam reduce hetero-cellular gap-junctional coupling between F98 glioma cells and glial cells in vitro.
Topics: Animals; Antineoplastic Agents; Astrocytes; Cell Communication; Cell Line, Tumor; Connexin 43; Connexins; Dexamethasone; Gap Junction beta-1 Protein; Gap Junction delta-2 Protein; Gap Junctions; Glioma; In Vitro Techniques; Levetiracetam; Microglia; Neuroglia; Piracetam; Rats; Tumor Cells, Cultured | 2017 |
The risk of hypotension and seizures in patients receiving prophylactic anti-epileptic drugs for supratentorial craniotomy.
Topics: Acetamides; Adult; Anticonvulsants; Blood Pressure; Craniotomy; Female; Humans; Hypotension; Lacosamide; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Pre-Exposure Prophylaxis; Retrospective Studies; Seizures; Supratentorial Neoplasms | 2018 |
Evolving use of seizure medications after intracerebral hemorrhage: A multicenter study.
Topics: Adult; Aged; Anticonvulsants; Cerebral Hemorrhage; Cohort Studies; Craniotomy; Electronic Health Records; Female; Humans; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Seizures | 2017 |
Extracorporeal Clearance of Levetiracetam During Continuous Venovenous Hemofiltration in a Critically Ill Patient and New Dosing Recommendation.
Topics: Aged; Anticonvulsants; Critical Illness; Dose-Response Relationship, Drug; Extracorporeal Circulation; Hemofiltration; Humans; Levetiracetam; Male; Metabolic Clearance Rate; Piracetam | 2017 |
Levetiracetam for the Treatment of Seizures in Neonatal Hypoxic Ischemic Encephalopathy.
Topics: Adult; Anticonvulsants; Female; Follow-Up Studies; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Levetiracetam; Male; Phenobarbital; Piracetam; Retrospective Studies; Seizures; Treatment Outcome | 2017 |
Successful treatment of paroxysmal ataxia and dysarthria in multiple sclerosis with levetiracetam.
Topics: Adult; Anticonvulsants; Brain; Dysarthria; Female; Humans; Levetiracetam; Magnetic Resonance Imaging; Multiple Sclerosis, Relapsing-Remitting; Piracetam; Video Recording | 2016 |
Pancytopenia associated with levetiracetam in an epileptic woman.
Topics: Aged; Anticonvulsants; Epilepsy; Female; Humans; Leukocyte Count; Levetiracetam; Pancytopenia; Piracetam | 2016 |
Regression of a glioblastoma multiforme: spontaneous versus a potential antineoplastic effect of dexamethasone and levetiracetam.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cognition Disorders; Dacarbazine; Dexamethasone; Glioblastoma; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Regression, Spontaneous; Neoplasms, Second Primary; Piracetam; Temozolomide | 2016 |
Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein.
Topics: Anilides; Anticonvulsants; Brain; Dose-Response Relationship, Drug; Drug Interactions; HEK293 Cells; Humans; Levetiracetam; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam; Protein Binding; Pyrrolidinones; Radioligand Assay; Time Factors; Transfection; Tritium | 2017 |
Antiepileptic drugs: Impacts on human serum paraoxonase-1.
Topics: Amines; Anticonvulsants; Aryldialkylphosphatase; Cyclohexanecarboxylic Acids; Enzyme Inhibitors; Gabapentin; gamma-Aminobutyric Acid; Humans; Kinetics; Levetiracetam; Phenytoin; Piracetam; Primidone; Turkey; Valproic Acid | 2017 |
Acute liver injury induced by levetiracetam and temozolomide co-treatment.
Topics: Adult; Aged; Anticonvulsants; Antineoplastic Agents, Alkylating; Brain Neoplasms; Case-Control Studies; Chemical and Drug Induced Liver Injury; Dacarbazine; Drug Therapy, Combination; Female; Humans; Israel; Levetiracetam; Liver Function Tests; Male; Middle Aged; Multivariate Analysis; Piracetam; Regression Analysis; Retrospective Studies; Temozolomide | 2017 |
Rhabdomyolysis associated with levetiracetam administration.
Topics: Adult; Anticonvulsants; Humans; Levetiracetam; Male; Piracetam; Rhabdomyolysis | 2017 |
Different response to antiepileptic drugs according to the type of epileptic events in a neonatal ischemia-reperfusion model.
Topics: Animals; Animals, Newborn; Anticonvulsants; Brain; Brain Ischemia; Disease Models, Animal; Epilepsy; Female; Levetiracetam; Lithium Compounds; Male; Phenobarbital; Pilocarpine; Piracetam; Random Allocation; Rats, Wistar; Reperfusion Injury; Stroke | 2017 |
Adjuvant quercetin therapy for combined treatment of epilepsy and comorbid depression.
Topics: Animals; Anticonvulsants; Behavior, Animal; Brain; Combined Modality Therapy; Convulsants; Depression; Depressive Disorder; Disease Models, Animal; Epilepsy; Levetiracetam; Male; Mice; Pentylenetetrazole; Piracetam; Quercetin | 2017 |
Disseminated eruptive granuloma annulare induced by levetiracetam.
Topics: Anticonvulsants; Female; Granuloma Annulare; Humans; Levetiracetam; Middle Aged; Piracetam; Skin | 2017 |
Heightened cortical excitability in aged rodents with memory impairment.
Topics: Animals; CA3 Region, Hippocampal; Cerebral Cortex; Cognition; Disease Models, Animal; Levetiracetam; Male; Memory; Memory Disorders; Piracetam; Proto-Oncogene Proteins c-fos; Rats, Long-Evans | 2017 |
The clinical and neurobehavioral course of Down syndrome and dementia with or without new-onset epilepsy.
Topics: Adult; Anticonvulsants; Dementia; Disease Progression; Down Syndrome; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Myoclonus; Piracetam | 2017 |
Is levetiracetam neuroprotective in neonatal rats with hypoxic ischemic brain injury?
Topics: Animals; Animals, Newborn; Apoptosis; Brain; Brain Injuries; Disease Models, Animal; Dose-Response Relationship, Drug; Hypoxia-Ischemia, Brain; In Situ Nick-End Labeling; Injections, Intraperitoneal; Levetiracetam; Male; Neuroprotective Agents; Piracetam; Rats; Rats, Sprague-Dawley; Rats, Wistar | 2016 |
Acute generalized exanthematous pustulosis secondary to levetiracetam and valproic acid use.
Topics: Acute Generalized Exanthematous Pustulosis; Aged; Anticonvulsants; Female; Humans; Levetiracetam; Piracetam; Treatment Outcome; Valproic Acid | 2017 |
Preserving brain function in a comatose patient with septic hyperpyrexia (41.6 °C): a case report.
Topics: Adult; Amantadine; Anticonvulsants; Brain; Brain Injuries; Cognition Disorders; Coma; Dopamine Agents; Drug Therapy, Combination; Glutamic Acid; Humans; Levetiracetam; Male; Malignant Hyperthermia; Piracetam; Tomography, X-Ray Computed | 2017 |
Levetiracetam-induced thrombocytopenia in a patient with status epilepticus.
Topics: Aged; Anticonvulsants; Female; Humans; Levetiracetam; Piracetam; Status Epilepticus; Thrombocytopenia | 2017 |
Interaction of Approved Drugs with Synaptic Vesicle Protein 2A.
Topics: Animals; Anticonvulsants; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Humans; Levetiracetam; Ligands; Loratadine; Membrane Glycoproteins; Molecular Structure; Nerve Tissue Proteins; Piracetam; Pyrrolidinones; Quinine; Structure-Activity Relationship | 2017 |
Levetiracetam-induced eosinophilic pneumonia.
Topics: Female; Humans; Levetiracetam; Middle Aged; Piracetam; Prednisolone; Pulmonary Eosinophilia; Treatment Outcome | 2017 |
Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Body Weight; Dose-Response Relationship, Drug; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Seizures; Treatment Outcome; Young Adult | 2017 |
The effect of newer antiepileptic drugs in combination therapy.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Cross-Sectional Studies; Drug Therapy, Combination; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Oxcarbazepine; Piracetam; Retrospective Studies; Seizures; Treatment Outcome | 2017 |
Levetiracetam Induced Increase in Creatine Phosphokinase Levels.
Topics: Adult; Anticonvulsants; Creatine Kinase; Humans; Levetiracetam; Male; Piracetam; Seizures | 2017 |
Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study.
Topics: Aged; Anticonvulsants; Brain Neoplasms; Cohort Studies; Electroencephalography; Epilepsy; Female; Humans; Levetiracetam; Male; Mental Disorders; Middle Aged; Piracetam; Psychiatric Status Rating Scales; ROC Curve | 2017 |
Unfavorable effect of levetiracetam on cultured hippocampal neurons after hyperthermic injury.
Topics: Animals; Anticonvulsants; Apoptosis; Cell Death; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Fever; Hippocampus; L-Lactate Dehydrogenase; Levetiracetam; Necrosis; Neurons; Neuroprotective Agents; Piracetam; Rats; Rats, Sprague-Dawley | 2017 |
Levetiracetam and topiramate poisoning: Two overdoses on those drugs with no lasting effects.
Topics: Anticonvulsants; Antidotes; Charcoal; Drug Overdose; Female; Fructose; Humans; Levetiracetam; Piracetam; Topiramate; Young Adult | 2017 |
Prophylactic Anticonvulsants in Intracerebral Hemorrhage.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Cerebral Hemorrhage; Drug Prescriptions; Female; Guideline Adherence; Humans; Levetiracetam; Male; Middle Aged; Outcome Assessment, Health Care; Piracetam; Prevalence; Retrospective Studies; Seizures | 2017 |
Lacosamide Lowers Valproate and Levetiracetam Levels.
Topics: Acetamides; Adolescent; Anticonvulsants; Brain Neoplasms; Drug Interactions; Epilepsies, Partial; Humans; Lacosamide; Levetiracetam; Neoplasms, Neuroepithelial; Piracetam; Seizures; Valproic Acid | 2017 |
Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model.
Topics: Amines; Analgesics; Animals; Anticonvulsants; Antioxidants; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Levetiracetam; Male; Mice; Mice, Inbred C57BL; Piracetam; Pregabalin | 2017 |
Early Lance-Adams syndrome after cardiac arrest: Prevalence, time to return to awareness, and outcome in a large cohort.
Topics: Adult; Aged, 80 and over; Anticonvulsants; Cardiopulmonary Resuscitation; Clonazepam; Drug Combinations; Electroencephalography; Female; Heart Arrest; Humans; Intensive Care Units; Levetiracetam; Male; Middle Aged; Myoclonus; Piracetam; Prospective Studies; Registries; Seizures; Syndrome; Time Factors; Valproic Acid | 2017 |
Transient epileptic amnesia without epileptic seizures: proposal of a new entity.
Topics: Amnesia; Anticonvulsants; Electroencephalography; Epilepsy; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Seizures; Treatment Outcome | 2017 |
Real-life experience with brivaracetam in 101 patients with difficult-to-treat epilepsy-A monocenter survey.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Drug Substitution; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Pyrrolidinones; Treatment Failure; Treatment Outcome; Young Adult | 2017 |
Secondary paroxysmal dyskinesia in multiple sclerosis: Clinical-radiological features and treatment. Case report of seven patients.
Topics: Acetazolamide; Adult; Anticonvulsants; Cerebellum; Clonazepam; Dyskinesias; Dystonia; Female; Follow-Up Studies; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Piracetam; Tegmentum Mesencephali; Thalamus; Treatment Outcome | 2017 |
Reproductive toxicity after levetiracetam administration in male rats: Evidence for role of hormonal status and oxidative stress.
Topics: Animals; Anticonvulsants; DNA Damage; Epilepsy; Follicle Stimulating Hormone; Levetiracetam; Luteinizing Hormone; Male; Oxidative Stress; Piracetam; Rats; Rats, Wistar; Reproduction; Sperm Count; Sperm Motility; Spermatozoa; Testis; Testosterone | 2017 |
Seizures in Pediatric Patients With Liver Transplant and Efficacy of Levetiracetam.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Electroencephalography; Female; Humans; Infant; Levetiracetam; Liver Diseases; Liver Transplantation; Magnetic Resonance Imaging; Male; Piracetam; Risk Factors; Seizures | 2017 |
Levetiracetam Pharmacokinetics in a Patient with Intracranial Hemorrhage Undergoing Continuous Veno-Venous Hemofiltration.
Topics: Aged; Anticonvulsants; Hemofiltration; Humans; Intracranial Hemorrhages; Levetiracetam; Male; Piracetam; Seizures | 2017 |
Combination therapy of levetiracetam and gabapentin against nonconvulsive seizures induced by penetrating traumatic brain injury.
Topics: Amines; Animals; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroencephalography; Gabapentin; gamma-Aminobutyric Acid; Head Injuries, Penetrating; Levetiracetam; Male; Piracetam; Rats; Rats, Sprague-Dawley; Seizures | 2017 |
The efficacy of different kinds of intravenously applied antiepileptic drugs in the treatment of status epilepticus. How can it be determined?
Topics: Acetamides; Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anticonvulsants; Female; Health Behavior; Humans; Lacosamide; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Retrospective Studies; Status Epilepticus; Treatment Outcome; Valproic Acid | 2017 |
Sensitive inexpensive spectrophotometric and spectrofluorimetric analysis of ezogabine, levetiracetam and topiramate in tablet formulations using Hantzsch condensation reaction.
Topics: Carbamates; Drug Combinations; Drug Stability; Formaldehyde; Fructose; Hydrogen-Ion Concentration; Levetiracetam; Limit of Detection; Linear Models; Pentanones; Phenylenediamines; Piracetam; Reproducibility of Results; Spectrometry, Fluorescence; Tablets; Topiramate | 2017 |
Comparison of Plasma, Saliva, and Hair Levetiracetam Concentrations.
Topics: Adolescent; Adult; Anticonvulsants; Chromatography, Liquid; Drug Monitoring; Epilepsy; Female; Hair; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Plasma; Saliva; Tandem Mass Spectrometry; Young Adult | 2017 |
Spatial recognition test: A novel cognition task for assessing topographical memory in mice.
Topics: Alzheimer Disease; Animals; Cognition; Disease Models, Animal; Donepezil; Indans; Levetiracetam; Male; Maze Learning; Memantine; Memory; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nootropic Agents; Piperidines; Piracetam; Recognition, Psychology | 2017 |
Psychiatric side effects and antiepileptic drugs: Observations from prospective audits.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Dibenzazepines; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Fructose; Humans; Lacosamide; Levetiracetam; Male; Medical Audit; Mental Disorders; Middle Aged; Nitriles; Piracetam; Pregabalin; Prospective Studies; Pyridones; Retrospective Studies; Seizures; Sodium Channel Blockers; Topiramate; Young Adult | 2017 |
Haemodialysis significantly reduces serum levetiracetam levels inducing epileptic seizures: Case report.
Topics: Adult; Anticonvulsants; Epilepsy; Female; Humans; Levetiracetam; Piracetam; Renal Dialysis; Seizures | 2017 |
Fatigue during treatment with antiepileptic drugs: A levetiracetam-specific adverse event?
Topics: Adult; Anticonvulsants; Epilepsy; Fatigue; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam | 2017 |
The influence of levetiracetam on psychosocial and behavioral functioning in children: A case-control and follow-up study.
Topics: Adolescent; Anticonvulsants; Case-Control Studies; Child; Child Behavior; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Piracetam; Valproic Acid | 2017 |
Comparison of Levetiracetam Dosing Regimens in End-Stage Renal Disease Patients Undergoing Intermittent Hemodialysis.
Topics: Adult; Aged; Anticonvulsants; Clinical Protocols; Drug Administration Schedule; Female; Humans; Kidney Failure, Chronic; Levetiracetam; Male; Middle Aged; Piracetam; Renal Dialysis; Seizures | 2017 |
Impact of generic substitution on levetiracetam serum concentration-A prospective study in an outpatient setting.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Cohort Studies; Dose-Response Relationship, Drug; Drug Substitution; Drugs, Generic; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Outpatients; Piracetam; Time Factors; Treatment Outcome; Young Adult | 2017 |
Low risk of seizures with slow flumazenil infusion and routine anticonvulsant prophylaxis for high-dose benzodiazepine dependence.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anticonvulsants; Antidotes; Benzodiazepines; Female; Flumazenil; Humans; Hypnotics and Sedatives; Levetiracetam; Male; Middle Aged; Piracetam; Quality of Life; Seizures; Substance-Related Disorders; Valproic Acid; Young Adult | 2017 |
Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Topics: Acetamides; Adult; Affect; Aged; Anticonvulsants; Brain Neoplasms; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy; Female; Historically Controlled Study; Humans; Lacosamide; Levetiracetam; Male; Middle Aged; Outcome Assessment, Health Care; Piracetam; Prospective Studies; Quality of Life | 2017 |
An unusual case of
Topics: Abdominal Pain; Acute Kidney Injury; Aged; Anti-Bacterial Agents; Anticonvulsants; Critical Care; Enterocolitis, Pseudomembranous; Escherichia coli Infections; Escherichia coli O157; Gastrointestinal Hemorrhage; Hemolytic-Uremic Syndrome; Humans; Levetiracetam; Male; Piracetam; Renal Replacement Therapy; Sigmoidoscopy; Treatment Outcome; Valproic Acid | 2017 |
Treatment with levetiracetam improves cognition in a ketamine rat model of schizophrenia.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Ketamine; Levetiracetam; Locomotion; Male; Maze Learning; Memory Disorders; Nootropic Agents; Piracetam; Rats; Rats, Long-Evans; Schizophrenia | 2018 |
Herpes simplex encephalitis presenting as stroke-like symptoms with atypical MRI findings and lacking cerebrospinal fluid pleocytosis.
Topics: Acyclovir; Aged; Antiviral Agents; Biomarkers; Brain; Clonazepam; DNA, Viral; Drug Therapy, Combination; Encephalitis, Herpes Simplex; Female; Humans; Leukocytosis; Levetiracetam; Magnetic Resonance Imaging; Methylprednisolone; Neuroimaging; Piracetam; Simplexvirus; Stroke | 2017 |
Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus.
Topics: Administration, Intravenous; Administration, Oral; Anticonvulsants; Blood Pressure; Databases, Factual; Diazepam; Drug Substitution; Emergency Medical Services; Female; Hospitals, General; Humans; Japan; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Recurrence; Retrospective Studies; Seizures; Status Epilepticus; Treatment Outcome | 2017 |
Risk of angioedema associated with levetiracetam compared with phenytoin: Findings of the observational health data sciences and informatics research network.
Topics: Angioedema; Community Networks; Databases, Factual; Epilepsy; Female; Humans; Levetiracetam; Male; Phenytoin; Piracetam | 2017 |
Lamotrigine Drug Interactions in Combination Therapy and the Influence of Therapeutic Drug Monitoring on Clinical Outcomes of Adult Patients.
Topics: Adult; Anticonvulsants; Carbamazepine; Clonazepam; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Fructose; Humans; Lamotrigine; Levetiracetam; Male; Phenytoin; Piracetam; Seizures; Topiramate; Triazines; Valproic Acid | 2017 |
Transient lesions of the splenium of the corpus callosum following rapid withdrawal of levetiracetam.
Topics: Adolescent; Anticonvulsants; Corpus Callosum; Female; Humans; Levetiracetam; Magnetic Resonance Imaging; Piracetam; Substance Withdrawal Syndrome | 2017 |
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy.
Topics: Adult; Animals; Anticonvulsants; Benzodiazepines; Carbamazepine; Clobazam; Disease Models, Animal; Drug Resistant Epilepsy; Drug Therapy, Combination; Electroencephalography; Epilepsy, Frontal Lobe; Female; Fenofibrate; Humans; Lamotrigine; Levetiracetam; Male; Mice; Mice, Transgenic; Middle Aged; Mutation; Oxcarbazepine; Piracetam; Polysomnography; PPAR alpha; Receptors, Nicotinic; Triazines; Valproic Acid; Young Adult | 2017 |
Chronic levetiracetam decreases hippocampal and testicular aromatase expression in normal but not kainic acid-induced experimental model of acute seizures in rats.
Topics: Animals; Aromatase; Cerebral Cortex; Epididymis; Hippocampus; Kainic Acid; Levetiracetam; Male; Nerve Tissue Proteins; Oxidoreductases Acting on CH-CH Group Donors; Piracetam; Rats, Wistar; Seizures; Testis; Time Factors; Vas Deferens | 2017 |
Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Brain Neoplasms; Epilepsy; Female; Humans; Italy; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Treatment Outcome; Young Adult | 2017 |
Safety of switching from brand-name to generic levetiracetam in patients with epilepsy.
Topics: Adult; Anticonvulsants; Epilepsy; Female; Humans; Levetiracetam; Male; Piracetam; Retrospective Studies | 2017 |
Effect of sleep patterns on levetiracetam induced mood changes.
Topics: Adult; Analysis of Variance; Anticonvulsants; Anxiety Disorders; Circadian Rhythm; Depressive Disorder; Epilepsy; Female; Humans; Incidence; Levetiracetam; Male; Middle Aged; Mood Disorders; Piracetam; Retrospective Studies; Sleep; Surveys and Questionnaires; Young Adult | 2017 |
Treatment with lacosamide impedes generalized seizures in a rodent model of cortical dysplasia.
Topics: Acetamides; Animals; Anticonvulsants; Electroencephalography; Female; GABA Antagonists; Lacosamide; Levetiracetam; Malformations of Cortical Development; Pentylenetetrazole; Piracetam; Pregnancy; Prenatal Exposure Delayed Effects; Radiation Exposure; Rats; Rats, Sprague-Dawley; Seizures | 2017 |
Conformational Preference and Spectroscopical Characteristics of the Active Pharmaceutical Ingredient Levetiracetam.
Topics: Entropy; Hydrogen Bonding; Levetiracetam; Models, Molecular; Molecular Conformation; Molecular Structure; Pharmaceutical Preparations; Piracetam; Quantum Theory; Spectrum Analysis; Water | 2017 |
Levetiracetam monotherapy for treatment of structural epilepsy in dogs: 19 cases (2010-2015).
Topics: Animals; Anticonvulsants; Dog Diseases; Dogs; Epilepsy; Follow-Up Studies; Levetiracetam; Piracetam; Retrospective Studies; Seizures; Treatment Outcome | 2017 |
Effects of arachidonyl-2'-chloroethylamide (ACEA) on the protective action of various antiepileptic drugs in the 6-Hz corneal stimulation model in mice.
Topics: Acetamides; Animals; Anticonvulsants; Arachidonic Acids; Avoidance Learning; Benzodiazepines; Clobazam; Cornea; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Electroshock; Epilepsy, Complex Partial; Lacosamide; Levetiracetam; Male; Mice; Muscle Strength; Nipecotic Acids; Phenobarbital; Phenylmethylsulfonyl Fluoride; Piracetam; Psychomotor Performance; Receptor, Cannabinoid, CB1; Tiagabine; Valproic Acid | 2017 |
Suspected Phenobarbital-Induced Pseudolymphoma in a Dog.
Topics: Animals; Anticonvulsants; Dog Diseases; Dogs; Epilepsy; Levetiracetam; Male; Phenobarbital; Piracetam; Pseudolymphoma | 2017 |
Levetiracetam+nonsteroidal anti-inflammatory drug binary systems: A contribution to the development of new solid dosage forms.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Drug Combinations; Drug Liberation; Flurbiprofen; Ibuprofen; Ketoprofen; Levetiracetam; Naproxen; Piracetam; Stereoisomerism | 2017 |
Levetiracetam improves symptoms of multiple chemical sensitivity: Case report.
Topics: Adult; Female; Humans; Levetiracetam; Multiple Chemical Sensitivity; Nitric Oxide; Piracetam; Receptors, N-Methyl-D-Aspartate | 2017 |
Antiepileptic drug-related neuropsychiatric adverse events in brain tumor-related epilepsy: levetiracetam front and center.
Topics: Anticonvulsants; Brain Neoplasms; Epilepsy; Humans; Levetiracetam; Piracetam | 2017 |
Unilateral Thalamic Infarct Presenting as a Convulsive Seizure.
Topics: Aspirin; Atorvastatin; Cerebral Angiography; Cerebral Infarction; Humans; Hydrocephalus; Levetiracetam; Magnetic Resonance Angiography; Male; Middle Aged; Piracetam; Seizures; Thalamus | 2017 |
Autistic Regression: Should it Prompt Urgent EEG?
Topics: Anticonvulsants; Autism Spectrum Disorder; Early Diagnosis; Electroencephalography; Humans; Infant; Levetiracetam; Methylprednisolone; Piracetam; Seizures; Speech Therapy; Time-to-Treatment | 2017 |
The antiepileptic drug levetiracetam promotes neuroblast differentiation and expression of superoxide dismutase in the mouse hippocampal dentate gyrus via PI3K/Akt signalling.
Topics: Animals; Anticonvulsants; Cell Differentiation; Dentate Gyrus; Levetiracetam; Male; Mice, Inbred ICR; Neural Stem Cells; Phosphatidylinositol 3-Kinases; Piracetam; Proto-Oncogene Proteins c-akt; Signal Transduction; Superoxide Dismutase | 2018 |
Effects of the Antiepileptic Drugs Phenytoin, Gabapentin, and Levetiracetam on Bone Strength, Bone Mass, and Bone Turnover in Rats.
Topics: Administration, Oral; Amines; Animals; Anticonvulsants; Bone Density; Bone Remodeling; Bone Resorption; Cancellous Bone; Cyclohexanecarboxylic Acids; Epilepsy; Femur; Fractures, Bone; Gabapentin; gamma-Aminobutyric Acid; Humans; Levetiracetam; Male; Osteoclasts; Phenytoin; Piracetam; Rats; Rats, Sprague-Dawley; Tibia; Tomography, X-Ray Computed | 2017 |
Pharmacokinetics of Single Oral Dose Extended-Release Levetiracetam in Healthy Cats.
Topics: Administration, Oral; Animals; Anticonvulsants; Cats; Delayed-Action Preparations; Half-Life; Immunoassay; Levetiracetam; Piracetam | 2018 |
Carbamazepine, lamotrigine, levetiracetam and valproic acid in dried blood spots with liquid chromatography tandem mass spectrometry; method development and validation.
Topics: Carbamazepine; Chromatography, Liquid; Dried Blood Spot Testing; Female; Humans; Lamotrigine; Levetiracetam; Linear Models; Male; Piracetam; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Triazines; Valproic Acid | 2018 |
A Favorable Response to Levetiracetam in a Patient with Metastatic Adenoid Cystic Carcinoma.
Topics: Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Cisplatin; Deoxycytidine; Epilepsy; Gemcitabine; Humans; Levetiracetam; Lung Neoplasms; Male; Middle Aged; Piracetam; Tomography, X-Ray Computed | 2018 |
Early Seizure Prophylaxis in Traumatic Brain Injuries Revisited: A Prospective Observational Study.
Topics: Adult; Anticonvulsants; Brain Injuries, Traumatic; Female; Humans; Incidence; Levetiracetam; Male; Middle Aged; Piracetam; Prospective Studies; Seizures | 2018 |
Authors' response to letter on "levetiracetam in toxic seizures".
Topics: Humans; Levetiracetam; Piracetam; Seizures | 2018 |
Letter in response to "Levetiracetam in toxic seizures".
Topics: Humans; Levetiracetam; Piracetam; Seizures | 2018 |
Absence Seizures as a Feature of Juvenile Myoclonic Epilepsy in Rhodesian Ridgeback Dogs.
Topics: Animals; Anticonvulsants; Dog Diseases; Dogs; Electroencephalography; Epilepsies, Myoclonic; Female; GTP Phosphohydrolases; Levetiracetam; Mutation; Photic Stimulation; Piracetam; Seizures; Tumor Suppressor Proteins | 2018 |
Influence of Comedication on Levetiracetam Pharmacokinetics.
Topics: Adult; Anticonvulsants; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Enzyme Induction; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Young Adult | 2018 |
Intermittent catatonia and complex automatisms caused by frontal lobe epilepsy in dementia.
Topics: Aged, 80 and over; Anticonvulsants; Automatism; Catatonia; Dementia; Diagnosis, Differential; Electroencephalography; Epilepsy, Frontal Lobe; Humans; Levetiracetam; Lorazepam; Magnetic Resonance Imaging; Male; Piracetam | 2017 |
Population pharmacokinetics of levetiracetam in neonates with seizures.
Topics: Anticonvulsants; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Levetiracetam; Male; Models, Biological; Piracetam; Prospective Studies; Seizures; Tissue Distribution | 2018 |
Continuous subcutaneous levetiracetam in end-of-life care.
Topics: Aged, 80 and over; Anticonvulsants; Dementia, Vascular; Disease Progression; Female; Humans; Infusions, Subcutaneous; Levetiracetam; Piracetam; Quality of Life; Seizures; Terminal Care; Treatment Outcome | 2018 |
Potent and selective pharmacodynamic synergy between the metabotropic glutamate receptor subtype 2-positive allosteric modulator JNJ-46356479 and levetiracetam in the mouse 6-Hz (44-mA) model.
Topics: Allosteric Regulation; Animals; Anticonvulsants; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Agonists; Levetiracetam; Male; Mice; Piracetam; Receptors, Metabotropic Glutamate; Seizures | 2018 |
Population pharmacokinetic model of levetiracetam in Korean neonates with seizures
.
Topics: Age Factors; Anticonvulsants; Drug Dosage Calculations; Drug Monitoring; Female; Hospitals, Pediatric; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Levetiracetam; Male; Metabolic Clearance Rate; Models, Biological; Piracetam; Republic of Korea; Retrospective Studies; Seizures | 2018 |
A serious adverse event secondary to rapid intravenous levetiracetam injection in a dog.
Topics: Animals; Anticonvulsants; Dog Diseases; Dogs; Drug Administration Schedule; Epinephrine; Fatal Outcome; Female; Levetiracetam; Piracetam; Sympathomimetics | 2018 |
Safety of antiepileptic drugs in children and young people: A prospective cohort study.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Chi-Square Distribution; Child; Child, Preschool; Cohort Studies; Epilepsy; Female; Humans; Levetiracetam; Male; Piracetam; Surveys and Questionnaires; Valproic Acid | 2018 |
The effect of levetiracetam on rat bone mineral density, bone structure and biochemical markers of bone metabolism.
Topics: Animals; Biomarkers; Biomechanical Phenomena; Body Weight; Bone Density; Femur; Levetiracetam; Lumbar Vertebrae; Male; Organ Size; Piracetam; Rats; Rats, Wistar | 2018 |
Levetiracetam monotherapy for the treatment of infants with epilepsy.
Topics: Anticonvulsants; Child, Preschool; Electroencephalography; Epilepsy; Female; Humans; Infant; Infant, Newborn; Levetiracetam; Male; Piracetam; Retrospective Studies; Treatment Outcome | 2018 |
Treatment outcomes after the introduction of a new seizure management protocol.
Topics: Adult; Anticonvulsants; Clinical Protocols; Drug-Related Side Effects and Adverse Reactions; Emergency Service, Hospital; Female; Humans; Levetiracetam; Male; Middle Aged; Phenobarbital; Phenytoin; Piracetam; Retrospective Studies; Status Epilepticus; Treatment Outcome; Valproic Acid | 2018 |
Antinociceptive and pronociceptive effect of levetiracetam in tonic pain model.
Topics: Analgesics; Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Levetiracetam; Male; Nociception; Pain; Pain Measurement; Piracetam; Rats; Rats, Wistar | 2018 |
Levetiracetam mitigates lipopolysaccharide-induced JAK2/STAT3 and TLR4/MAPK signaling pathways activation in a rat model of adjuvant- induced arthritis.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cathepsin K; Cytokines; Female; Freund's Adjuvant; Humans; Immunologic Factors; Janus Kinase 2; Levetiracetam; Lipopolysaccharides; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Phosphorylation; Piracetam; Rats; STAT3 Transcription Factor; Synovial Membrane; Toll-Like Receptor 4 | 2018 |
A Cross-Sectional Study to Assess the Modulation of Wnt Inhibitors following Anti-Epileptic Drug Therapy and their Correlation with Vitamin D and Receptor Activator of Nuclear Factor κ B Ligand in Indian Women with Epilepsy.
Topics: Adaptor Proteins, Signal Transducing; Adult; Anticonvulsants; Bone Morphogenetic Proteins; Carbamazepine; Case-Control Studies; Cross-Sectional Studies; Epilepsy; Female; Genetic Markers; Humans; India; Intercellular Signaling Peptides and Proteins; Levetiracetam; Piracetam; RANK Ligand; Valproic Acid; Vitamin D; Wnt Signaling Pathway; Young Adult | 2018 |
Benign rolandic epilepsy and generalized paroxysms: A study of 13 patients.
Topics: Anticonvulsants; Brain; Child; Child, Preschool; Electroencephalography; Epilepsy, Rolandic; Female; Humans; Levetiracetam; Male; Piracetam; Retrospective Studies; Seizures; Valproic Acid | 2018 |
Dantrolene for Treatment of Suspected Neuroleptic Malignant Syndrome.
Topics: Analgesics, Opioid; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Dantrolene; Diagnosis, Differential; Fentanyl; Haloperidol; Humans; Levetiracetam; Male; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Phenytoin; Piracetam | 2018 |
Development and full validation of an innovative HPLC-diode array detection technique to simultaneously quantify lacosamide, levetiracetam and zonisamide in human plasma.
Topics: Acetamides; Anticonvulsants; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Isoxazoles; Lacosamide; Levetiracetam; Piracetam; Zonisamide | 2018 |
[A nationwide multi-center questionnaire survey on the management and treatment of post-stroke seizure and epilepsy in Japan].
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Japan; Levetiracetam; Male; Piracetam; Seizures; Stroke; Surveys and Questionnaires; Valproic Acid | 2018 |
Rapid antiepileptic drug withdrawal may obscure localizing information obtained during presurgical EEG recordings.
Topics: Acetamides; Anticonvulsants; Brain; Electroencephalography; Epilepsy; Humans; Lacosamide; Levetiracetam; Male; Piracetam; Preoperative Period; Seizures; Young Adult | 2018 |
Determination of plasma Levetiracetam level by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS) and its application in pharmacokinetics studies in neonates.
Topics: Chromatography, Liquid; Drug Stability; Female; Humans; Infant, Newborn; Levetiracetam; Linear Models; Male; Piracetam; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2018 |
Development and validation of a HPLC-UV assay for quantification of levetiracetam concentrations in critically ill patients undergoing continuous renal replacement therapy.
Topics: Chromatography, High Pressure Liquid; Critical Illness; Drug Stability; Humans; Levetiracetam; Linear Models; Piracetam; Renal Replacement Therapy; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2018 |
Occipital epilepsy versus progressive myoclonic epilepsy in a patient with continuous occipital spikes and photosensitivity in electroencephalogram: A case report.
Topics: Anticonvulsants; Atrophy; Cerebral Cortex; Diagnosis, Differential; Disease Progression; Electroencephalography; Epilepsies, Partial; Female; Humans; Levetiracetam; Magnetic Resonance Imaging; Membrane Proteins; Mental Status and Dementia Tests; Mutation; Myoclonic Epilepsies, Progressive; Neuronal Ceroid-Lipofuscinoses; Occipital Lobe; Photosensitivity Disorders; Piracetam; Valproic Acid; Young Adult | 2018 |
Serum levetiracetam concentrations and adverse events after multiple dose extended release levetiracetam administration to healthy cats.
Topics: Animals; Anticonvulsants; Cats; Delayed-Action Preparations; Drug Administration Schedule; Levetiracetam; Piracetam | 2018 |
Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: A population-based case-control study.
Topics: Aged; Amines; Anticonvulsants; Carbamazepine; Case-Control Studies; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Hospitalization; Humans; Hyponatremia; Lamotrigine; Levetiracetam; Logistic Models; Male; Multivariate Analysis; Odds Ratio; Oxcarbazepine; Piracetam; Registries; Retrospective Studies; Time Factors; Triazines | 2018 |
Superior Sagittal Sinus Thrombosis Related to the Use of Tamoxifen: A Case Report and Review of Literature.
Topics: Anticoagulants; Anticonvulsants; Antineoplastic Agents, Hormonal; Blood Coagulation; Blood Coagulation Tests; Breast Neoplasms; Female; Humans; Levetiracetam; Magnetic Resonance Angiography; Middle Aged; Phlebography; Piracetam; Sagittal Sinus Thrombosis; Superior Sagittal Sinus; Tamoxifen; Treatment Outcome; Warfarin | 2016 |
Intermittent oral levetiracetam reduced recurrence of febrile seizure accompanied with epileptiform discharge: a pilot study.
Topics: Administration, Oral; Ambulatory Care; Anticonvulsants; Child, Preschool; Cohort Studies; Comorbidity; Dose-Response Relationship, Drug; Drug Administration Schedule; Electroencephalography; Epilepsy; Female; Humans; Infant; Levetiracetam; Male; Pilot Projects; Piracetam; Prognosis; Recurrence; Retrospective Studies; Seizures, Febrile; Severity of Illness Index; Treatment Outcome | 2018 |
Influenza B-related meningoencephalitis in adults.
Topics: Aged, 80 and over; Antiviral Agents; Betainfluenzavirus; Confusion; Humans; Influenza, Human; Levetiracetam; Male; Meningoencephalitis; Nasopharynx; Piracetam; Seizures; Treatment Outcome; Valproic Acid | 2018 |
Brand name to generic substitution of levetiracetam in patients with epilepsy.
Topics: Adult; Anticonvulsants; Drug Substitution; Drugs, Generic; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Seizures; Treatment Outcome; Young Adult | 2018 |
Adult-onset epileptic aphasia.
Topics: Aged; Anticonvulsants; Aphasia; Cerebral Cortex; Electroencephalography; Epilepsy; Female; Humans; Levetiracetam; Magnetic Resonance Angiography; Piracetam | 2018 |
First Molecular Diagnosis of a Patient with Unverricht-Lundborg Disease in Korea.
Topics: Adult; Anticonvulsants; Blotting, Southern; Cystatin B; Female; Genetic Predisposition to Disease; Humans; Isoxazoles; Levetiracetam; Piracetam; Republic of Korea; Seizures; Treatment Outcome; Unverricht-Lundborg Syndrome; Valproic Acid; Zonisamide | 2018 |
A case of posterior reversible encephalopathy syndrome associated with sepsis.
Topics: Anticonvulsants; Antihypertensive Agents; Brain; Diabetic Ketoacidosis; Humans; Hypertension; Levetiracetam; Magnetic Resonance Imaging; Male; Nicardipine; Piracetam; Posterior Leukoencephalopathy Syndrome; Sepsis; Tomography, X-Ray Computed; Young Adult | 2018 |
Experience with levetiracetam to epilepsy cases in neurodevelopmental disorders.
Topics: Adult; Anticonvulsants; Drug Combinations; Epilepsy; Female; Humans; Levetiracetam; Male; Neurodevelopmental Disorders; Piracetam | 2016 |
Levetiracetam and lamotrigine effects as mono- and polytherapy on bone mineral density in epileptic patients.
Topics: Adolescent; Adult; Amino Acids; Anticonvulsants; Biomarkers; Bone Density; Bone Remodeling; Case-Control Studies; Drug Therapy, Combination; Epilepsy; Female; Humans; Lamotrigine; Levetiracetam; Male; Osteocalcin; Piracetam; Triazines; Valproic Acid; Young Adult | 2018 |
Tolerability, efficacy and retention rate of Brivaracetam in patients previously treated with Levetiracetam: A monocenter retrospective outcome analysis.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Epilepsy; Female; Follow-Up Studies; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Pyrrolidinones; Retrospective Studies; Treatment Outcome; Young Adult | 2018 |
Inflammasome-derived cytokine IL18 suppresses amyloid-induced seizures in Alzheimer-prone mice.
Topics: Alzheimer Disease; Amyloid; Animals; Inflammasomes; Interleukin-18; Interleukin-1beta; Levetiracetam; Mice; Mice, Knockout; NLR Family, Pyrin Domain-Containing 3 Protein; Piracetam; Seizures; Synaptic Transmission | 2018 |
[A case of anti-myelin oligodendrocyte glycoprotein (MOG) and anti-N-methyl-D-aspartate (NMDA) receptor antibody-positive encephalitis with optic neuritis].
Topics: Adult; Autoantibodies; Biomarkers; Brain; Encephalitis; Female; Hemofiltration; Humans; Immunoglobulins, Intravenous; Levetiracetam; Magnetic Resonance Imaging; Methylprednisolone; Myelin-Oligodendrocyte Glycoprotein; Neuroimaging; Optic Neuritis; Piracetam; Pulse Therapy, Drug; Receptors, N-Methyl-D-Aspartate; Treatment Outcome; Young Adult | 2018 |
Vitamin D status in children with epilepsy treated with levetiracetam monotherapy.
Topics: Child; Epilepsy; Humans; Levetiracetam; Piracetam; Valproic Acid; Vitamin D; Vitamin D Deficiency | 2018 |
Levetiracetam-induced a new seizure type in a girl with a novel SV2A gene mutation.
Topics: Anticonvulsants; Brain; Child, Preschool; Female; Humans; Levetiracetam; Membrane Glycoproteins; Mutation; Nerve Tissue Proteins; Piracetam; Seizures | 2019 |
Etiology of neonatal seizures and maintenance therapy use: a 10-year retrospective study at Toulouse Children's hospital.
Topics: Anticonvulsants; Carbamazepine; Clonazepam; Cohort Studies; Databases, Factual; Dose-Response Relationship, Drug; Drug Administration Schedule; Electroencephalography; Epilepsy; Female; France; Hospitals, Pediatric; Hospitals, University; Humans; Infant, Newborn; Levetiracetam; Magnetic Resonance Imaging; Male; Phenobarbital; Piracetam; Prognosis; Retrospective Studies; Risk Assessment; Severity of Illness Index; Survival Rate; Term Birth; Time Factors; Treatment Outcome; Valproic Acid | 2019 |
Levetiracetam in Neonatal seizures.
Topics: Epilepsy; Humans; Infant, Newborn; Levetiracetam; Phenobarbital; Piracetam; Seizures | 2019 |
Population Pharmacokinetics and Dosing Recommendations of Levetiracetam in Adult and Elderly Patients With Epilepsy.
Topics: Adult; Aged; Anticonvulsants; Epilepsy; Humans; Levetiracetam; Models, Biological; Piracetam; Prospective Studies | 2020 |
Effects of perampanel on secondary bilateral synchrony and behavioral problems in adolescents with epilepsy showing insufficient response with levetiracetam.
Topics: Adolescent; Anticonvulsants; Epilepsy; Humans; Infant; Levetiracetam; Nitriles; Piracetam; Problem Behavior; Pyridones; Treatment Outcome | 2020 |
Trends of anti-seizure medication use in pediatric patients in six cities in China from 2013 to 2018.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; China; Epilepsy; Female; Humans; Infant; Lamotrigine; Levetiracetam; Male; Oxcarbazepine; Piracetam; Seizures; Valproic Acid | 2020 |
High-Dose Levetiracetam for Neonatal Seizures: A Retrospective Review.
Topics: Aged; Anticonvulsants; Humans; Infant, Newborn; Levetiracetam; Piracetam; Prospective Studies; Retrospective Studies; Seizures | 2020 |
Hypothalamic-pituitary-testicular axis derangement following chronic phenytoin-levetiracetam adjunctive treatment in male Wistar rats.
Topics: Animals; Anticonvulsants; Levetiracetam; Male; Phenytoin; Piracetam; Rats; Rats, Wistar; Testis | 2020 |
Behavioral alterations associated with levetiracetam in pediatric epilepsy.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Epilepsy; Female; Humans; Levetiracetam; Male; Piracetam; Prospective Studies; Quality of Life | 2020 |
Levetiracetam as first-line monotherapy for Idiopathic Generalized Epilepsy in women.
Topics: Adolescent; Adult; Anticonvulsants; Epilepsy, Generalized; Female; Follow-Up Studies; Humans; Levetiracetam; Piracetam; Retrospective Studies; Treatment Outcome; Valproic Acid; Young Adult | 2021 |
Levetiracetam monotherapy in children with epilepsy: Experience from a tertiary pediatric neurology center.
Topics: Adult; Anticonvulsants; Child; Cohort Studies; Epilepsy; Female; Humans; Levetiracetam; Male; Neurology; Piracetam; Retrospective Studies; Treatment Outcome | 2021 |
Differences in levetiracetam and perampanel treatment-related irritability in patients with epilepsy.
Topics: Anticonvulsants; Epilepsy; Humans; Japan; Levetiracetam; Nitriles; Piracetam; Pyridones; Retrospective Studies | 2021 |
Levetiracetam, perampanel, and the issue of aggression: A self-report study.
Topics: Aggression; Anticonvulsants; Humans; Levetiracetam; Nitriles; Piracetam; Pyridones; Self Report | 2021 |
Long-term safety, efficacy, and tolerability of levetiracetam in pediatric patients with epilepsy in Uygur, China: A retrospective analysis.
Topics: Anticonvulsants; Child; Child, Preschool; China; Epilepsy; Humans; Levetiracetam; Piracetam; Retrospective Studies; Treatment Outcome | 2021 |
Blood concentration of levetiracetam after bolus administration in patients with status epilepticus.
Topics: Anticonvulsants; Diazepam; Humans; Levetiracetam; Piracetam; Seizures; Status Epilepticus | 2021 |
Comparison of efficacy and safety of levetiracetam and phenobarbitone in neonatal seizure.
Topics: Anticonvulsants; Epilepsy; Humans; Infant, Newborn; Levetiracetam; Phenobarbital; Piracetam; Seizures | 2022 |
Evaluation of Time to Administration, Benzodiazepine Use, and Safety of Intravenous Push Levetiracetam in a Neuro-Spine Intensive Care Unit.
Topics: Adult; Anticonvulsants; Benzodiazepines; Humans; Infusions, Intravenous; Intensive Care Units; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies | 2021 |
Rapid administration of undiluted intravenous levetiracetam.
Topics: Adult; Anticonvulsants; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Humans; Levetiracetam; Piracetam; Seizures; Status Epilepticus; Treatment Outcome | 2021 |
The impairment of motor coordination following chronic carbamazepine-levetiracetam combination treatment with evidence of corticocerebellar toxicity in male Wistar rats.
Topics: Animals; Anticonvulsants; Ataxia; Carbamazepine; Cerebellar Ataxia; Cerebellum; Drug Therapy, Combination; Levetiracetam; Male; Motor Activity; Piracetam; Rats; Rats, Wistar | 2021 |
Seizure Deterioration with Increased Levetiracetam Blood Concentration during the Postpartum Period in Refractory Temporal Lobe Epilepsy.
Topics: Adult; Anticonvulsants; Epilepsy, Temporal Lobe; Female; Humans; Levetiracetam; Piracetam; Postpartum Period; Pregnancy; Seizures; Treatment Outcome | 2022 |
Successful Treatment of Symptomatic Epilepsy with Oral Valproic Acid and Levetiracetam in a Patient with Short-bowel Syndrome.
Topics: Aged; Anticonvulsants; Epilepsy; Humans; Levetiracetam; Male; Piracetam; Valproic Acid | 2022 |
Effect of valproate and add-on levetiracetam on inflammatory biomarkers in children with epilepsy.
Topics: Anticonvulsants; Biomarkers; Child; Epilepsy; Humans; Levetiracetam; Neuroinflammatory Diseases; Piracetam; Prospective Studies; Quality of Life; Valproic Acid | 2021 |
Observations Regarding Recently Published Amelioration of Levetiracetam-Induced Behavioral Side Effects by Pyridoxine.
Topics: Anticonvulsants; Drug-Related Side Effects and Adverse Reactions; Humans; Levetiracetam; Piracetam; Pyridoxine | 2022 |
Effect of antiepileptic drug levetiracetam on cochlear function.
Topics: Animals; Anticonvulsants; Epilepsy, Reflex; Levetiracetam; Piracetam; Rats; Synaptic Vesicles | 2022 |
Efficacy of levetiracetam in STXBP1 encephalopathy with different phenotypic and genetic spectra.
Topics: Anticonvulsants; Brain Diseases; Humans; Levetiracetam; Munc18 Proteins; Phenotype; Piracetam | 2022 |
Efficacy of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Female; Humans; Infant; Infusions, Intravenous; Levetiracetam; Male; Phenytoin; Piracetam; Retrospective Studies; Seizures; Status Epilepticus | 2022 |
Effect of levetiracetam on nocturnal sleep in patients with epilepsy.
Topics: Anticonvulsants; Epilepsy; Humans; Levetiracetam; Piracetam; Sleep | 2022 |
Relationship between bone density and levetiracetam monotherapy in epilepsy patients.
Topics: Adolescent; Adult; Anticonvulsants; Bone Density; Cross-Sectional Studies; Epilepsy; Female; Humans; Levetiracetam; Male; Osteoporosis; Piracetam; Treatment Outcome; Young Adult | 2022 |
Evaluation of levetiracetam for early post-traumatic seizure prophylaxis: A level II trauma center experience.
Topics: Adult; Aged; Anticonvulsants; Epilepsy, Post-Traumatic; Female; Humans; Levetiracetam; Male; Middle Aged; Piracetam; Retrospective Studies; Trauma Centers | 2023 |
Analysis of two mixtures containing racetams in their pharmaceuticals using simple spectrophotometric methodologies.
Topics: Anticonvulsants; Levetiracetam; Piracetam; Powders; Sodium Hydroxide; Vincamine | 2022 |
Effect of Nonadherence on Levetiracetam Pharmacokinetics and Remedial Dose Recommendations Using Monte Carlo Simulations.
Topics: Anticonvulsants; Computer Simulation; Humans; Levetiracetam; Monte Carlo Method; Piracetam; Seizures | 2022 |
Perioperative levetiracetam for seizure prophylaxis in seizure-naive brain tumor patients with focus on neurocognitive functioning.
Topics: Anticonvulsants; Brain Neoplasms; Humans; Levetiracetam; Piracetam; Prospective Studies; Quality of Life; Seizures; Supratentorial Neoplasms | 2022 |
Vitamin B6 decreases the risk of levetiracetam discontinuation in children with epilepsy: A retrospective study.
Topics: Anticonvulsants; Child; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Humans; Levetiracetam; Piracetam; Pyridoxine; Retrospective Studies; Vitamin B 6 | 2022 |
Regulation of Inflammation-Related Genes through
Topics: Animals; Anticonvulsants; Disease Models, Animal; Epilepsy; Inflammation; Levetiracetam; Mice; Pilocarpine; Piracetam; Status Epilepticus | 2022 |
Subcutaneous Levetiracetam and Sodium Valproate Use in Palliative Care Patients.
Topics: Anticonvulsants; Humans; Levetiracetam; Palliative Care; Piracetam; Retrospective Studies; Seizures; Treatment Outcome; Valproic Acid | 2022 |
Irritability and its relationship with psychosocial symptoms and quality of life in adolescents with epilepsy receiving levetiracetam therapy: A case-control study.
Topics: Adolescent; Anticonvulsants; Case-Control Studies; Child; Cross-Sectional Studies; Epilepsy; Humans; Levetiracetam; Piracetam; Quality of Life; Valproic Acid | 2022 |
The differential effect of levetiracetam on memory and anxiety in rats.
Topics: Animals; Anticonvulsants; Anxiety; Levetiracetam; Male; Maze Learning; Piracetam; Rats; Rats, Wistar | 2022 |
Evaluation of Levetiracetam Dosing Strategies for Seizure Prophylaxis Following Traumatic Brain Injury.
Topics: Anticonvulsants; Brain Injuries, Traumatic; Cohort Studies; Humans; Levetiracetam; Piracetam; Retrospective Studies; Seizures | 2023 |
Effectiveness of Antiseizure Medication Duotherapies in Patients With Glioma: A Multicenter Observational Cohort Study.
Topics: Anticonvulsants; Cohort Studies; Glioma; Humans; Levetiracetam; Piracetam; Retrospective Studies; Seizures; Valproic Acid | 2022 |
Association of Levetiracetam Concentration With Seizure Frequency in Pregnant Women With Epilepsy.
Topics: Anticonvulsants; Epilepsy; Female; Humans; Levetiracetam; Piracetam; Pregnancy; Pregnant Women; Retrospective Studies; Seizures; Treatment Outcome | 2023 |
Extensive pharmacokinetic variability of Levetiracetam. ¿Are doctors aware?
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Levetiracetam; Piracetam; Retrospective Studies | 2022 |
Levetiracetam-associated pancytopenia.
Topics: Anticonvulsants; Humans; Levetiracetam; Pancytopenia; Piracetam | 2023 |
Experience of Subcutaneous Levetiracetam in Palliative Care.
Topics: Anticonvulsants; Humans; Levetiracetam; Palliative Care; Piracetam; Seizures; Treatment Outcome | 2023 |
Clinical value of therapeutic drug monitoring for levetiracetam in pediatric patients with epilepsy.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Monitoring; Epilepsy; Humans; Infant; Infant, Newborn; Levetiracetam; Piracetam; Retrospective Studies | 2023 |
Levetiracetam dosing for seizure prophylaxis in neurocritical care patients.
Topics: Adult; Anticonvulsants; Brain Injuries, Traumatic; Female; Humans; Levetiracetam; Male; Middle Aged; Phenytoin; Piracetam; Retrospective Studies; Seizures; Subarachnoid Hemorrhage | 2023 |
Status epilepticus prognosis following levetiracetam administration: Analysis of loading doses.
Topics: Adult; Anticonvulsants; Humans; Levetiracetam; Piracetam; Prognosis; Prospective Studies; Retrospective Studies; Status Epilepticus | 2023 |
Use of Levetiracetam for Post-Traumatic Seizure Prophylaxis in Combat-Related Traumatic Brain Injury.
Topics: Adult; Anticonvulsants; Brain Injuries, Traumatic; Female; Humans; Levetiracetam; Male; Piracetam; Retrospective Studies; Seizures; Wounds, Gunshot | 2023 |
Contingency learning in zebrafish exposed to apomorphine- and levetiracetam.
Topics: Animals; Anticonvulsants; Apomorphine; Epilepsy; Levetiracetam; Piracetam; Zebrafish | 2023 |
Dosage, time, and polytherapy dependent effects of different levetiracetam regimens on cognitive function.
Topics: Anticonvulsants; Cognition; Female; Humans; Levetiracetam; Male; Piracetam; Retrospective Studies; Seizures | 2023 |